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Central nervous system (CNS) myelination is important for proper nervous system 
function in vertebrates. In demyelinating diseases such as multiple sclerosis, 
autoimmune-mediated myelin destruction results in neurological impairment; and 
although remyelination does occur spontaneously, it is poorly understood and 
insufficient in humans. Zebrafish (Danio rerio) are known to harbour tremendous 
regenerative capacity of various CNS tissues; however, there is presently only little 
knowledge of their myelin repair efficiency. An experimental model of myelin injury 
in zebrafish would permit study of the mechanisms involved in successful 
remyelination and could potentially guide the development of novel therapeutic 
agents for mammalian remyelination. This doctoral thesis describes the 
characterisation of the novel myelin protein Claudin k in zebrafish, demonstrates 
the establishment of adult zebrafish as an experimental model for CNS de- and 
remyelination and explores some mechanisms underlying myelin repair. 
A variety of myelin markers have previously been investigated in zebrafish, 
including myelin basic protein and myelin protein zero. However, the use of these is 
limited by either late developmental expression or presence in compact myelin 
only. Claudin k is a novel tight junction protein specific to zebrafish CNS and PNS, 
which can be observed early in development and throughout nervous system 
regeneration. Utilising specific antibodies and a novel transgenic zebrafish line, in 
which the claudin k promoter drives the expression of green fluorescent protein in 
myelinating cells, the studies herein characterise the expression of Claudin k, 
demonstrate the fidelity of the transgenic construct, and investigate the 
relationship of Claudin k with established myelin and CNS inflammation markers. 
Data demonstrate that Claudin k expression closely resembles expression patterns 
of the endogenous gene, and as such provides a key tool for examining CNS 
myelination in zebrafish. 
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For the study of de- and remyelination in the zebrafish, the experiments herein 
describe the use of lysophosphatidylcholine (LPC), a detergent-like myelin toxin, 
which is used widely in rodent models to demyelinate axons. Its application to the 
adult zebrafish optic nerve induced focal demyelinating lesions, critically without 
detectable axonal injury, and permitted the study of time course and efficiency of 
remyelination. Myelin in the lesion area was reduced as detected by both 
immunohistochemistry and electron microscopy at 8 days post lesion (dpl), and 
return of the markers to control levels suggested regeneration by 28 dpl. In addition 
microglial activation was observed along the optic pathway, which also returned to 
levels compared to unlesioned control by 28 dpl. In young zebrafish (aged 4-6 
months), the myelin thickness of remyelinated fibres showed no difference to the 
pre-lesion state, which is different to mammals, where the myelin thickness is 
reduced. However, in old fish (aged 18+ months), remyelinated fibres presented 
with thinner myelin, suggesting that the regenerative capacity of zebrafish declines 
with age.  
While the zebrafish as an experimental system has tremendous benefits, such as 
potential for drug screens using the transparent larvae, capacity for transgenesis 
and live imaging, experimental models in zebrafish potentially bear several 
limitations, in particular their distant relationship to humans. To determine whether 
zebrafish remyelination involves homologous signalling mechanisms to mammals, 
demyelinated zebrafish optic nerves were treated with human recombinant 
Semaphorin 3A, an axonal guidance molecule which is well known to inhibit 
oligodendrocyte precursor cell (OPC) recruitment and remyelination in mammals. 
Results demonstrated fewer oligodendroglial cells at 14 dpl and less myelinated 
fibres at 28 dpl in the optic nerve lesion area compared to control treated animals, 
supporting the hypothesis that zebrafish remyelination may indeed respond to 
human signalling molecules.  
Taken together, the findings in this doctoral thesis suggest that this new 
experimental zebrafish-based model of CNS remyelination can be added to the suite 
of current models to better understand the remyelination process and that some 
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signalling mechanisms observed in mammals around myelination and OPC 
recruitment are likely conserved in the zebrafish. In addition, it could potentially be 
used to discover novel therapeutic targets that promote myelination in injury. 
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CHAPTER 1 – Introduction 
_____________________________________________ 
 
Myelination is critical for neuronal function in mammals and destruction of myelin 
impairs neurological function. In certain chronic neurodegenerative disorders, 
repeated myelin injury eventually leads to failure of remyelination. In contrast to 
human remyelination, zebrafish possess a high regenerative capacity and I 
wondered whether zebrafish would be able to repair their myelin following injury 
and perhaps serve as a model organism to investigate signalling mechanisms 
underlying successful remyelination. In this doctoral thesis, 1) I characterised a 
novel myelin protein in zebrafish, Claudin k, and investigated its expression during 
zebrafish development and regeneration, 2) I developed an adult zebrafish model of 
CNS de- and remyelination and 3) I used this model to determine whether 
remyelination efficiency can be manipulated. In the introduction I will discuss the 
importance of myelin, its relevance for nerve conduction and its pathology in 
human demyelinating disease. I will further describe the experimental platforms 




Myelin was first described in the early 19th century by Rudolf Virchow (Virchow, 
1854), who reported the finding of a white substance around the nerve fibres. It is a 
plasma membrane extension of glial cells – oligodendrocytes in the CNS and 
Schwann cells in the PNS – and is wrapped around the axon of neuronal cells in a 
spiral fashion (Geren and Schmitt, 1954). The myelin around an axon is not a single 
tube, but rather many areas of myelin ensheathment – internodes – are separated 
by non-myelinated nodes of Ranvier, which are important for nerve impulse 
propagation (Figure 1.1). While the myelin composition in the PNS and CNS is 
thought to be somewhat similar, the main difference lies in the myelinating cells 
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and how they myelinate. In the peripheral nervous system, Schwann cells form 
internodes on a one-to-one ratio, meaning that one cell will generate one internode 
only, and hence the cell is closely associated with the axon it myelinates. By 
contrast, oligodendrocytes in the CNS are able to form many internodes on multiple 
axons and are therefore usually located at some distance from the axons they 
myelinate (Figure 1.1). An oligodendrocyte can produce approximately 50x103 µm2 
myelin membrane surface area per day (Pfeiffer et al., 1993) and myelinate up to 40 
axons (discussed in Baumann and Pham-Dinh, 2001). In the human brain, 
myelination begins in midgestation (Inder and Huppi, 2000); at birth only a few 
areas of the brain are myelinated and this process continues until at least 25-30 
years of age.  Histological and magnetic resonance imaging studies in humans have 
showed that the myelinated fibre density in various cortical regions was extremely 
low at birth but continued to grow until well into the third decade (reviewed in 
Baumann and Pham-Dinh, 2001; Miller et al., 2012). It has been suggested that 
oligodendrocytes are the cell type generated last during nervous system 
development (reviewed in Thomas et al., 2000). 
 
 
Figure 1.1: Schwann cell vs. oligodendrocyte myelination. While Schwann cells can only form one 
internode per cell and are therefore located immediately adjacent to the axon, oligodendrocytes are 
able to generate multiple internodes on many different axons through process extension. 
Page | 14  
 
Origin of oligodendrocytes 
During embryogenesis and early postnatal life, oligodendrocytes originate from 
multipotent neural stem cells, which can form neurons, astrocytes and 
oligodendrocytes (McKay, 1997; Rao, 1999). The origin of these oligodendrocyte 
precursors has been widely debated (reviewed in Richardson et al., 2006); early 
studies suggested that oligodendrocyte precursors were formed under the 
influence of sonic hedgehog (Shh) and restricted to ventral regions of the 
ventricular progenitor zone from where they would migrate dorsally and laterally 
(Noll and Miller, 1993; Pringle et al., 1996; Warf et al., 1991). However, recent 
investigations provided evidence of an additional dorsal source of oligodendrocytes 
in the spinal cord, in which the specification of oligodendrocyte precursors is 
independent of Shh but involves BMP and FGF (Cai et al., 2005; Fogarty et al., 2005; 
Vallstedt et al., 2005). NG2+ cells (described in more detail lateron) have also been 
discussed as a source of multipotent neural stem cells capable of forming 
oligodendrocytes during development and in the adult CNS (Richardson et al., 
2011). The initial discovery of the O-2A progenitor cell, which was found throughout 
the mature brain (Dawson et al., 2003), comprised 5% of all cells in the CNS and 
could generate both oligodendrocytes and type-2-astrocytes in vitro (Raff et al., 
1983) gave rise to the possibility that these cells could contribute to the generation 
of oligodendroglial lineage cells in vivo. However, type-2-astrocytes could not be 
identified in vivo and recent studies using an inducible NG2-transgenic mouse line 
showed that there are distinct subtypes of NG2+ cells that either form astrocytes or 
oligodendrocytes, but not both (Zhu et al., 2011). NG2+ cells are therefore thought 
to be a population of slowly cycling progenitor cells in the CNS, which contributes to 
the formation of oligodendroglial lineage cells in the developing and adult brain, 
and may also play an important role for myelin repair after injury (reviewed in Zuo 
and Nishiyama, 2013). 
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Myelin function 
Myelination is a very important process in the nervous system as it is needed for 
fast nerve conduction velocity in mammals. At early stages of evolution, organisms 
possessed only unmyelinated nerve fibres, which would have led to decreased 
conduction velocity and the need of incredibly thick axons as organisms increased in 
size throughout evolution (reviewed in Hartline and Colman, 2007). Myelination 
allowed them to grow while maintaining sufficient nerve conduction velocity by 
only permitting depolarisation at the intersegmental nodes of Ranvier and leading 
to fast, saltatory nerve impulse conduction (from the Latin “saltare” – to jump), 
which was first discovered in the 20th century (Huxley and Stampfli, 1949; Tasaki, 
1939). Most axons in the central nervous system are myelinated for fast conduction, 
with some unmyelinated axons present in the hippocampus and cerebellum 
(Debanne et al., 2011). In the corpus callosum, approximately 80% of axons are 
myelinated; the unmyelinated fibres are mostly of sensory modality and are small 
enough to conduct action potentials at sufficient speed without myelination 
(personal communication Dr. Anna Williams). In unmyelinated axons, voltage 
dependent ion channels are present along the length of the axon, causing the 
electrical impulse or area of depolarisation to slowly travel along the axon. The 
formation of internodes however, leads to clustering of depolarisation machinery to 
the nodes of Ranvier; this allows much faster impulse propagation as the area of 
depolarisation can jump from one node of Ranvier to the next (Ritchie and Rogart, 
1977; Waxman and Ritchie, 1985) (Figure 1.2). The basis of electrical signalling in 
nerve fibres was discovered by Hodgkin and Huxley and is discussed in more detail 
elsewhere (Catterall, 2012; Vandenberg and Waxman, 2012). Briefly, the nodes of 
Ranvier contain voltage-gated Na+-channels, which are normally shut but rapidly 
open if there is a rise in membrane potential above the threshold maximum. This 
allows an inward flow of Na+-ions, and a potentiation of this effect leads to a 
reversal of the membrane polarity upon which the channels rapidly inactivate. Na+-
ions no longer enter the axon and activated voltage-gated paranodal K+-channels 
open to generate an outward flow of K+ in order to restore the membrane 
potential. During repolarisation, the voltage-gated Na+-channels remain inactivated 
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to prevent the action potential from expanding bidirectionally until the membrane 
hyperpolarises.  Active transporters (Na+/K+ ATPases and Na+/Ca2+ exchangers) then 
pump Na+-ions back out of and K+-ions into the axon until the electrochemical 
gradient is back at resting levels. If nerve fibres are demyelinated, these ion voltage-
gated ion channels are no longer clustered around the nodes of Ranvier (England et 
al., 1990), leading to decreased nerve conduction velocity and neurological 
impairment.  Histopathological analysis of tissue from demyelinating MS lesions, 
which contain demyelinated axons, Na+-channels are no longer clustered to allow 
saltatory conduction but rather have been found in a patchy distribution along the 
axons (Black et al., 2007). It is thought that due to this changed distribution in 
demyelinated fibres, an increase of Na+-ions in the axon leads to an axonal 
accumulation of Ca2+-ions through reversal of the Na+/Ca2+ exchanger (Stys et al., 
1991). This causes activation of Ca2+-dependent proteases, such as calpains, which 
degrade cytoskeletal proteins and result in disruption of axonal transport (Hassen et 
al., 2008). Sodium channels therefore present a possible therapeutic target to 
prevent axonal damage in demyelinating disease (reviewed in Smith, 2007). 
Blockage of the Na+-channels with anti-epileptics such as Lamotrigine have shown 
decreased neurodegeneration in mice with experimental autoimmune encephalitis, 
an experimental model of MS (Bechtold et al., 2006). However, a clinical trial 
investigating the effect of Lamotrigine in MS patients with secondary progressive 
disease reported decreasing brain volume and rebound inflammation in patients 
receiving the treatment led to discontinuation of further clinical trials with 
Lamotrigine. Instead other anti-epileptics acting on sodium channels are being 
explored for their value in preventing axonal damage in neuroinflammatory disease, 
for example optic neuritis (http://clinicaltrials.gov, identifier number 
NCT01451593).  
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Figure 1.2: Action potential transmission in myelinated nerve fibres. Voltage-gated Na
+
-channels 
are clustered at the node. Upon rise in membrane potential above the threshold maximum, these 
open, thereby creating an inward flow of Na
+
 and a change in membrane polarity. When the peak of 
the action potential is reached, the Na
+
-channels inactivate and voltage-gated K
+
-channels in the 
paranodes open to allow an outward flow of K
+














 exchangers.  
 
Besides playing an important role in impulse propagation velocity and providing 
structural support, myelin is also important for trophic and metabolic support of the 
axon. It has been suggested that oligodendrocytes produce various trophic factors, 
which can promote neuronal survival (reviewed in Bankston et al., 2013). Neuronal 
cultures have showed increased survival if treated with conditioned medium from 
differentiated oligodendrocytes that contained glial cell line-derived neurotrophic 
factor (GDNF), and appeared to be dependent on phosphoinositide-3 kinase-Akt 
signalling, as a specific inhibitor resulted in poor neuronal survival (Wilkins et al., 
2003). Rat embryonic cortical neurons survived better when co-cultured with 
oligodendrocytes and this was abolished upon treatment with a neutralising 
antibody to insulin-like growth factor 1 (IGF1), suggesting that this is also important 
for the survival of neurons (Wilkins et al., 2001). The brain-derived neurotrophic 
factor (BDNF) has also been associated with functions around neuronal survival 
when it is expressed in glial cells particularly following injury (Dougherty et al., 
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2000). A recent in vivo study provides evidence for the importance of BDNF for axon 
protection, as mice deficient for BDNF in immune cells exhibited a decreased 
immune response, a more severe course of experimental autoimmune 
encephalomyelitis and progressive disability with enhanced axonal loss (Linker et 
al., 2010). Moreover, human embryonic stem cell-derived oligodendrocyte 
progenitor cells have been shown to express neurotrophic factors, which are 
thought to stimulate neurite outgrowth of rat neurons in vitro (Zhang et al., 2006).   
In addition, oligodendrocytes do not just offer support to the axon by secreting pro-
survival trophic factors, but also by providing metabolic support. When the myelin 
sheath is formed, the cytoplasmic channels come to lie within close proximity to the 
axon and it has been suggested that the lactate transporter provides one of the 
main gates through which the metabolic support from glial cells to axon is carried 
out (Lee et al., 2012). Lee et al. showed that the monocarboxylate transporter 1 
(MCT1), which is highly expressed in oligodendrocytes in the white matter and 
serves to supply the axon with energy in form of lactate,  is required for neuronal 
survival in vitro. Heterozygous MCT1-null mice develop an axonopathy in the CNS 
with axonal swelling but critically no change in myelination; upon selective down-
regulation of MCT1 in oligodendrocytes, similar axonopathy was observed. 
Moreover, Fünfschilling and colleagues demonstrated that myelinating 
oligodendrocytes are able to supply axons with energy in the form of lactate in the 
absence of mitochondrial function and full glucose metabolism (Funfschilling et al., 
2012). Cox10 mutant mice lacking the terminal electron transport chain complex in 
oligodendroglial mitochondria (cytochrome c oxidase, COX), which is normally 
required for full glucose metabolism, exhibit no dysmyelination phenotype. Proton 
magnetic resonance spectroscopy showed increased levels of lactate in mutant 
mice white matter during isoflurane anaesthesia with rapid normalisation after 
anaesthesia cessation and suggests that lactate is efficiently metabolised by 
myelinated neurons as an alternative energy source. These results highlight the 
importance of oligodendrocytes not just for saltatory conduction, but also for 
structural and metabolic support of neurons, which may lead to severe axonopathy 
if altered or defective. 
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Oligodendrocyte markers 
For myelination to occur in the central nervous system, oligodendrocytes need to 
be developed from precursor cells and differentiate into mature cells with the 
capacity to myelinate. Throughout their development along the oligodendrocyte 
lineage, mammalian oligodendroglial cells express different markers, with which 
they can be identified (Figure 1.3). Neural precursor cells express nestin, an 
intermediate filament protein related to other neurofilaments, which distinguishes 
them from more differentiated cell types and is also expressed by glial precursors 
such as radial glia (Lendahl et al., 1990). Oligodendrocyte precursor cells also 
express the platelet-derived growth factor alpha (PDGF-α) receptor, the 
polysialated-neural cell adhesion molecule (PSA-NCAM) and the chondroitin 
sulphate proteoglycan NG2 (reviewed in Baumann and Pham-Dinh, 2001). As OPCs 
differentiate and become immature oligodendrocytes with processes but no 
associated myelin sheaths, they can be labelled by antibodies to O4, a surface 
antigen on pre-myelinating oligodendrocytes (Sommer and Schachner, 1981). 
Mature oligodendrocytes actively wrap axons and synthesise structural proteins of 
myelin, hence they can be visualised by markers for myelin such as myelin basic 
protein (MBP), proteolipid protein (PLP), myelin-associated glycoprotein (MAG) or 
myelin oligodendrocyte glycoprotein (MOG) (reviewed in Grinspan, 2002). In 
addition, the transcription factors olig1, olig2 and nkx2.2 are expressed throughout 
all stages of oligodendrocyte maturation, which are induced by sonic hedgehog 
signalling from the notochord and floorplate during development and are important 
for oligodendrocyte specification (Orentas et al., 1999; Pringle et al., 1996). Some 
motor neuron progenitors also express olig2 and it has been demonstrated that the 
fate switch between motor neuron and oligodendrocyte generation is regulated by 
dephosphorylation of Serine 147 in the olig2 domain in mice, chicks and in vitro (Li 
et al., 2011). The transcription factor sox10 is expressed by early oligodendroglial 
cells and it has been demonstrated to play an important role during terminal 
differentiation in mammals (Stolt et al., 2002). More specifically, the basic helix-
loop-transcription factors olig1 and olig2 both bind to sox10 in mice to initiate the 
expression of MBP (Li et al., 2007). In zebrafish, sox10 is only bound by olig1(Li et 
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al., 2007) and has been established as an important factor for survival of 
myelinating oligodendrocytes, as precursor cells in zebrafish lacking sox10 
proliferate, migrate and begin to myelinate but then die (Takada et al., 2010). Once 
precursor cells have committed to the oligodendrocyte lineage, nkx2.2 appears to 
be important for their differentiation to mature oligodendrocytes; studies in nkx2.2 
null mice show severely retarded expression of mature myelin markers such as MBP 
and PLP (Qi et al., 2001). Oligodendrocyte specification and development is 
therefore a tightly regulated system, which shows severe effects if signals are 
slightly altered.    
 
Figure 1.3: Expression of markers of oligodendrocyte lineage cells during various stages of 
oligodendrocyte differentiation. Oligodendrocyte precursor cells express stem cell markers such as 
nestin, but also oligodendrocyte lineage markers like PSA-NCAM, NG2 and PDGFα-receptor. As 
precursor cells mature, they begin to express myelin markers including O4, MBP, MAG and MOG. 
The transcription factors olig1 and olig2 are active early in oligodendrocyte lineage cells, whereas 
Nkx2.2 is only active from a pre-myelinating state and is transiently expressed. Cell schematics are 
not to scale.   
Regulation of myelination  
The process of myelin ensheathment of axons in the peripheral and central nervous 
system has been much studied. It has been established that there is a threshold for 
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myelination, meaning that only axons above a certain diameter will be myelinated. 
In the peripheral nervous system, myelination appears to be regulated by one main 
signalling pathway involving neuregulin-1 signalling through ErbB receptors, which 
allows Schwann cells to myelinate axons with the right myelin thickness (reviewed 
by Birchmeier and Nave, 2008). However the regulation of myelin ensheathment of 
central nervous system axons appears more complex and is currently poorly 
understood; especially which axons are myelinated by a particular oligodendrocyte 
and how the formation of the internodes is achieved remains unclear (reviewed in 
Emery, 2010).  It has been well established that oligodendrocytes in vitro can 
differentiate and express myelin proteins in the absence of axons (Knapp et al., 
1987; Raff et al., 1985). However, in vivo it is not clear whether extend and timing of 
myelination is regulated by intrinsic properties of oligodendrocytes or extracellular 
axonal signals. Time-lapse live imaging of oligodendrocytes in the spinal cord of 
zebrafish show a very dynamic behaviour, with multiple cell process extensions and 
retractions while the cells migrate and finally settle into their final position (Kirby et 
al., 2006). Furthermore Almeida et al. demonstrated that oligodendrocytes in the 
zebrafish spinal cord either myelinate several small calibre axons or associate with 
one axon of large diameter (Mauthner axon), however in the presence of 
supernumerary large diameter Mauthner axons, these oligodendrocytes are able to 
myelinate more than one Mauthner axon or ensheathe Mauthner axons in addition 
to small calibre fibres (Almeida et al., 2011). These observations support the theory 
that oligodendroglial cells are able to recognise their target axons by particular 
cues, which will guide them to establish the axon-glial contact at the right place. 
These signals could be:  
 
a) Cell adhesion molecules PSA-NCAM, integrins, L1 and contactin 
Certain cell adhesion molecules like PSA-NCAM, integrins, L1 and contactin have 
been investigated for their potential role in regulating CNS myelination. The 
abundance of the polysialic acid (PSA) modification of the neuronal cell adhesion 
molecules (NCAM) present on oligodendrocytes in culture is reduced during 
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myelination suggesting a function for PSA in regulating myelination and in vivo 
studies showed that only PSA-NCAM-negative axons were myelinated in the mouse 
optic nerve (Charles et al., 2002). Transgenic mice expressing the polysialtransferase 
ST8SialV driven by the PLP promoter did not exhibit down-regulation of PSA 
synthesis and showed decreased myelination in the forebrains during active 
myelination associated with abnormalities like redundant myelin and axonal 
degeneration (Fewou et al., 2007). However, more detailed studies to confirm the 
role of PSA-NCAM in myelination have not yet been conducted. Other neuron-glial 
signalling mechanisms which may be important for CNS myelination are integrins 
expressed by oligodendrocytes and their interaction with the neuronal laminins. 
The integrin receptor contains eight subunits, which all follow a different expression 
pattern throughout the course of oligodendrocyte development and maturation 
(reviewed in O'Meara et al., 2011). It is thought that in particular beta-1-integrin 
plays an important role in oligodendrocyte proliferation and survival through 
downstream signalling molecules such as phosphoinositide-3 kinase (PI3K) and 
mitogen-activated protein kinase (MAPK). More specifically it has been shown that 
in transgenic mice expressing dominant negative beta-1-integrin in 
oligodendrocytes, axons remain unmyelinated in the spinal cord and optic nerve 
and this is accompanied by altered MAPK activity and fewer oligodendrocytes (Lee 
et al., 2006). In vitro studies also confirm that beta-1-integrin signalling appears to 
be important but not sufficient for oligodendrocyte survival, as beta-1-integrin 
expressing oligodendrocytes survived better when plated on a plate coated with the 
beta- 1-integrin ligand laminin compared to alpha-integrin specific coatings in a 
growth-factor deprived environment, but they did not survive as well as control 
cells in a control medium (Frost et al., 1999).  Beta-1-integrin knockout mice exhibit 
a myelination deficit that appears to be caused by the inability of oligodendrocytes 
to extend their myelin sheath due to failure of Akt activation, an essential kinase for 
axon ensheathment (Barros et al., 2009). These data were confirmed by expressing 
a constitutively active Akt or inhibiting the negative Akt regulator PTEN in beta-1-
integrin deficient oligodendrocytes in vitro, which restored myelin sheath 
outgrowth. Further studies show that beta-1-integrin is in fact able to regulate 
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translation of the myelin protein MBP by binding to the inhibitory mRNA binding 
protein hnRNP-K and reversing its inhibitory effects (Laursen et al., 2011). Integrins 
can also form complexes with the cell adhesion molecule contactin, which is 
expressed in oligodendrocytes and neurons (De Benedictis et al., 2006; Gennarini et 
al., 1989; Ranscht, 1988). Zebrafish studies showed that Contactin is normally only 
detectable during development however is re-expressed in differentiating 
oligodendrocytes in optic nerve and spinal cord following lesioning of these 
structures and suggests a possible role for Contactin in myelinating cells (Schweitzer 
et al., 2007). In vitro studies have further demonstrated the importance of 
Contactin in oligodendrocyte survival, as interaction with the Contactin ligand L1 
promoted myelination in neuron-oligodendroglial co-cultures through the control of 
Fyn phosphorylation (Laursen et al., 2009). L1 is expressed on the neuronal surface 
in vitro (van den Pol and Kim, 1993) and its expression in vivo peaks at the onset of 
myelination (Joosten and Gribnau, 1989).  Studies in murine co-cultures showed 
that L1 expression was down-regulated in axons after they had been myelinated 
and that myelination could be inhibited by a blocking antibody to L1 (Barbin et al., 
2004). However, as L1 knockout mice show no defect in developmental myelination, 
it is not clear what role this cell adhesion molecule plays in regulating CNS 
myelination (Cohen et al., 1998).  
As such, signalling through adhesion molecules such as PSA-NCAM, integrin, 
contactin and L1 is involved in regulating myelin formation in the central nervous 
system; however, there appears to be no sole regulator of CNS myelination.  
  
b) Neuregulin 
In the peripheral nervous system, the signals regulating myelination are clearer; it 
has been demonstrated that the neuronal produced protein neuregulin-1 type 3 is 
able to bind to ErbB2/3 receptors on Schwann cells and by activating several 
downstream signalling pathways including PI3K/Akt, Erk1/2, FAK and Rac/Cdc42 can 
mediate a specific Schwann cell behaviour leading to axonal sorting and myelination 
including regulation of myelin thickness (reviewed in Newbern and Birchmeier, 
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2010). In the central nervous system, neuregulin appears to have no direct effect on 
the behaviour of oligodendrocytes, as mutant mice lacking the oligodendroglial 
ErbB receptors during development myelinate normally (Brinkmann et al., 2008). It 
has also been shown that overactivation of the Akt/mTOR pathway or knockdown 
of PI3K/PTEN in oligodendrocytes leads to increased relative myelin sheath 
thickness (Flores et al., 2008; Harrington et al., 2010); however, this effect of 
neuregulin signalling is not observed after demyelination and may only suggest a 
role in developmental myelination (Brinkmann et al., 2008). In vitro co-culture 
studies demonstrate that absence of neuregulin-1 type 3 in neurons does not affect 
differentiation of oligodendrocytes, but leads to significantly reduced internode 
formation (Taveggia et al., 2008). Furthermore, heterozygous neuregulin-3 type 1 
knockout mice exhibit thinner myelin and fewer myelin wraps in the corpus 
callosum with normal myelin appearance in spinal cord and optic nerve, suggesting 
possible regional differences of neuregulin-3 type-1 effect on myelination. It 
appears therefore that Schwann cell and oligodendrocyte signalling is very different 
and in the central system not exclusively dependent on neuregulin, leaving 
questions regarding the regulation of myelination and remyelination in the CNS.  
 
c) LINGO-1 
The transmembrane protein and nogo-receptor interacting protein LINGO-1 is 
expressed by oligodendrocytes and appears to be a negative regulator of 
myelination, as functional inhibition leads to increased differentiation of 
oligodendrocytes in vitro and an increased proportion of myelinated fibres in Lingo-
1 knockout mice compared to wild-type littermates (Mi et al., 2005). This is thought 
to be mediated through decreased downstream signalling of RhoA GTP and 
increased Fyn phosphorylation, both of which have been associated with effects on 
oligodendrocyte differentiation (Jepson et al., 2012; Liang et al., 2004). Furthermore 
it was found that LINGO-1 is also expressed on neurons and that inhibition of either, 
the oligodendrocyte LINGO-1 or the neuronal one, could promote oligodendrocyte 
differentiation and myelination (Lee et al., 2007). 
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d) Notch 
Another inhibitory signal for oligodendrocyte differentiation and myelination is 
Notch1. During development, the Notch1-receptor is expressed by 
oligodendrocytes and interacts with its ligand Jagged1 on neuronal axons. Jagged1 
expression decreases with a time course that is consistent with increasing 
appearance of myelination markers, and suggests a regulating inhibitory function of 
Notch1-Jagged1 signalling for myelination (Wang et al., 1998). This was confirmed 
by studies reporting Jagged1 expression only in unmyelinated axons during 
development and an increased number of myelinated axons in specific parts of the 
CNS of Notch1-mutant mice compared to wild type mice (Givogri et al., 2002). 
Notch/Jagged signalling therefore appears to be actively involved in the regulation 
of central nervous system myelination during development; however, it is not clear 
whether and how the Notch-receptor interacts with any other ligands, such as 
delta, to affect central nervous system myelination as the Notch-Delta signalling 
pathway has already been reported as important for oligodendrocyte specification 
and differentiation during development in zebrafish (Park and Appel, 2003). 
  
e) Wnt/ß-Catenin 
Similarly, the Wnt pathway appears to play a role in regulating developmental 
myelination, mainly through inhibitory signalling. The conditional activation of ß-
catenin, which is a protein complex acting as an intracellular signal transducer in the 
Wnt pathway, does not impair the embryonic development of oligodendrocytes but 
rather affects their differentiation as fewer numbers of oligodendrocytes expressing 
mature myelin markers (PLP) were observed in the white matter of these transgenic 
mice (Fancy et al., 2009). Consequently, electron microscopic analysis at postnatal 
day 15 (P15) showed hypomyelination and higher G-ratios, a measure of myelin 
thickness in relation to axon diameter, which becomes higher with thinner myelin. 
However by P50 no difference to wild type mice was found. This suggests that Wnt 
signalling does not block oligodendrocyte differentiation but rather delays it. 
Studies using a heat shock-inducible dominant repressor of Wnt-mediated 
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transcription in larval zebrafish also demonstrated reduced levels of myelin basic 
protein, myelin protein zero and proteolipid protein highlighting the importance for 
Wnt signalling in developmental myelination (Tawk et al., 2011). Interestingly, 
Glycogen synthase kinase 3ß (GSK-3ß), which is known to stimulate the nuclear 
translocation of ß-catenin and signals via the Wnt pathway, has been shown to 
stimulate oligodendrocyte precursor proliferation and survival if inhibited, and 
hence seems to override the negative effect of Wnt-signalling (Azim and Butt, 
2011). It seems therefore, that the Wnt/ß-catenin pathway occupies a complex role 
in regulating developmental myelination.  
 
Taken together, it appears that compared to the peripheral nervous system, 
regulation of myelination in the central nervous system is more complex and 
remains poorly understood. No single mechanism responsible for regulating 
developmental myelination in the central nervous system in vivo has been 
described hitherto. However, research over recent years has identified several 
factors that appear to influence oligodendrocyte myelination mainly through 
inhibitory signalling, such as the Notch1/Jagged and Wnt pathways and several cell 
adhesion molecules; and neuronal activity also seems to at least partly drive the 
myelination process (Barres and Raff, 1993). It therefore remains unclear which 
pathways exactly control myelination in the CNS in vivo and if these different 
signalling mechanisms link together.  
 
Myelin sheath formation 
Although the regulation of myelin formation is rather complex, the process itself 
has been well studied (reviewed in Sherman and Brophy, 2005). Once 
oligodendrocytes have determined and established contact with their target axons, 
the myelin membrane begins to wrap around the axon and form the myelin sheath. 
Live in vivo imaging has revealed evidence that the initial contact only occurs 
between the tip of an oligodendrocyte process and a very small part of the axon, 
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and as more myelin layers are formed, the further the internode extends along the 
axon (Sobottka et al., 2011). To generate the myelin sheath, the oligodendrocyte 
must produce vast amounts of myelin proteins and evidence shows that in the case 
of myelin basic protein, the transcribing machinery is not membrane-bound but 
rather allows translation distant from the cell body in the cell processes and close to 
the edge of the growing myelin sheath (Colman et al., 1982). As multiple layers of 
myelin are formed, structural myelin proteins interact between adjacent membrane 
layers, resulting in a compaction of the myelin sheath with formation of major 
dense lines with the exception of areas containing cytoplasmic channels in the 
mesaxon and paranodal loops in the CNS and Schmidt-Lanterman incisures in the 
PNS, which are believed to be important for axonal nourishment (Lee et al., 2012). 
 
Myelin components 
As an extension of the glial cell membrane, myelin is characterised by a high 
proportion (70-85%) of lipids and especially cholesterol has been shown to be 
essential for myelin sheath formation (Saher et al., 2005). The other 15-30% 
comprises of different proteins, which are embedded within the lipid bilayer or 
attached to its surface and play a role in the structure or function of myelin. The 
most abundant proteins are myelin basic protein (MBP) and proteolipid protein 
(PLP), making up about 60-80% of the protein composition. Other myelin proteins in 
the central nervous system include myelin associated glycoprotein (MAG) and 
myelin/oligodendrocyte protein (MOG), with myelin protein zero (P0) and the 
peripheral nerve myelin protein 22 (PMP22) in the peripheral nervous system in 
mammals. Every protein has a specific function within the myelin sheath; these are 
described below and are visually illustrated in Figure 1.4.  
 
a) Proteolipid protein (PLP/DM20) 
PLP is the major constituent of myelin in the central nervous system. It is a 
structural myelin protein with 4 transmembrane domains and exists as two splice 
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variants, the longer PLP isoform (30 kDa) and the shorter DM20 (25 kDa). The jimpy 
mouse mutants, which carry a deletion in the PLP gene, exhibit relatively normal 
myelination and compaction; however, they do exhibit late axonopathy with axonal 
swelling and degeneration, suggesting a possible role of PLP in long-term integrity 
of axons (Griffiths et al., 1998). Human mutations in the PLP gene have been linked 
to Pelizaeus-Merzbacher disease presenting with severe dysmyelination in the 
central nervous system during early infancy. PLP is also produced by Schwann cells 
at low levels, but appears to not be actively integrated into the myelin sheath and 
therefore appears to have no major function in the peripheral nervous system 
myelin (Puckett et al., 1987).  
 
b) Myelin basic protein (MBP) 
This is the second most abundant myelin protein in the central and peripheral 
nervous system, which is required for compact myelin formation, and comprises 
about 30% of the total myelin proteins (Boggs, 2006). MBP is spliced into many 
isoforms ranging from 14-22 kDa; the major isoform in human CNS is 18.5 kDa 
compared to 14 kDa in rodents and recent research suggests that function might 
vary depending on the MBP isoform (Smith et al., 2013). It binds to negatively 
charged lipids on the cytosolic surface of the oligodendrocyte plasma membrane, 
thereby creating a stable interaction between two adjacent lipid bilayers. It is 
thought that MBP initiates myelin compaction and along with P0 stabilises the 
major dense lines as rodent models with mutations or deletions in the MBP gene – 
the shiverer mouse and the Long Evans shaker rat – exhibit strong defects in 
formation of compact myelin with absence of the major dense lines (Carre et al., 
2002; Readhead et al., 1990). In the peripheral nervous system the mutants show a 
more subtle phenotype, presumably due to the cytoplasmic P0 domain, which may 
act as a functional substitute to MBP (Martini et al., 1995). 
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c) Myelin protein zero (P0) 
With a single transmembrane domain, a small cytoplasmic domain and an 
extracellular IgG-like domain, myelin protein zero is a structural protein found in the 
peripheral nervous system (Eichberg, 2002). P0 proteins homophilically bind in trans 
to tightly connect adjacent myelin membrane layers, and thus are an integral part 
of compact myelin. Mouse mutants lacking P0 have shown major deficits in myelin 
compaction with dysmyelination and absence of major dense lines in peripheral 
nerves (Martini et al., 1995), highlighting the importance of the protein for proper 
myelin membrane formation. In mammals, P0 is present in the peripheral nervous 
system myelin only, while zebrafish express P0 in the myelin of the central and 
peripheral nervous system. This is thought to be due to the vertebrate evolution 
and is described in more detail later on. Deletions in the human P0 gene have been 
associated with Charcot-Marie-Tooth disease type 1B (Hayasaka et al., 1993) and a 
wide variety of sub-classified syndromes, all of which share the common 
dysmyelinating pathology in the peripheral nervous system.  
 
d) Peripheral nerve myelin protein 22 (PMP22) 
This tetraspan myelin protein has a size of 22 kDa and is a major constituent in 
compact myelin of the peripheral nervous system. Studies show that PMP22 is able 
to form complexes with P0 in the peripheral nerve myelin, hence it is thought to be 
important for maintaining myelin structure (D'Urso et al., 1999). Dominant point 
mutations leading to duplication of the PMP22 gene result the peripheral 
neuropathy Charcot-Marie-Tooth disease type 1A (Patel et al., 1992; Roa et al., 
1993) and deletions cause hereditary liability to pressure palsy (Nicholson et al., 
1994). PMP22-deficient trembler mice also exhibit a dysmyelinating phenotype with 
delayed myelination onset, production of hypermyelination at young age followed 
by demyelination, axonal loss and functional disability (Adlkofer et al., 1995).  
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e) Myelin associated glycoprotein (MAG) 
Myelin associated glycoprotein is a 100kDa transmembrane myelin protein present 
in the central and peripheral nervous system but only constitutes 1% of the total 
myelin proteins. In the central nervous system MAG only localises to the periaxonal 
cytoplasmic channel (Trapp et al., 1989). The function of MAG has been studied in 
mice deficient of the protein and myelination appears to be mostly normal with the 
exception of the periaxonal cytoplasmic channel, which is impaired in most 
internodes (Li et al., 1994). In MAG-deficient mice, the onset myelination appears to 
be delayed with a reduced number of myelinated axons present in the optic nerve 
of 11 day old MAG-/- mice compared to wild type animals and is often associated 
with the presence of two or more myelin sheaths around one axon (Montag et al., 
1994). MAG-deficient mice also show no abnormalities in their motor coordination 
and spacial learning, a subtle intention tremor has been reported (Li et al., 1994).  
This perhaps suggests a role of MAG in axon-glial contact and maintenance of the 
periaxonal space rather than a critical function during myelin formation (Li et al., 
1998). 
 
f) Myelin/oligodendrocyte glycoprotein (MOG) 
Located on the outermost lamellae of the myelin sheath and on mature 
oligodendrocytes is the myelin/oligodendrocyte glycoprotein (Brunner et al., 1989), 
which is 26-28 kDa in size after glycosylation. MOG is thought to act as a cell 
adhesion molecule that interacts with a ligand to stabilise the compact myelin, 
however this function of MOG is not yet proven and a specific ligand for MOG 
remains to be identified (Johns and Bernard, 1999).  
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Figure 1.4: Major myelin proteins in the central and peripheral nervous system. Close apposition of 
adjacent myelin layers through interactions of myelin proteins with each other and the lipid bilayer 
form the major dense lines in the myelin sheath. The most common myelin proteins are: myelin 
basic protein (MBP), proteolipid protein (PLP), myelin protein zero (P0), peripheral myelin protein 22 
(PMP22), myelin associated glycoprotein (MAG) and myelin/oligodendrocyte protein (MOG). 
Schematic is not to scale.  
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1.2 Multiple sclerosis 
 
Clinical aspects 
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, which was first 
described in the late 19th century. Approximately 2.5 million people are affected 
worldwide (Pugliatti et al., 2002) and 1 in 500 people in Scotland. It is the most 
common cause of non-traumatic disability in young people and despite much 
scientific research effort its cause is still poorly understood. Neurological 
impairment in MS includes impaired visual function, sensory deficits and paresis 
(reviewed in Noseworthy et al., 2000). There is no single identified cause for MS, 
rather a multifactorial aetiology including genetic susceptibility, epigenetic 
regulation and environmental factors has been suggested (Costenbader et al., 
2012). 
The pathological hallmark is white matter lesions in the brain and spinal cord, which 
is thought to be caused by an autoimmune response to self-antigens (reviewed in 
Sriram, 2011; Wu and Alvarez, 2011). It has been proposed that MS shares the 
underlying pathology of autoimmune diseases, which originates from 
immunological molecular mimicry whereby a peptide antigen presented by MHC 
class II antigen presenting cells is indistinguishable from self-antigens within the 
body (for example components of the myelin) and cause T-cells to generate an 
inappropriate immunological response against these peptides (reviewed in Chastain 
and Miller, 2012). As a result, auto-reactive T-cells enter the circulation and induce 
a break-down of the blood-brain barrier through expression of inflammatory 
cytokines and reactive oxygen species, thereby allowing access to the central 
nervous system (reviewed in Larochelle et al., 2011). Other immune cells like 
macrophages can infiltrate the brain parenchyma, creating an irreversible loop of 
pro-inflammatory enhancement, which can, if it persists for extended periods or 
occurs frequently, set up mechanisms leading to axonal degeneration and 
neurological disability  (reviewed in Compston and Coles, 2002). Transient 
gadolinium-enhancing brain lesions in MRI studies and oligoclonal immunoglobulin 
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G bands in the cerebrospinal fluid are commonly seen in MS patients, and are 
indicative of inflammatory nature of the disease and blood-brain barrier breakdown 
(Compston and Coles, 2008). Pathological analysis of post-mortem brains from MS 
patients demonstrated a positive correlation between the degree of inflammation 
and axonal transection, and as remyelinated lesions showed reduced axonal 
damage, it has been the widely accepted view that MS has a primary 
autoinflammatory aetiology, which may lead to secondary effects such as 
demyelination and neurodegeneration (Bitsch et al., 2000; Kuhlmann et al., 
2002,Trapp, 1998 #646). However, recent evidence questions this hypothesis 
(reviewed in Stys et al., 2012). Wide spread lesions in the deep grey matter have 
been found in MS patients, which have fewer T-cells and less immune cell 
infiltration (Vercellino et al., 2009). In addition, studies have shown that cortical 
grey matter lesions and progressive brain atrophy correlate with irreversible 
cognitive impairment, which is thought to progress with disease progression 
(Calabrese et al., 2009). This raises the possibility of an underlying 
neurodegenerative disease, leading to primary axonal damage. However, the 
pathogenesis of MS and whether it is primarily an autoimmune or 
neurodegenerative process remains poorly understood and researchers continue to 
explore and link both possibilities (reviewed in Stys et al., 2012; van Noort et al., 
2012).  
Most patients in early stages of MS typically have relapsing-remitting disease, 
whereby the periods of functional deficits are thought to result from acute 
inflammation and demyelination within the CNS are followed by periods of 
functional recovery without significant clinical symptoms.  These relapses can be 
treated by immunosuppressants such as oral and i.v. glucocorticoids to shorten 
acute symptomatic attacks, and immune modulatory treatments like interferons 
and glatiramer acetate, which decrease the frequency of relapses. Recent research 
has shown that approximately 65% of patients with initial relapsing-remitting MS 
enter the phase of secondary progressive disease, ultimately leading to irreversible 
functional disability (Compston and Coles, 2008). This, and primary progressive 
disease, is currently untreatable. The anti-inflammatory and immune suppressing 
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treatments available (including Fingolimod and Natalizumab which are more 
effective and recently licensed) do not appear to delay or slow MS progression. 
Recent research indicates that degeneration of axons is one of the key contributors 
of clinical decline in progressive MS and it is thought that intact myelin is essential 
for neuroprotection and maintenance of axonal integrity (Reynolds et al., 2011; 
Stadelmann and Bruck, 2008). Evidence suggests that demyelination leads to 
dysfunction of mitochondria in axons and that this is possible a key contributor to 
their degeneration (Andrews et al., 2005; Qi et al., 2007; Su et al., 2009).  However, 
histopathological analysis of post-mortem brains from MS patients shows that 
axonal damage is already extensive in early stages of the diseases and decreases 
with time (Ferguson et al., 1997; Kuhlmann et al., 2002). Moreover, patients with 
secondary progressive disease appear to have more axonal injury than of those with 
primary progressive MS (Bitsch et al., 2000), suggesting that neurodegeneration is 
associated with the relapsing-remitting stage. As such, it is thought that axonal 
damage is not necessarily only a result of demyelination but may occur 
simultaneously and in association with the inflammatory process (reviewed in 
Bruck, 2005). Research shows that activated microglia can contribute to axonal loss 
by the secretion of  possible mediators including but not limited to pro-
inflammatory cytokines and free radicals (Hendriks et al., 2005), and that these 
reactive oxygen species inhibit axonal transport leading to axonal degeneration 
(Fang et al., 2012). It is therefore important to consider both the demyelinating and 
the inflammatory neurodegenerative aspect of MS in the development of potential 
treatment strategies (reviewed in Franklin and Ffrench-Constant, 2008; Franklin et 
al., 2012).  
 
Failure of remyelination 
In early stages of MS spontaneous remyelination does occur (Goldschmidt et al., 
2009; Patrikios et al., 2006), however these myelin sheaths appear thinner and with 
shorter internodal lengths (Perier and Gregoire, 1965; Prineas and Connell, 1979; 
Raine and Wu, 1993) and one of the primary foci in MS research over the past 
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decades has been to understand how remyelination is regulated and what causes 
this remyelination failure.  
Research in rodent experimental models of MS shows that following a 
demyelinating lesion, there is an increase of proliferating cells, which are mostly 
expressing markers of the oligodendrocyte lineage; and that in remyelinated areas 
increased numbers of mature oligodendrocytes, expressing markers of late myelin 
differentiation, have been found when compared to before demyelination  
(Prayoonwiwat and Rodriguez, 1993). Cre-lox fate mapping of PDGFα/NG2+ 
oligodendrocyte progenitor cells in mice showed very clearly that this population is 
responsible for generating almost all remyelinating cells in demyelinating lesions in 
the adult CNS (Zawadzka et al., 2010).  Moreover, it has been demonstrated that 
once an oligodendrocyte is differentiated and myelinating, it does not contribute to 
the myelin repair, despite its survival within a demyelinated lesion or its 
transplantation from a normally myelinating area into a lesion site. Keirstead and 
Blakemore showed that demyelination of the adult rat spinal cord and additional 
irradiation of the same area to destroy proliferating cells, did not result in 
consequent myelin repair by post-mitotic oligodendrocytes, which survived the 
demyelinating insult (Keirstead and Blakemore, 1997; Targett et al., 1996). Similarly, 
studies by Targett and colleagues described a lack of remyelination in the adult rat 
spinal cord after transplantation of mature human oligodendrocytes into the 
demyelinated area (Targett et al., 1996). This ultimately leads to the assumption 
that although oligodendrocytes may survive the demyelination process, there must 
also be a mechanism for the production and recruitment of new remyelinating cells. 
Most evidence points to oligodendrocyte progenitor cells (OPCs), as they can 
proliferate, migrate, mature, attach to axons and form new myelin sheaths. Groves 
et al. showed that rat OPCs were able to differentiate into myelinating 
oligodendrocytes and produce robust myelin after transplantation into 
demyelinated areas (Groves et al., 1993).  Furthermore, endogenous immature 
dividing cells in adult brain are able respond to demyelination by differentiating into 
oligodendrocytes, which then produce myelin and remyelinate axons (Gensert and 
Goldman, 1997). It is therefore thought that endogenous oligodendrocyte precursor 
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cells are capable of responding to demyelinated lesions and aid myelin repair. 
However, this is a very intricate process as has already been demonstrated during 
development and although most animal models show quite robust remyelination, in 
the human condition the remyelination capacity is limited. As such, the question 
whether this is due to a failure of OPC recruitment, differentiation or both, and why 
the extent of remyelination decreases with time, remains.  
It has been suggested that one of the reasons remyelination is insufficient is 
because of a mismatch of axonal signalling and OPC response. This especially raises 
questions about the differences between developmental myelination when full 
myelin thickness is achieved and remyelination when this process is insufficient 
(reviewed in Fancy et al., 2011), and whether differential signalling mechanisms 
could explain the failure of sufficient remyelination. The “recapitulation versus 
delay”-hypothesis (reviewed in Franklin and Hinks, 1999), suggests that during 
myelination in development, an oligodendrocyte precursor cell contacting an axon 
with a diameter above myelinating threshold for the first time will myelinate it. As 
all axons during development are smaller, both axon and myelin will then mature 
together; the axon will become larger in diameter and the myelin proportionally 
thicker. After a demyelinating insult however, the axon already possesses its full-
grown diameter and the precursor cells surrounding the lesion will be adult 
oligodendrocyte progenitor cells, suggesting that they might respond differently to 
myelination signals. Studies have demonstrated already that the adult progenitor 
cells show different behaviour, as NG2-positive progenitor cells in the developing 
system can differentiate into oligodendrocytes, astrocytes and neurons, while these 
adult NG2+ expressing progenitors will only differentiate into oligodendrocytes 
(Kang et al., 2010). Since they are halted in a precursor-like state from development 
onwards and will only reach the myelination stage with delay it might be more 
difficult for them to respond to signals and myelinate axons, especially if these 
already exist at full diameter. It could mean that there is a mismatch in the axon-
glial signalling, caused by the axon which might not be able to signal its need for 
sufficient remyelination or the adult progenitor cell which might not be able to 
respond to the signals in a way it would during developmental myelination, or both. 
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Therapeutic strategies 
As myelination is important for neuronal function and metabolic axon support, 
myelin repair in demyelinating diseases plays an important role in preventing axonal 
loss and associated neurological impairment, which is thought to occur secondary 
to immune-mediated demyelination. Axonal damage occurs most extensively at 
early stages of MS when acute demyelination is most active, and appears to be a 
major contributor to permanent disability (Kuhlmann et al., 2002; Trapp et al., 
1999). To date it is unclear what mechanisms drive neurodegeneration; however it 
has been proposed that demyelinated axons have a higher metabolic demand as 
electrogenic machinery along the axons such as sodium channels no longer cluster 
at the nodes of Ranvier and nerve impulse conduction becomes less efficient. If this 
increased metabolic demand is not met by mitochondria, which also have to 
reorganise in a demyelinated axon, the production of nitric oxide is thought to 
further potentially compensate axonal integrity (reviewed in Campbell and Mahad, 
2011; Su et al., 2009). This hypothesis is supported by the fact that in MS brain, 
axonal degeneration is most prevalent in active lesions where inflammation is 
greatest and that sodium channels in these areas are found diffusely located in 
demyelinated axons (Craner et al., 2004).  
 
Prevention of axonal loss by remyelination has been explored in a murine 
experimental model, where irradiation following cuprizone-induced demyelinating 
lesions resulted in reduced remyelination (due to irradiated remyelinating cells) and 
increased axonal loss; this could be rescued by transplantation of neural progenitor 
cells into the irradiated and demyelinated area (Irvine and Blakemore, 2008). 
Compared to active demyelinating lesions in brain tissue from MS patients, 
remyelinated lesions also exhibited less axonal loss (Kuhlmann et al., 2002). 
Moreover, CNS remyelination in various experimental animal models has been 
associated with functional recovery, indicating prevention of axonal loss and 
associated neurological changes by myelin repair (Duncan et al., 2009; Liebetanz 
and Merkler, 2006; Murray et al., 2001). However, recent studies suggest that 
remyelination perhaps does not completely prevent axonal loss as late functional 
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decline in mice experimental models of demyelination has been observed after 
initial remyelination and functional recovery, and this was concurrent with axonal 
loss in affected white matter tracts and changes in myelin composition (Manrique-
Hoyos et al., 2012). Taken together, these results support a clear association of 
remyelination with increased axonal survival and functional outcome, but also 
present the possibility of continuous processes leading to axonal loss independent 
of remyelination, which may in future elucidate putative pathological mechanisms 
in progressive disease.  
 
In early stages of MS, spontaneous remyelination does take place, however it is 
often insufficient in humans (Hagemeier et al., 2012). The aim to protect axons as 
best as possible and to prevent disease progression has led to research around the 
development of novel therapeutic strategies. 
 
As immune cells play a major role in the disease pathology of MS, much research 
has focussed on strategies to modulate the immune system. In fact, most of the 
currently used Food and Drug Association (FDA)-approved disease modifying 
therapies for MS, such as beta-interferon, glatiramer acetate and the newly licensed 
fingolimod, were discovered in animals with experimental autoimmune 
encephalomyelitis (EAE), which models the immunological aspect of MS (reviewed 
in Denic et al., 2011).  While clinical studies clearly show that these therapies have 
the short-term benefit of reducing both the frequency of relapses and the 
development of new inflammatory lesions in MS; the long-term outcome remains 
much debated and it is thought that disease modifying therapy has only little to no 
impact on disease progression (Katrych et al., 2009; Trojano et al., 2011). Recently 
completed clinical trials investigating the monoclonal antibody alemtuzumab as a 
treatment for MS showed that treatment with this medication resulted in fewer 
relapses and this was also evident for patients with relapsing-remitting MS, which 
had failed on beta-interferon therapy. Moreover, alemtuzumab also demonstrates 
the effect of delayed disease progression in MS patients with the exception of cases 
with very early MS or progressive disease, and this is the first time this has been 
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reported of an anti-inflammatory agent (Cohen et al., 2012; Coles et al., 2012). 
However, it is not clear whether this is a long-lasting effect and why delayed disease 
progression is only observed in patients with certain disease courses. 
 
Therapy strategies enhancing the remyelination process therefore seem promising 
to try and limit disease progression, and there are several possible approaches. One 
is the transplantation of remyelinating cells for the repair of focal lesions (Franklin, 
2002a), however, there are significant hurdles associated with cell transplantation 
(Lindvall and Kokaia, 2010). Firstly, MS is a multifocal disease and would therefore 
probably require cell transplantation into all areas of demyelination as it has already 
been suggested in experimental animal models that transplanted glial progenitor 
cells may have limited migration potential (Blakemore et al., 2002). Secondly, 
controlling the proliferation and differentiation process of transplanted cells is very 
difficult; the cells could migrate inappropriately or proliferate excessively, and fail to 
remyelinate. Animal models, on which the transplantation would be tested first, 
may fail to reflect the exact human pathology, leading to different cell behaviour 
and effect in clinical trials. Thirdly, as these cells would be transplanted into the 
lesion sites in the human brain, they would have to be absolutely clean and could 
not be raised in animal serum, which makes the handling process extremely 
difficult. And finally, as with any transplantation procedure, patients receiving stem-
cell transplants would have to be strongly immunosuppressed and as the disease is 
multifocal and on-going, repetitive cell transplantations may be required with the 
many associated risks for the patient. In addition, the source of stem cells also 
associates many ethical and safety issues, especially in the case of human 
embryonic stem cells, as concerns of a higher tumour formation risk are raised. 
Perhaps, some of these problems may be solved by the use of oligodendrocyte 
progenitor cells derived from patient-specific induced pluripotent stem cells; 
protocols for differentiating functional oligodendrocytes from induced pluripotent 
stem cells are already being investigated in mice (Czepiel et al., 2011). Recently, 
researchers reported their success in differentiating human induced pluripotent 
stem cells into OPCs, which then exhibited robust myelination upon transplantation 
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into dysmyelinated neonatal mouse brain (Wang et al., 2013). However, these 
techniques are still being developed and therefore the pharmacological promotion 
of endogenous remyelination currently presents a much more attractive approach 
(reviewed in Franklin and Ffrench-Constant, 2008). 
 
For successful remyelination to take place, OPCs need to be able to respond to 
demyelination by proliferation and/or migration to the lesion site, followed by 
differentiation and ensheathment of axons. It has been shown that these most 
likely come from within the lesion or from the immediately surrounding white 
matter (Franklin et al., 1997), however other evidence suggests that precursor cells 
in the subventricular zone can also contribute to remyelination if the lesion site is 
within close proximity (Menn et al., 2006; Nait-Oumesmar et al., 1999). To enhance 
remyelination, research has therefore focussed on the two essential steps; to 
repopulate the demyelinated area with OPCs and to promote their remyelinating 
ability; and some factors/pathways have already been identified (Figure 1.5). 
 
To aid the migration of OPCs to the demyelinated area, various signalling molecules 
seem to play important roles. Many chemokines, which are able to influence 
immune cell migration, have been detected in astrocytes around demyelinating 
lesions. Omari et al. found that immature and more mature OPCs expressed 
chemokine receptors CXCR1-3 in vitro. The respective ligands CXCL8,1 and 10  were 
absent from normal CNS tissue, but could be detected in reactive astrocytes 
bordering the lesion. Hence OPCs could respond to this cue for increased OPC 
recruitment (Omari et al., 2006; Omari et al., 2005). Similarly, it has been shown 
that OPCs express the platelet-derived-growth-factor alpha (PDGFα) receptor, and 
that more PDGFα receptor expressing OPCs repopulate the lesion site during the 
early remyelination process (Redwine and Armstrong, 1998). These findings indicate 
that PDGFα might be involved in OPC recruitment to demyelinating lesions and 
further research by Zhang et al. proposes that polysialic acid neural cell adhesion 
molecule (PSA-NCAM) is necessary for this directional OPC migration (Zhang et al., 
2004). Other migratory molecules are the class 3 Semaphorins, in particular Sema3A 
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and 3F, which actively direct oligodendrocyte migration during development may 
also play a key role in regulation OPC migration following a demyelinating lesion 
(reviewed in Williams et al., 2007); these will be further discussed in Chapter 5.   
 
When the demyelinated area has been repopulated with OPCs, these need to 
differentiate into myelinating oligodendrocytes in order to repair and regenerate 
the myelin sheath. This is a tightly regulated process, which is thought to possibly 
be impaired in MS  (Chang et al., 2002; Fancy et al., 2010; Kuhlmann et al., 2008) 
and several key factors and potential therapeutic targets have been identified 




LINGO-1 is a protein containing N-terminal leucine-rich repeat domains, which 
interacts with the Nogo receptor and has been shown to regulate axon outgrowth 
(Mi et al., 2004). Recent research suggests a key role of LINGO-1 as a potent 
negative regulator of OPC differentiation and remyelination in spinal cord of MOG-
induced experimental autoimmune encephalomyelitis (EAE) and 
Lysophosphatidylcholine (LPC)/Cuprizone induced demyelination in rats. Treatment 
of LINGO-1 deficient mice with an anti-LINGO-1 antagonist resulted in functional 
recovery from EAE and also increased remyelination (Mi et al., 2007). Similarly, the 
anti-LINGO-1 antagonist also showed increased remyelination in LPC-induced 
demyelinating lesions in rats, by direct stimulation of OPC differentiation (Mi et al., 
2009; Pepinsky et al., 2011). As such LINGO-1 is a potential target for MS therapy 
and specific antibodies could potentially promote remyelination in the clinical 
setting; a clinical trial in phase 1b has already been completed, however the results 
have not yet been reported (http://clinicaltrials.gov/ct2/show/NCT01244139).  
 
b) Notch1 
Also expressed by reactive astrocytes is the Notch1 receptor ligand Jagged1, which 
was first identified as a potential negative regulator of remyelination in a 
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microarray screen investigating putative astrocytic inhibitors of remyelination (John 
et al., 2002). During development Notch-Jagged signalling inhibits OPC 
differentiation and it has been shown that mouse models lacking of Notch1 in cells 
of the oligodendrocyte lineage leads to accelerated oligodendrocyte differentiation 
and myelination (Givogri et al., 2002; Wang et al., 1998). As such it has been 
proposed that Notch-signalling might be responsible for failure of remyelination. In 
vivo studies using experimental animal models show that Notch1 and its effector 
Hes5 are detected in OPCs in demyelinating lesions, and in vitro studies revealed 
that Notch signalling permitted expansion of OPCs but hindered their maturation 
and myelin formation (Zhang et al., 2009). Moreover, it has been shown that the 
transforming growth factor-beta (TGF-ß), a cytokine upregulated in MS, was able to 
trigger Jagged1 expression in reactive human astrocytes, which are known to border 
MS plaques lacking remyelination, while Notch1 and the downstream effector gene 
Hes5 localised to immature oligodendroglial cell (John et al., 2002; Zhang et al., 
2010). This suggests a role of Notch1 in regulation of remyelination and makes it a 
target for potential therapeutic strategies. 
 
c) Retinoid X receptor-ϒ 
Recent microarray analysis of different remyelination stages identified the nuclear 
retinoid X receptor-ϒ (RXR-ϒ) as a positive regulator endogenous remyelination 
(Huang et al., 2011b). Huang et al. were able to show that RXR-ϒ is highly expressed 
in OPCs during remyelination and that inhibition of RXR-ϒ by siRNAs resulted in 
oligodendrocytes of a morphologically less differentiated phenotype in vitro. Focal 
demyelinating lesions in RXR-ϒ knockout mice showed accumulation of immature 
oligodendrocyte lineage cells and contained less differentiated oligodendrocytes. 
Treatment of OPCs with RXR-ϒ antagonist in vitro resulted in impaired OPC 
maturation, whereas incubation with 9-cis-retinoic acid, a RXR agonist, stimulated 
differentiation and formation of myelin membrane like sheaths in OPC cultures and 
cerebellar slice cultures (Huang et al., 2011b). These results therefore propose a key 
role of RXR-ϒ-signalling in the regulation of oligodendrocyte differentiation and 
RXR-agonists as potential promoters of endogenous remyelination. 
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d) Wnt/ß-Catenin 
Signalling through the Wnt pathway has been shown to negatively affect 
developmental myelination. Transgenic mice which actively express a dominant 
active ß-catenin gene show exhibit delayed oligodendrocyte differentiation and 
hypomyelination during development but catches up eventually (Fancy et al., 2009). 
Similarly, experimental toxin-induced demyelination in these mice also resulted in 
delayed oligodendrocyte differentiation with no effect on OPC recruitment. Tcf4, a 
intranuclear binding partner of ß-catenin that is normally detected in developing 
mice but not in adult white matter, is re-expressed upon white matter 
demyelination in adult animals (Fancy et al., 2009; Ye et al., 2009). As Tcf4 locates 
to OPCs, which are being recruited to the lesion site in experimental models and it is 
also highly expressed in MS lesions, it is thought that Tcf4 could possibly play role in 
regulating oligodendrocyte differentiation and therefore myelin repair through 
active Wnt signalling.   
 
 e) Chemokines 
The chemokine CXCL12 is known to influence migration, proliferation and 
differentiation of neural precursors during development. Studies have shown that in 
a rodent model of CNS demyelination, CXCL12 and its receptor CXCR4 we 
significantly upregulated in activated astrocytes and microglia and that in vivo RNA 
silencing resulted in decreased OPC differentiation and increased remyelination 
failure (Patel et al., 2010).   
 
f) Hyaluronan 
Hyaluronan is a glycosaminoglycan, which is currently being examined for its ability 
to block remyelination (reviewed in Hanafy and Sloane, 2011). It has been observed 
in MS lesion in human brain tissue, as well as in lesions of EAE mice (Back et al., 
2005). Studies using both toxin-induced rodent demyelinating lesion and in vitro 
oligodendrocyte culture could show that upon presence of hyaluronan, there was 
no differentiation of OPCs, implicating a role in oligodendrocyte maturation. This 
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effect is thought to be mediated through the Toll-like receptors (TLR) 2, as this 
receptor is strongly expressed by oligodendrocytes and TLR2-agonists are able to 
inhibit OPC differentiation in vitro (Sloane et al., 2010). Moreover, neutralising 
antibodies of TLR2 have been shown to prevent the hyaluronan-mediated failure of 
OPC differentiation and TLR-null mice exhibit faster and more effective 
remyelination, suggesting an inhibitory signalling pathway, which may be 
influencing remyelination in the human condition. 
 
g) Bone morphogenic protein (BMP) 
Another group of cytokines, the bone morphogenic proteins (BMPs), were originally 
discovered by their ability to induce bone and cartilage formation, however are now 
believed to play a role in many more processes, including myelin repair. 
Upregulation of BMP 4,6 and 7 in demyelinating lesions of MOG-induced EAE mice 
has been demonstrated (Ara et al., 2008) and inhibition of BMP4 in vivo and could 
increase the number of remyelinated axons in areas of focal CNS demyelination in 
mice (Sabo et al., 2011). However, whether this is due to direct promotion of OPC 
differentiation or by inhibiting BMP-mediated astrogliosis (reviewed in See and 
Grinspan, 2009) is not yet known. 
 
h) Sonic Hedgehog (Shh) 
Sonic Hedgehog is essential for oligodendrocyte specification during embryonic 
development. Studies in the adult brain have shown that in Shh is still active in 
certain areas, mainly for maintenance of stem cell niches, which show reduced 
proliferation in vivo if Shh signal is blocked (Lai et al., 2003; Machold et al., 2003). 
Viral application of Shh into the lateral ventricle of adult mice showed an increase in 
proliferating oligodendrocyte progenitor cells and following OPC differentiation, 
suggesting that Shh can modify the stem cell niches to increase the production of 
precursor cells which will ultimately differentiate along the oligodendroglial lineage 
(Loulier et al., 2006). Very recently, Ferent and colleagues found that also in 
experimental demyelinating lesions, Shh upregulation in oligodendroglial cells 
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resulted in increased OPC proliferation and a Shh antagonist impaired myelin repair 
(Ferent et al., 2013).  
 
Taken together, many pathways have been identified that evidently influence 
oligodendrocyte precursor migration to the site of injury and differentiation into 
myelinating oligodendrocyte and might affect remyelination in vivo. The advantage 
of having an array of possible pathways potentially involved in remyelination is that 
processes such as OPC migration and OPC differentiation may be influenced 
separately, which could be important bearing in mind that the majority of MS 
lesions contain plentiful OPCs, which appear to have stalled in their differentiation 
process but 30% of MS lesions lack undifferentiated OPCs, pointing towards 
insufficient OPC migration (Chang et al., 2002; Lucchinetti et al., 1999). LINGO-1 
antibodies and RXR agonists both mainly affect differentiation of oligodendrocyte 
precursors into myelinating oligodendrocytes and could be used to enhance 
remyelination in those lesions containing OPCs with impaired differentiation, 
however, with not much effect in OPC-deficient lesions. On the other hand, 
molecules such as Semaphorins, which have been shown to affect OPC migration, 
could be helpful in treating lesions with a lack of progenitor cells. However, as MS 
patients mostly present with both types of lesions, potential systemic medication 
affecting only one particular pathway might not result in overall remyelination 
effects; and local treatment of individual lesions would be rather difficult as 
patients would require multiple intracranial injections to deliver the medication to 
the lesion site.  In addition, pathways such as the Notch and ß-catenin pathway are 
widely involved in other body functions and systemic treatment might lead to 
severe undesirable side effects. Moreover, any treatment aiming to affect 
remyelination does not necessarily affect the underlying disease course, making the 
treatment symptomatic rather than curative. The current challenge of MS research 
therefore is to establish if and how these pathways act together to regulate 
remyelination and whether the underlying disease pathology can be altered to 
enhance myelin repair capacity and disease progression. 
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Figure 1.5: Schematic showing factors that influence remyelination. For successful remyelination, 
OPCs need to be recruited to the lesion site and then differentiate into myelinating 
oligodendrocytes. Some factors/signalling pathways have been identified, which positively (green) or 
negatively (red) influence remyelination by altering these steps. 
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1.3 Experimental models to study MS 
 
As multiple sclerosis appears to be limited to humans and does not occur in 
animals, there is no natural model of MS and various experimental animal models 
have been established for research of CNS de- and remyelination. The difficulty is, 
however, that different model systems will only mimic certain aspects of the human 
disease and as such they have different benefits and limitations in studying MS 
pathology and therapeutic targets.  
 
Experimental autoimmune encephalomyelitis (EAE) 
Rodent EAE models are probably the most widely studied animal model for 
inflammatory CNS disease. To induce EAE, animals are actively immunised with CNS 
antigens such has spinal cord homogenate, common myelin proteins (mainly MBP, 
but also PLP and MOG) or peptides of these proteins emulsified in an adjuvant, 
which is needed to boost the immune response. The difficulty is that different 
antigens in combination with different host animals will produce a wide variety of 
disease courses and clinical phenotypes (reviewed in Kipp et al., 2012). When 
susceptible animals are immunised with CNS tissue they exhibit a monophasic but 
self-limiting episode with acute paralysis and full recovery or a chronic disease 
course with progressive paralysis without recovery. Immunisation of Lewis rats with 
MBP and Freund’s adjuvant (antigen emulsified in mineral oil, which can also 
contain inactivated and dried mycobacteria to potentiate the immune response) for 
example results in an acute monophasic EAE disease course with minimal 
demyelination and recovery (Swanborg, 2001). In contrast, immunisation of Biozzi 
ABH mice with MOG, PLP or spinal cord homogenate in adjuvant leads to a 
relapsing disease pattern resembling relapsing remitting MS and secondary 
progressive MS, with minimal demyelination during the acute phase of EAE and 
more extensive myelin damage during chronic relapses (Amor et al., 1993; Amor et 
al., 1994; Baker et al., 1990). In addition, these mice also show axonal damage and 
neurological deficits, which increase with time and number of relapses. In particular 
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immunisation of Biozzi ABH mice with spinal cord homogenate and adjuvant results 
in a secondary progressive disease pattern with inflammation, extensive de- and 
remyelination, gliosis and axonal loss (Hampton et al., 2008). However, although a 
wide variety of EAE disease patterns can be induced in susceptible animal models 
and they resemble certain aspects of the MS disease courses, such as neurological 
impairment and extend of demyelination, the underlying pathogenesis is not 
identical. EAE is thought to be mediated through T-cells, in particular Th1 CD4+ cells 
as studies have been able to show that depletion of CD4+ cells inhibits EAE 
induction and prevents clinical disease in experimental models (Abdul-Majid et al., 
2003). EAE is therefore the prototype to study CD4+ T-cell-mediated diseases such 
as MS. The experimental advantages are that it mimics the auto-immune 
pathogenic mechanisms involved in MS closely and as such permit investigation of 
T-cell mediated immune damage of the CNS and the exploration of pharmacological 
targets in this cascade of innate immunity. Moreover, as EAE also associates with 
different clinical stages, it is possible to evaluate functional outcome. The 
limitations include that like MS, various clinical disease courses are also present in 
EAE, depending on the auto-antigen, host species and their relative genetic 
background. EAE models also show parallel appearing inflammatory demyelination 
and remyelination, thereby making it difficult to detect direct changes in either de- 
or remyelination and amount of inflammation following drug treatment. Moreover, 
recent studies suggest that CD8+ T-cells are also emerging as a possible contributor 
to MS pathology (Friese and Fugger, 2009; Johnson et al., 2007), and EAE models 
with a CD8+ T-cell mediate autoimmune disease are being developed to study this 
further (Ji and Goverman, 2007). Similarly, the influence of B-cells in MS is not 
modelled in EAE either. Lastly, a primary progressive disease course where MS 
progresses from the beginning has been well described in MS patients; however, 
current EAE models fail to display this type of clinical progression.    
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Viral models 
Similarities in the pathogenesis of MS and CNS viral diseases have led to hypothesis 
of a possible viral aetiology of MS. Although various viral infections such as Epstein-
Barr virus have been linked to MS susceptibility, it is not thought that these are the 
direct causative agent for MS (reviewed in Owens and Bennett, 2012). The Theiler’s 
murine encephalomyelitis virus (TMEV), which is one of the most commonly used 
and best studied in viral models, for example, was discovered by its ability to cause 
paralysis and encephalomyelitis in susceptible mouse strains (Theiler, 1934). It 
induces a biphasic disease of progressive CNS demyelination that shows similar 
pathology to MS (Dal Canto and Lipton, 1975, 1977; Lipton, 1975). The virus is 
persistent in oligodendrocytes and microglia, and infection of the CNS results in 
inflammation and concurrent demyelination, with further axonal damage and spinal 
cord atrophy in some mouse strains with chronic disease (Tsunoda and Fujinami, 
2010). Remyelination in this model is often sparse, with thinner myelin sheaths 
months after the initial demyelinating event (Dal Canto and Lipton, 1975). In vitro 
studies suggest that TMEV leads to demyelination through direct effects on 
myelinating oligodendrocytes; by infecting early OPC precursors expressing NG2 
and A2B5 as well as CNPase-positive immature oligodendrocytes, TMEV blocks their 
differentiation and is thought to delay or inhibit remyelination in vivo (Pringproa et 
al., 2010). The viral model benefits from the possibility to study the impact of 
immunosuppressive therapies on CNS infections, but limitations include the fact 
that disease only occurs after the virus is directly injected into the CNS, thereby not 
permitting the investigation of whether peripheral infections also play a role in the 
aetiology of CNS autoimmune diseases. 
 
Toxin-induced demyelination in vivo 
Over recent years, a variety of myelin toxins have been employed to induce focal 
demyelinating lesions or systemic disease depending on their mode of application. 
Lysophosphatidylcholine (LPC) and ethidium bromide are the most commonly used 
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and their local injection into spinal cord or brain causes a well-defined 
demyelinating lesion with a reduced detectability of myelin markers and fewer 
oligodendroglial cells in the lesion area (Woodruff and Franklin, 1999). A 
systemically applied  toxin is cuprizone, which when fed to mice for several weeks 
results in demyelination of highly myelinated white matter tracts such as the corpus 
callosum (Blakemore, 1973a; Ludwin, 1978). The benefit of these toxin-based 
models is that through local stereotactic injection of a defined toxin volume, the 
lesion area remains constant, permitting the close analysis of how remyelination 
takes place including the exploration of the origin of remyelinating cells and their 
migration towards the defined lesion, which is useful for testing potential 
remyelination-enhancing target drugs. Limitations include toxicity to neurons at 
higher toxin concentrations in lesions and that the immunological aspect of MS 
cannot be studied due to missing T-cell recruitment. These toxin-induced models 
are further detailed in chapter 4. 
 
In vitro cell culture systems 
For exploring interactions between specific cell types, in vitro approaches have 
proven beneficial, as particular cells of interest can be grown and observed outside 
of the in vivo environment and can be easily manipulated. Cell cultures contain cells 
from various sources, most often from rodent or human origin, and therefore 
permit the testing of rodent findings in a human system. Various types of co-
cultures have been described (reviewed in Jarjour et al., 2012); however, especially 
co-cultures of oligodendroglial cells and neurons have been useful in understanding 
how oligodendrocyte precursor cells differentiate into myelinating oligodendrocytes 
and single cell imaging has opened up new avenues to further explore the initiation 
of axon-glial contact and myelin formation (Ioannidou et al., 2012). Neuron-glial co-
cultures also permit the exploration of possible factors that are able to influence 
the interaction between oligodendrocytes and neurons. For example, factors 
enhancing oligodendrocyte differentiation or myelin formation can be closely 
studied by treating co-cultures with chemical compounds, such as agonists or 
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antagonists of a specific signalling pathway, or by comparing the co-cultures from 
wild-type and knockout animals. However, although in vitro systems are useful to 
study cell-to-cell interaction, they are limited by the lack of environmental cues like 
growth factors and support through other cells, which are present in an in vivo 
system. Hence, cultured cells may behave quite differently to in vivo experimental 
models with an intact environment; for example it has been shown that a 
myelinating oligodendrocyte in vivo is able to produce approximately 500 times 
more myelin than an oligodendrocyte in culture (Pfeiffer et al., 1993). It is therefore 
important to take these limitations into consideration when extrapolating findings 
from in vitro studies to in vivo situations, in particular in the case of de- and 
remyelination, which occurs in the presence of inflammation and injury. 
 
Ex vivo slice culture 
An alternative to in vitro cell culture is the ex vivo slice culture model, which was 
initially developed for neurophysiological purposes. By creating slices from 
explanted animal CNS tissue and then keeping them in a culture environment, this 
method permits the exploration of cell-to-cell interactions and ease of manipulation 
with the added benefit of intact tissue architecture. This system has been refined 
throughout recent years; slices are commonly 200-500 µm thick and are grown on 
semiporous membranes, allowing survival of mouse cerebellum, brainstem, 
cerebral hemisphere and spinal cord slices for at least 4 weeks in culture (reviewed 
in Jarjour et al., 2012). Ex vivo slice cultures have also been well established in 
remyelination research, especially as myelin toxins can be added to the slice 
cultures to induce focal or global demyelinating lesions (Birgbauer et al., 2004; 
Zhang et al., 2011) and myelination can then be imaged using high resolution live 
imaging (Sobottka et al., 2011). As this is a culture system however, there are 
limitations for example in investigating cell migration from distant sources. In 
particular questions around the origin of remyelinating cells may be difficult to 
address in this model system and highlight the need for in vivo models with the 
potential for live imaging. 
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Zebrafish 
Over the recent years, zebrafish (Danio rerio) have become increasingly significant 
in the field of biological research and are now regarded as one of the most 
important vertebrate model organisms. This ray-finned fish is a teleost of the 
cyprinid family, and has a genome of 1.7 gigabases in size, which is divided onto 25 
chromosomes (Nüsslein-Volhard and Dahm, 2002). The advantage of the zebrafish 
in the scientific field is that external development of embryos can easily be 
observed through the chorion. During the first 24 hours of development, the 
embryos are completely transparent, but also at later stages, up to a few days of 
age, the larvae remain mostly transparent, allowing easy observation of the 
internally developing organs. This is particularly useful in transgenic zebrafish, in 
which the development of single fluorescent cells can be observed. Zebrafish 
embryos show a very rapid development; they progress from egg to larvae in 3-5 
days. The breeding of fish also has many advantages compared to other 
vertebrates. Zebrafish can be mated daily, and have reliable egg production with 
quite a large clutch size all year around. Scientific work with zebrafish also benefits 
from the ease of genetic manipulation and high throughput embryo screening. 
Finally, global zebrafish networks, such as ZFIN (www.zfin.org), are developing 
rapidly, where genes, plasmids and probes are recorded and other relevant 
information is shared. 
Zebrafish genetic and drug high throughput screens have been well established over 
the last decade and are now commonly used to screen chemical compound libraries 
for the identification of new drug targets and pathways (Hao et al., 2010; Hong, 
2009). The rate at which screens can be conducted depends on many variables; 
these include whether the screening takes place at one particular time point or 
requires analysis of processes over time and also whether the read out is a 
particular phenotype (eg. expression of transgene) or an effect that requires more 
detailed analysis (eg. cell count, differentiation or function). Manual screening of 
chemical compounds allows examination of several 100 compounds per week, 
which can be increased manifold with the development of new automated read-out 
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systems and embryo sorting devices (Pfriem et al., 2012; Spomer et al., 2012). Many 
research laboratories are exploiting these advantages to perform zebrafish screens 
for the discovery of genes implicated in myelination (Pogoda et al., 2006; Simmons 
and Appel, 2012; Takada and Appel, 2010) and moreover to discover substances 
with potential pro-myelinating effect that could be useful for remyelination therapy 
(Buckley et al., 2010). These zebrafish screens focus on substances which may affect 
physiological myelination during larval development; however, it is unclear whether 
myelination in larvae is regulated in the same manner as in adult zebrafish, whether 
myelination during development accurately models myelination that occurs after 
myelin injury, and finally, it is currently unknown how processes involved in 
myelination and remyelination in zebrafish compare to those observed in mammals. 
Orthologues for most human genes can be investigated in the zebrafish (Barbazuk 
et al. 2000; Postlethwait et al. 2000), which is also true for myelin genes and 
proteins. Most mammalian myelin proteins are present in fish and show a similar 
distribution; however, there are some notable differences as listed in Table 1.6. 
During evolution, duplications of the genome after the divergence of the tetrapods 
have resulted in the presence of multiple zebrafish genes for each mammalian 
gene. This is for example the case for the proteolipid protein and its splice variant 
DM20, which have multiple paralogues in teleost fish (Schweitzer et al., 2006). The 
main difference between zebrafish and mammalian myelin, however, is that myelin 
protein zero (P0) is the major structural myelin protein in zebrafish CNS, whereas in 
mammalian CNS this role is occupied by myelin proteolipid protein (PLP/DM20) and 
P0 is only present in peripheral Schwann cell-derived myelin. Evolutionary studies 
suggest that with the first appearance of myelin ~440 million years ago in 
cartilaginous fish (sharks and rays), P0 was the initial primary structural protein of 
myelin in the CNS and PNS (Kirschner et al., 1989; Kitagawa et al., 1993; Saavedra et 
al., 1989; Stratmann and Jeserich, 1995; Waehneldt et al., 1986). As P0 is co-
expressed with PLP or DMα (the DM20 orthologue in fish) in the CNS and PNS of 
bony fish and amphibia, it is thought that a co-existence of DM20 and P0 was 
necessary in the CNS due to high mutation rates (Yoshida and Colman, 1996). The 
slightly longer isoform of DM20, PLP, with an additional 35 amino acids in exon 3 
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and first appeared ~400 million years ago after the divergence of bony fish (Macklin 
et al., 1987; Nave et al., 1987). It has been suggested that the evolution of this PLP-
specific domain allowed stable integration of PLP into the mammalian CNS myelin 
and functional replacement of P0 (Waehneldt, 1990; Yoshida and Colman, 1996). 
These differences in the composition of zebrafish and mammalian myelin need to 
be kept in mind when findings made in zebrafish are extrapolated to other 
vertebrate systems, especially investigations concerning the function of particular 
myelin components and their interactions. However, despite evolutionary distance, 
zebrafish screens have led to the discovery of a g-coupled protein receptor 
(grp126), which is essential for myelin formation in the zebrafish PNS and has 
recently also been associated with significant functions in peripheral nerve 
development and myelination in mammals (Monk et al., 2009; Monk et al., 2011). 
These findings highlight the importance of zebrafish screens in identifying potential 
signalling pathways implicated in mammalian myelination. 




Structural protein, necessary for 
the compaction and 
maintenance of myelin structure 
CNS CNS  
Myelin basic protein 
(MBP) 




Myelin protein zero 
(MPZ, P0) 
Structural protein, necessary for 
the compaction and 
maintenance of myelin structure 
PNS PNS and 
CNS 
Peripheral myelin 
protein 22 (PMP22) 
Structural protein, early PNS 









Structural protein, assumed role 
in axon-glial contact 
CNS ? 
 
Table 1.6: Major mammalian myelin proteins are also present in zebrafish, and similarly 
distributed. The main exception is myelin protein zero, which is only in the peripheral nervous 
system of mammals, but in both the CNS and PNS of zebrafish (Data modified from Bai et al., 2011; 
Baumann and Pham-Dinh, 2001; Brosamle and Halpern, 2002; Wulf et al., 1999). 
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Another difference between mammals and zebrafish is the regeneration of tissues. 
While regeneration in mammals seems to be somewhat limited, zebrafish possess 
an incredibly high capacity to regenerate. This was already observed in several 
different organ systems such as the heart (Poss et al., 2002), retina (Bernardos et 
al., 2007; Fausett and Goldman, 2006; Fimbel et al., 2007), spinal cord (Becker and 
Becker, 2008; Reimer et al., 2008) and brain (Kroehne et al., 2011), but knowledge 
about the ability of zebrafish to regenerate their myelin is limited. Previous studies 
in the closely related goldfish show that myelin can successfully be restored around 
regenerated axons; however by using nerve crush as an injury paradigm, these 
studies do not investigate remyelination, but rather de novo myelination of 
regenerating axons. These processes might comprise quite different signalling 
mechanisms especially as it has been proposed that an oligodendrocyte, which 
contacts a growing axon for the first time may be more successful in its myelination 
than an oligodendrocyte aiming to remyelinate a once myelinated axon (Fancy et 
al., 2011; Franklin and Hinks, 1999). I therefore sought to develop an adult zebrafish 
model, which would allow the study of myelin repair, including time course and 
mechanisms underpinning zebrafish de- and remyelination without axonal injury, in 
a highly regenerative environment, and determine possible similarities and/or 
differences between zebrafish and mammals.  
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1.4 Central hypothesis 
 
The central hypothesis is that following focal demyelinating injury of the central 
nervous system, adult zebrafish are able to repair their myelin effectively. 
 
1.5 Statement of aims 
 
1) To characterise a myelin marker that can be used for quantification of 
myelin throughout all stages of myelination in developing and adult 
zebrafish 
2) To develop a method for the induction of focal demyelinating lesions in the 
adult zebrafish central nervous system without concurrent axonal injury 
3) To use this zebrafish-based model for the study of remyelination time course 
and efficiency in a highly regenerative environment 
4) To test whether remyelination mechanisms in this zebrafish-based model 
show homologies to the mammalian system  
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CHAPTER 2 – Materials and methods 
_____________________________________________ 
 
A list of materials and recipes for the solutions used are detailed at the end of this 
chapter. Abbreviations are listed from page 212 onwards. 
 
2.1 Fish husbandry and housing 
 
All zebrafish lines were kept and raised in our animal facility under standard 
conditions (Westerfield, 1995), with a 14 hour light and 10 hour dark cycle at 
26.5°C. Embryos were obtained from natural spawning and kept at 28.5°C in 
embryo medium or conditioned aquarium water containing 0.00001% methylene 
blue; some embryos were raised in the presence of 0.003% n-phenylthiourea from 
20 hours post fertilisation (hpf) to prevent pigmentation. All embryos were staged 
by days post fertilisation (dpf) using standard procedures (Kimmel et al., 1995).  
 
2.2 Operational procedures 
 
All experiments were performed under British Home Office regulations. For all 
operational procedures, young zebrafish aged between 4 – 7 months were used 
unless otherwise stated in the text. 
Optic nerve crush 
Optic nerve crush of adult zebrafish was performed as previously described (Becker 
et al., 2000). In short, fish were anaesthetised in tricane mesylate (MS222) (1:5000 
in phosphate buffered saline (PBS)) and positioned under a stereomicroscope on an 
ice cold surface. Using fine forceps, the left eye was gently lifted from its socket and 
the exposed optic nerve was crushed behind the eyeball. A translucent strip across 
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the usually white opaque optic nerve indicated a successful lesion. The eye was 
rotated back into the socket and the fish placed back into the water. 
 
Optic nerve injection 
For optic nerve injections, the optic nerve of anaesthetised adult zebrafish was 
exposed as described above. Using a 5 µl Hamilton Injection Syringe (Hamilton®, 
Reno, USA) with an attached glass needle on a micromanipulator, 0.2 µl of 1% 
lysophosphatidylcholine (LPC) (weight/volume) was injected into the optic nerve. 
The eye was placed back into its socket and the fish returned back into the water. 
 
Intraperitoneal injection of Bromodeoxyuridine (BrdU) / Ethynyl-deoxyuridine (EdU) 
Adult zebrafish were anaesthetised in MS222 (1:5000 in PBS) and transferred onto a 
wet surface on ice. Using a 5 µl one-time use injection needle, 0.5 µl of a BrdU (5 
mg/ml) or EdU (16.3 mM) solution was carefully injected intraperitoneally without 
damage of vital organs. The fish was then returned to the water. 
 
Compound application to optic nerve 
For application of compounds to the optic nerve, small pieces of absorbable 
gelatine foam (Gelfoam) soaked in specific compounds were prepared. Adult fish 
were anaesthetised in MS222 (1:5000 in PBS), placed on an ice cold surface under a 
stereo microscope and using fine forceps, the eye was gently rotated out of the 
socket. A small piece of gelatine foam was placed next to the optic nerve behind the 
eyeball, and the eye was placed back into the socket. Finally, the fish was returned 
to its tank. As described in chapter 4, demyelination was successfully achieved with 
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Retrograde axonal tracing 
Retrograde labelling of optic nerve axons has already been described (Becker et al., 
2000). Briefly, the optic nerve was exposed as described above. The tracer was 
applied to severed axons of the optic nerve using small pieces of biocytin soaked 
gelatine foam and the tracer was allowed to be retrogradely transported along the 
optical projection for 4 hours. Fish were perfusion fixed and retrogradely labelled 
axons in the optic tectum were analysed in vibrating blade microtome sections. 
 
Perfusion and fixation of tissue 
Embryo and adult zebrafish were terminally anaesthetised in aminobenzoic acid 
ethylmethylester (MS222, 1:1000 in PBS) and fixed by immersion in 4% PFA in PBS 
(embryos) or perfusion with 4% paraformaldehyde (PFA) in PBS (adults) overnight. 
Tissue from Tg(claudin k:GAL4,UAS:GFP) transgenic fish was usually post-fixed for 2-
3 days for technical reasons. 
 
2.3 Sectioning of tissue 
 
Cryostat sections 
Fixed whole embryos or dissected tissue from fixed adult zebrafish were immersed 
in 30% sucrose in PBS overnight, embedded in O.C.T. cryostat embedding medium 
and flash frozen in liquid nitrogen cooled methyl-2-butane. The regions of interest 
were cut into 14 µm sections on a cryostat (CM3050 S, Leica, Wetzlar, Germany) 
and mounted on Superfrost coated glass slides. 
 
Vibrating blade microtome sections 
Dissected tissue from fixed adult zebrafish was embedded in 4% agar in PBS and cut 
into 50 µm sections on a vibrating blade microtome (Microtom HM650V, Zeiss, 
Oberkochen, Germany). Sections were collected in 24-well plates in PBS.  
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Semi-thin sections 
For semi-thin sections, EPON embedded tissue blocks (see electron microscopy 
section for details) were mounted on a stage, cropped using carbon steel blades, 
cut into 0.5 µm thick sections on a microtome (Reichert Jung Ultracut Microtome, 
Leica, Wetzlar, Germany) and collected on microscope glass slides.  
 
Ultra-thin sections 
Ultra-thin sectioning was performed by Steven Mitchell in the Science Faculty 
Electron Microscope Facility, Daniel Rutherford Building, King’s Buildings, Mayfield 





For immunohistochemistry on cryostat sections, these were encircled with a 
hydrophobic PAP-pen, washed in 1x PBS, blocked in 5% donkey serum in 0.2% 
Triton X-100 in PBS (PBSTx) for 1 hour in a wet chamber at room temperature and 
incubated with primary antibody in 0.2% PBSTx at 4°C overnight. They were then 
washed in PBS, incubated with fluorescently labelled secondary antibody in 0.2% 
PBSTx in a wet chamber for 2 hours and washed in PBS again. Finally, the sections 
were mounted in 70% glycerol in PBS or Fluoromount-G. 
For retinal sections of adult transgenic fish for myelin protein zero (P0) 
immunohistochemistry, the following modifications of the protocol were used: 
adult fish were terminally anesthetized as above. The unfixed tissue was then 
dissected, frozen and cut as above. The sections were treated in ice cold methanol 
for 10 min, then blocked in 1.5% donkey serum in PBS for 30 min and then 
incubated in primary antibody in PBS at 4°C overnight. The slides were then washed 
in PBS, incubated in secondary antibody in PBS for 45 min at room temperature and 
washed in PBS again before being mounted as above.  
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For retinal sections of transgenic fish lines the following protocol was used: The 
tissue was dissected from terminally anaesthetised and perfused zebrafish, 
incubated in sucrose, embedded, frozen, and cut as above. The sections were fixed 
in ice cold ethanol for 10 min, washed in PBS and heated in 10 mM sodium citrate 
(pH 6.5) for 10 min at 80°C for antigen retrieval. Sections were then incubated in 
blocking solution (10% donkey serum in 0.3% PBStx) for 1 hour and then in primary 
antibody in blocking solution at 4°C overnight. They were then washed in PBS, 
incubated in secondary antibody in blocking solution for 90 min at room 
temperature and washed in PBS again before being mounted as above. 
 
Vibratome sections 
For vibrating blade microtome sections, the sections were washed in PBS, followed 
by antigen retrieval in 10 mM sodium citrate in PBS for 30min at 80°C and washed 
in PBS again. After a 10 min incubation in 50 mM glycine in 0.1% PBSTx at room 
temperature, the floating sections were washed in 0.1% PBStx, blocked in 2% 
donkey serum in PBS for 30 min at room temperature and incubated with primary 
antibody in 0.1% PBStx at 4°C overnight. The sections were then washed in 0.1% 
PBStx, followed by incubation with secondary antibody in 0.1% PBStx for 45 min at 
room temperature.  After this, the sections were washed twice in 0.1% PBStx and 
once in PBS. If nuclear staining was required, 1 µg/ml Hoechst in PBS was added for 
a few minutes between the washes. Finally, the sections were mounted in 70% 
glycerol in PBS or Flouromount-G™. 
 
Whole mount preparations 
Following perfusion of adult zebrafish, desired tissue was dissected out and kept in 
PBS at 4°C. Just before the staining procedure, the tissue was digested with 2 
mg/mL collagenase for 5 min and washed in PBS. The tissue was blocked in blocking 
buffer (1% goat serum, 1% bovine serum albumin (BSA), 1% dimethyl sulfoxide 
(DMSO), and 0.7% Triton X-100) for 30 min followed by incubation with the primary 
Page | 62  
 
antibody in blocking buffer at 4°C overnight. After washing in PBS, specimens were 
incubated with the fluorescently labelled secondary antibody in blocking buffer at 
4°C overnight. Finally, specimens were washed again and mounted onto slides in 
70% glycerol in PBS. 
 
Bromodeoxyuridine (BrdU) immunohistochemistry 
Tissue from adult perfused zebrafish was dissected, dehydrated in sucrose, 
embedded, frozen, and cut as above. The sections were washed in 0.1% PBStx for 5 
min, then incubated in 2 M hydrochloric acid for 1 hour at room temperature. After 
washing the sections in 0.1% PBStx for 5 min, they were blocked in 1.5% donkey 
serum in 0.1% PBStx for 30 min and incubated in primary antibody in blocking 
solution overnight at 4°C. They were then intensively washed in 0.1% PBStx, 
incubated in secondary antibody in 0.1% PBStx for 45 min at room temperature, 
washed in 0.1% PBStx again and mounted in Fluoromount-G™. 
 
Ethynyl-deoxyuridine (EdU) detection 
Cryostat sections from perfused adult zebrafish were encircled with a PAP-pen, 
dehydrated and permeabilised in a methanol bath at -20°C for 10 min and washed 
in PBS for 10 min at room temperature. For EdU detection the Click-iT™ kit was 
used. The Click-iT™ reaction cocktail was prepared according to manufacturer’s 
guidelines: For 100 µl total volume, 4.3 µl 10x Click-iT™ reaction buffer was 
combined with 88.7 µl dH2O, 2 µl copper sulphate, 0.1 µl Alexa Fluor azide and 5 µl 
reaction buffer additive. 100µl of this reaction cocktail was added to each slide and 
covered with parafilm and the slides were incubated for 3 hours at room 
temperature in the dark. Next, the reaction cocktail was removed and the slides 
were washed in PBS, three times 10 minutes. Finally, the sections were mounted in 
Fluoromount-G™ or processed for further immunohistochemistry. 
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Anti-4C4 antibody generation 
Hybridoma cell line 7.4.C4, producing 4C4 antibodies, was obtained from Health 
Protection Agency Cultures Collection, Salisbury, United Kingdom. The hybridoma 
cells were thawed upon arrival and then kept in suspension in cell culture medium 
at 37°C at the cell culture facility, Centre for Regenerative Medicine, Edinburgh, 
United Kingdom under the care of Judy Fletcher. Every 2-3 days more medium was 
added (normally 10 ml/flask) until cells became too dense and were split for further 
expansion. After 2-3 weeks, the cells were centrifuged (5000 rpm/5 min), the 
supernatant collected and the antibody tested on vibratome sections of zebrafish 
brain. For preservation, 0.2% sodium azide was added to the supernatant, which 
was then aliquoted and frozen at -80°C for further use.  
 
Colorimetric immunolabelling using Vectastain ABC kit 
After the vibratome sections have been collected in 24-well plates in PBS they were 
treated with hydrogen peroxide (0.5% in 0.1% PBStx) for 20min followed by 20 min 
incubation with 50 mM glycine and a quick wash in 0.1% PBStx. The sections were 
then incubated in complex A+B solution from the Vectastain ABC kit for 90 min the 
dark and washed again in 0.1% PBStx and PBS. Washing solutions were replaced by 
500 µl/well DAB working solution and incubated for 30 min at 4°C, then 50 µl/well 
hydrogen peroxide (30%, 1:1000) was added to the wells and reaction stopped with 
PBS when sufficient staining was present (usually 2-5min). The sections were kept in 
PBS at 4°C until further processing. After sorting the sections they were mounted 
and dried on chromalaungelatine coated glass slides and then counter stained. 
For counterstaining, dried sections on the coated glass slides were sorted into racks 
and incubated in a series of solutions at room temperature: 1) distilled water (1-2 
min), 2) neutral red solution (6 min), 3) distilled water (briefly), 4) distilled water 
(briefly), 5) 70% ethanol (2-5 min), 6) 95% ethanol (2-5 min), 7) 100% acetone (15 
sec), 8) 100% acetone (15 sec), 9) 100 xylene (5 min), 10) xylene (5 min). Finally the 
sections were embedded with Eukitt mounting medium. 
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For coating of glass slides, the slides were sorted into racks, incubated with washing 
solution (500 ml 95% ethanol/10 ml 100% acetic acid) for 5 min, then dried in the 
oven at 65°C. Subsequently they were coated with chromalaungelatine solution for 
1 min and dried in the oven as before. This coating process with 
chromalaungelatine solution was then repeated and slides dried again.  
 
2.5 Western blot analysis 
 
Lysis of tissue 
Embryo and adult zebrafish were terminally anaesthetised in tricane mesylate 
(MS222) (1:1000 in PBS). Desired tissue was dissected and collected in lysis buffer, 
homogenised and incubated on ice for 30 min before being centrifuged at 6000 rpm 
for 5 min. The supernatant was collected and transferred into new tubes, 




For protein quantification, the Pierce® BCA Protein Assay Kit was used according to 
manufacturer’s guidelines. Briefly, the experimental samples were diluted to 
different concentrations and distributed in a 96-well plate; diluted bovine serum 
albumin (BSA) standards were used as control. Working solution was prepared for 
all samples and the plate was incubated at 37°C for 30 min, or until sufficient colour 




Samples were diluted with 4x NuPage SDS Page sample buffer and distilled water 
and boiled at 80°C for 5 min. They were then loaded into polyacrylamide gels and 
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run in 1x hepes running buffer at 150 V for 45 min, or until loading line was 
sufficiently advanced. As a marker the Precision Pro Plus Protein marker was used. 
The gels were taken out of the holders and transferred onto polyvinylidene fluoride 
(PDVF) membranes, which had been fixed for 15 sec in each methanol and distilled 
water, in transfer buffer at 400 mA for 2 hours at 4°C. Then the membranes were 
blocked in blocking buffer (4% bovine serum albumin (BSA) in tris buffered saline 
(TBS) with 0.1% Tween 20) for 1 hour at room temperature on a shaker and 
incubated with primary antibody in blocking buffer on a shaker at 4°C overnight. 
Following three 10 min washes in TBST (0.1% Tween 20 in TBS), the membranes 
were incubated with secondary antibodies in blocking buffer for 30 min at room 
temperature, then washed in TBST again, developed with the Pierce ECL Western 
Blotting substrate Kit and exposed to film in the dark room.    
 
2.6 In situ hybridisation 
 
The in situ hybridisation protocol has been published previously (Lieberoth et al., 
2003). Briefly, work surfaces were thoroughly cleaned with RNase Zap and 
vibratome sections of adult perfused zebrafish were washed twice in PBS with 0.1% 
Tween 20 (PBST), digested with Proteinase K in PBST (10 µg/ml) for 9 min at room 
temperature and reaction was stopped by washing the sections twice in glycine in 
PBST (2 mg/ml) for 5 min each and fixing them again in 4% PFA for 20 min at room 
temperature before washing them three times 5 min in PBST. The washing solution 
was replaced with hybridisation buffer and sections were incubated at 65°C for 5 
min and after changing to new hybridisation buffer they were prehybridised for 4-5 
hours at 65°C. Preheated digoxygenin-labelled probes (1:1000 in hybridisation 
buffer) were added, and the sections hybridised overnight at 65°C.  The following 
washing steps were conducted at 65°C for 10 min each with pre-warmed solutions: 
once in each 75% hybridisation mix for washes (HMW) in 2xSSC/0.1% Tween 20, 
40% HMW in 2xSSC/0.1% Tween 20, 100% 2xSSC/0.1% Tween 20, 100% 1xSSC/0.1% 
Tween 20 and then twice in 0.2xSSC for 30 min. Progressively, the 0.2xSSC was 
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replaces with PBST through a series of 10 min washes in 75% 0.2xSSC in PBST, 40% 
0.2xSSC in PBST and 100% PBST. The sections were blocked for 3-4 hours in in situ 
blocking buffer at room temperature; anti-DIG conjugated antibody solution was 
diluted 1:10,000 in blocking buffer and left on the sections overnight at 4°C with 
gentle agitation. The sections were subsequently washed six times in PBST for 15 
min at room temperature, three times alkaline tris buffer and then in 5-Bromo-4-
chloro-3-indolyl phosphate (BCIP)/ Nitro blue tetrazolium chloride (NBT) staining 
solution (one tablet/10 ml dH2O) in the dark until sufficient signal development. 
Finally when the desired staining intensity was reached, the reaction was stopped 
by washing the sections twice in stop solution for 15 min each and then twice in 
PBST for 10 min. The sections were mounted onto glass slides in Elvanol (Polyvinyl 
alcohol mounting medium) or kept in PBS at 4°C for further immunohistochemical 
processing. 
 
2.7 Electron microscopy 
 
Tissue preparation for electron microscopy 
Adult zebrafish were perfused with primary fixative (2% glutaraldehyde/ 4% 
formaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4) and kept in fixative for at 
least 2 hours at room temperature. The tissue was then dissected out and kept in 
fresh primary fixative at 4°C overnight. The tissue was rinsed in 0.1 M cacodylate 
buffer 3 times for 10 min at room temperature before being fixed in secondary 
fixative (2% osmium tetroxide in 0.1 M cacodylate buffer and 0.1 M imidazole, pH 
7.5). For the secondary fixation, all microwave steps were performed in a water 
bath at 15°C ± 3°C, which was continuously adjusted throughout the following 
microwave steps. The samples were stimulated at 100 watts for 1 min, kept at room 
temperature for 1 min, and then stimulated again at 100 watts for 1 min. This was 
followed by another microwaving regime: stimulation at 450 watts for 20 sec/room 
temperature for 20 sec, which was repeated 5 times. Finally, the samples were left 
in secondary fixative for 1 hour at room temperature. The tissue was then rinsed in 
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distilled water 3-5 times for 10 min and stained en bloc with saturated (8%) uranyl 
acetate. To dehydrate the samples, they were microwave stimulated at 250 watts in 
a series of ethanol (50%, 70%, 95%, 100%), followed by stimulation at 250 watts 
with 100% EM grade acetone. For pre-infiltration, a 1:1 mix of EPON embedding 
medium and EM grade acetone was prepared and added to the samples and left 
overnight; and then pre-infiltrated in pure EPON for a minimum of 6 hours while the 
acetone was allowed to evaporate. Finally, the tissue samples were embedded in 
EPON in silicon moulds, properly aligned and the blocks were incubated at 60-65°C 
to polymerise for at least 24 hours. 
EPON embedding medium was made with the EMbed 812 kit according to 
manufacturer’s guidelines. Briefly, 100ml EMbed, 45 ml dodecenylsuccinic 
anhydride (DDSA) and 60ml methyl-5-Norbornene-2,3-Dicarboxylic Anhydride 
(NMA) were heated to 65°C in an oven and mixed. The mixture was allowed to cool 
down, while stirring, for 1 hour. Then, 6.15 ml benzyldimethylamine (BDMA) was 
added to the mixture and after thorough mixing, the embedding medium was 
aliquoted and frozen at -20°C.  
 
Semi-thin sectioning 
Semi-thin sections were cut as described above; the sections were stained with 1% 
toluidine blue staining solution. 
 
Ultra-thin sectioning, lead staining and electron microscopy 
Further processing of the samples prepared for electron microscopy was done by 
the Science Faculty Electron Microscope Facility, Daniel Rutherford Building, King’s 
Buildings, Mayfield Road, Edinburgh EH9 3JH, United Kingdom.  
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2.8 Behavioural analysis 
 
To record swimming behaviour, the fish were tested for their free swimming 
capability in a 175cm2 arena. The fish was tracked with the EthoVision XT software 
(Noldus, Leesburg, USA), which also extracted and calculated the total distance 
moved and the average swimming velocity. Each fish was tracked 3 times for 10 
minutes, with an acclimatisation of 5 min once it had been placed in the arena and a 
minimum of 30min between tracking sessions. 
 
2.9 Image acquisition and processing 
 
Imaging of live zebrafish larvae 
Live embryos were anaesthetised in MS222 (1:5000 in PBS) and mounted on a glass 
slide in 1.5% low melting point (LMP) agarose. After imaging, they were removed 
from the agarose and transferred back into the water. 
 
Microscopes 
For imaging of fluorescent and calorimetric sections, the following microscopes 
were used: Zeiss LSM 710 confocal microscope, Zeiss Scope.A1 microscope, Zeiss 
Imager.Z Apotome (all from Zeiss, Oberkochen, Germany) and Leica DMI 4000B 
confocal microscope (Leica, Wetzlar, Germany) using 5x, 10x, 20, 40x and 63x lenses 
and using the Zen 2009 or Axio Vision (both from Zeiss, Oberkochen, Germany)  
software. Embryos were exclusively live imaged on the Zeiss LSM 710 confocal 
microscope. Fluorescent images of the adult zebrafish were taken on a Zeiss 
fluorescent stereo microscope. Electron microscope images were taken on a Philips 
CM120 electron microscope at the Science Faculty Electron Microscope Facility, 
Daniel Rutherford Building, King’s Buildings, Mayfield Road, Edinburgh EH9 3JH, 
United Kingdom.  
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Images were processed using Image J (National institute of health, Bethesda, MD, 
USA) and Adobe Photoshop CS4 (Adobe, San Jose, CA, USA). Compilations of figure 
panels were done with Adobe Illustrator CS5.1 (Adobe, San Jose, CA, USA).  
 
2.10 Protein sequence alignment and identity calculations 
 
Protein sequences were determined using the NCBI database and aligned using the 
EMBL-EBI EMBOSS-Needle Pairwise Sequence Alignment tool, which utilises the 
Needleman-Wunsch algorithm.  
 
2.11 Quantification and statistical analysis 
 
Pixel intensity measurements 
For measurements of average pixel intensity, the randomly selected sections of one 
experiment were imaged with the same intensity settings on the confocal 
microscope; they were opened in Image J (National institute of health, Bethesda, 
MD, USA) and stacked using the “Z-Project” function. Using the “Analyze-
histogram” command, I measured the pixel intensity of the desired marker/channel 
in a square in the area of interest (lesioned optic nerve) in a blinded fashion. This 
process was repeated for the unlesioned site with an equally sized square. Finally, a 
ratio was determined between lesioned-to-unlesioned sides for accurate 
comparison between animals. For technical replicates, multiple areas of interest 
were measured per lesion site. 
 
Cell profile counts 
Similarly, for cell profile counts, randomly selected sections of a lesion area were 
imaged on the confocal microscope. The images were opened in Image J (National 
institute of health, Bethesda, MD, USA) and cell profiles in a defined field of interest 
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(0.01 mm2) were counted in a stereological fashion throughout the z-stack, taking 
into account half cut-off cells on two sides of the field of interest but not on the 
other two.  
 
Myelinated/unmyelinated axons 
The technique for determining the percentage of myelinated axons has also been 
described previously (Edgar et al., 2009). For this, the same images as analysed for 
the G-ratios were taken and blinded for further measurements. A grid with star-
shaped lines (see below) was devised by Dr J Edgar, and using Adobe Photoshop 
(Adobe, San Jose, CA, USA), this was laid over the image. Any axon intersecting with 
any of these lines would be counted as myelinated or unmyelinated and an average 
percentage was determined. At least 100 axons were counted per animal, and at 





  Grid used for counting of %myelinated/unmyelinated axons 
G-ratios 
The G-ratio is determined by dividing the diameter of the axon by the combined 
diameter of axon and myelin (see figure below). Previously described techniques 
were used for G-ratio measurements (Edgar et al., 2009). Generally, to obtain the 
axon diameter, the area of the axon was measured with a Bamboo Pen and Touch 
pad (Wacom, Vancouver, WA, USA), and assuming that every axon was perfectly 
circular, the diameter was calculated with the formula: diameter = 2*√(area/∏) (see 
figure below).  The optic nerve lesion area was determined by visual cues, such as 
difference to the normal optic nerve, random myelin clusters not associated with 
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axons (“myelin debris”), and macrophages with engulfed myelin droplets. Randomly 
selected areas in the lesion area were imaged on the electron microscope at a fixed 
magnification (x4800). Images were blinded for further measurement. A 0.5 µm-
sized grid was overlaid using Image J (National institute of health, Bethesda, MD, 
USA), and any axon that intersected with lines of the grid was measured. The grid 
size was chosen so that the largest axons would fit inside a grid square (and not 
create bias towards these larger axons) and approximately 15 axons were selected 
at random. Pre-calculations demonstrated that the average axon diameter 
calculated from the randomly selected axons (0.50 ± 0.13, mean ± SD) was not 
different to when all axons in an image were measured (0.49 ± 0.12, mean ± SD). At 
least 200 axons were measured per animal, and at least 3 animals were analysed 
per condition (n=3).  
Technique used for measuring G-ratios 
Western blot quantifications 
Intensity of bands was measures using the “Analyze - Gel” command in Image J 
(National institute of health, Bethesda, MD, USA). Values were normalised to those 
obtained for anti-ß-tubulin immunolabelled bands from the same protein isolations.  
 
Statistical analysis 
The software Graphpad Prism 5 (GraphPad Software Inc., San Diego, CA, USA) was 
used for statistical analysis. The tests chosen were dependant on experimental 
setup and are specified in the test/figure legends. Generally experiments with two 
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variables were analysed by t-test or Mann Whitney U-test (in case normality could 
not be shown) and experiments with three or more variables by ANOVA with 
Bonferroni post-test or Kruskal Wallis test with Dunn’s post-test (in case normality 
could not be shown). A p value of 0.05 or less was considered statistically 
significant. Throughout the thesis, * denotes p<0.05, ** denotes p<0.01 and *** 
denotes p<0.001). Error bars represent mean ± standard deviation (SD) or standard 




Solutions and buffers 
Acetate buffer 75 ml 0.1M sodium acetate 
50 ml 0.1M acetic acid 
 
Alkaline Tris buffer for in situ 
hybridisation 
100 mM Tris buffer (1 M stock, pH 9.0) 
50 mM MgCl2 
100 mM NaCl 
0.1% Tween 20 
 
Blocking buffer for in situ 
hybridisation 
1x PBS 
0.1% Tween 20 
2% Normal sheep serum 
2 mg/ml Albumin (BSA) 
 
Blocking buffer for western blot 1x TBS 
0.1% Tween 20 
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Blocking buffer for whole mount 
immunohistochemistry 
0.7% Triton X-100 
1% Dimethyl sulfoxide (DMSO) 
1% Albumin (BSA) 
1% Goat serum  
 
Cell culture medium Dulbecco’s modified eagle medium 
2 mM Glutamine  
1% Hypoxanthine, Thymidine (HT) 
supplement  
10% Foetal Bovine Serum (FBS) 
 
Chromalaungelatine solution 2.5 g gelatine 
250 ml dH2O 
This was warmed to 50°C and 0.13 g 
Chromium (III) potassium sulphate 
dodecahydrate was added 
 
DAB (diaminobenzidine) solution 1:120 in PBS (from 6% stock solution) 
2 µl/ml NiCl2 (from 1% stock solution) 
2 µl/ml CoSO4 (from 1% stock solution) 
 
Embryo medium 15 mM NaCl 
0.5 mM KCl 
1 mM CaCl2 
1 mM MgSO4 
0.15 mM KH2PO4 
0.05 mM NaH2PO4 
0.7 mM NaHCO3 
 
Glutaraldehyde 
2%/paraformaldehyde 4% Primary 
For 10ml: 
2.5 ml 16% paraformaldehyde (EM grade) 
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EM fixative 0.8 ml 25% glutaraldehyde (EM grade) 
1 ml 1M cacodylate buffer, pH 7.4 
5.7 ml ultra-pure dH2O 
 
Glycine, 50mM For 10 ml: 0.0375g glycine in 10 ml 
PBS/PBStx 
 
Hybridisation buffer 50% Formamide 
5x SSC 
0.1% Tween20 
50 µg/ml heparin (50 mg/ml) 
5 mg/ml tRNA from brewer’s yeast  
in DEPC-H2O, adjust pH to 6.0 
 




Imidazole 0.2 M 700mg imidazole 
50 ml dH2O 
 
Lysis buffer 20 mM Tris base, pH 7 
150 mM NaCl 
5 mM EGTA 
1% Triton X-100 
0.1% SDS 
1:100 Protease Inhibitor cocktail mix 
Neutral red staining solution 4 ml acetate buffer (pH 4.8) 
100 ml 1% neutral red in dH2O 
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Osmium-Imidazole solution (EM 
grade), secondary EM fixative 
1 part 4% OsO4 solution 





16 g paraformaldehyde 
40 ml 10x PBS 
Make to 400 ml with dH2O 
 
Phosphate buffered saline (PBS), 10x 
pH 5.5 
80 g NaCl 
10.8 g Na2HPO4 
65 g NaH2PO4 
2 g KCl 
In 1L dH2O 
Adjust pH to 5.5 
 
Phosphate buffered saline (PBS) 10x, 
pH 7.4 
80 g NaCl 
14.16 g Na2HPO4 
2 g KCl 
2.4 g KH2PO4 
In 1L dH2O 
Adjust pH to 7.4 
 
Running buffer for western blot 20x Hepes buffer, diluted with dH2O to 1x 
SSC 20x pH 7.0 175.3 g NaCl 
88.2 g Sodium citrate 
in 1L DEPC-H2O 
Adjust pH to 7.0 
 
Sodium Cacodylate Buffer 1 M 8.56 g sodium cacodylate 
40 ml dH2O 
 
Page | 76  
 
Sodium citrate (10 mM) 1 L 2.94 g Sodium citrate 
1L dH2O 
Adjust pH to 6.5 
 
Stop solution for in situ hybridisation 1x PBS, pH 5.5 
1 mM EDTA 
0.1% Tween 20 
 
Tris buffered saline (TBS) 10x 1 L 50 g NaCl 
2 g KCl 
30 g Tris base 
Adjust pH to 7.5 
 
Transfer buffer for western blot 10x 
1L 
30.3 g Tris base 
144 g Glycine 
Adjust pH to 8.0 
 
Uranyl acetate Saturated solution which is about 8%. 
8 g uranyl acetate 
100 ml dH2O 
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Primary antibodies 
Primary antibody Host species Origin/Reference Dilution 
α-4C4 mouse Hybridoma cell line from HPC Cell 





mouse Sigma-Aldrich, St Louis, MO, USA 
(T6793) 
1:1000 
α-ß-tubulin rabbit Abcam, Cambridge, MA, USA 
(ab6046) 
1:1000 
α-BrdU rat Serotec, Oxford, United Kingdom 1:500 
α-Claudin k rabbit  Eurogentec, Seraing, Belgium 1:1000 
α-Claudin k rat (Schaefer, 2009) 1:1000 
α-GFP chicken Abcam, Cambridge, MA, USA 
(ab13970) 
1:500 





mouse Developmental studies hybridoma 




rabbit (Lyons et al., 2005) 1:50 
α-Myelin Protein 
Zero 
rabbit (Bai et al., 2011) 1:1000 
α-Pan-sodium 
channel 






mouse Dako, Sigma-Aldrich, St Louis, MO, 
USA (M0879) 
1:1000 
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Secondary antibodies for immunohistochemical analysis 
Fluorescent coupled antibodies were obtained from Stratech Scientific, Sydney, 
Australia and all were used at a dilution of 1:200. 
Secondary antibody Catalogue # 
Donkey anti-mouse Cy 3 715-165-151-JIR 
Donkey anti-mouse Alexa Fluor 647 715-605-151-JIR 
Donkey anti-rat Cy 3 712-165-153-JIR 
Donkey anti-rat Alexa Fluor 647 712-605-153-JIR 
Donkey anti-rabbit Cy3 711-165-152-JIR 
Donkey anti-rabbit Alexa Fluor 647 711-605-152-JIR 
Anti-chicken Alexa Fluor 488 703-545-155-JIR 
 
Secondary antibodies for western blot 
All antibodies were obtained from Amersham, GE Life Sciences, Little Chalfont, 
United Kingdom. 
Secondary  antibody Catalogue # Dilution 
ECL Anti-rat IgG 323640 1:5000 
ECL Anti-mouse IgG 399402 1:5000 
ECL Anti-rabbit 4646554 1:10000 
 
In situ hybridisation oligonucleotide probes 
The generation of the probes for P0 and Sema3Aa/3Ab and their sequences are 
described elsewhere (P0:  (Schweitzer et al., 2003); Sema3Aa: (Feldner, 2005); 
Sema3Ab: (Roos et al., 1999)). 
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Transgenic fish lines and mutants 
Tg(claudin k:GAL4,UAS:mGFP)   (Schaefer, 2009) 
Tg(claudin k:GAL4,UAS:mGFP) x Tg(olig2:DsRed)    (Münzel et al., 2012) 
Tg(UAS:nfsB-mCherry)    (Davison et al., 2007) 
Tg(claudin k:GAL4,UAS:mGFP) x Tg(UAS:nfsB-mCherry)  (Münzel et al., 
unpublished) 
Tg(olig2:GFP)    (Shin et al., 2003) 
Tg(olig2:DsRed)    (Kucenas et al., 2008) 
Tg(FoxD3:GFP)    (Gilmour et al., 2002) 
Tg(MBP:EGFP)    (Almeida et al., 2011) 
sox10t3(colourless) mutant    (Dutton et al., 2001) 
 
Chemicals reagents and products 
Acetic acid >99% Sigma-Aldrich, St Louis, MO, USA (45762) 
Acetone, EM grade Electron microscope sciences, Hatfield, 
PA, USA (10012) 
Agarose Oxoid, Basingstroke, United Kingdom 
(LP0028) 
Agarose, Hi-Strength LMP BioGene Ltd, Kimbolton, United Kingdom 
(300-800) 
Albumin (BSA) Sigma-Aldrich, St Louis, MO, USA (A3912) 
Albumin (BSA) standard, fraction V Thermo Fisher Scientific, Waltham, MA, 
USA (23209) 
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Aminobenzoic acid ethylmethylester Sigma-Aldrich, St Louis, MO, USA (A5040) 
 (MS222)  
BCIP/NBT tablet Sigma-Aldrich, St Louis, MO, USA (B5655) 
Biocytin hydrochloride Sigma-Aldrich, St Louis, MO, USA (13758) 
Blades, carbon steel Sigma-Aldrich, St Louis, MO, USA (T585) 
Bromodeoxyuridine (BrdU) Sigma-Aldrich, St Louis, MO, USA (B9285) 
Calcium Chloride, CaCl2 Sigma-Aldrich, St Louis, MO, USA 
(223506) 
Chromium (III) potassium sulphate Sigma-Aldrich, St Louis, MO, USA (24331) 
Copper (II) sulphate CoSO4 Sigma-Aldrich, St Louis, MO, USA 
(451657) 
DEPC-treated H2O, ultra-pure Invitrogen, Carlsbad, CA, USA (750023) 
Diaminobenzidine 99% (DAB) Thermo Fisher Scientific, Waltham, MA, 
USA (112080250) 
α-Digoxygenin-AP conjugate Roche Diagnostics Ltd, Burgess Hill, 
United Kingdom (11093274910) 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, St Louis, MO, USA (D2650) 
Dulbecco’s Modified Eagle Medium Thermo Fisher Scientific, Waltham, MA, 
 (DMEM), low glucose USA (SH30021.01) 
DPX mounting medium Thermo Fisher Scientific, Waltham, MA, 
USA (D/5319/05) 
ECL 2 western blotting substrate, Pierce Thermo Fisher Scientific, Waltham, MA, 
USA (80196) 
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Ethanol VWR International, Radnor, PA, USA 
(20821-330) 
Ethanol absolute Sigma-Aldrich, St Louis, MO, USA (E7023) 
Ethylene glycol tetraacetic acid (EGTA) Sigma-Aldrich, St Louis, MO, USA (34596) 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, St Louis, MO, USA (EDS) 
Ethynyl-deoxyuridine (Edu) Invitrogen, Carlsbad, CA, USA (A10044) 
Eukitt mounting medium Sigma-Aldrich, St Louis, MO, USA (03989) 
Fetal bovine serum (FBS) Invitrogen, Carlsbad, CA, USA (16000044) 
Fluoromount-G™ Southern Biotech, Birmingham, AL, USA 
(0100-01) 
Formamide Sigma-Aldrich, St Louis, MO, USA (F7508) 
Gelatine from porcine skin Sigma-Aldrich, St Louis, MO, USA (G1890) 
Gelfoam®, absorbable gelatine sponge Pfizer, New York, NY, USA 
Glutaraldehyde 25% EM grade Agar Scientific, Stansted, United Kingdom 
(R1020) 
Glutamine Thermo Fisher Scientific, Waltham, MA, 
USA (119951000) 
Glycine Sigma-Aldrich, St Louis, MO, USA (G8898) 
Glycerol Sigma-Aldrich, St Louis, MO, USA (G5516) 
Heparin sodium salt Sigma-Aldrich, St Louis, MO, USA (H3393) 
Histoacryl® Tissue seal Braun, Melsungen, Germany 
Hoechst 33342, Biotium Cambridge Bioscience, Cambridge, United 
Kingdom (40046) 
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Hydrochloric acid, HCl Sigma-Aldrich, St Louis, MO, USA 
(320331) 
Hydrogen peroxide 30%, H2O2 Sigma-Aldrich, St Louis, MO, USA 
(216763) 
Hypoxanthine, Thymidine (HT)  Invitrogen, Carlsbad, CA, USA (41065012) 
 supplement 50x   
Imidazole Sigma-Aldrich, St Louis, MO, USA (I5513) 
Lysophosphatidylcholine (LPC) Sigma-Aldrich, St Louis, MO, USA (L1381) 
Magnesium sulfate, MgSO4 Sigma-Aldrich, St Louis, MO, USA 
(208094) 
Methanol Sigma-Aldrich, St Louis, MO, USA 
(179957) 
Methylene Blue VWR International, Radnor, PA, USA 
(3470.0025) 
Methyl-2-butane Sigma-Aldrich, St Louis, MO, USA 
(320404) 
Metronidazole Sigma Ultra Sigma-Aldrich, St Louis, MO, USA (M1547) 
Neutral red Thermo Fisher Scientific, Waltham, MA, 
USA (SDS254-2) 
Nickel (II)-chloride, NiCl2 Thermo Fisher Scientific, Waltham, MA, 
USA (38732-0500) 
Normal donkey serum Millipore, Billerica, MA, USA (S30) 
Normal goat serum Abcam, Cambridge, MA, USA  (ab7481) 
Normal sheep serum Covance, Princeton, NJ, USA (SMI-6050C) 
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N-Phenylthriourea (PTU) 98% Sigma-Aldrich, St Louis, MO, USA (P7629) 
NuPAGE LDS Sample buffer Invitrogen, Carlsbad, CA, USA 
O.C.T Cryo embedding medium Thermo Fisher Scientific, Waltham, MA, 
USA  
Osmium tetroxide 2% Electron microscope sciences, Hatfield, 
PA, USA 
PAP-Pen for immunohistochemistry Sigma-Aldrich, St Louis, MO, USA 
(Z377821) 
Paraformaldehyde (PFA) Sigma-Aldrich, St Louis, MO, USA (P6148) 
Paraformaldehyde (PFA) 16% EM grade Agar Scientific, Stansted, United Kingdom 
(R1026)  
PDVF membrane for western blotting Millipore, Billerica, MA, USA 
 
Polyvinyl alcohol mounting medium with  Sigma-Aldrich, St Louis, MO, USA (10981) 
 DABCO®, pH 8.7 (Elvanol)  
Potassium chloride, KCl Sigma-Aldrich, St Louis, MO, USA (P5404) 
Potassium dihydrogen orthophosphate, VWR International, Radnor, PA, USA  
 KH2PO4  (2321820) 
Precise protein gels 4-20%, Pierce Thermo Fisher Scientific, Waltham, MA, 
USA (0025 224) 
Precision Pro Plus Marker “Kaleidoscope” Bio Rad, Hercules, CA, USA 
Protease inhibitor cocktail set III Calbiochem, Millipore, Billerica, MA, USA 
(539134) 
RNaseZAP Sigma-Aldrich, St Louis, MO, USA (R2020) 
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Semaphorin 3A, human recombinant R&D Systems, Minneapolis, MN, USA 
Sodium azide VWR International, Radnor, PA, USA 
(1155190) 
Sodium acetate, CH3COONa Sigma-Aldrich, St Louis, MO, USA (S2889) 
Sodium bicarbonate, NaHCO3 Sigma-Aldrich, St Louis, MO, USA (S8875) 
Sodium cacodylate Agar Scientific, Stansted, United Kingdom 
(R1102) 
Sodium chloride, NaCl Sigma-Aldrich, St Louis, MO, USA (S7653) 
Sodium citrate Sigma-Aldrich, St Louis, MO, USA (S1804) 
Sodium dodecyl sulphate (SDS) Sigma-Aldrich, St Louis, MO, USA (L4909) 
Sodium hydroxide, NaOH Sigma-Aldrich, St Louis, MO, USA (S5881) 
Sodium phosphate dibasic, Na2HPO4 Sigma-Aldrich, St Louis, MO, USA (S0876) 
Sodium dihydrogen phosphate, NaH2PO4 Sigma-Aldrich, St Louis, MO, USA (S5011) 
Sucrose 98% Sigma-Aldrich, St Louis, MO, USA 
(179949) 
Superfrost coated glass slides VWR International, Radnor, PA, USA 
Super RX x100 Fuji Xray film Fujifilm, United Kingdom (47410 19236) 
Toluidine blue Sigma-Aldrich, St Louis, MO, USA (89640) 
Tris-Base Sigma-Aldrich, St Louis, MO, USA (93362) 
Tris-HEPES-SDS Buffer, 20x, Pierce Thermo Fisher Scientific, Waltham, MA, 
USA (28368) 
Triton X-100 Sigma-Aldrich, St Louis, MO, USA (93426) 
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tRNA from brewer’s yeast Roche Diagnostics Ltd, Burgess Hill, 
United Kingdom (10109517001) 
Tween 20 Sigma-Aldrich, St Louis, MO, USA 
(274348) 
Uranyl acetate Taab, Aldermaston, United Kingdom 
(U008) 
Whatman chromatography paper Thermo Fisher Scientific, Waltham, MA, 
USA (FB59065) 
Xylene VWR International, Radnor, PA, USA 
(305756G) 
 




24-well plates Greiner Bio-One Inc., Germany (T-3026-1) 
Corning® 10 cm petri dishes Sigma-Aldrich, St Louis, MO, USA 
(CLS430588) 
Corning® 3.5 cm petri dishes Sigma-Aldrich, St Louis, MO, USA 
(CLS430591) 
Centrifuge tubes (15 + 50 ml) Greiner Bio-One Inc. Germany 
(188271/227261) 
Plastipak syringe 1ml disposable Scientific Lab supplies, Augustine, FL, USA 
(SYR6001) 
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Kits 
EdU Click-iT™ kit Invitrogen, Carlsbad, CA, USA (C10340) 
EMbed 812 kit Electron microscope sciences, Hatfield, 
PA, USA (14120) 
BCA Protein Assay kit, Pierce Thermo Fisher Scientific, Waltham, MA, 
USA (23228/23224) 




Collagenase Sigma-Aldrich, St Louis, MO, USA (C9891) 
Proteinase K Roche Diagnostics Ltd, Burgess Hill, 
United Kingdom (03 115 887 001) 
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To observe and measure myelination and regeneration of myelin in the zebrafish, it 
is important to have a reliable myelin marker. In zebrafish, Claudin k is strongly and 
exclusively expressed in autotypic tight junctions of oligodendrocytes and Schwann 
cells; it was discovered in a microarray expression screen investigating differential 
expression of myelin specific genes, which was performed by Karin Schaefer for her 
dissertation at the Ludwig-Maximilan University in Munich (Schaefer, 2009). She 
also began the characterisation of Claudin k expression in the zebrafish using both a 
rat monoclonal and rabbit polyclonal antibody that she generated against Claudin k, 
as well as a transgenic zebrafish line expressing membrane-bound GFP under the 
Claudin k promoter - tg(Claudin k:Gal4,UAS:mGFP) - that she developed for this 
purpose. I used these tools as the basis of my PhD project, and will first summarise 
relevant key findings from Karin’s work, before proceeding to my own results.  
Claudins are tetraspan transmembrane proteins and major components of tight 
junctions, which are present in various vertebrate tissues (reviewed in Findley and 
Koval, 2009), including myelin. Tight junctions are areas of a cell, where the 
membranes of two adjacent cells are closely connected and thus creating an 
impermeable barrier. Typically, transmembrane proteins such as claudins, junction 
adhesion molecules (JAM) or occludins are connected to the cytoskeleton on the 
adjacent cell via adapter proteins such as zonula occludens proteins 1-3 or cingulin 
(Figure 3.1-A). Their function is to hold the cells together, but they also play an 
important role in material transport and osmotic balance: As tight junctions prevent 
material from passing in-between the cells, molecules and ions can only pass this 
barrier by entering the cells through diffusion or active transport. Depending on the 
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composition of the tight junctions, the barrier can be selective for molecule size 
and/or charge, thereby allowing close regulation of fluid composition on either side 
of the barrier. 
Tight junctions in myelinating glia are known as autotypic tight junctions because 
they connect two adjacent layers of myelin. These autotypic tight junctions are 
present along the inner and outer mesaxon as well as in Schmidt-Lanterman 
incisures and paranodal loops of myelin sheaths (Figure 3.1-B). Electron microscope 
studies of autotypic tight junctions appear as close associations of adjacent myelin 
sheaths (Figure 3.1-C). 
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Figure 3.1: Tight junctions in myelin form a diffusion barrier between adjacent cells. (A) Typical 
adhesion molecules in tight junctions are junctional adhesion molecules (JAM), Claudins and 
Occludins and they interact with intracellular adaptor proteins such as the zona occludens molecule 
and cingulin. (B) A schematic of a myelinated nerve at the node of Ranvier (NOR) is shown. Red dots 
mark the tight junctions. Modified from (Poliak et al., 2002). (C) Tight junctions between myelin 
lamellae can be clearly observed (arrowheads) in freeze-fracture processed myelinated nerve tissue. 
Arrow points out the outer cytoplasmic tongue. Modified from (Rash, 2010). Scale bar: C = 1 µm. 
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Many claudin family genes have been identified to date; 24 types in humans and 
more than twice the number in teleost fish (Lal-Nag and Morin, 2009; Loh et al., 
2004). The claudin k gene lies on chromosome 3 at 48,270,951-48,274,629 bp and 
consists of two exons, with the entire 648 bp open reading frame on the second 
exon (Figure 3.2-A). The Claudin k protein is 216 aa long and has a calculated 
molecular weight of 22.8 kDa. Computational analysis predicts the typical Claudin 
topology with 4 transmembrane domains, a short intracellular N-terminus, a long 
intracellular C-terminus and a long first extracellular loop (Figure 3.2-B). 
Phylogenetic analysis suggests that Claudin k clusters with other claudins (Figure 
3.2-C); in particular the orthologues of Takifugu rubripes Claudin 31 (80% aa 
identity) and Salmo salar Claudin 6 (82% aa identity) show a high sequence 
homology. Claudins have also been previously described in mammals: Claudin 11, 
known as oligodendrocyte specific protein, in the CNS and Claudin 19 in the PNS are 
both expressed in tight junctions and are thought to play a role in regulating nerve 
conduction velocity (Devaux and Gow, 2008; Miyamoto et al., 2005). However, 
these proteins are not closely related to Claudin k and the mammalian claudin with 
the highest sequence homology is mouse and human Claudin 6 (54% aa identity). 
Due to an evolutionary duplication in zebrafish genome, most genes are present as 
two paralogues, however Claudin k has no paralogue. The zebrafish claudin with the 
highest homology to Claudin k is Claudin g (47% aa identity), which is an orthologue 
of the mammalian Claudin 4. 
The claudin k mRNA can be observed from 2 days post fertilisation (dpf) in the 
hindbrain and spinal cord (Figure 3.2-D I, II), the areas where myelination by 
oligodendrocytes first occurs (Brosamle and Halpern, 2002), and from 3 dpf the 
mRNA is also present in the zebrafish posterior lateral line nerve (Schaefer, 2009). 
This suggests that it is selectively expressed by both oligodendrocytes in the CNS 
and Schwann cells in the PNS from early in the myelination process. For the 
generation of the Claudin k antibodies, two peptides from the cytosolic C-terminus 
were chosen because this is the most divergent part of Claudin family proteins. The 
two peptides (PTFSSDESSPRRAGV and SPRRAGVSSQVKGYV) were each injected into 
two rabbits (performed by Eurogentec, Southamton, United Kingdom), giving rise to 
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a polyclonal serum. The rat monoclonal antibody was generated by using the 
peptide SPRRAGVSSQVKGYV and was generated in the SFB 596 antibody facility (E. 
Kremmer, Helmholtz-Zentrum, Munich, Germany). The specificity of both 
antibodies was confirmed by western blot analysis and specific labelling of the CNS 
and PNS in whole mounted zebrafish larvae (Schaefer, 2009).  On a subcellular level, 
Claudin k localises to the autotypic tight junctions and specifically labels the 
paranodal loops, mesaxon and Schmidt-Lanterman incisures in the PNS (Figure 3.2-
E). It also co-labels with the tight junction zona occludens-1 protein in preparations 
of single nerve fibres indicating that it is indeed a tight junction protein (Figure 3.2-
F). However, as Claudin k immunoreactivity can only be demonstrated in fixed 
material and does not label the entire morphology of myelinating cells, K. Schaefer 
generated a transgenic zebrafish line, in which the claudin k promoter drives the 
expression of a membrane-bound GFP utilising the previously described GAL4:UAS 
system (Figure 3.2-G) (Asakawa and Kawakami, 2008). I then studied the 
developmental expression of Claudin k in embryonic zebrafish and the expression 


























Figure 3.2 (A-C): The claudin k gene. (A) The zebrafish claudin k consists of two exons (dark blue, 215 
and 1031bp) separated by an intron (2433bp); the entire open reading frame (light blue region) lies 
on the second exon. (B) The predicted membrane topology of Claudin k protein is typical of the 
claudin family with 4 transmembrane domains, a short intracellular N-terminus, a long intracellular 
C-terminus and two extracellular loops. (C) A phylogenetic tree of Danio rerio Claudin k (red) shows 
close homology with other claudins, in particular the salmo salar Claudin 6 and Takifugu rubripes 
























Figure 3.2 (D-F) The claudin k gene. (D) Claudin k mRNA is can be observed in the hindbrain (arrows) 
and spinal cord (arrowheads) from 2 dpf (I, II, III), in the dorsal spinal cord from (triangles, III) and in 
the posterior lateral line (arrowhead, IV) from 3 dpl. Expression in the epiphysis was detected in the 
rostral part of the zebrafish head (asterisk). I, II and III show larvae from lateral, II from dorsal. 
Rostral is left. (E) Preparation of a single teased peripheral nerve fibre shows that Claudin k localises 
to the mesaxon (arrows), Schmidt-Lanterman incisures (arrowheads) and paranodal loops (node 
indicated by asterisk). (F) Immunolabelling with Claudin k (red) and the tight junction marker ZO-1 
(green) in single peripheral nerve fibres shows overlapping localisation in mesaxon (arrow), Schmidt-
Lanterman incisures (arrowhead) and paranodal looks (node indicated by asterisk). (G) Schematic of 
Driver and responder construct used to make the transgenic zebrafish line. Scale bars: C = 50 µm, E,F 
= 10 µm. D,E,F and G were modified from results obtained by Karin Schaefer (Schaefer, 2009). 
 
  




Claudin k labels myelin in the CNS and PNS 
To confirm that the previously generated antibodies worked in my hands, I 
repeated some of the experiments performed by K. Schaefer. Using western 
blotting, I could show that both the monoclonal and the polyclonal antibody 
recognise a single band of protein at ~20 kDa in peripheral nerve and brain tissue, 
which was not present in the negative control tissue (ovaries), confirming the 
specific expression  of Claudin k in nervous tissue (Figure 3.3-A). To validate the 
specificity of the rat monoclonal anti-Claudin k antibody in tissue sections, I used 
immunohistochemistry to co-label Claudin k+ brain sections of zebrafish larvae with 
other myelin markers, such as myelin basic protein (MBP) and myelin protein zero 
(P0). I could show that all three myelin markers label the same structures during 
development in the larval brain, however, the onset of labelling differed: Claudin k 
could be detected in the medial longitudinal fascicle from as early as 3 dpf, whereas 
MBP immunoreactivity in the same structure was only present from 4 dpf and P0 
from 5 dpf (Figure 3.3-C). To investigate whether this staggered expression was also 
true for other myelinated areas in the zebrafish CNS, I examined the optic chiasm 
and found a similar differential expression in time (Figure 3.3-D). The reason for this 
is perhaps that these different myelin proteins have different functions in myelin, 
which are only needed successively throughout myelin formation in development. 
Alternatively, the antibodies may also have different sensitivities for their target 
protein, leading to differential expression.  
 
As antibody specificity was confirmed, I further aimed to investigate whether it 
could be used to quantify myelination. I therefore labelled brain cross sections of 
wild type and sox10t3 (colourless) mutant larvae with different myelin markers 
(Figure 3.4-A,B). Sox10t3 (colourless) mutant larvae have reduced myelination 
(Takada et al., 2010) and in situ hybridization indicates fewer GFP-expressing cells in 
sox10 mutants compared to wild type fish (Schaefer, 2009). Indeed, Claudin k, MBP 
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and P0 immunoreactivity was significantly lower in the mutant larvae at 8 dpf 
compared to wild type larvae of the same age (Figure 3.4-C). This confirms that 
Claudin k is expressed in myelinating cells and that it can be used to quantify 
myelination. 
  





Figure 3.3: Claudin k antibodies specifically label myelinated tracts in the zebrafish. (A) Specific 
bands for Claudin k are detected with the monoclonal and polyclonal antibody at ~20kDa in the CNS 
(brain) and PNS (posterior lateral line nerve, PLLN). The negative control (ovaries) shows no Claudin k 
band. (B) Schematic of a larval zebrafish indicates locations of cross sections displayed in C and D. 
(C,D) Cross sections of zebrafish larvae at various dpf are shown (dorsal is up). Immunolabelling with 
Claudin k, MBP and P0 of cross sections through the larval brain (C) show that Claudin k labels 
myelinated tracts such as the medial longitudinal fascicle from 3 dpf, MBP and P0 label these 
structures later at 4 and 5 dpf respectively (full arrowheads). No immunolabelling can be detected 
earlier in these locations (empty arrowheads). Similarly, Claudin k labels the optic chiasm (D) from 4 
dpf, while MBP and P0 are only detectable from 5 dpf (full arrows). No immunoreactivity is seen in 









Figure 3.4: Claudin k expression is reduced in sox10 mutant larvae. (A) Schematic of a larval 
zebrafish indicates location of cross sections displayed in B. (B) Immunolabelling of different myelin 
markers in hindbrain cross sections of 8 dpf zebrafish larvae is shown. Labelling of Claudin k, MBP 
and P0 in the hindbrain (arrows) is severely reduced in sox10 mutant larvae compared to age 
matched wild type controls. (C) Quantification of immunofluorescence in the hindbrain of sox10 
mutants compared to wild type fish is shown (p<0.05, Mann Whitney U-test, n=3). Error bars 
represent mean ± SEM. Scale bar: B = 100 µm. 
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Developmental expression of Claudin k and tg(Claudin k:Gal4,UAS:mGFP) in fixed 
and live larvae 
To study Claudin k expression during zebrafish development, I utilised the rat 
monoclonal anti-Claudin k antibody as well as the transgenic line tg(Claudin 
k:Gal4,UAS:mGFP). I analysed cryostat sections of developing larvae at 1-5 dpf and 
found that Claudin k was first detectable at 3 dpf in the medial longitudinal fascicle 
in the hindbrain, the spinal cord and the posterior lateral line nerve (PLLN) (Figure 
3.5-A-C) and over time, labelling increased in these locations and throughout the 
CNS and PNS. The claudin k transgene was already present at 24 hours post 
fertilisation (hpf) in cells in the rostral head (Figure 3.5-D), reflecting early claudin k 
mRNA expression as described by K. Schaefer (Schaefer, 2009), however these 
labelled cells are unlikely to be oligodendrocytes at this early developmental stage. 
The onset of GFP expression in presumed oligodendrocytes in the hindbrain was 
detected at 2 dpf (Figure 3.5-A,B). At this time point, labelling in the Mauthner 
axons of the spinal cord was also found, and the PLLN was GFP-positive from 3 dpf 
(Figure 3.5-A,C). Thus, the transgene labelling appeared in the same structures as 
Claudin k immunoreactivity and claudin k mRNA, but was detectable slightly earlier 
than Claudin k immunoreactivity. 
Next, I tested whether the claudin k transgene could be used to identify and analyse 
differentiation of myelin-forming cells in individual live larvae. To investigate if the 
transgene expression occurred in oligodendrocytes, I crossed this transgenic fish 
with a previously characterised line, which expresses cytoplasmic DsRed under the 
control of the olig2 promoter in oligodendrocytes and motor neurons. Migrating 
olig2:DsRed+ cells in the dorsal spinal cord of these fish have been identified as 
oligodendrocytes (Kucenas et al., 2008). I found that some of these DsRed+ cells 
were also surrounded by a cell membrane labelled with the membrane-tethered 
GFP, which was also observed the cell processes and myelinated internodes (Figure 
3.6-A). It was notable that not all DsRed+ cells co-labelled with a GFP+ cell 
membrane, a phenomenon that is likely due to variegated transgene expression, 
which is discussed later on. 
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 In dorsal (Figure 3.6-B) and lateral (Figure 3.6-C) live imaged views of the same 
larva, the first transgene expression was detected at 54–66 hpf in the medial 
longitudinal fascicle in the hindbrain, in structures medial to the otic cavity, as well 
as in the rostral spinal cord and PLLN. Wild-type embryos did not show such 
fluorescence. As individual larvae developed, GFP expression extended along the 
spinal cord and PLLN in a rostral to caudal pattern (Figure 3.6-C) between 60 and 90 
hpf, similarly to previously published myelination patterns (Brosamle and Halpern, 
2002). Motor axons were associated with GFP fluorescence suggestive of 
myelination from 78 hpf onward (Figure 3.6-C). GFP expression was also detected in 
the fins of the zebrafish larvae (Figure 3.6-B), but this expression could not be co-
labelled with anti-Claudin k antibody (data not shown), and therefore was deemed 
ectopic. However, this expression did not affect observation of oligodendrocytes 
and Schwann cells in the nervous system. Thus, the progress of differentiation of 
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Figure 3.5: Developmental Claudin k and tg(Claudin k:Gal4,UAS:mGFP) expression in sectioned 
embryonic zebrafish. (A) Schematic of larval zebrafish indicates locations of cross sections shown in 
B and C. (B) Cryostat cross sections through hindbrain at different ages were double labelled with the 
anti-Claudin k antibody and claudin k transgene. First expression of Claudin k is observed at 3 dpf in 
the medial longitudinal fascicle of the hindbrain (arrows). Dorsal is up. (C) Cryostat cross sections of 
spinal cord at different ages were double labelled with the Claudin k antibody and claudin k 
transgene. First expression of Claudin k is observed at 3 dpf the spinal cord Mauthner axons 
(arrowheads) and the PLLN (open arrows) at 3 dpf, claudin k transgene expression in the spinal cord 
Mauthner axons is already present from 2 dpf. The ventricle is marked by the asterisk. Dorsal is 
up.(D) Images of a whole mounted tg(Claudin k:Gal4,UAS:mGFP) zebrafish at 30 hpf shows a few GFP 
labelled cells in the rostral head (arrow). Rostral is left. Scale bars: A = 50 µm, B = 100 µm, D = 200 
µm. 
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Figure 3.6: Developmental Claudin k and tg(Claudin k:Gal4,UAS:mGFP) expression in live imaged 
embryonic zebrafish. (A) An oligodendrocyte in a tg(Claudin k:Gal4,UAS:mGFP) x tg(olig2:DsRed) live 
zebrafish at 4 dpf in the dorsal spinal cord is shown. GFP expression can be observed in the cell 
membrane (asterisk), cell processes (arrows) and myelinating internodes (arrowheads). The open 
arrowhead indicated a putative Node of Ranvier between two internodes. (B) GFP expression time 
course of a single live transgenic zebrafish is shown (view from dorsal, rostral is up). No expression 
can be detected at 40 hpf. At 60 hpf, GFP expression associated with the Mauthner axons 
(arrowhead), fibres of the ventral commissure (asterisk) and PLLN (open arrow) can be observed. No 
GFP expression is detected in wild-type larva at this time. GFP expression increases in these 
structures and also labels nerves innervating the eye at 90 hpf (arrow). Ectopic expression in the fins 
is observed (circles). (C) A time course of the rostral and caudal trunk region of a single transgenic 
zebrafish is shown (dorsal is up, rostral is left). At 60 hpf, GFP expression was observed in the ventral 
(arrow) and dorsal (arrowheads) aspects of the rostral, but not the caudal spinal cord. The PLLN 
already shows GFP expression in the rostral as well as the caudal trunk region at 60 hpf (open 
arrows). No GFP expression is detectable in the wild-type larvae at this time point. At 90 hpf, GFP 
expression is now present in the caudal spinal cord as well (arrows), including the dorsal spinal cord 
fibres (arrowheads). GFP expression is associated with motor axons leaving the spinal cord, which is 
suggestive of myelination, was also observed in both regions (asterisks).  Scale bars: A = 20 µm; B,C= 
100 µm. 
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Expression of Claudin k and tg(Claudin k:Gal4,UAS:mGFP) in adult zebrafish 
To investigate whether Claudin k is also a usable marker for myelin in adult 
zebrafish, I double-labelled sections of the adult tg(Claudin k:Gal4,UAS:mGFP) 
zebrafish with the anti-Claudin k antibody. Claudin k and transgenic GFP expression 
were detectable throughout the CNS, in particular myelinated white matter tracts in 
the optic tectum (Figure 3.7-A) showed co-labelling. While myelinated tracts, such 
as the tectobulbar tract were labelled by the anti-Claudin k antibody and the 
transgenic GFP, oligodendroglial cell bodies in the CNS were only labelled by the 
claudin k transgene (Figure 3.7-A). Moreover, these GFP positive cell bodies could 
be double-labelled with P0 mRNA, confirming the oligodendroglial-specific labelling 
of the transgenic GFP (Figure 3.7-B). This difference in labelling between the anti- 
Claudin k antibody and the claudin k transgene is due to a membrane tag of the 
transgenic GFP, which means it will be incorporated into any membrane in the cell. 
In contrast, the Claudin k antibody only recognises the protein in its final location, ie 
the myelin membrane sheath. This difference, however, allows the visualisation of 
myelinating oligodendroglial cells as well as their membrane sheath, and as such 
the anti-Claudin k antibody and the claudin k transgenic zebrafish line tg(Claudin 
k:Gal4,UAS:mGFP) are very powerful tools for myelination studies in zebrafish.  
To confirm the specificity of the Claudin k antibody and GFP transgene, I double 
labelled sections of CNS tissue with another myelin marker, P0 antibody. Claudin k 
and P0 immunostaining in spinal cord sections showed a high degree of overlap, 
and confirm the myelin-specific labelling pattern of the Claudin k antibody in adult 
zebrafish (Figure 3.7-C). However, I observed that the transgenic GFP did not label 
all myelinated fibres that could be detected with the P0 antibody (Figure 3.7-D). P0 
is only present in compact myelin sheaths, but Claudin k can be found in both non-
compacted and compacted myelin wraps and therefore would be expected to co-
label all P0-positive myelinated fibres. As this is not the case, these results suggest 
that the tg(Claudin k:Gal4,UAS:mGFP) fish exhibits a variegated transgenic 
expression pattern.  To quantify the extent of this variegated expression, I counted 
GFP positive glial cells in the outer layers of the tectum in tg(olig2:GFP) and 
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tg(Claudin k:Gal4,UAS:mGFP) fish. I found that the membrane-bound GFP in 
tg(Claudin k:Gal4,UAS:mGFP) fish only labelled approximately half the number of 
cells compared to the tg(olig2:GFP) fish  (claudin k transgenic fish: 16.3 ± 3.3 cells 
per field, olig2 transgenic fish: 37.2 ± 6.8 cells per field, p<0.01, Mann Whitney U 
test, n=3). Thus, Claudin k immunoreactivity quantitatively labels myelin sheaths, 
whereas transgenic GFP exhibits a variegated expression pattern in oligodendroglial 
cells in the adult zebrafish CNS.  
In the peripheral nervous system, as exemplified by the posterior lateral line nerve, 
co-labelling of the claudin k transgene and the antibody was also detected (Figure 
3.7-E); and peripheral nerves surrounding the eyes of live adult zebrafish were 
visible through the skin (Figure 3.7-F). Variegated transgene expression in the 
peripheral nervous system was not quantified. 
These results thus suggest that both the Claudin k antibody and transgenic GFP can 
be used to visualise myelin and myelinating glial cells in the adult zebrafish, but only 
the antibody immunoreactivity should be used for quantification as the claudin k 
transgene exhibits a variegated expression. 
 
  











Figure 3.7 (A-C): Claudin k and tg(Claudin k:Gal4,UAS:mGFP) expression in adult zebrafish. (A) 
Cryostat cross sections of adult optic tectum shows co-labelling of the Claudin k antibody and the 
transgenic GFP, however oligodendroglial cell bodies are only labelled by the transgene as it contains 
a membrane tag (inset, arrowheads). Dorsal is up. (B) In the outer layers of the optic tectum, GFP-
positive cells in the tg(Claudin k:Gal4,UAS:mGFP) transgenic zebrafish are also positive for P0 mRNA 
(arrowheads), indicating that they are oligodendrocytes. (C) Double labelling of spinal cord cross-
sections with Claudin k and P0 antibodies shows an overlapping staining pattern. Labelling of myelin 
sheaths around the Mauthner axons can be observed (arrowheads). Asterisk marks the ventricle. 
Dorsal is up. Scale bar: A = 200 µm; Inset = 60 µm, B = 50 µm, C = 100 µm. 
 
  







Figure 3.7 (D-F): Claudin k and tg(Claudin k:Gal4,UAS:mGFP) expression in adult zebrafish. (D) In 
cross sections of the adult telencephalon transgenic GFP expression largely co-labels with P0 
antibody immunoreactivity, however there are some P0 positive/GFP-negative myelin sheaths 
(arrows). The boxed area in the left image is shown in higher magnification on the right. (E) A whole 
mounted PLLN shows co-labelling of GFP expression, Claudin k antibody and acetylated tubulin 
immunoreactivity. (F) Transgenic GFP expression in peripheral nerves around the eye is visible in 
anaesthetised live adult zebrafish under a fluorescent stereomicroscope. Rostral is left, dorsal is up.  
Scale bars: D = 100 µm (low magnification, left); 10 µm (high magnification, right), E = 100 µm, F = 
0.5 mm. 
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Claudin k expression in the visual system of adult zebrafish 
The optic nerve in adult zebrafish is ideal for experimental lesions as it is easily 
accessible through the large orbita. Previous studies in goldfish use the optic nerve 
for myelination studies; however differential myelination patterns along retinal 
ganglion cell (RCG) axons between species prompted detailed analysis of Claudin k 
expression in the optic system of zebrafish. In rodents, the optic nerve contains 
myelinated fibres, while axons of the retinal fibre layer remain unmyelinated, 
presumably to allow sufficient light to reach the photoreceptors in the inner layers 
of the retina. Evidence has shown that in these species a barrier (the glia limitans) 
prevents oligodendrocytes from migrating into and myelinating the retinal fibre 
layer (Ffrench-Constant et al., 1988). Previous studies of the zebrafish optic system 
indicated the presence of loose myelin wraps in the intraretinal part of the retinal 
ganglion cell axons, and that glial cells of the RGC layer express contactin 1a mRNA, 
which is usually only found in actively differentiating oligodendrocytes (Schweitzer 
et al., 2007).  As P0, a marker of compact myelin is only found in the optic nerve and 
tract but not in the retinal fibre layer (Schweitzer et al., 2003), I hypothesised that 
the adult zebrafish retina may contain oligodendrocytes that have retained a 
somewhat immature differentiation status. However, such cells have not been 
directly visualised previously.  
By using the Claudin k antibody and the tg(Claudin k:Gal4,UAS:mGFP) fish line, I 
could show that Claudin k is indeed expressed in the retina and optic nerve of adult 
zebrafish, and that the staining pattern was similar to that of MBP (Figure 3.8-A). By 
comparison, the P0 antibody only labelled the optic nerve and optic nerve head and 
no immunoreactivity could be detected in the retina, confirming earlier in situ 
hybridisation results (Schweitzer et al., 2003). However, when I investigated the 
retinal fibre layer in olig2:GFP transgenic zebrafish, I found olig2-positive cells in the 
retina and optic nerve, confirming that oligodendroglial cells are present in both 
locations (Figure 3.8-B). To visualise these oligodendroglial cells in retina and optic 
nerve, I used the variegated transgene labelling in tg(Claudin k:Gal4,UAS:mGFP) fish 
to my advantage as then positive cells were more separated and could be 
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distinguished from each other. In whole mounted retina and optic nerve, I found 
claudin k transgene-positive cells, which were also olig2-positive, confirming their 
oligodendroglial origin (Figure 3.8-C,D). Moreover, their morphology was typical for 
oligodendrocytes with multiple processes ending in longitudinal structures, 
reminiscent of internodes (Grinspan, 2002). The identity and morphology of these 
intraretinal oligodendroglial cells has not been described before in teleosts; and 
confirms the hypothesis that these are indeed responsible for loose wraps of myelin 
around retinal ganglion cell axons. However, why they are only present in fish and 
do not form P0+ compact myelin sheaths remains unknown. 
  







Figure 3.8: Claudin k and tg(Claudin k:Gal4,UAS:mGFP) expression in the adult zebrafish optic 
nerve and retinal fibre layer. (A) Cross sections through adult zebrafish eyes show co-labelling of 
GFP, Claudin k and MBP in the central retina (arrowheads) and optic nerve (asterisks), while P0 
immunoreactivity can only be detected in the optic nerve. (B) Olig2:GFP  are present in the optic 
nerve (asterisk) and throughout the retina (arrowheads). (C) Single GFP-positive cells are visible in a 
whole-mounted optic nerve of tg(Claudin k:Gal4,UAS:mGFP) zebrafish. (D) A whole-mounted retina 
of adult tg(Claudin k:Gal4,UAS:mGFP) x tg(olig2:DsRed) double transgenic fish at low magnification 
(top row) and single oligodendrocytes therein at high magnification (bottom row) are shown. GFP-
positive processes in the retinal optic fibre layer orientate around the optic disk (asterisk). Single 
oligodendroglial cells (arrow) with processes (arrowheads) co-label with transgenic GFP and DsRed, 
while other oligodendroglial cells are only olig2:DsRed positive (open arrows). Scale bars: A, B = 200 
µm, C = 40 µm, D = 300 µm (low magnification); 20 µm (high magnification). 
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Oligodendrocyte and myelin regeneration after adult optic nerve lesion 
Due to its easy access, the zebrafish optic system is ideal to study nerve 
regeneration and related changes in oligodendrocyte differentiation. It has been 
shown previously that following an optic nerve crush in adult zebrafish, severed 
axons degenerate along the optic tract within hours, and newly formed axons 
repopulate the entire optic pathway already by day 16 post lesion (Wyatt et al., 
2010), and fully reinnervate the tectum within 4 weeks (Becker et al., 2000). To 
investigate the dynamics of claudin k-positive oligodendroglial cells during optic 
nerve regeneration, I performed optic nerve crushes in adult tg(Claudin 
k:Gal4,UAS:mGFP) transgenic zebrafish and quantified Claudin k immunoreactivity 
and GFP as a marker for differentiating oligodendrocytes and LINC 
immunoreactivity as a marker for axons (Figure 3.9). Claudin k, LINC and transgenic 
GFP were significantly reduced in the lesion site at 3 days post lesion (dpl), the 
earliest time point analysed. These findings indicate loss of oligodendrocytes and 
axons. Proximal (towards the retina) and distal (towards the brain) of the lesion, 
immunofluorescence persisted, likely due to the presence of intact axonal segments 
(proximal) and fibre debris (distal), which prevented me from further quantifying 
changes in these regions. At 7 dpl, Claudin k immunoreactivity and transgenic GFP 
was still significantly less than in controls, however, GFP-positive cell bodies were 
observed in the lesion site. LINC immunoreactivity showed increased and no longer 
significantly different levels from the 3 dpl time point, suggesting that axonal 
regrowth was in progress. At 14 dpl, GFP-positive oligodendrocytes with varying 
morphologies were observed in the lesion area, ie some with more and some with 
less processes (suggesting more and less mature cells) (Figure 3.9-A), and by 28 dpl 
all investigated markers had returned to normal levels and were comparable to 
those in unlesioned control nerve, suggesting that both axons and oligodendrocytes 
had regenerated (Figure 3.9-B,C). 
Variegated expression in the tg(Claudin k:Gal4,UAS:mGFP) fish allowed more 
detailed analysis of oligodendroglial morphology during this regenerative process as 
single transgenic cells could be visualised in the regenerating optic nerve (Figure 
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3.10-A,B). I therefore quantified GFP-positive cells 200 µm proximal and distal of 
the lesion epicentre in longitudinal nerve sections at the same time points as 
described before. There was an overall significant increase of GFP-positive 
oligodendroglial cells in the lesion from 3.0 ± 2.0 cells at 3 dpl to 17.7 ± 3.5 cells at 
28 dpl (mean ± SD, p<0.05, n=3, Mann Whitney U-test). GFP-positive cells with a 
simple morphology (≤ 2 processes, Figure 3.10-A) were present in the lesion site at 
3 dpl (3.0 ± 2.0 cells), significantly increased at 7 dpl (13.3 ± 3.1 cells, p<0.01, n=3, 
Kruskal Wallis test, Dunn’s post-test) and became fewer in number again at 14 dpl 
(4.0 ± 3.6 cells) and 28 dpl (0.3 ± 0.6 cells). By comparison, cells with a more 
complex morphology that resemble that of differentiated and myelinating 
oligodendrocytes with more than 2 processes (Figure 3.10-A) were not found in the 
lesion at 3 dpl. They were observed in the lesion site at 7 dpl (3.3 ±1.5 cells) and 14 
dpl (14.7 ± 9.8 cells), and were significantly increased toward the end of the 
regeneration process at 28 dpl (17.3 ± 3.5 cells, p<0.01, n=3, Kruskal Wallis test, 
Dunn’s post-test) This increased morphological complexity and number of axon-
associated processes of oligodendrocytes in the lesion site is suggestive of 
myelination of the regenerated axons. 
In mammalian studies, the majority of oligodendrocytes associated with 
myelination after axonal regeneration is generated by proliferation of 
oligodendrocyte precursor cells (OPCs) (Blakemore and Keirstead, 1999; Gensert 
and Goldman, 1997). To determine whether regenerated axons in zebrafish are also 
myelinated by newly generated oligodendrocytes, the animals received daily 
injections of bromodeoxyuridine (BrdU at 2,3 and 4 days post lesion. In contrast to 
the contralateral unlesioned nerve, there was a significant increase of BrdU 
labelled/GFP-positive cells in the lesion site of the crushed nerve at 14 dpl (26.7% ± 
5.6% in the lesioned vs. 5.7% ± 8.6% in the control nerve, mean ± SD, p<0.05, n=4, 
Mann Whitney-U test, Figure 3.10-C,D,E). This increased uptake of the proliferation 
marker BrdU in myelinating GFP-positive oligodendrocytes suggests a lesion-
induced generation and differentiation of oligodendrocytes during regeneration of 
the adult zebrafish optic nerve. 








Figure 3.9: Claudin k and tg(Claudin k:Gal4,UAS:mGFP) expression during optic nerve regeneration. 
(A) A schematic shows the site of crush and the part of the nerve imaged in B. (B) Immunolabelling of 
the lesion area shows decreased Claudin k, transgenic GFP and LINC (marking axons) 
immunoreactivity at 3 and 7 dpl (arrows) Myelin debris is detected distal (toward the brain) of the 
lesion site (asterisks). By 28 dpl, GFP fluorescence, Claudin k and LINC immunoreactivity have 
returned to similar levels as observed in the unlesioned nerve, suggesting successful regeneration. 
GFP-positive oligodendroglial cells with varying number of processes were detected in the lesion site 
at 14 dpl (arrowheads). (C) Quantification of immunoreactivity in the lesion site, described as a ratio 
to the signal intensity in the contra-lateral unlesioned control nerve is shown. (p< 0.05, Two-way 
ANOVA, Bonferroni post-test, n = 3). Error bars represent mean ± SD. Scale bar: B = 300 µm.  
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Figure 3.10: Oligodendroglial morphology and BrdU labelling during optic nerve regeneration.  (A) 
Variegated GFP expression labels single oligodendrocytes (cell bodies indicated by arrowheads) with 
varying number of processes in the lesion site at 14 dpl. (B) There is an overall significant increase in 
total number of labelled oligodendrocytes in the lesion site over the time points analysed (p<0.05, 
n=3, Mann Whitney U-test). The number of GFP-positive cells with two or fewer processes in the 
lesion site peaks at 7 dpl (p<0.01, n=3, Kruskal Wallis test, Dunn’s post-test). The number of GFP-
positive cells with more than two processes in the lesion site increases during the regeneration 
process until 28 dpl (p<0.01, n=3, Kruskal Wallis test, Dunn’s post-test). (C) Coronal cross sections of 
adult tg(Claudin k:Gal4,UAS:mGFP) transgenic zebrafish optic nerves 14 dpl and  BrdU injections at 
2,3 and 4 dpl show reduced GFP expression in the lesioned optic nerve and an increase in BrdU+ 
cells. (D) A single differentiating oligodendrocyte (arrowhead) in the optic nerve shows positive BrdU 
labelling at 14 dpl. (E) The proportion of GFP+/BrdU+ cells is significantly increased in the lesioned 
optic nerve (p<0.05, Mann Whitney-U test, n=4). Error bars represent mean ± SD. Scale bars: A = 20 
µm, C = 80 µm, D = 10 µm. 




Claudin k is a myelin associated protein, which is expressed in the zebrafish central 
and peripheral nervous system. Analysis of Claudin k by specific antibody 
immunolabelling and transgenic GFP expression showed a dynamic expression 
pattern during development and optic nerve regeneration that is similar to 
previously described myelination patterns (Brosamle and Halpern, 2002; Schweitzer 
et al., 2003). Moreover, the transgenic zebrafish line, which expresses membrane-
bound GFP under the claudin k promoter, allowed the morphological 
characterisation of single oligodendrocytes and their myelin sheaths around the 
retinal ganglion axons, and during the process of optic nerve regeneration following 
crush injury.  
During development, Claudin k is detectable from 3 dpf in the hindbrain, which is 
consistent with detectable mRNA in the same location from 2 dpf (Schaefer, 2009), 
and the onset of other myelination markers such as P0, DM20 (proteolipid protein) 
and MBP (Brosamle and Halpern, 2002). It is as such one of the earliest markers for 
differentiating oligodendrocytes found in zebrafish. Claudin k immunolabelling and 
transgenic GFP expression are lower in the hypomyelinating sox10t3(colourless) 
mutant zebrafish larvae compared to wild type, and after an optic nerve crush both 
markers are initially reduced in the lesion area and re-appear in a time course that 
is consistent with optic nerve regeneration. Hence, both Claudin k immunoreactivity 
and transgenic GFP can be used effectively to quantify the level of myelination and 
to track myelin-forming cells in development and in lesioned adult zebrafish. 
Throughout my studies with the transgenic tg(Claudin k:Gal4,UAS:mGFP) line, I 
observed variegated GFP expression patterns as indicated by some transgenic 
animals showing more and brighter fluorescence than others. I also found that even 
in the fish with the most labelled cells, GFP was not consistently expressed in all 
oligodendrocyte processes labelled with Claudin k or P0 antibody nor in all cell 
membranes of olig2:GFP expressing cells. This may be due to a variance in the loci 
where the transgene was integrated or the number of integrated transgene copies 
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in the individual animal. To stabilise expression patterns in this transgenic line, I 
used in- and out-crossing breeding strategies, however I continued to observe this 
variegated expression pattern. This perhaps suggests another reason, such as the 
GAL4/UAS system, which was used to generate the tg(Claudin k:Gal4,UAS:mGFP) 
line. The GAL4/UAS system was first utilised in drosophila for easy and effective 
transgenesis, and commonly uses 14 repetitive upstream activating sequences 
(UAS) (Brand and Perrimon, 1993). It allows an enhanced expression of fluorescent 
proteins even if the promoters are very weak, as the binding of GAL4 to repetitive 
UAS leads to increased production of fluorescent protein.  Recent studies in 
transgenic zebrafish with this system have shown that because the UAS is present in 
multiple identical repeats, parts become silenced through methylation (Akitake et 
al., 2011), and therefore present an explanation for the variegated expression I 
observed in the tg(Claudin k:Gal4,UAS:mGFP) line. However, although only a 
proportion of oligodendrocytes are labelled in the transgenic line, these cells are 
visible in their entire morphology and as such this provides a unique opportunity to 
use the tg(Claudin k:Gal4,UAS:mGFP) line for the study of individual 
oligodendrocytes.   
As differential myelin patterns in the adult zebrafish retina had been described 
previously, I used the tg(Claudin k:Gal4,UAS:mGFP) line to visualise individual 
myelinating cells in this area. Earlier electron microscope studies of the adult 
zebrafish retina showed that intraretinal ganglion axons are ensheathed only by 
loose wraps of cell membrane; the optic nerve by comparison showed compact 
myelination (Schweitzer et al., 2007). This is different to mammals, which do not 
possess a myelinated retina, with exception of the rabbit (Morcos and Chan-Ling, 
1997), and is consistent with findings in goldfish and other teleosts (Easter et al., 
1984; Wolburg, 1980). Previous studies have demonstrated that contactin 1a 
mRNA, which is normally only expressed by actively differentiating 
oligodendrocytes and neurons, is present in the adult zebrafish retinal fibre layer, 
whereas P0, a marker for compact protein is not detectable in the retina 
(Schweitzer et al., 2003). Thus it was not clear whether the loose myelin wraps of 
intraretinal axons originated indeed from oligodendrocytes. By investigating whole-
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mounted retinae of tg(Claudin k:Gal4,UAS:mGFP) x tg(olig2:DsRed) double 
transgenic fish, I could demonstrate that intraretinal myelinating cells indeed 
exhibit an oligodendrocyte-like morphology with several processes emanating from 
the cell body to associate with axons. This strongly supports the hypothesis that the 
cells ensheathing axons in the adult zebrafish retina are indeed oligodendrocytes.  
In mammalian retinae, a barrier prevents OPCs from migrating into the retina from 
the optic nerve head (Ffrench-Constant et al., 1988). However, when OPCs are 
injected into the normally non-myelinated rat retina, they are able to form compact 
myelin (Laeng et al., 1996; Setzu et al., 2004; Setzu et al., 2006), indicating that also 
in mammals, intraretinal axons are fully myelination competent. This raises the 
intriguing possibility that in fishes, other factors may prevent retinal 
oligodendrocytes from forming compact myelin. What these factors may be is 
unknown, but this model may be a useful tool to further investigate factors that 
could be involved in preventing oligodendrocytes from forming compact myelin, 
which as previously discussed in the context of MS, may be highly relevant in 
investigating the failure of oligodendroglial cells to fully mature into myelinating 
oligodendrocytes, one cause of remyelination failure in MS (reviewed in Piaton et 
al., 2009). 
To explore myelination in regeneration, I used the previously established optic 
nerve crush injury in adult zebrafish. I could show that at 3 days after the lesion, 
Claudin k and transgenic GFP are severely reduced and become re-detectable as the 
nerve regenerates within 4 weeks. This corresponds to earlier findings of other 
myelin markers; contactin 1a mRNA marks early differentiating oligodendrocytes 
and is most strongly up-regulated at 7 dpl, followed by P0 at 28 dpl, which marks 
the reappearance of compact myelin (Schweitzer et al., 2003). Moreover, studies in 
goldfish demonstrate the presence of the myelin molecules 36 kDa protein, 
galactocerebroside and MBP from 3.5 weeks after optic nerve crush (Ankerhold and 
Stuermer, 1999). These results suggest, that zebrafish are capable of not only 
regenerating their retinal ganglion cell axons, but can also myelinate them. 
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To gain further insight into these newly myelinating cells, I used the transgenic 
tg(Claudin k:Gal4,UAS:mGFP) line to identify GFP-positive cells in the lesion site at 
early time points following the crush injury. These cells had a simple, bipolar 
morphology and were reminiscent of oligodendrocyte precursor cells (Grinspan, 
2002). At later time points, they had a more complex morphology with multiple 
processes; this is a clear indication of oligodendroglial identity. Thus, these cells 
were unlikely to be Schwann cells, which have been shown to invade the 
regenerating optic nerve of goldfish (Nona et al., 1992). In addition, I could show 
that ~25% of oligodendrocytes in the lesion site took up the proliferation marker 
BrdU, suggesting that these cells had been newly generated.  Goldfish studies using 
dye fills of oligodendrocytes have previously demonstrated, that these are capable 
of de- and re-differentiation following optic nerve crush and only a minority (7.5%) 
are newly generated (Ankerhold and Stuermer, 1999). However, due to the 
differential nature of the dye fill and BrdU protocols, it is not possible to compare 
these findings quantitatively. Other studies also highlight the possibility that 
oligodendrocyte lineage cells could be capable of de- and redifferentiation. Using in 
vitro studies of primary cell cultures enriched in oligodendrocytes, Grinspan and 
colleagues were able to show the dedifferentiating potential of mature 
oligodendrocytes as they observed an increase in oligodendrocyte progenitor cells 
upon basic fibroblast growth factor treatment of the cultures (Grinspan et al., 
1993). Further, the authors could demonstrate that this effect of basic fibroblast 
growth factor was direct and not mediated through other cell types, and also 
required the oligodendrocytes to re-enter the cell cycle (Grinspan et al., 1996). 
Other studies investigating the role of voltage-gated potassium channels, which are 
known to be involved in growth-factor induced cell proliferation of oligodendrocyte 
lineage cells, suggest that these channels are upregulated in NG2-positive 
oligodendrocyte progenitor cells within MS lesions (Tegla et al., 2011). In addition, 
they seem to regulate cell cycle activation and oligodendrocyte dedifferentiation in 
vitro by controlling the activation of complement and the assembly of the terminal 
complement complex (C5b-9), which has been shown to play an important role in 
the pathogenesis of neurodegenerative CNS diseases like MS (Rus et al., 2006). 
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Mature oligodendrocytes in vivo therefore appear to be capable of 
dedifferentiation; however, in vivo approaches investigating the origin of 
remyelinating oligodendrocytes indicate that while in the mammalian CNS only 
oligodendrocytes that newly arise from OPCs appear capable of remyelination 
(reviewed in Blakemore and Keirstead, 1999; Franklin and Ffrench-Constant, 2008), 
Schwann cells in the PNS seem to be able to de- and re-differentiate (Mirsky et al., 
2008). Bearing in mind that fish oligodendrocytes have some similarities with 
mammalian Schwann cells, such as de-differentiation in culture (Jeserich and Rauen, 
1990) and expression of P0 (Schweitzer et al., 2003), it would be interesting to 
further investigate whether this could be the reason for successful CNS 
regeneration in fish. The results from the BrdU studies are also compatible with 
dedifferentiation, division and re-differentiation of oligodendrocytes following optic 
nerve injury and as such don’t answer the question about the origin of the cells that 
myelinate newly generated optic nerve fibres. To investigate this closer, one would 
need to design a transgenic line which would allow colour conversion of cells after 
the lesion. This is further discussed in chapter 5.  
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As highlighted in the main introduction of this dissertation, various experimental 
animal models to study demyelinating disease have already been established. 
Zebrafish are transparent during embryonic development and this advantage is 
widely used to investigate the process of myelination more closely (Almeida et al., 
2011; Czopka and Lyons, 2011; Kirby et al., 2006; Raphael and Talbot, 2011; Takada 
et al., 2010), with the goal of potentially extrapolating important findings to the 
mammalian system. Large scale screens for genes involved in myelination and for 
the discovery of pro-myelinating substances have been conducted in zebrafish 
larvae (Buckley et al., 2010; Pogoda et al., 2006; Simmons and Appel, 2012), and 
zebrafish have also been investigated as potential model organisms to study 
demyelinating diseases (Buckley et al., 2008). As such, they could be very useful to 
study promotion of myelin repair for clinical translation; however it is unclear 
whether the mechanisms of myelination in developing zebrafish are similar to 
remyelination in adult zebrafish in which developmental myelination has largely 
finished, and whether the process of remyelination in teleost fish is in fact similar to 
that in mammals. I therefore thought it important to generate an adult zebrafish 
de/remyelination model to compare with mammalian remyelination and to validate 
potential drug candidates identified in prior zebrafish screens for further testing in 
rodent or non-human primate models of demyelination and possible clinical 
translation.  
Adult zebrafish are able to regenerate various CNS tissues after injury, including 
retina, spinal cord and brain (Becker and Becker, 2008; Fimbel et al., 2007; Kroehne 
et al., 2011), however there is only limited knowledge about the regenerative 
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capacity of myelin. Previous studies investigating myelination following nerve crush 
injury in goldfish demonstrate that regenerated axons are myelinated successfully 
(Wolburg, 1978, 1981) and that this is most likely achieved by previously present 
de- and re-differentiated oligodendroglial cells (Ankerhold and Stuermer, 1999). 
However by applying a nerve crush injury, these studies effectively investigated de 
novo myelination of regenerated axons rather than remyelination of existing axons 
which have been stripped of their myelin. Hence a more accurate model system to 
study de- and remyelination without axonal injury in fish could give valuable insight 
into the processes of successful myelin regeneration. 
 
 Methods to induce demyelinating lesions 
As outlined in the general introduction, studies exploring mechanisms underpinning 
myelin repair use different experimental animal models and depending on the 
preference for focal or global demyelination, mode of application or timeframe of 
recovery, various methods to induce demyelination are available. I reviewed these 
in other species in order to choose the most appropriate for the adult zebrafish. 
These include:  
 
- Local toxin induced demyelinating lesions with substances such as 
ethidium bromide or lysophosphatidylcholine 
- Dietary intake of substances known to cause CNS demyelination such as 
Cuprizone 
- Targeting single cells of interest by laser phototoxicity 
- Transgenic conditional cell ablation by use of heat shock promoters or 
tamoxifen/diphtheria toxin inducible systems 
- Experimental autoimmune encephalitis 
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Local application of toxins 
Ethidium bromide (EtBr): Previous studies investigating remyelination in rodents 
and cats locally injected the intercalating agent EtBr and could demonstrate a toxic 
effect on myelinating cells (Blakemore, 1982; Bondan et al., 2009). While not much 
axonal damage has been reported with this model, presumably as most neuronal 
cell bodies which could be subject to EtBr intercalation are located outside of the 
white matter, the disadvantages of EtBr includes that it exhibits auto fluorescent 
qualities, which may limit the use of immunohistochemical methods following 
demyelinating injury. In addition, EtBr is highly carcinogenic and this toxic effect 
makes it impractical to handle.  
Lysophosphatidylcholine (LPC): Many experimental models of demyelinating disease 
in rodents use the detergent-like substance LPC, also known as lysolecithin, to 
demyelinate axons. It is unclear how the substance leads to demyelination; it is 
thought that like a detergent, it dissolves the myelin sheaths and leads to apoptotic 
death of oligodendrocytes. However, there is also a hypothesis that LPC has direct 
influence on immune cells. LPC results from the hydrolysis of naturally occurring cell 
membrane derived phosphatidylcholines, whereby one of the fatty acid groups is 
removed by the enzyme phospholipase A2 (PLA2). PLA2 activation is associated with 
multiple stimuli, in particular stress and inflammatory signals, and leads to the 
production of multiple pro-inflammatory lipids. The secreted form of PLA2 is 
released from macrophages and other cell types at the site of injury (Bingham and 
Austen, 1999), and by producing extracellular LPC promotes inflammatory effects 
such as the up-regulation of endothelial cell adhesion molecule and growth factors 
(Kume and Gimbrone, 1994), chemotaxis of monocytes and T-lymphocytes 
(McMurray et al., 1993; Rong et al., 2002) and activation of macrophages, which is 
thought to be T-cell mediated (Ghasemlou et al., 2007). Recent research has 
identified the G-protein-coupled receptors G2A and GPR4 in macrophages and 
dendritic cells as specific targets of LPC. Activation of these receptors leads to ERK 
MAP kinase phosphorylation, intracellular calcium increase via Gαi g-proteins and 
transcriptional activation of serum response factor (Kabarowski et al., 2002). Using 
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local application of LPC in the rat brain striatum, researchers could show an initial 
increase in number of immune cells, and chemotactic functions of LPC could be 
confirmed in in vitro cultures with microglia and astrocytes (Sheikh et al., 2009). 
This suggests that LPC may directly influence the innate immune response and 
antigen presentation prior to the LPC-induced demyelination. It is currently not 
clear if LPC primarily causes demyelination, which then triggers the immune 
response, or whether LPC mainly attracts microglia, which then lead to 
demyelination. However LPC remains a beneficial tool in remyelination research, as 
the process of de- and remyelination can be observed separately from the adaptive 
immune response.  
LPC is commonly used to induce focal demyelinating lesions in vivo and its ability to 
demyelinate axons was established as early as the 1980’s (Foster et al., 1980; 
Waxman et al., 1979). Following injection of LPC in vivo or application to slices of 
CNS tissue in vitro a reduction in immunolabelling of myelin-associated proteins 
such as myelin basic protein has been observed, while detectability of axonal 
markers such as neurofilament in immunohistochemistry remained largely 
unchanged (Birgbauer et al., 2004; Nait-Oumesmar et al., 1999; Zhang et al., 2011). 
Hence LPC can be used to induce focal demyelinating lesions. Advantages include 
the possibility of local injection and safe use for the investigator; however higher 
doses can be toxic to axons. 
It appeared possible to use both EtBr and LPC for the induction of focal 
demyelinating lesions in adult zebrafish, but as EtBr is highly toxic and LPC likely 
safer to use, I decided to trial this method. 
 
General application of toxin in diet 
Cuprizone diet-induced demyelination: Cuprizone-induced demyelination is 
commonly used in rodent experimental models and involves the feeding with a 
copper chelator, which results in demyelination of well-defined regions in the 
mouse brain (mainly the corpus callosum) within several weeks of commencing the 
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diet (Matsushima and Morell, 2001; Steelman et al., 2012). To date it is not known 
how Cuprizone leads to demyelination and what the subcellular processes are, 
however it may involve mitochondrial pathology and copper deficiency (Acs and 
Komoly, 2012; Benetti et al., 2010). Cuprizone also has a neurotoxic effect, which is 
thought to be mediated through its ability to chelate copper (Benetti et al., 2010). 
This method of demyelination has not been tried in zebrafish previously and as the 
food is fed through the water, it would be difficult to determine a) the dose of 
Cuprizone to be given to the fish and b) possible side effects as it dissolves in the 
water.  
 
Demyelination using laser ablation 
Another method to specifically target myelinating cells is laser-induced phototoxic 
apoptosis, whereby phototoxicity could induce apoptosis in specific cells of interest 
expressing a certain transgene. This method has been applied to zebrafish embryos 
and larvae before (Kirby et al., 2006), however as adult zebrafish are much bigger 
and, more importantly, not transparent, this method may only have limited 
potential in the generation of an adult zebrafish demyelination model. 
 
Transgenic conditional cell ablation 
Various methods are available for the generation of a transgenic model permitting 
an inducible ablation of specific cells of interest. As the activity of a particular gene 
can be controlled in space and time in almost any tissue, these techniques open up 
many possibilities to study the influence of single genes in specific cells in animal 
models of human disease.  
The inducible Cre/lox site-specific recombination system is widely used in rodent 
experimental models and has emerged as a powerful tool for the generation of 
mutant animals (Hayashi and McMahon, 2002). In this system, the inducible gene 
inactivation is based on tamoxifen-inducible excision of a gene of interest flanked 
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by loxP sites in cells expressing a tamoxifen dependent Cre recombinase (Figure 4.1-
A). Briefly, the Cre recombinase is fused to a mutated ligand binding domain of the 
oestrogen receptor (ER), and while CreER normally remains in the cytoplasm, on 
binding of tamoxifen to the ligand binding domain (ER), the recombinase is 
relocated into the nucleus. As oestrogen receptors normally act in the nucleus, 
application of tamoxifen, and its binding to the ER fused to Cre recombinase allows 
temporal control of its translocation into the nucleus and recombination of the 
gene of interest.  It can then recombine its loxP-flanked DNA substrate containing 
parts of the gene of interest, leaving the animal with a mutated gene. A variation of 
this method uses a loxP-flanked stop cassette followed by a gene of interest to 
selectively switch on this gene. Under normal conditions, transcription would stop 
at the stop signal and the gene of interest would remain untranscribed, however 
upon Cre recombinase translocation into the nucleus, excision of the stop cassette 
would lead to transcription of the gene of interest. To generate an inducible 
targeted cell ablation in adult zebrafish, this method could be used to create a 
transgenic line in which cells contained a loxP-flanked stop cassette followed by an 
apoptotic signal such as caspase signalling, and crossing it with another line that 
expressed tissue specific CreER. The addition of tamoxifen in animals containing 
both transgenic constructs would then cause an excision of the stop cassette and 
the tissue specific promoter could drive the expression of apoptotic signals for 
specific death of oligodendrocytes (Figure 4.1-B). Apoptosis, also known as 
programmed cell death, is mediated through caspase (cysteine aspartatic 
proteases) signalling. Caspases have been assigned a major role in programmed cell 
death; they are synthesized as inactive procaspases and participate in the cell death 
cascade once activated (reviewed in Thornberry and Lazebnik, 1998). The caspase 
cascade is executed via the initiating caspases (2,8,9 and 10) and the effector 
caspases (3,6 and 7). Overexpression or activation of caspases in this signalling 
cascade is associated with increased cell death (Druskovic et al., 2006; Yang et al., 
2007), and this can be used to specifically target cells of interest (Chelur and Chalfie, 
2007; Mallet et al., 2002).  
Page | 124  
 
Similarly, a Cre inducible diphtheria toxin receptor can mediate cell lineage specific 
cell death (Buch et al., 2005). This system could be successfully employed in the fish 
by generating a transgenic line with a loxP-flanked stop cassette prohibiting 
diphtheria toxin receptor (DTR) expression, which is removed when crossed with a 
fish line expressing Cre in the specific tissue of interest. Expression of the diphtheria 
toxin receptor sensitises the tissue to cell death induced by application of 
diphtheria toxin (Figure 4.1-C). In addition, Cre could also be expressed under the 
heatshock promoter, which would permit temporal control of Cre expression, as a 
heatshock promoter is only activated upon incubation of the animal carrying the 
construct at higher temperature. This would allow the generation of a zebrafish line 
which could be raised in normal conditions and only when Cre expression is desired, 
the fish could be incubated at higher temperatures. These inducible systems, where 
Cre recombinase leads to expression of the diphtheria toxin, are already used in 
zebrafish with success in ablating cardiomyocytes (Wang et al., 2011b), however 
transgenic zebrafish lines allowing central nervous system specific cell death would 
have to be generated. 
A relatively new method for transgenic conditional cell ablation that is widely and 
successfully used in zebrafish is the nitroreductase/metronidazole (NTR/MTZ) 
system (Curado et al., 2008). Metronidazole is an antibiotic medication normally 
used to treat infections with anaerobic organisms. When it is taken up by bacteria, 
it is non-enzymatically reduced and deactivates critical bacterial enzymes. 
Metronidazole metabolites can also be taken up into bacterial DNA to form 
unstable molecules and harm bacterial survival. In transgenic models using this 
system for conditional cell ablation, a tissue specific promoter drives NTR, a 
bacterial enzyme, which converts the compound MTZ from an inactive metabolite 
to its active cytotoxic form. As a result, the application of MTZ leads to toxic 
ablation of specific cells containing the enzyme NTR (Figure 4.1-D). This method 
shows reproducible results, and as it is only dependent on the addition of MTZ, it is 
also reversible. A clear advantage of this system is that metronidazole can be 
applied locally or globally, as such resulting in different extents of cell ablation. 
Recent research shows that this system can be used successfully in larval Xenopus 
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laevis to specifically ablate oligodendroglial cells and to investigate the events of 
demyelination and myelin repair (Kaya et al., 2012), however this is not known for 
zebrafish. Moreover, there is yet no evidence that this transgenic inducible system 
is retained into adulthood in any species and could be useful for the generation of 
an adult demyelination model. 
As I aimed to investigate whether the previously described tg(Claudin 
k:Gal4,UAS:mGFP) transgenic zebrafish line, Tg(claudin k:GAL4,UAS:GFP) could be 
used to generate offspring in which cells of the oligodendrocyte lineage could be 
specifically ablated, I chose to trial this system. 
 
Experimental autoimmune encephalomyelitis (EAE) 
EAE is commonly used to study de- and remyelination in rodent experimental 
models as described in chapter 1. Although it is useful for investigation of 
inflammation due to its immunological component in disease pathogenesis, the de- 
and remyelination in this model is ongoing as the disease pattern is often relapsing 
or chronic, making it more complicated to separate the remyelination process for 
closer examination. Limitations also include associated axonal damage and the 
many different disease courses described in murine EAE (Kipp et al., 2012). While it 
has been described that immunisation of zebrafish with central nervous system 
homogenate was able to trigger inflammation of the CNS (Quintana et al., 2010), it 
is unclear how the immune system of fish and mammals compares and whether this 
method would lead to demyelinating lesions in the fish brain.  
To study de- and remyelination in adult zebrafish, I therefore chose to generate a 
zebrafish line for transgenic conditional cell ablation utilising the NTR/MTZ 
technique. In addition I sought to determine whether LPC can be used to generate 
focal demyelinating lesion in the adult zebrafish optic nerve, as this is a part of the 
central nervous system which is very easily accessible for operative procedures.  
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Figure 4.1: Outline of methods available to generate tools for transgenic conditional cell ablation. 
(A) Cre/lox-site specific recombination controlled by the steroid tamoxifen. When tamoxifen binds to 
the ligand binding domain of the oestrogen receptor (ER) fused to the Cre, CreER translocates to the 
nucleus and recombines loxP sites within a gene of interest. (B) In fish this system could be used to 
drive an apoptotic signal under a tissue specific promoter after recombination of the loxP-flanked 
stop-cassette. (C) Similarly, Cre could excise a stop-cassette under a tissue specific promoter to drive 
the expression of diphtheria toxin receptor, rendering specific cells sensitive to the toxin. (D) In the 
nitroreductase (NTR)/metronidazole(MTZ) cell ablation method, NTR is expressed under  a tissue 
specific promoter, allowing to convert inactive MTZ to its active form and resulting in toxic death of 
particular cells of interest.  




Transgenic conditional cell ablation in larval zebrafish using the nitroreductase/ 
metronidazole method 
A transgenic line making use of the NTR/MTZ system can be generated either by 
injecting a direct construct into zebrafish embryos, for example where a tissue 
specific promoter drives NTR and a fluorescently tagged protein directly, or by 
crossing two transgenic lines containing the driver and responder constructs. To 
explore the usefulness of my previously characterised driver line, I chose to use the 
zebrafish line described in chapter 2, in which the glial cell promoter claudin k drives 
the expression of GFP via the Gal4-UAS system, Tg(claudin k:GAL4,UAS:GFP). The 
responder line expressing NTR linked to a mCherry fluorescent protein under the 
control of UAS, Tg(UAS:nfsb-mCherry) was generously provided by Dr Hitoshi 
Okamoto, Japan and has been described previously (Davison et al., 2007).  After 
crossing these lines, some of the offspring contained all constructs, allowing claudin 
k to drive the expression of Gal4, which should bind to the UAS of both other 
constructs, one driving expression of GFP and the other NTR and mCherry 
Tg(claudin k:GAL4,UAS:GFP) x Tg(UAS:nfsb-mCherry) (Figure 4.2-A). Double 
transgenic offspring showed glial cells expressing GFP and mCherry (Figure 4.2-B). 
However, as noted in the previous chapter, although the Gal4/UAS system was 
designed to enhance expression particularly in the presence of a weak promoter, 
multiple identical repetitive UAS sequences lead to silencing of the transgene 
through methylation (Akitake et al., 2011). As a result, the offspring I generated in 
the facility from the driver and responder lines described showed very variegated 
GFP and mCherry expression, where some glial cells expressed either GFP or 
mCherry, and others expressed both or neither. This implied some difficulties in 
generating a reliable tool for oligodendroglial cell ablation in zebrafish, and will be 
discussed further in the discussion section of this chapter. To investigate whether 
glial cells in this transgenic line could be specifically ablated, I treated zebrafish 
larvae with MTZ for 48 hours from 4-6 dpf and performed live imaging of the same 
fish at various time points (Figure 4.2-C). The treatment onset at 4 dpf was chosen 
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based on the observation that this was the earliest time point at which a sufficient 
number of cells were mCherry-positive in the spinal cord, suggesting that these 
would be sensitive to metronidazole; the treatment length of 48 hours was chosen 
based on the complete disappearance of mCherry transgene, which was still 
present in many spinal cord cells after only 24 hours of MTZ treatment (checked 
visually under the fluorescent stereomicroscope). I observed that at 4 dpf, 
transgenic zebrafish larvae had an average of 12.8 ± 4.6 (mean ± SD) mCherry-
positive cells over 6 segments, which significantly dropped to 0.3 ± 0.8 cells (mean ± 
SD, p<0.001, n=6, Kruskal Wallis test, Dunn’s post-test) after 48 hours of treatment 
with MTZ and partially recovered until 12 dpf (the latest time point analysed due to 
poor survival, p<0.05, n=6, Kruskal Wallis test, Dunn’s post-test, Figure 4.2-D). This 
means that the system is able to recover once MTZ is withdrawn, however, the 
question whether the recovery was a response to the pathological insult, or rather 
normal development (albeit delayed) remained.  
To investigate this further, I treated another clutch of transgenic offspring with MTZ 
and compared the number of mCherry-positive cells in the spinal cord before and 
after treatment to the number of cells in siblings of the same clutch, which had not 
received MTZ treatment (Figure 4.2-E,G). This clutch showed fewer mCherry-
positive cells in the spinal cord before treatment. As before, the treated group 
showed a marked decrease of mCherry-positive cells in the spinal cord after 48 
hours of MTZ treatment (3.9 ± 2.4 cells to 0.4 ± 0.5 cells, mean ± SD), with partial 
recovery to 2.1 ± 1.4 cells seen at the 10 dpf time point. The number of cells in 6 
segments of the spinal cord in the control group increased from 3.8 ± 2.3 at 4 dpf to 
5.9 ± 2.0 mCherry+ cells (mean ± SD) at 10 dpf and indicates normal development. 
These finding indicate that while there is some recovery and generation of new 
mCherry+ cells in the treated group, these do not reach control levels within 4 days 
of treatment cessation. The rate of mCherry+ oligodendrocyte addition between 6 
dpf and 10 dpf was not different in the MTZ-treated group compared to the control 
group and suggesting a normal developmental generation, which is not accelerated 
due to previous ablation. To determine whether the cell number in the treated 
group catches up to normal levels again, I attempted live imaging at longer time 
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points after treatment, however this was severely hindered by the poor survival of 
the zebrafish larvae. Whether this was due to the treatment or to the conditions 
they were kept in during the analysis is unclear.  
Throughout my analysis, I noticed that mCherry-positive cells in the PNS, specifically 
the posterior lateral line nerve (PLLN), were also reduced after treatment, however 
as I was aiming to ablate oligodendrocytes in the CNS, I did not investigate this any 
further. To determine whether the ablation of mCherry-positive cells would lead to 
a deficit in myelination, I measured Claudin k pixel intensity before and after MTZ 
treatment (Figure 4.2-F), and found that there was no difference in the Claudin k 
pixel intensity in the spinal cord after MTZ treatment, indicating that probably not 









Figure 4.2 (A-B): Investigating the efficiency of the nitroreductase/metronidazole (NTR/MTZ) 
system in zebrafish larvae. (A) Schematic of driver and responder zebrafish lines used to generate 
transgenic offspring in which targeted cell ablation is inducible by treatment with MTZ. (B) Live 
imaging of transgenic offspring from lateral show GFP and mCherry expression in cells of the central 
(red arrows) and peripheral (green arrows) nervous system. Scale bars: B = 0.5 mm. 
 
 






Figure 4.2 (C-G): Investigating the efficiency of the nitroreductase/metronidazole (NTR/MTZ) 
system in zebrafish larvae. (C) Schematic of MTZ treatment and live imaging time points in 
transgenic larvae. (D, E) Cell counts of mCherry-positive cells over 6 spinal cord segments in live 
imaged transgenic zebrafish larvae from different clutches are shown. (D) mCherry-positive cells are 
notably decreased after 48 hours of MTZ treatment and recover following the treatment cessation 
(p<0.05, n=6, Kruskal Wallis test, Dunn’s post-test). (E) Live imaging of transgenic zebrafish larvae 
with and without MTZ treatment shows that some mCherry-positive cells are generated after 
cessation of MTZ treatment, however the amount of cells recovered do not reach control levels by 
10 dpf. (F) Claudin k pixel intensity measurements in the spinal cord of MTZ treated transgenic ZF 
larvae shows no difference to control indicating that not sufficient cells were ablated to cause myelin 
deficiency. (G) Live imaging of one control and one MTZ treated fish at time points shows mCherry-
positive cells in the spinal cord before MTZ treatment (black arrowheads), disappearance of these 
cells after 48 hours of MTZ treatment (red arrowheads) and the appearance of new mCherry 
expressing cells at 10 dpf (green arrowhead). Error bars represent mean ± SD. Scale bars: G = 100 
µm. 
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Transgenic conditional cell ablation in adult zebrafish using the nitroreductase/ 
metronidazole method 
To determine whether this system could be used in adult zebrafish to specifically 
ablate cells of oligodendroglial lineage, I generated NTR-transgenic zebrafish 
offspring as before, sorted them for the strongest mCherry expression and raised 
them to adulthood. At this time, I treated them with MTZ until I could see less 
mCherry-positive transgene in superficial nerves of anaesthetised adult zebrafish 
under a fluorescent stereomicroscope. I observed that after 1 week of treatment, 
the mCherry-positive transgene was largely absent in the superficial skin nerves 
(data not shown). In addition, the MTZ treated NTR transgene-positive group 
showed less active swimming behaviour compared to the non-treated control group 
carrying the NTR transgene, and this was confirmed with behavioural testing, which 
showed a decreased mean velocity and total distance moved (Figure 4.3-A,B). 
However, the NTR transgene-negative group, which also received MTZ treatment 
showed similar changes in swimming behaviour and hence, I concluded that this 
was probably a toxic effect of MTZ.  
Upon histological analysis of the brain of the NTR transgene-positive adult zebrafish, 
which had not been treated with MTZ, I was surprised to find no mCherry 
expression in the brain at all (Figure 4.3-C). However, sections of the posterior 
lateral line nerve (PLLN) of the same fish suggested that the NTR transgene was still 
expressed in the PNS, as I observed many mCherry+ cells in cross sections of the 
PLLN (Figure 4.3-D). In fish, which had been treated with MTZ for 1 week, mCherry 
immunofluorescence in the PLLN was reduced and appeared very clumpy (Figure 
4.3-D). Thus, the system appears to be working in the PNS, not the CNS; possible 
reasons for this include an inactive promoter in adulthood or transgene silencing. 
These findings highlight the difficulties with variegated transgenic expression and 
potential silencing in specific tissues. As my aim was to create an experimental 
model to explore myelin injury in the central nervous system of adult zebrafish, this 
genetic cell ablation method proved insufficient for my purposes and I focussed on 
using focal application of LPC. 
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Figure 4.3: Targeted cell ablation in adult zebrafish using the NTR/MTZ technique. (A,B) Adult 
zebrafish were treated with MTZ for 1 week. Behavioural analysis shows a difference between the 
control group and the MTZ treated group in the mean velocity and total distance moved. A group 
treated with MTZ but not transgenic for NTR showed no difference to the MTZ treated group 
containing the transgene (p>0.05, n=3, Mann Whitney-U test) indicating that this was a toxic effect 
of MTZ. (C) Immunohistochemical analysis of vibratome cross sections of adult zebrafish brain show 
that NTR-mCherry is not expressed. (D) Cryostat cross sections of adult zebrafish PLLN indicate that 
NTR-mCherry is expressed in the peripheral nervous system, and is reduced after 1 week of MTZ 
treatment. Error bars represent mean ± SEM. Scale bar: C = 200 µm, D = 50 µm.  
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Toxin-induced demyelinating lesions by LPC injection 
As genetic targeted cell ablation in the central nervous system of adult zebrafish 
was insufficient with the transgenic line I had generated, I chose a different method 
to induce demyelinating lesions. Lysophosphatidylcholine (LPC) is a detergent-like 
substance, which is used widely in rodent models to induce demyelinating lesions, 
usually administered by injection into the corpus callosum or other strongly 
myelinated tracts within the brain or spinal cord (Foster et al., 1980). In the 
zebrafish optic nerve approximately 95% of the fibres are myelinated. Hence I 
injected the optic nerve of adult zebrafish with 2µl of 1% LPC, the standard 
concentration used in rodents, and within 8 days I observed a much reduced 
immunohistochemical myelin staining in longitudinal sections of the lesioned optic 
nerve, while the axonal marker LINC was present across the lesion site (Figure 4.4-
A,B). At this time point 4C4+ microglia were also increased in the lesioned optic 
nerve (Figure 4.4-C). 
To investigate the time course of myelin injury and repair using this method of LPC 
injections, I performed multiple immunohistochemical analyses of optic nerve cross 
sections at various time points following the LPC injection (Figure 4.5-A). To quantify 
myelin and axons, I measured pixel intensity of Claudin k and LINC 
immunofluorescence and calculated a ratio of lesioned to unlesioned optic nerve, 
hence the closer the ratio was to 1 the more similar the signal was to that in 
unlesioned optic nerve. This method was chosen to account for any differences of 
the immunohistochemical staining between the different animals. 
 I found that Claudin k immunoreactivity was significantly reduced at 8 dpl 
(compared to 2dpl and 28dpl, p<0.05, n=3-6, Kruskal Wallis test, Dunn’s post-test) 
and had returned to control levels within 4 weeks, while the axonal stain LINC 
remained constant throughout the time course (Figure 4.5-B,C). Counts of 4C4-
positive cells in the optic nerve, representative of microglia, showed a significant 
increase at early time points (p<0.05, n=3, Kruskal Wallis test, Dunn’s post-test), 
which also returned to control levels within 4 weeks (Figure 4.5-D). To confirm that 
this increase of microglia number was an effect of the LPC rather than the injection 
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process, I compared the numbers of 4C4-positive cells in the optic nerve after LPC 
injection to PBS injection and unlesioned control (Figure 4.5-E,F). The number of 
4C4-positive cells at 8 days following the lesion was significantly larger in the optic 
nerve of LPC injected animals than in those injected with PBS (p<0.05, n=3, Mann 
Whitney U-test), hence this increase in cell number is probably due to the direct 
effect of LPC rather than the injection. However, the number of 4C4-positive cells in 
PBS injected animals was also higher than compared to unlesioned control optic 
nerves, indicating that the injection process is also associated with an immune 
response (p<0.05, n=3, Mann Whitney U-test). 
  





Figure 4.4: LPC injection into adult zebrafish optic nerve. (A) LPC was injected into the optic nerve 
as shown on this schematic. (B) Immunohistochemical analysis of longitudinal optic nerve sections at 
8 dpl shows reduced Claudin k immunoreactivity while the axonal stain LINC is present across the 
lesion site. (C) Immunohistochemical analysis of a section through the optic chiasm at 8 dpl shows an 
increase in 4C4-positive microglia in the lesioned optic nerve (arrows). Schematic shows the region 
where the cross section was taken. Scale bars: B,C = 100 µm. 
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Figure 4.5: Analysis of regeneration following LPC injection into adult zebrafish optic nerve. (A) 
Schematic of time course performed to investigate regeneration is shown. (B) Claudin k 
immunofluorescence is maximally decreased at 8 dpl (p<0.05, n=3-6, Kruskal Wallis test, Dunn’s 
post-test). (C) LINC immunofluorescence does not show differences throughout the time course. (D) 
4C4-positive cells are significantly increased at early time points after the lesion and return to normal 
levels within 4 weeks (p<0.001, n=3, Kruskal Wallis test, Dunn’s post-test). (E) Numbers of 4C4-
positive cells in longitudinal sections of the optic nerve were significantly higher 8 days after LPC 
injection compared to PBS injected controls (p<0.05, n=3, Mann Whitney U-test). Numbers of 4C4-
positive cells in PBS injected optic nerves are also higher than unlesioned controls indicating that the 
injection is associated with an immune response as well (p<0.05, n=3, Mann Whitney U-test). (F) 
Images of optic nerve cross sections stained for 4C4+ cells are representative for data shown in E. 
Error bars represent mean ± SEM. Scale bar: F = 100 µm.  
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To further investigate myelination of optic nerve fibres and myelin regeneration, I 
performed electron microscopy studies. Analysis of optic nerve cross sections 
showed many unmyelinated axons at 8 dpl compared to contralateral unlesioned 
optic nerves, but after 28 dpl most were ensheathed by myelin again (Figure 4.6-
A,B,C). More specifically, in the unlesioned control optic nerve 93% ± 2.3% (mean ± 
SEM) of axons were myelinated and this was reduced significantly to 17% ± 11.9% at 
8 dpl (mean ± SEM, p<0.05, n=3, Kruskal Wallis test, Dunn’s post-test) and not 
different to unlesioned controls at 28 dpl with 84% ± 9.6% myelinated axons (mean 
± SEM, Figure 4.6-D). In the lesion site at 8 dpl, I also observed myelin debris around 
bare axons and many macrophages/microglia with ingested myelin droplets (Figure 
4.6-E,F). For further examination of myelin regeneration after LPC injection, I 
measured G-ratios in the unlesioned control, lesioned and regenerated optic nerve 
and found that while the average G-ratio was significantly increased at 8 dpl due to 
many non-myelinated fibres (p<0.01, n=3, Kruskal Wallis test, Dunn’s post-test), the 
regenerated axons showed no difference to unlesioned controls (Figure 4.6-G). As it 
is difficult to determine the location of the lesion site in a fully regenerated optic 
nerve I performed serial sections every 100µm for the first 400µm from the distal 
side (near chiasm) of each regenerated optic nerve (Location A-D). By 
immunohistochemistry for Claudin k, the lesion could always be found within this 
distance from the chiasm and ensured that the lesion site was also sectioned and 
analysed in electron microscopy. By electron microscopic analysis, the average G-
ratio was not different at any of the optic nerve locations analysed at 28 dpl, 
suggesting full myelin regeneration (Figure 4.6-G). Correlations of G-ratio and axon 
diameter show similar populations at 28 dpl and in unlesioned control, while most 
axons at 8 dpl have larger G-ratios indicating thinner myelin (Figure 4.6-H-M). 
These results suggest that zebrafish optic nerve axons are able to fully regenerate 
their myelin sheath after LPC injection. However, on closer evaluation of the images 
at 8 dpl, it seemed that there were many more small diameter axons, which 
appeared closely clustered together and reminiscent of regenerated fibres or axon 
sprouts. I therefore wondered whether these fibres had possibly been damaged 
during the injection process and not primarily demyelinated, and so also not 
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remyelinated but just myelinated for the first time, similarly to the optic nerve crush 
situation. Previous studies in fish show that severed axons in the optic nerve are 
capable of re-growing and re-innervating the optic tectum (Becker et al., 2000).  
These regenerated fibres are known to be small calibre axons, which run in bundles 
of close axonal density (Nona, 1994). A frequency distribution of axonal diameter 
was significantly different in lesioned optic nerves compared to unlesioned controls 
(p<0.05, Kolmogorov-Smirnov test), with more small calibre axons (0.2-0.29 µm) 
present in the LPC-injected optic nerves (p<0.05, n=3, Mann Whitney U-test, Figure 
4.7-B). This might indicate that some of the axons were indeed damaged and the 
unmyelinated, small calibre axons seen may be sprouts. The previous finding of 
microglia activation upon PBS injection supports the hypothesis of mechanical axon 
damage. 
To further investigate whether axonal damage was induced during the injection 
process and to which extent, I performed neuronal tracer experiments. For this I 
injected biocytin tracer into the optic nerve, which would only be taken up and 
transported along the optic pathway by damaged axons, and I assessed labelling of 
the optic tectum after 4 hours (Figure 4.7-C). In zebrafish, like in other fish, almost 
all optic nerve fibres cross the midline at the chiasm. This is different to mammals 
where 50% of fibres cross the midline to the contralateral side and 50% remain 
ipsilateral. I could therefore measure the uptake of the biocytin tracer in the 
contralateral tectum in zebrafish after tracer application and make a quantitative 
statement about the percentage of damaged optic nerve fibres.  Compared to the 
positive control in which all axons had been severed and traced, and as a result the 
entire optic tectum of the contralateral side showed tracer uptake, there was only 
partial labelling in the tracer injected animals (Figure 4.7-D). Measuring the length 
of the tectum and the percentage labelled by the neuronal tracer permitted 
quantification of these findings. In the injected animals, approximately one-third of 
the tectum was labelled with tracer, indicating that the process of injecting into the 
optic nerve damaged approximately one-third of the axons (Figure 4.7-E). As the 
injection of LPC into the zebrafish optic nerve led to axonal damage, this was not 
the optimal model for demyelination. 





Figure 4.6 (A-F): Electron microscopy studies of optic nerve cross sections before and after LPC 
injection. (A-C) Electron microscopy analysis of optic nerve cross sections shows myelinated fibres in 
unlesioned nerves (A), many non-myelinated fibres at 8 dpl (B), and fibres with regenerated myelin 
at 28 dpl (C). (D) Quantification of myelinated and non-myelinated fibres show a significant decrease 
in myelinated fibres at 8 dpl and regeneration within 4 weeks (p<0.05 n=3, Kruskal Wallis test, 
Dunn’s post-test). (E-F) Areas of demyelination at 8 dpl presented with microglia/macrophages with 
ingested myelin droplets (red arrows) and myelin debris around axons (yellow arrows). Scale bars: 
A,B,C = 1 µm; E = 2 µm, F = 0.2 µm. 
 
 




Figure 4.6 (G-M): Electron microscopy studies of optic nerve cross sections before and after LPC 
injection. (G) Quantification of average G-ratios showed significant differences at 8 dpl compared to 
unlesioned controls (p<0.01, n=3, Kruskal Wallis test, Dunn’s post-test). The optic nerve at 28 dpl 
was cut in 4 different locations each 100 µm apart to ensure the lesion site was sectioned. The 
average G-ratio in all locations at 28 dpl was not different to unlesioned controls, suggesting full 
myelin regeneration. Error bars represent mean ± SEM. (H-M) Correlations of G-ratio and axon 
diameter show similar populations at 28 dpl (all locations) and in unlesioned control, while most 
axons at 8 dpl have a much larger G-ratio indicating thinner myelin (circle).  




Figure 4.7: Investigation of axonal damage after LPC injection into adult zebrafish optic nerve. (A) 
Axon density in lesioned optic nerves higher than unlesioned controls. (B) A frequency distribution 
analysis of axon diameter in lesioned optic nerves is significantly different to that found in control 
optic nerves (p<0.05, Kolmogorov-Smirnov test). Moreover, it suggests more small calibre axons in 
the lesioned optic nerve (0.2-0.29 µm diameter) compared to non-lesioned controls (p<0.05, n=3, 
Mann Whitney U test). (C) The schematic shows how tracer experiments were performed: Tracer 
was injected into the optic nerve and assessed by positive labelling of the tectum. (D) Vibratome 
cross sections of an adult zebrafish brain after neuronal tracing are shown. The control group in 
which all axons were severed and traced shows full tectal labelling (black arrows), while the tracer 
injected group only shows partial labelling (red arrows). Neutral red staining labels neuronal cell 
bodies. Dorsal is up. (E) Quantification of tracer labelled area in the tectum (length of tectum 
labelled was measured) suggests that one-third of the axons are damaged during the injection 
process. Error bars represent mean ± SEM. Scale bar: D = 400 µm. 
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Toxin-induced demyelinating lesions by local LPC application 
As injections of LPC result in partial axonal damage and therefore could be used to 
investigate pure de- and remyelination, I applied LPC by soaking a medical sponge 
(Gelfoam®) in the LPC solution and placing it next to the optic nerve in order to 
prevent manual axonal damage during the application process. I then also 
performed neuronal tracer experiments to check for axonal damage (Figure 4.8-A). 
For this, I placed a small piece of gelfoam soaked with different amounts of a 1% 
LPC solution next to the optic nerve. The axons were traced at 8 days after the 
placement of the LPC-sponge, which is the time point at which I had observed a 
reduction in the immunoreactivity of myelin-associated proteins with LPC injection 
and this method. The nerve was cut proximal to the lesion side and the neuronal 
tracer biocytin applied to the end of the severed optic nerve to allow for uptake 
into the axons. Two possible outcomes were considered: in the event of no axonal 
damage, all axons would transport the tracer to the optic tectum and I would 
observe full labelling of the contralateral side, whereas in case of damaged axons 
some would not transport the tracer to the tectum, and only partial labelling would 
be visible. To control for all axons remaining intact, I soaked the gelfoam with PBS 
instead of LPC, and as a control for partial axon damage I performed a partial crush 
of the optic nerve where only a fraction of optic nerve axons were severed. 
As expected, full tectal labelling was visible in the control animals treated with the 
PBS-soaked gelfoam and animals, which received the partial optic nerve crush 
showed only partial labelling (Figure 4.8-B). To quantify this, I measured pixel 
darkness in the optic tectum and calculated a ratio to the unlesioned/untraced side 
to normalise for varying tissue darkness across different sections; hence a ratio of 
1.0 would indicate no tracer uptake and equal darkness to the unlesioned/untraced 
side. After 5 µl LPC on gelfoam the labelling was not different to the PBS treated 
controls, while 10 µl of LPC on gelfoam resulted in a clear reduction in tectal 
labelling darkness and was similar to that of the partial crush (p<0.05, n=3, Kruskal 
Wallis test, Dunn’s post-test, Figure 4.8-B,C). These results indicate that larger 
amounts of LPC lead to axonal damage and that the optimal amount for 
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demyelination has to be determined for this model. Hence I analysed longitudinal 
sections of optic nerves demyelinated with different amounts of LPC. For this, the 
widest diameter of a Claudin k-negative demyelinated lesion in optic nerve sections 
was measured and expressed as a percentage of total nerve diameter. I found that 
5 µl and 10 µl both demyelinated approximately 70% of the optic nerve, compared 
to only ~15% demyelination with 1 µl LPC (p<0.01, n=3, Kruskal Wallis test, Dunn’s 
post-test, Figure 4.8-D). Pixel intensity measurements of Claudin k and LINC in the 
lesion area and compared to the non-lesioned contralateral optic nerve 
representing myelination and axons respectively demonstrated a significant 
decrease in optic nerve myelination with 5 µl and 10 µl LPC (p<0.05, n=3, Kruskal 
Wallis test, Dunn’s post-test) while axonal immunoreactivity only appeared reduced 
with 10 µl LPC (p<0.01, n=3, Kruskal Wallis test, Dunn’s post-test, Figure 4.8-E).  
Taken together these results show that 1 µl LPC is not sufficient for demyelination, 
5 µl LPC leads to demyelination and 10µl LPC causes loss of myelin and axonal 
damage. Hence I chose to proceed with 5µl LPC on gelfoam to establish the time 
course for de-and remyelination in the adult zebrafish optic nerve, which are 
described in chapter 5. 
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Figure 4.8 (A-C): Assessing neuronal damage after lesioning the optic nerve with LPC on gelfoam. 
(A) Schematic shows how neuronal tracing experiments were performed: The optic nerve was 
lesioned with LPC on a gelfoam sponge and after 8 days the nerve was cut proximal to the lesion for 
the application of a tracer. If no axons were damaged, the tracer would be expected to travel along 
the optic pathway and label the entire tectum of the contralateral side. In case of axonal damage 
only part of the axons would take up the tracer and partial tectal labelling would be observed. (B) 
Vibratome sections of adult zebrafish brains after LPC lesions and neuronal tracer application are 
shown. Treatment with PBS leads to labelling of the entire optic tectum, whereas a partial crush 
results in partial labelling (black arrows). Tracer uptake is also much reduced after 10 µl LPC, 
indicating axonal damage. Dorsal is up. (C) Quantification of tectal labelling was done by calculating a 
ratio of pixel darkness between lesioned/traced and unlesioned/untraced side. PBS and 5 µl LPC 
treatment show no difference, while partial crush and 10 µl LPC treatment result in reduced tracer 
uptake suggesting axonal damage (p<0.05, n=3, Kruskal Wallis test, Dunn’s post-test). Error bars 
represent mean ± SEM. Scale bars: B = 100 µm (top row), 200 µm (bottom row).  







Figure 4.8 (D-E): Assessing neuronal damage after lesioning the optic nerve with LPC on gelfoam. 
(D) To quantify the amount of demyelination, the widest diameter of a demyelinated optic nerve 
lesion marked by reduced Claudin k immunoreactivity was measured and expressed as a percentage 
of total nerve diameter. While 1µl LPC did not cause any notable demyelination, 5 µl and 10 µl 
demyelinated approximately 70% of the optic nerve fibres (p<0.05, n=3, Kruskal Wallis test, Dunn’s 
post-test). (E) Pixel intensity quantification of Claudin k (myelin) and LINC (axons) show reduced 
Claudin k immunoreactivity with 5 µl and 10 µl treatment and reduced LINC immunoreactivity with 
10µl treatment suggesting demyelination with 5 µl LPC and axonal damage with 10 µl LPC (p<0.05, 
n=3, Kruskal Wallis test, Dunn’s post-test). Error bars represent mean ± SD (D) and ± SEM (E).   




Regeneration of myelin is often insufficient in humans and as zebrafish demonstrate 
a remarkably high capacity to fully repair various tissues I aimed to generate a 
model in adult zebrafish that would allow analysis of myelin de- and regeneration 
without concurrent axon injury.  
Various ways to induce demyelinating lesions in experimental animal models have 
been described in literature, including the use of ethidium bromide (Blakemore, 
1982), Cuprizone (Matsushima and Morell, 2001) and inducible transgenic methods 
(Kaya et al., 2012), however to date none have been established in zebrafish, and 
therefore I tried and compared different approaches.  
Transgenic conditional cell ablation has only been developed in recent years and 
relies on transgenic expression of a toxin receptor to which a cell toxic substance 
can bind or an enzyme which can convert inactive substances to active cell toxic 
metabolites. If these constructs are driven by a promoter specific to the cells of 
interest, targeted cell death can be induced. The nitroreductase/metronidazole 
method has already been successfully employed in zebrafish to ablate cells in 
specific tissues (Ariga et al., 2010; White et al., 2011; Zhou and Hildebrandt, 2012), 
however targeted ablation of oligodendroglial cells in zebrafish has not been 
described. As I wanted to investigate whether my previously described line, 
Tg(claudin k:GAL4,UAS:GFP) could be used to generate offspring in which cells of 
the oligodendrocyte lineage could be specifically ablated, I crossed it with the driver 
line Tg(UAS:nfsb-mCherry). While many offspring showed some expression of driver 
and responder transgenes there was a highly variable expression pattern across 
different siblings from the same clutch and amongst clutches from the same 
parents. This was mainly visible in the number of cells labelled with GFP and/or 
mCherry, as some only expressed GFP or mCherry and others expressed both or 
neither, despite the fact that all transgenic fluorescent proteins were driven by the 
same promoter claudin k. This variegated expression in the Tg(claudin 
k:GAL4,UAS:GFP) zebrafish line has been described before (Chapter 3 and Münzel et 
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al., 2012). One of the possible reasons  for this is DNA methylation due to the 14x 
repetitive UAS sequences causing gene silencing and attempts have been made to 
develop constructs which do not contain repetitive sequences to alleviate this 
problem (Akitake et al., 2011). DNA methylation is a process whereby a methyl 
group is added to the cytosine or adenine in the DNA, thereby suppressing the 
expression of genes (for example viral genes), which could be harmful to the cell. 
The presence of 14 identical UAS sequences in the responder lines to enhance 
transgene expression is therefore probably recognised as potentially harmful and 
methylation prevents further expression, along with silencing of the transgene. 
Akitake and colleagues have developed non-repetitive UAS sequences, which have 
been shown to result in less DNA methylation, and are also associated with less 
transgene silencing (Akitake et al., 2011). 
As a result of using a transgenic line with repetitive UAS sequences, only a limited 
number of oligodendroglial cells, namely the ones expressing the NTR transgene, 
could be ablated with the MTZ treatment and although live imaging showed clearly 
that NTR-mCherry-positive cells were destroyed and new ones generated, this was 
not sufficient to cause disruption of myelin in MTZ treated zebrafish larvae. As such, 
this system could be useful to investigate glial cell ablation and regeneration on a 
single cell level, but cannot be used to induce local demyelinating lesions or global 
ablation of glial cells. Due to this reason, this system is also not ideal for drug 
screening, in particular to evaluate the pro-myelinating effects of chemical 
compounds, as the number of oligodendroglial cells varies between clutches and 
siblings of the same clutch and does not offer a stable read-out.  
In adult zebrafish, I found that the NTR-mCherry transgene was not expressed at all 
in oligodendroglial cells in the brain and only appeared in a clumpy distribution in 
cells of the posterior lateral line nerve, which is part of the peripheral nervous 
system. The lack of expression is presumably due to transgene silencing, rather than 
a switched-off promoter in adulthood, as I could demonstrate that claudin k-driven 
GFP expression in the adult zebrafish brain was still present. The clumpy 
distribution of NTR-mCherry in the posterior lateral line nerve could be due to the 
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size of the fluorescent protein as similar non-homogenous distribution patterns of 
the similar sized fluorescent protein DsRed have been described previously (Okita et 
al., 2004).  
In summary, the zebrafish line that I generated for conditional cell ablation is not 
useful for adult demyelination studies. To use the transgenic embryos for further 
investigation of the cellular events following destruction of single oligodendroglial 
cells, it would be necessary to determine what occurs during normal development 
as it is difficult to investigate the response to injury in a developing system. It could 
also be useful to explore whether there is a time point at which the generation of 
new NTR-mCherry-positive cells plateaus but NTR-mCherry is still expressed in 
oligodendroglial cells in the larval zebrafish, compared to adult zebrafish where the 
transgene is no longer visible in the CNS.  
To bypass the problem of lack of NTR-mCherry transgene expression in the adult 
zebrafish, I investigated whether demyelinating lesions could also be induced by the 
myelin toxin LPC. Firstly I injected the toxin into the optic nerve and could show that 
there was reduced immunoreactivity of myelin and axons markers, both of which 
returned within 4 weeks. However, visual evaluation of the electron microscope 
images at 8 dpl also appeared to have more small calibre axons clustered together 
in bundles. This was reminiscent of what has been shown in studies investigating 
axonal regeneration in fish, as they describe axonal sprouting and the presence of 
many small calibre axons which regrow in bundles of high axonal density (Becker et 
al., 2000; Nona, 1995). 
A frequency distribution of axonal diameter clearly indicates that the lesioned optic 
nerve contains a significant increase in number of small calibre axons, suggesting 
that some axons are damaged and are beginning to regrow at this stage following 
the lesion. There was also an increased frequency of larger diameter axons; this 
could be due to swelling as a result of the injury, which has been previously 
described in the context of traumatic axonal injury (Wang et al., 2011a). Studies in 
traumatic brain injury show that damaged axons are often swollen due to Neuronal 
tracing experiments clearly demonstrated that some axonal damage is caused by 
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the injection and that approximately one-third of the optic nerve axons are 
affected. As such, LPC injections are not ideal to induce demyelinating lesions 
without concurrent injury and I went on to investigate whether LPC could be 
applied differently to bypass this problem. 
Gelfoam is used medically for patient care, is able to soak up liquid and disintegrate 
within the body. I wondered whether this could be used to induce demyelinating 
lesions in adult zebrafish as it has been used previously in a lesion context in the 
zebrafish optic nerve (Becker et al., 2000). Neuronal tracing experiments and 
immunohistochemical analysis of optic nerve sections suggested that a very small 
amount of LPC was not sufficient to demyelinate the optic nerve and very large 
amounts were toxic and caused diffuse axonal injury. The latter is undesirable when 
attempting to evaluate remyelination, as it would be difficult to differentiate 
between newly formed myelin around regenerated axons and remyelination of pre-
existing, demyelinated axons, especially as these two processes may involve very 
different signalling mechanisms.  
In summary, it is important to note that although there was no difference in tectal 
labelling after 5 µl LPC compared to control, this does not imply that there is no 
axonal damage at all. The neuronal tracing method is limited by the fact the only 
pixel intensity or area of tracer uptake can be measured rather than number of 
single traced fibres and so a few damaged fibres may not be detected. Moreover, as 
5 µl LPC demyelinated approximately 70% of the optic nerve, with no detectable 
damaged axons by LINC immunohistochemistry and neuronal tracing, any subtle 
axon damage not detected by the methods used in this thesis may be disregarded 
because most fibres will be demyelinated only. Therefore, I have developed a 
method in adult zebrafish to reliably demyelinate optic nerve fibres in adult 
zebrafish permitting the study of remyelination. However, it has to be kept in mind 
that this is not a model of multiple sclerosis, as the demyelinating lesions do not 
occur naturally in zebrafish but have to be induced with the myelin toxin LPC. This 
does not allow the investigation of pathogenesis; however, signalling mechanisms 
involved in remyelination might be explored in this zebrafish-based model. 
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CHAPTER 5 – Remyelination in adult zebrafish optic 





LPC-induced demyelination has been studied extensively in rodents and was first 
used to lesion peripheral nerve in mice (Hall, 1973; Hall and Gregson, 1971). In the 
CNS, injection of 1µl of the standard 1% solution into the white matter of the 
rodent spinal cord leads to a defined demyelinating lesion (Hall, 1972). Within the 
lesion the majority of oligodendrocytes are lost due to LPC toxicity (Caillava et al., 
2011), with some cells surviving the demyelinating injury. Remyelination studies in 
the cerebellar peduncle of rats have shown that at 8 days post injection most axons 
in the lesion area remained demyelinated and remyelination occurred as early as 6 
weeks post lesion beginning from the outside perimeter of the lesion (Woodruff 
and Franklin, 1999). However, while most fibres are remyelinated with great 
efficiency, the myelin sheath is often thinner and with shorter internodes compared 
to myelin produced during developmental (Blakemore and Franklin, 2008). 
Zebrafish are highly effective in repairing various CNS tissues, including spinal cord 
(Becker and Becker, 2008), retina (Fimbel et al., 2007) and brain (Kroehne et al., 
2011), but knowledge of myelin regeneration is limited. I therefore aimed to 
characterise toxin-mediated de- and remyelination in zebrafish and compare this to 
the processes evident in mammals. 
For successful remyelination to take place, oligodendrocyte precursor cells (OPCs) 
need to be activated, migrate to the lesion area, and differentiate into myelinating 
oligodendrocytes. Alternatively, mature oligodendrocytes could de-differentiate, 
migrate to the lesion area and re-differentiate into myelinating oligodendrocytes. In 
multiple sclerosis (MS) lesions spontaneous remyelination does occur (Lassmann et 
al., 1997); however, failure to repair myelin is a prominent feature of MS pathology 
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and leads to axonal degeneration, which is thought to be a major contributor to 
clinical disability of patients and progressive disease (Reynolds et al., 2011). It has 
been postulated that reasons for this reduced remyelination capacity in MS include 
repeated demyelination, due to the relapsing-remitting nature of the disease, a 
hostile environment due to inflammatory debris and cytokine signalling and age-
related insufficient repair mechanisms (reviewed in Franklin, 2002b; Franklin et al., 
2002). OPCs are found in MS lesions in human post-mortem brain tissue (Chang et 
al., 2000) and evidence also indicates sufficient ability of OPCs to repopulate 
experimental demyelinating lesions in the rat spinal cord (Chari and Blakemore, 
2002), suggesting that insufficient differentiation of progenitor cells rather than 
recruitment failure might be responsible for impaired remyelination. Closer analysis 
of OPCs in human chronic MS lesions showed that while they expressed markers of 
the early oligodendrocyte lineage, they appeared to be quiescent and lacking 
expression of proliferation and differentiation markers (Wolswijk, 1998). In 
experimental rat models, repeated focal toxin-mediated demyelination did not lead 
to depletion of OPCs in or around the lesion, nor a difference in percentage of 
demyelinated axons, or remyelination capacity (Penderis et al., 2003), and post 
mortem tissue from human MS patients even after many years of disease still 
showed plentiful OPCs (Chang et al., 2002). In contrast, differentiated 
oligodendrocytes in vitro present with an increased vulnerability to repeated 
demyelinating insults (Fressinaud, 2005). These results propose a possible 
mechanism for reduced myelin repair following chronic disease: differentiated 
oligodendrocytes die as a result of repeated demyelination insults, and although 
OPCs are present in and around lesions, they are not capable of differentiating into 
mature oligodendrocytes to repair the damage.  In recent years, inflammation has 
been positively associated with remyelination; pathological studies in human MS 
lesions demonstrated that acute lesions with a high immune cell infiltrate, 
especially macrophages, showed much higher remyelination capacity than chronic 
demyelinated areas, which presented with reduced inflammation (Raine and Wu, 
1993; Wolswijk, 2002). Moreover, depletion of macrophages in adult rats preceding 
a demyelination spinal cord lesion resulted in altered OPC response and decreased 
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remyelination (Kotter et al., 2005), and more specifically the presence of myelin 
debris in the lesion site has been identified as a factor adversely affecting 
remyelination (Kotter et al., 2006). Thus, macrophages and immune response are 
important for myelin repair, and are thought to affect rate and efficiency of 
remyelination at chronic disease stages and with increasing age. It has been noted 
that white matter injury is more extensive in old rats compared to young ones in a 
focal demyelination model and that remyelination in aged rats is not as effective, as 
many axons remain unmyelinated after 4 weeks when much remyelination has 
already occurred in younger rats (Hampton et al., 2012; Shields et al., 1999). In 
parabiosis studies, where old mice where joined to young ones, so that they share a 
blood supply, and a demyelinating lesion was placed in the old mouse’s spinal cord, 
more differentiating oligodendrocytes were observed in the lesion site and 
remyelination took place much more effectively than in old mice joined to old ones. 
Further experiments suggested that the macrophages of a young mouse traversing 
into the lesion of the old animal are important for successful remyelination (Ruckh 
et al., 2012). As zebrafish show a much higher regenerative capacity than rodents 
and other experimental models, it will therefore be interesting to investigate 
whether old zebrafish also show a decreased remyelination efficiency. 
The remyelination process involves many steps which can potentially be targeted 
and influenced in a way that promotes remyelination speed and capacity. Several 
signalling pathways involved in OPC differentiation, including Notch and Wnt 
signalling, the chemokine CXCL12 and the retinoid X receptor-ϒ, have already been 
described (Huang et al., 2011b; John et al., 2002; Patel et al., 2010) and are further 
summarised in the main introduction of this thesis. Studies investigating 
mechanisms underlying OPC recruitment focus on migratory cues, and in particular 
the Semaphorins 3A and 3F have been identified as potential key regulators of this 
process (Williams et al., 2007).  
The semaphorins are a class of secreted and transmembrane proteins, which were 
primarily described as axonal guidance molecules with great importance for the 
developing nervous system (reviewed in Kolodkin, 1996). Class 3 semaphorins have 
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also been identified as chemotactic factors for oligodendroglial cells during 
development, in particular Semaphorin 3A (Sema 3A) and Semaphorin 3F (Sema 3F) 
aid the recruitment of glial precursor cells from the brain to the developing optic 
nerve by their repulsive and attractive properties (Spassky et al., 2002; Sugimoto et 
al., 2001). Signalling of class 3 semaphorins occurs through binding to receptor 
complexes containing Neuropilin 1 and 2 (NRP1/2) and the class A Plexins (reviewed 
in Sharma et al., 2012), however the Neuropilins exhibit different affinities for Sema 
3A and 3F. While Neuropilin 1 binds Sema 3A with high affinity and Sema 3F as well 
as several other Semaphorins with low affinity (He and Tessier-Lavigne, 1997; 
Kolodkin et al., 1997), Neuropilin 2 shows high affinity for Sema 3F and 3C and 
lower affinity for Sema 3B and 3G (Chen et al., 1997). However, these affinities were 
observed in in vitro studies and may well be different in vivo, especially as 
observations in other laboratories have shown that in NRP2 knockout mice, no 
binding of Sema 3F could be detected, suggesting that it also does not bind to 
Neuropilin 1 in vivo (Giger et al., 2000). Moreover Neuropilins are also able to bind 
cytokines of the Vascular endothelial growth factor (VEGF) family, which bear 
different structural and functional properties to semaphorins (reviewed in Geretti 
et al., 2008). Structurally, Neuropilins are comprised of a large extracellular domain 
containing four sub-domains: 1) the N-terminal CUB domain (a1 and a2 sub-
domain), which binds class 3 semaphorins amongst other ligands, 2) the coagulation 
factor domain, which is also known as b1/b2 sub-domain and binds VEGF, 3) and 
the C-terminal MAM-domain.  While VEGF only binds to the b1b2 sub-domain, it 
has been shown that class 3 semaphorins can interact with both, the a1a2 and the 
b1b2 sub-domain, but the critical domain is the a1a2. Expression of NRPs has been 
demonstrated in the vascular system, and appear to play a central role in normal 
blood vessel development as NRP1 knockout mice are embryonic lethal with 
disorganised vascular formation and transposition of great vessels and NRP2 
knockout mice displayed a severe reduction of small lymphatic vessels and 
capillaries (Kawasaki et al., 1999; Yuan et al., 2002). Class 3 semaphorins have been 
demonstrated to negatively regulate tumour growth; in particular Sema 3B and 3F 
have been shown to reduce tumour formation in mice and inhibit tumour 
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angiogenesis and metastasis (Bielenberg et al., 2004; Kessler et al., 2004; Tse et al., 
2002). As class 3 semaphorins are unable to directly interact with plexins, the signal 
transducing subunits, it is thought that semaphorins bind to neuropilin/plexin 
receptor complexes (Sema3A/NRP1/PlexinA4 and Sema3F/NRP2/PlexinA3), which 
then mediate intracellular signalling (reviewed in Zhou et al., 2008). Upon 
semaphorin3 binding, FARP2 dissociates from plexinA, activates Rac1 which is 
thought to control actin dynamics via PAK and Cofilin. In addition, plexinA signalling 
is associated with RasGAP (Ras GTPase activating protein) stimulation and 
phosphoinositide 3-kinase (PI3K) inactivation ultimately leading to inhibition of 
integrin-mediated adhesion signalling and CRMP2 (collapsin response-mediated 
protein) inactivation via GSK3ß. CRMP2 is thought to be involved in microtubule 
dynamics and endocytosis through signalling via cyclin-dependent kinase 5 (Cdk5) 
and Fyn. The culminating effects of Sema3/NRP/Plexin signalling are changes in the 
actin cytoskeleton, permitting modulation in cell shape and motility. 
 
Schematic of semaphorin 3A signalling via neuropilin 1/plexin A1 receptor complex 
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In LPC-induced demyelinating lesions in rat spinal cord as well as in active plaques 
of MS brain transcripts of both Sema 3A and 3F are upregulated (Williams et al., 
2007). Moreover, expression of the semaphorin receptors neuropilins and plexins is 
increased on oligodendrocyte precursor cells and upon Sema 3A/3F overexpression 
in a murine demyelination model OPC recruitment and remyelination rate could be 
manipulated (Piaton et al., 2011). These results suggest a key role of Sema 3A and 
3F in OPC recruitment following a demyelinating insult and a possible target for 
promotion of remyelination.  
In this chapter I aimed to determine if zebrafish are able to regenerate their myelin 
with the same capacity as they repair other CNS tissues. Furthermore, I sought to 
investigate if the mechanisms underpinning zebrafish remyelination are 
homologous to mammals and whether manipulation of these could alter myelin 








Characterisation of LPC-induced demyelinating optic nerve lesions in adult zebrafish  
The previous chapter details how focal demyelinating lesions were achieved in the 
adult zebrafish optic nerve through local application of the myelin toxin LPC, 
critically without concomitant axonal injury. A small piece of absorbable gelatine 
sponge was soaked in LPC and placed onto the optic nerve in a simple operative 
procedure (Figure 5.1-A). Eight days following the placement of the LPC sponge, the 
time point of maximum reduction in myelin after LPC injection, I quantified pixel 
intensity in cryostat cross sections of the optic nerves and chiasm and observed a 
reduction in Claudin k immunoreactivity in the lesion site representing a loss of 
myelin (Figure 5.1-B). Accordingly, I also found fewer olig2+ oligodendroglial cells in 
the lesion area and an increase of 4C4+ microglia/macrophages in the lesioned optic 
nerve, while the neuronal immunostaining with LINC indicated no axonal change 
(Figure 5.1-B). 
To further investigate the events after myelin injury, I lesioned the animals as 
described above and then analysed cryostat sections of the optic nerve (as shown in 
Figure 5.1-B) at various time points after the lesion (Figure 5.2-A). By measuring 
pixel intensity of Claudin k in the lesion area and calculating a ratio to the 
unlesioned contralateral optic nerve to account for differences in labelling 
brightness, I could show that myelin is maximally reduced at 8 days following the 
lesion (p<0.01, n=6, Kruskal Wallis test, Dunn’s post-test, Figure 5.2-B). 
Oligodendroglial cells marked by olig2:DsRed were also decreased at early time 
points after the lesion, with a significant decrease at 8 dpl compared to unlesioned 
control optic nerves (p<0.05, n=6, Kruskal Wallis test, Dunn’s post-test, Figure 5.2-
C). Both pixel intensity of Claudin k immunoreactivity and the number of 
olig2:DsRed-positive oligodendroglial cells in the lesion area had increased within 4 
weeks (Figure 5.2-B,C). 4C4+ microglia were significantly increased in number at 4 
dpl (p<0.05, n=6, Kruskal Wallis test, Dunn’s post-test) and returned levels 
comparable to the unlesioned control at 14 dpl (Figure 5.2-D). Axons marked by 
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pixel intensity of LINC immunoreactivity were not different to the unlesioned 
contralateral optic nerve (pixel intensity of 1) at any time point, (Figure 5.2-E). 
These findings indicate that LPC leads to a demyelinating lesion in the optic nerve 
by 8 dpl, which is able to regenerate within 4 weeks. 
 
  




Figure 5.1: Characterisation of the toxin-induced demyelinating lesion. (A) Schematic shows how 
the demyelinating lesions were performed: A small sponge soaked in LPC was placed next to the 
optic nerve. Cross sections of the optic nerve were then evaluated at 8 days post lesion. (B) Cryostat 
cross sections of adult zebrafish optic nerves and chiasm showing a reduction in Claudin k (myelin) 
immunoreactivity and number of olig2:DsRed-positive oligodendroglial cells in the lesion site. 4C4+ 
microglial cells were increased around the lesion area and axons seemed intact by LINC 
immunohistochemistry. Sections showing olig2:DsRed, 4C4 and Hoechst are the same, Claudin k and 
LINC immunohistochemistry is shown on alternate sections. Dorsal is up. Schematic shows the where 
the cryostat sections were taken. Scale bars: B = 100 µm.   
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Figure 5.2: Investigation of myelin, oligodendroglial cells, microglia and axons following 
demyelinating injury. (A) Lesion and analysis time points are indicated in the schematic. (B) Pixel 
intensity measurements and cell profile counts in longitudinal cryostat sections of adult zebrafish 
optic nerves and chiasm show: (B) a significant reduction in Claudin k (myelin) immunoreactivity 
(p<0.01, n=6, Kruskal Wallis test, Dunn’s post-test), (C) fewer olig2+ oligodendroglial cells in the 
lesion site (p<0.05, n=6, Kruskal Wallis test, Dunn’s post-test), (D) up-regulated 4C4+ microglial cells 
at 4dpl (p<0.05, n=6, Kruskal Wallis test, Dunn’s post-test) and (E) no change in LINC+ axon pixel 
intensity. Immunohistochemical analysis of longitudinal optic nerve sections at 28 dpl are 
representative of data shown in graphs. Error bars represent mean ± SEM. Scale bar: B-E = 100 µm.  
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Electron microscopic analysis of de- and remyelinated optic nerve 
To further investigate myelin repair after toxin induced demyelinating lesions, I 
performed electron microscopy (EM) studies of the optic nerve. EM analysis of optic 
nerve cross sections showed that at 8 days post lesion, many axons had been 
stripped of their myelin sheath, leaving most axons unmyelinated compared to the 
unlesioned contralateral control optic nerve (24% ± 9% vs. 93% ± 1% myelinated 
axons, mean ± SEM, p<0.05, n=3, Kruskal Wallis test, Dunn’s post-test). After 4 
weeks most axons had regained their myelin sheath (92% ± 1%, mean ± SEM) and 
were not different from unlesioned controls, suggesting completion of myelin repair 
(Figure 5.3-A,B). Compared to in the unlesioned optic nerve, the remyelinated fibres 
appeared much further apart with longs strands of cytoplasm running through the 
lesioned area at 28 dpl. These are probably astroglial processes, which help to re-
establish fascicular architecture of the optic nerve, as has been suggested 
previously in goldfish optic nerve regeneration (Nona et al., 1998). As remyelination 
results in thinner myelin sheaths in human brain (Perier and Gregoire, 1965) and 
rodent experimental  demyelination models (Blakemore and Franklin, 2008), I 
wondered whether fish would also show this phenotype. Therefore I measured G-
ratios in remyelinated optic nerves and compared them to unlesioned controls. 
Scatter graphs of G-ratio vs. axon diameter show clustering of axons with a 
diameter of 0.3-0.5µm and G-ratio of 0.6-0.8 in remyelinated optic nerves and 
unlesioned controls, while at 8 dpl axons of similar size present with a much larger 
G-ratio of 0.8-1.0 and clearly indicate demyelination (Figure 5.3-C). When I 
compared the average G-ratio of 28 dpl optic nerves and unlesioned controls (3 
animals per condition and 200-300 measured axons per animal), I found no 
difference in average G-ratio (Figure 5.3-D). As the G-ratio only evaluates myelin 
thickness and not compactness, ie the G-ratio may appear the same even if the 
myelin wraps are looser and there are less of them, visual observations confirmed 
that the myelin sheaths was indeed compact. The quality of the electron 
microscope preparations did not allow closer analysis of myelin structure such as 
major dense lines.  In summary, these data suggest that zebrafish are capable of 
regenerating their myelin sheath completely, both in number of axons remyelinated 
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and the thickness of the myelin sheath and this differs from what has been 
observed in rodent studies. 
During EM analysis, I also noted that optic nerve cross sections after LPC-induced 
demyelination looked very different to those after optic nerve crush with severed 
axons (Figure 5.4-A). While after demyelination many axons of variable axon 
diameter without myelin were present in optic nerve cross sections, the average 
axon diameter after nerve crush was smaller (Figure 5.4-B). When I compared the 
axon diameter frequency of both conditions, I observed a left shifted curve in the 
nerve crush population with more small diameter axons compared to unlesioned 
controls and LPC treated optic nerves (p<0.05, n=3, Mann Whitney U-test, Figure 
5.4-C). It is well established that following nerve transection axons in the nerve 
stump will sprout in an effort to regenerate (Nona, 1995; Wolburg, 1981), and while 
mammals are only able to regrow peripheral nerves, zebrafish can regrow their 
optic projection and other central nervous system axons with high efficiency 
(Becker and Becker, 2007). Moreover I noted some axons that appeared to have 
continuous cytoplasm suggestive of branching/sprouting, and these were not 
present in the optic nerve after demyelination (Figure 5.4-A, inset); this has been 
observed previously after nerve crush in the goldfish optic nerve (Nona, 1995; 
Wolburg, 1981). As such, these results provide further evidence that no major 
axonal damage is present in the optic nerve after demyelination. 
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Figure 5.3: Electron microscopic evaluation of remyelination. (A) Cross sections through optic 
nerves and electron microscopic analysis thereof show many demyelinated axons at 8 dpl (asterisks) 
compared to unlesioned controls and complete regeneration at 28 dpl. (B) At 8 dpl the number of 
myelinated axons in the lesion area is significantly reduced to unlesioned controls (p<0.05, n=3, 
Kruskal Wallis test, Dunn’s post-test), while there is no difference between remyelinated and control 
optic nerves. (C) Correlations of G-ratio and axon diameter show similar populations at 28 dpl and in 
unlesioned control, while most axons at 8 dpl have a much larger G-ratio indicating thinner myelin 
(circle). (D) Average diameter between unlesioned and remyelinated optic nerve is not different 
(p>0.05, n=3-6, Mann Whitney U-test). Error bars represent mean ± SEM. Scale bar: A = 1 µm.  







Figure 5.4: Electron microscopic analysis shows no axonal damage after LPC induced demyelinating 
lesions. (A) Electron microscopic analysis of cross sections through optic nerves show demyelinated 
axons of various axonal diameter compared to crushed optic nerve in which axons were severed and 
axonal diameter is smaller. Axons that are joined together (inset, arrows) are only observed after 
nerve crush and indicative of axonal sprouting. (B) Quantification of average axon diameter shows 
the presence of more small calibre axons after optic nerve crush compared to LPC treated optic 
nerves and unlesioned control. (C) Axons of small diameter are much more frequent after nerve 
crush compared to unlesioned controls and LPC treatment, and indicate no major axonal damage 
and sprouting during demyelination (p<0.05, n=3, Mann Whitney U-test). Error bars represent mean 
± SEM. Scale bar: A = 1 µm; inset = 0.5 µm.  
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Remyelination in old zebrafish is impaired  
During remyelination studies of the optic nerve of adult zebrafish (age 4 – 7 
months) described previously in this thesis, I found that these are able to repair the 
myelin completely after demyelination, without any change in G-ratio. 
Remyelination capacity to this extent is uncommon and I wondered whether aged 
zebrafish would show the same efficiency in myelin repair. Previously lesioned 
animals were between 4 – 7 months (“young zebrafish”), and to investigate 
remyelination efficiency in aged animals further, I lesioned adult zebrafish older 
than 1.5 years (“old zebrafish”). The lesions were induced by placing a gelatine 
sponge soaked in LPC onto the optic nerve, as described above. I then used electron 
microscope analysis to measure G-ratios as an indicator of myelin thickness in optic 
nerve cross sections at 28 days post lesion in aged zebrafish. This analysis indicated 
that compared to unlesioned age-matched control and remyelinated optic nerve 
from young animals, the myelin sheath in old zebrafish at 28 dpl was much thinner 
(Figure 5.5-A). This difference was also notable when visually comparing myelin 
thickness in the lesioned area to another more distant area in the optic nerve of old 
zebrafish optic nerve at 28 dpl, suggesting that this is specific for the lesion area 
(Figure 5.5-A). The average G-ratio in the optic nerve of old zebrafish at 28 dpl was 
indeed significantly higher compared to young zebrafish at 28 dpl and old age-
matched unlesioned controls (p<0.05, 3 animals per condition and 200-300 axons 
per animal, Mann Whitney U-test, Figure 5.5-B). This could be due to a higher 
proportion of unmyelinated axons present in the old zebrafish optic nerve; however 
the percentage of unmyelinated axons in old zebrafish at 28 dpl was comparable to 
young zebrafish at 28 dpl and old age-matched unlesioned controls, suggesting that 
a difference in proportion of myelinated axons was not the cause of a higher 
average G-ratio (Figure 5.5-C). Claudin k pixel intensity measurements in young and 
old zebrafish optic nerve were not different and suggest similar extent of 
myelination (Figure 5.5-D). In agreement with other rodent studies investigating 
remyelination in old animals, my results propose that old zebrafish are not able to 
repair myelin as effectively as their young counterparts, however whether this is a 
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problem of insufficient repair mechanisms or speed (and they would remyelinate 
fully after a longer time period) is not yet clear.  




Figure 5.5: Remyelination in old zebrafish. (A) Electron microscopic analysis of cross sections 
through the lesion area in the optic nerves of young (4-7 months) and old (>1.5 years) zebrafish show 
differences in myelin thickness at 28 dpl. Old zebrafish present with much thinner myelin in the 
remyelinated lesion area compared to young remyelinated zebrafish, other areas in the old zebrafish 
optic nerve distant to the lesion site and unlesioned age-matched controls. (B) At 28 days after LPC-
induced demyelination, axons in the lesion area of old zebrafish present with a significantly 
increased G-ratio compared to young zebrafish at 28 dpl and age-matched unlesioned controls 
(p<0.05, n=3, Mann Whitney U-test). (C) Percentage of unmyelinated axons in young and old 
zebrafish 28 days after LPC treatment compared to age-matched old zebrafish unlesioned controls 
shows no differences, suggesting that the higher average G-ratio is not a result of an increased 
proportion of unmyelinated fibres but instead of thinner myelin. (D) Claudin k pixel intensity in the 
lesion area at 28 dpl is not different between young and old zebrafish, indicating no differences in 
extend of myelination. Error bars represent mean ± SEM. Scale bars: A = 1 µm.  
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Origin of remyelinating cells 
In mammalian studies, remyelination is thought to be carried out by 
oligodendrocyte precursor cells located in the white matter immediately 
surrounding the demyelinated area (Franklin et al., 1997) or from progenitor zones 
within the brain such as the subventricular zone (Nait-Oumesmar et al., 1999) and 
not from de-differentiation of mature oligodendrocytes and re-differentiation, 
which has been suggested in nerve regeneration studies in goldfish (Ankerhold and 
Stuermer, 1999). In order to determine where the cells responsible for 
remyelination in the zebrafish optic nerve originate, I first investigated proliferating 
cells in the optic nerve surrounding the demyelinating lesion by 
immunohistochemistry in cryostat sections. While I observed an increase of 
proliferating cell nuclear antigen (PCNA)-positive cells at 4 and 8 days post lesion 
compared to unlesioned controls (p<0.05, n=3-7, Kruskal Wallis test, Dunn’s post-
test), these did not co-label with the oligodendroglial cell marker olig2:DsRed, 
suggesting that cells of the oligodendroglial cell lineage were not proliferating 
around the lesion site (Figure 5.6-A). More likely, the increase in PCNA-positive cells 
was due to activation of immune cells which respond to the demyelinating injury. As 
the remyelinating cells did not seem to proliferate around the lesion area, I 
performed studies in which I treated lesioned fish with 5-Ethynyl-2'-deoxyuridine 
(EdU), which is a thymidine analogue that is incorporated into dividing cells during 
S-phase. In contrast to PCNA, which labels cells that are currently dividing at the 
point of analysis, EdU is incorporated into dividing cells at the point of in vivo 
administration and retained in the cells as they migrate from their point of division. 
EdU only has a very short bioavailability; pharmacokinetic studies investigating the 
clearance of EdU in mice following intravenous injection show that EdU is 
eliminated with a half-life of approximately 35min (Cheraghali et al., 1995). EdU 
treatment permits labelling of cells which divided at some point during the time of 
EdU application and their progeny. Due to the limited bioavailability of EdU, 
zebrafish needed to be treated frequently over a short period of time in order to 
label as many cells as possible. More specifically, I lesioned the optic nerve with LPC 
as previously described, injected the fish daily with EdU between post lesion day 3 
Page | 169  
 
and 10 and then analysed the remyelinated optic nerve at 28 dpl for 
oligodendrocytes with incorporated EdU (Figure 5.6-B). I found that in the lesioned 
optic nerve 9.3% ± 3.3% (mean ± SEM) of oligodendrocytes were also EdU-positive 
compared to the unlesioned control with 1% ± 1% (mean ± SEM) co-labelled cells 
(Figure 5.6-C,D). These findings suggest that some of the remyelinating cells are 
newly generated, though as the PCNA immunostaining was negative in 
oligodendroglial cells, they were not generated locally to the lesion. However, 
assumptions about whether local mature myelinating oligodendroglial cells are also 
capable of de- and re-differentiation and where those newly generated 
remyelinating cells originate from cannot be made.  
Previous studies also demonstrate that peripheral myelinating Schwann cells can be 
involved in remyelination of the central nervous system. In the rodent spinal cord, 
Schwann cells are able to invade from the periphery to aid the remyelination 
process following focal toxin-induced lesions (Black et al., 2006) and upon 
transplantation into the spinal cord, they can migrate and remyelinate 
demyelinated axons (Baron-Van Evercooren et al., 1992). I therefore wondered 
whether the remyelination in fish was due to Schwann cell infiltration and tested 
this by making use of a transgenic zebrafish line, Tg(FoxD3:GFP), which labels neural 
crest-derived Schwann cells (Gilmour et al., 2002). When I analysed cryostat 
sections at 28 dpl, I found no GFP-positive cells in the remyelinated spinal cord, 
however labelled peripheral innervating nerves could be seen in muscle fascicles 
close by (Figure 5.7-A) confirming that transgene is still active in the adult zebrafish. 
Moreover, when I investigated cross sections of remyelinated optic nerve by EM, I 
also did not observe any Schwann cells (Figure 5.7-B), which can be easily 
distinguished from oligodendrocytes by their close association of nucleus and 
myelinated axon (one-to-one relationship) (Figure 5.7-C). Hence, neural crest-
derived Schwann cells do not appear to play a role in this model of zebrafish optic 
nerve remyelination. 
As remyelinating cells in the zebrafish optic nerve neither seemed to originate from 
local proliferation nor invasion of peripheral Schwann cells, I wondered whether 
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more distant sources such as the progenitor cell niches in the zebrafish brain could 
be a source for remyelination cells. In cryostat sections labelled with PCNA antibody 
to mark proliferating cells, I noticed an increase in proliferation in the 
periventricular progenitor zone in the midbrain at 8 days post LPC-induced 
demyelination. More specifically, PCNA+/olig2+ co-labelled cells situated 
immediately around the ventricle were significantly increased at 8 dpl compared to 
unlesioned controls (p<0.05, n=7, Kruskal Wallis test, Dunn’s post-test, Figure 5.8-
A,B). Since I had already shown that there is no local proliferation of olig2:DsRed-
positive cells in the optic nerve immediately surrounding the optic nerve, these 
results might propose that following a demyelinating lesion in the optic nerve, the 
cells in the periventricular progenitor zone are able to respond to this injury, 
proliferate and migrate to the lesion where they differentiate into myelinating 
oligodendrocytes (Figure 5.8-C). To substantiate this theory further, I conducted a 
follow-on experiment in which I injected GFP-expressing lentivirus into the ventricle 
of adult zebrafish to try to label and track periventricular progenitor cells and 
immediately lesioned the optic nerve. This is to test whether in my model in 
response to the demyelinating lesion, repairing OPCs are derived from the 
periventricular progenitor cells and migrate to the optic nerve. Similar experiments 
have been conducted in zebrafish previously (Rothenaigner et al., 2011). They rely 
on the principle that lentiviral vectors driving GFP-expression will infect any cell 
they come in contact with and integrate into their genome. This method therefore 
permits to permanently label any cell close to the application site and track them 
and their progeny. In my experiments, I found that in the control injected fish, no 
lentivirus had been taken up by progenitor zone cells, suggesting that the 
cytomegalovirus (CMV) promoter which is active in rodent cells was possibly not 
recognised in zebrafish and difficulties with the use of lentiviral vectors in zebrafish 
has been previously recognised (Dr Bally-Cuif, personal communication). As such, I 
was not able to directly show proliferation and migration of the progenitor cells into 
the lesion area to test my hypothesis.  
 






Figure 5.6: Origin of remyelinating cells. (A) Cryostat cross sections of lesioned optic nerve area 
were analysed for PCNA and olig2:DsRed co-label at various time points after LPC-induced 
demyelination. While PCNA+ cells counts are increased at 4 and 8 dpl compared to unlesioned 
controls (p<0.05, n=3-7, Kruskal-Wallis test, Dunn’s post-test), no marked co-label with olig2:DsRed 
was observed, suggesting that this reflects immune cell response rather than oligodendroglial cell 
proliferation. (B) Schematic describes the experimental set-up: Zebrafish received daily EdU 
injections between post-lesion day 3 and 10; optic nerves were then analysed at 28 dpl.  (C) In LPC 
lesioned optic nerve, some olig2:DsRed+ cells co-labelled with EdU, and although no statistical 
significance was found compared to the number of co-labelled cells in unlesioned control optic 
nerve, it suggests that these cells were newly generated. (D) Representative cryostat cross sections 
of lesioned optic nerve at 28 dpl show co-labelling of olig2:DsRed+ cells with EdU. Error bars 
represent mean ± SEM. Scale bar: D = 10 µm.  







Figure 5.7: Schwann cells are not involved in optic nerve remyelination. (A) Cryostat cross sections 
through the optic chiasm (inset) of transgenic zebrafish labelling neural crest-derived Schwann cells 
at 28 dpl show no FoxD3:GFP+ cells in the remyelinated optic nerve. Peripheral innervating nerves in 
muscle fascicles around the nerve are detectable (arrows) and confirm transgenic expression in adult 
zebrafish of this line. (B) Schwann cells are also not detected in electron microscopic analysis of 
remyelinated optic nerve cross sections. (C) Schwann cells have a typical phenotype: the nucleus is 
closely associated with its myelinated axon. Scale bar: A = 100 µm, B = 1 µm.  







Figure 5.8: Increased proliferation in periventricular progenitor zone following optic nerve 
demyelination. (A) Cryostat cross sections through the brain of adult zebrafish show increased PCNA 
labelling of cells in the periventricular progenitor zone at 8 dpl suggesting increased proliferation. (B) 
These cells largely co-label with olig2 and are significantly different from the unlesioned control at 8 
dpl (p<0.05, n=7, Kruskal Wallis test, Dunn’s post-test). (C) Schematic shows suggested hypothesis of 
optic nerve remyelination in adult zebrafish: upon demyelination in the optic nerve, periventricular 
progenitor cells proliferate and migrate to the optic nerve to aid myelin repair. Error bars represent 
mean ± SEM.  Scale bar: A = 25 µm.   
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Manipulation of optic nerve remyelination by treatment with Semaphorin 3A, a 
repelling oligodendrocyte precursor cell guidance molecule 
In rodents, Semaphorin 3A (Sema3A) is thought to play a key role in regulating 
remyelination due to its repellent function in oligodendrocyte precursor cell 
recruitment. To investigate the role of Sema3A in zebrafish optic nerve 
remyelination I firstly aimed to determine if and where it is expressed in normal 
adult zebrafish brain and whether the levels in the optic nerve are altered following 
LPC-induced demyelination. As genome duplications during fish evolution have led 
to many genes being present in duplicate, I wondered whether both forms of 
Sema3A (Sema3Aa and 3Ab) could be detected in adult zebrafish. In situ 
hybridisation studies in cross sections of adult zebrafish brain (conducted by my 
colleague in the Becker lab, Karolina Mysiak), showed overlapping RNA expression 
of Sema3Aa and 3Ab in the tractus pretectomammilaris, the ventral and dorsal zone 
of the periventricular hypothalamus, the periventricular granular zone, the lateral 
valvula cerebelli and the torus longitudinalis (Figure 5.9-A). Overlapping expression 
was also observed in the cerebellum (data not shown). Immunohistochemical 
analysis with the Sema3A antibody showed labelling of similar structures, 
represented by sections of cerebellum (Figure 5.9-B), however antibody labelling 
was not very strong and barely detectable in structures such as the tractus 
pretectomammilaris. Co-labelling of normal adult zebrafish brain cross sections with 
anti-Sema3A antibody and markers for other cells present in the brain showed 
overlapping immunostaining with the neuronal marker acetylated tubulin (Figure 
5.9-C), suggesting that like in mammals, Sema3A in zebrafish is expressed by 
neuronal cell bodies or axons in normal adult zebrafish brain. Co-labelling studies 
with Sema3A and olig2:DsRed-positive oligodendroglial cells in the zebrafish brain 
were negative. 
Previous results from our laboratory have demonstrated that the number of OPCs 
present in an MS lesion inversely correlated with the density of cells expressing the 
chemorepellent Sema3A within the lesion (Boyd et al., 2013. In a model of focal 
LPC-induced demyelination in the mouse corpus callosum, an increase in Sema3A 
immunofluorescence staining at 3 days post lesion (and time point of maximal 
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demyelination), followed by decreasing Sema3A expression, which is limited to the 
lesion edge at 7 dpl. Sema3F expression within the lesion is also increased at 3dpl, 
however clears at a slower rate than Sema3A. At 14 dpl both Sema3A and 3F are 
absent from the lesion (Boyd et al., 2013). I therefore wondered whether Sema3A 
levels in the zebrafish optic nerve were also altered following LPC-induced 
demyelination. Indeed I observed a decreased Sema3A band at 110 kDa in western 
blot analysis of whole optic nerve lysates at early time points after LPC-induced 
demyelination (Figure 5.9-D,E). These results propose the hypothesis that following 
a demyelinating optic nerve lesion, endogenous Sema3A is reduced in the optic 
nerve to allow oligodendrocyte progenitor cell migration towards the lesion area 
(Figure 5.9-F) and subsequent remyelination.  
Studies in our laboratory have shown that upon treatment with human 
recombinant Semaphorin 3A (rSema3A), the LPC-lesioned corpus callosum of mice 
did not remyelinate as effectively as in vehicle treated controls (Boyd et al., 2013). 
More detailed analysis demonstrated no change in cell death or oligodendrocyte 
proliferation and differentiation following rSema3A treatment, suggesting that the 
cause was indeed an inhibitory effect on oligodendrocyte precursor cell migration. 
To investigate whether similar mechanisms underpin zebrafish remyelination, I 
treated zebrafish with LPC-induced demyelinating lesions in the optic nerve with 
rSema3A. For the treatment time point I chose 8 days post lesion, as earlier 
characterisation of the demyelinating lesions showed that myelin and olig2:DsRed+ 
oligodendroglial cells were maximally reduced at this time point. Increasing 
numbers of olig2:DsRed+ cells in the lesion area after post-lesion day 8 in previous 
experiments suggested migration of olig2:DsRed+ cells into the lesion, and these 
were the ones I aimed to influence. In addition, endogenous Sema3A levels were 
also maximally reduced at 8 days after LPC as shown by the previous western bot. I 
then investigated the lesion area for olig2:DsRed+ oligodendroglial cells at 14 dpl, 
MBP:GFP+ cells at 21 dpl and electron microscopy at 28 dpl to assess effects on 
oligodendrocyte migration, differentiation and remyelination respectively (Figure 
5.10-A). At 14 dpl the number of olig2:DsRed+ oligodendroglial cells in the lesion 
area was significantly reduced compared to vehicle treated zebrafish (p<0.001, 
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n=10, Mann Whitney-U test, Figure 5.10-B,C). The number of differentiated 
MBP:GFP+ oligodendrocytes in Sema3A treated zebrafish at 21 dpl was found not to 
be different to vehicle treated controls (Figure 5.10-D,E). This was a little surprising 
as a lower number of OPCs would have led to expect fewer differentiated 
oligodendrocytes. However, perhaps by 21dpl, the reduced chemorepellent effect 
of Sema3A allowed OPCs to migrate from around the treated optic nerve area and 
differentiate.  Analysis of the lesion area by electron microscopy at 28 dpl showed 
that after treatment with rSema3A significantly less axons were remyelinated 
compared to vehicle treated animals (44.7% ± 10.18% myelinated axons compared 
to 89.9% ± 7.19%, mean ± SEM, p<0.05, n=5, Mann Whitney-U test, Figure 5.10-
F,G). However, some unmyelinated small diameter axons were also observed in the 
lesioned optic nerve treated with rSema3A, which were reminiscent of re-growing 
axons and a possible indicator of axonal damage caused by toxicity of the treatment 
(Figure 5.10-G).  
Taken together, these results suggest that perhaps some mechanisms underlying 
rodent remyelination may also be evident in zebrafish remyelination; however this 
is a hypothesis based on preliminary data only and would require more detailed 
analysis of the origin of endogenous Sema3A in adult zebrafish, possible signalling 
pathways involved in this remyelination process and putative effects of the 
rSema3A treatment on axons and other cells in the lesion area.  
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Figure 5.9: Endogenous Sema3A in zebrafish. (A) In cross sections of adult zebrafish brains Sema3Aa 
and 3Ab show overlapping in situ distribution patterns: Both Sema3Aa and 3Ab RNA is expressed in 
the tractus pretectomammilaris (red arrows), the ventral and dorsal zone of the periventricular 
hypothalamus (blue arrows), the periventricular granular zone (green arrows), the lateral valvula 
cerebelli (black arrows) and the torus longitudinalis (yellow arrow). (B) Overlapping staining of 
Sema3Aa RNA and anti-Sema3A antibody is observed in the cerebellum (marked area in brain cross 
sections). (C) Immunohistochemistry studies in cross sections show that Sema3A co-labels with 
neurons in the adult zebrafish brain. (D,E) A western blot and the quantification thereof show 
decreased levels of endogenous Sema3A (110kDa) at early time points after the lesion. (F) Schematic 
of hypothesis: Following demyelination, endogenous Sema3A is reduced to allow oligodendrocyte 
precursor cell (OPC) migration to the lesion area.   Error bars represent mean ± SD.  Scale bars: A,B = 
500 µm, C = 100 µm.  
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Figure 5.10: rSema3A treatment of lesioned optic nerve. (A) Schematic shows timeline of lesioning, 
treatment and analysis. (B) At 14 dpl Olig2:DsRed-positive oligodendroglial cells are reduced in the 
lesion area after rSema3A (p<0.001, n=10, Mann Whitney U-test). (C) Cryostat cross sections through 
the optic nerve lesion area at 14 dpl are representative of data shown in B. (D) At 21 dpl MBP:GFP-
positive cells in the lesion area are not different after rSema3A treatment compared to vehicle 
treated controls. (E) Cryostat cross sections through the optic nerve lesion area at 21 dpl are 
representative of data shown in D.  (F) At 28 dpl significantly fewer axons in the lesion site are 
myelinated after rSema3A treatment (p<0.05, n=5, Mann Whitney U-test). (G) Electron microscopic 
analysis of cross sections through the lesion site at 28 dpl show more unmyelinated axons (asterisks) 
after rSema3A treatment. Small diameter axons were also observed (arrows), indicating possible 
axon damage. Error bars represent mean ± SEM.  Scale bars: C,E = 100 µm, G = 1 µm.  




Various experimental animal models are used to investigate pathological 
mechanisms underpinning demyelinating diseases and to identify targets for 
potential therapeutic intervention. It has been well established that zebrafish are 
extremely capable of regenerating various parts of their central nervous system 
(Becker and Becker, 2008; Fimbel et al., 2007; Kroehne et al., 2011), and as 
knowledge around myelin regeneration in this model organism is limited, I sought 
to characterise the time frame of de- and remyelination in focal demyelinating 
lesions in the adult zebrafish optic nerve as well as explore possible mechanisms of 
repair.  
 
Remyelination of focal demyelinating lesions in the zebrafish optic nerve 
Using this newly generated model of LPC-induced demyelination in the adult 
zebrafish optic nerve, I was able to show that maximal demyelination marked by the 
significant reduction in immunolabelling of the tight junction myelin protein Claudin 
k was present at 8 dpl and occurred simultaneously with a decrease of 
oligodendrocytes in the lesion site and an activation of microglia. Within 4 weeks, 
returning immunohistochemical markers for myelin and oligodendroglial cells 
suggested that the myelin had been repaired; and also microglia number had 
returned to levels comparable to controls. This time course is similar to that found 
in mammals following focal LPC-induced lesions (Foster et al., 1980; Hall, 1973), 
although mice show maximum demyelination already at 3 days following LPC 
injection and zebrafish only at 8 dpl; this might be due to temperature differences, 
as fish are kept at standard temperatures of 26.5°C. However both mice and 
zebrafish show complete remyelination at 28 dpl and this might possibly suggest 
homologous repair mechanisms between species. As zebrafish are more cost-
effective and easier to handle than mice, and in addition have the benefit of easy 
transgenesis, rapid development and possibility of live imaging, it could be useful to 
validate candidate drugs from myelination screens in zebrafish larvae (Buckley et 
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al., 2010; Pogoda et al., 2006) in this adult zebrafish demyelination model to assess 
possible effects on remyelination (rather than developmental myelination) prior to 
moving onto mammalian model organisms.  
Electron microscopic analysis of de- and remyelination studies is important to 
assess the quality and thickness of the myelin sheath and to determine the extent 
of myelin repair following injury. A useful tool in assessing myelin sheath thickness 
is the myelination ratio or G-ratio, as this takes into account the size of the axon, 
and is calculated by dividing the diameter of the axon by the diameter of the axon 
and its myelin sheath. Using electron microscopic analysis and G-ratios, it has been 
shown that remyelination in lesions of MS patients is associated with thinner myelin 
(Perier and Gregoire, 1965; Prineas and Connell, 1979), and this incomplete myelin 
repair is also reflected in rodent models of demyelination (Blakemore and Franklin, 
2008). I could show that zebrafish are able to remyelinate their optic nerve with 
normal myelin thickness; this is a novel finding. Studies in the closely related 
goldfish demonstrate that regenerated fibres following optic nerve crush also regain 
their myelin sheath, however whether the regenerated myelin has the same 
thickness as pre-lesion is not known (Nona et al., 1992).  
By comparison to the well remyelinated young zebrafish optic nerve, the same 
demyelinating lesions in the optic nerve of aged zebrafish led to remyelinated fibres 
with thinner myelin (higher G-ratios) but not a higher proportion of unmyelinated 
axons. It is unclear if old zebrafish are not able to remyelinate with normal thickness 
myelin or whether remyelination is just slower and a longer regenerative time 
period would result in full thickness remyelination. Nevertheless, this suggests a 
difference in ability to remyelinate between young and old zebrafish and supports 
the notion that regenerative capacity declines with age as has been investigated in 
various rodent models (Hampton et al., 2012; Shields et al., 1999). While 
regenerative capacity declines with age, remyelination failure is also thought to be a 
mechanistic problem as MS mostly occurs in young adults and neonatal 
demyelinating diseases like periventricular white matter injury also present with 
insufficient myelin repair (Segovia et al., 2008). It would therefore be interesting to 
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compare the highly effective mechanisms of remyelination in young zebrafish to a 
system in which myelin is not fully regenerated such as rodents or aged fish, and to 
establish differences in signalling and/or mechanism that could be responsible for 
decreased myelin repair capacity. 
Although inability to remyelinate fully is not only dependent on age, it has become 
clear that general regeneration ability declines with age. In an attempt to 
understand the particular relationship between remyelination and ageing, research 
has focussed around the three possible stages which could impair successful 
remyelination in an aged organism. For successful remyelination to take place, OPCs 
need to migrate to the lesion site and differentiate. It has been suggested that in 
aged animals, fewer OPCs available for recruitment, slower recruitment rate or 
differentiation rate may be affected. Sim and colleagues investigated these 
questions in a model with toxin-induced demyelinating lesions in the caudal 
cerebellar peduncles (CCP) (Sim et al., 2002).  When they compared the absolute 
numbers of OPCs available for recruitment in unlesioned young and old rats, they 
found no change in total number of OPCs expressing PDGF-α-receptor mRNA 
suggesting that the same number of OPCs is available for recruitment in both age 
groups. However by investigating OPC density in the lesion site, which was 
decreased in aged rats, and appearance of markers for differentiated 
oligodendrocytes, which appeared later in aged rats, they were able to show that 
changes in remyelination of old animals is most likely due to slower OPC 
recruitment and differentiation rate. Moreover, parabiosis experiments in which old 
mice were joined to young ones so that they shared the same blood supply 
demonstrated that remyelination in a young and an old mouse is equally effective if 
the old mouse had access to the environment of the young one. Ruckh et al. 
postulated that these effects might be due to changes in macrophage recruitment 
to the lesion site, which is decreased in old mice, and moreover they were able to 
show that mice lacking the chemokine receptor CCR2, which is required for 
macrophage chemotaxis, exhibited mildly abrogated remyelination (Ruckh et al., 
2012). These studies open up possible pathways around macrophage recruitment, 
inflammatory signalling and oligodendrocyte differentiation that might be impaired 
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in successful remyelination and could potentially be targeted in therapeutic 
interventions. It would therefore be interesting to investigate whether 
microglia/macrophages recruitment to the lesion site in aged zebrafish is also 
altered, and might therefore explain the changes observed in remyelination. 
 
Origin of remyelinating cells 
The origin of remyelinating cells in the central nervous system has been focus of 
much research over recent years and is still not entirely clear. It has been shown 
that a minority of oligodendroglial cells survive a demyelinating insult, however as 
differentiated oligodendrocytes from both endogenous or transplanted sources 
appear incapable of remyelination (Keirstead and Blakemore, 1997; Targett et al., 
1996) it is thought that remyelinating cells must originate from endogenous 
progenitor cells (Gensert and Goldman, 1997), which could either come from 
progenitor cells in the white matter around the lesion or from stem cell niches such 
as the periventricular progenitor zone. Recent studies using Cre-lox fate mapping 
analysis in mice, have shown that a widely distributed population of progenitors 
give rise to almost all remyelinating cells in artificially induced demyelinating lesions 
in the adult CNS, and that PDGFα/NG2+ progenitors can generate remyelinating 
Schwann cells, which contribute to CNS remyelination in mice (Zawadzka et al., 
2010). To further investigate the origin of remyelinating cells in my zebrafish model, 
I used proliferation markers to assess proliferation of local and distant 
oligodendroglial cells, but also explored the possibility of contribution from other 
myelinating cells such as Schwann cells and cells involved in developmental 
myelination. 
For this I performed pulse-chase experiments with the proliferation marker EdU, 
which is incorporated and retained by any dividing cell. In an attempt to label most 
proliferating cells, the fish received daily intraperitoneal EdU injections for 1 week 
shortly after induction of the optic nerve lesion. At 28 dpl, I found that 
approximately 10% of remyelinating olig2:DsRed+ oligodendrocytes in the lesion 
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area had incorporated the proliferation marker, suggesting that they were newly 
generated. These results are similar to those of my zebrafish optic nerve 
regeneration studies in chapter 3, but do not elucidate from where these newly 
generated cells originate. They could come from the optic nerve surrounding the 
lesion, but this is unlikely as I found no co-labelling of olig2:DsRed+ oligodendroglial 
cells with PCNA (proliferating cell nuclear antigen), in cross section of the optic 
nerve at various time points after the lesion, making it unlikely to have missed the 
time of OPC proliferation. This suggests that proliferation and recruitment of 
oligodendrocyte precursors directly surrounding the lesion are likely not involved in 
optic nerve remyelination and this is different to LPC-induced lesions in the rat 
spinal cord which show decreased remyelination if the surrounding OPCs have been 
destroyed by irradiation (Franklin et al., 1997). As the optic nerve is close to the 
progenitor zones within the brain, it could therefore be possible that while 
remyelination in the distant spinal cord requires local oligodendrocyte progenitors, 
optic nerve lesions could trigger OPC recruitment from the brain. It is not known 
whether oligodendrocytes in zebrafish can only originate from progenitor cells in 
the ventricular zone or whether parenchymal progenitor cells, such as NG2+ cells 
exist in zebrafish. A slowly dividing subpopulation of oligodendroglial lineage cells in 
the zebrafish telencephalon parenchyma has been found, which could potentially 
give rise to mature oligodendrocytes (Marz et al., 2010), indicting similarities to the 
NG2+ cells in mammals. 
To further investigate the origin of remyelinating cells in the zebrafish optic nerve, I 
considered more distant areas, such as known proliferative zones in the brain as 
sources for the remyelinating oligodendrocytes. It has been well established that 
zebrafish are able to regenerate various CNS tissues and the reason for this has 
been attributed to a wide distribution of stem cell niches in the zebrafish brain (Kizil 
et al., 2012). I therefore investigated proliferation of progenitor cells in the 
periventricular progenitor zone in adult zebrafish following the LPC-induced 
demyelinating optic nerve lesion and observed an increased number of 
PCNA+/olig2+ progenitor cells at 8 dpl. This leads to the hypothesis that following 
the optic nerve lesion, progenitor cells in the brain proliferate, migrate to the optic 
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nerve and remyelinate the lesion site. This hypothesis is supported by the finding 
that in a model of demyelination in the corpus callosum in mice, following a 
demyelinating lesion, progenitor cells around the ventricle proliferate and migrate 
towards the lesion area (Nait-Oumesmar et al., 1999) and that in post-mortem brain 
tissue from MS patients an increased density and proliferation of GFAP+/PSA-
NCAM+ radial glia-derived progenitor cells is observed in the subventricular 
granular zone (Nait-Oumesmar et al., 2007). While it is unknown whether precursor 
cells in zebrafish would be able to migrate the distance between the periventricular 
progenitor zone and the lesion site (approximately 500-600 µm), I found no 
increase in local oligodendrocyte proliferation around the lesion area suggesting 
that the cells must originate from more distant sources. Recent research shows that 
inflammation in the zebrafish CNS initiates a neuroregenerative response by 
inducing reactive proliferation of S100ß-positive progenitor cells in the 
periventricular progenitor zone, and moreover, this proliferative response was 
dampened upon administration of the immunosuppressant dexamethasone 
(Kyritsis et al., 2012). It has also been demonstrated that rodent and human OPCs 
and neural stem cells express many cytokine receptors; their ligands are found to be 
upregulated in experimental demyelinating lesions in rodents and MS tissue, 
suggesting that there may be a chemotactic/trophic response resulting in 
proliferation and migration of the progenitors (Carbajal et al., 2010; Dziembowska 
et al., 2005; Kelland et al., 2011; Nguyen and Stangel, 2001). Hence it would be 
interesting to investigate the role of inflammation in optic nerve remyelination and 
whether inflammatory signalling could be responsible for proliferation in the 
periventricular progenitor zone in response to injury. Several findings throughout 
my analysis would support this theory: Firstly, I found up- regulation of microglia 
along the entire optic tract of the lesioned side not just local to the lesion (Figure 
5.11-A,B), and secondly the progenitor cells in the zebrafish brain possess long 
processes that are in close contact with the optic projection (Figure 5.11-A,C) and it 
would therefore be possible that they could directly respond to inflammatory 
signals with proliferation and migration to the lesion site. Furthermore, it has been 
demonstrated that LPC-induced demyelination in the mouse corpus callosum 
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resulted in proliferation of progenitor cells in the subventricular granular zone (SVZ) 
in young but not old animals (Decker et al., 2002), indicating that this potential 
mechanism of OPC recruitment is impaired with age and could explain a possible 
relationship between remyelinating and ageing.  To assess this signalling 
mechanism more closely, I conducted an experiment for which I injected GFP-
expressing lentivirus into the ventricle of lesioned zebrafish, assuming that 
periventricular progenitor cells would be infected and I could trace their 
proliferation and migration to the lesion site; however I found that progenitor cells 
did not take up the lentivirus, which might have been due to a promoter not 
recognised by zebrafish. All of these results taken together suggest that although 
the exact signalling mechanisms around OPC proliferation and migration remain 
unclear, a hypothesis involving OPC response in zebrafish to inflammatory cytokines 
may be plausible.  
 
However, as I was only able to label ~10% of remyelinating oligodendrocytes with 
the proliferation marker EdU in my zebrafish demyelination model, this also raises 
the question where the remaining 90% of remyelination cells originate from and 
there are several possible explanations. 
Firstly, Easter and colleagues showed that the goldfish optic nerve always contains a 
well-defined area of small calibre unmyelinated fibres, which originate from the 
peripheral edges of the retina and are the site where continuous axonal growth and 
myelination occurs throughout fish life (Easter et al., 1984; Easter et al., 1981). In 
the adult goldfish, this area occupies less than 1% of the optic nerve cross section 
(Easter et al., 1981). As this area must contain oligodendroglial cells that are 
capable of myelinating new axons, it raises the suggestion that perhaps these cells 
are involved in remyelination of artificially demyelinated optic nerve lesions. 
Throughout my studies, I also observed this well-defined area in electron 
microscopic cross sections of the zebrafish optic nerve (Figure 5.12). However in 
comparison to the demyelinating lesions, which would normally affect ~80% of the 
nerve cross section at the widest diameter, I found that this unmyelinated area was 
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very small and usually located on the nerve edge distant to the lesion site. As such it 
is questionable whether the cells involved in the myelination of these newly grown 
axons would be capable of remyelinating the entire experimentally demyelinated 
lesion. In addition, I have shown a loss of olig2:DsRed-positive cells, and it is 
possible that this loss also included some cells from the unmyelinated area. It is not 
clear which cells exactly myelinate the unmyelinated area and whether they are 
more progenitor-like and capable of proliferating, however it seems unlikely that 
they would be exclusively responsible for repairing the myelin in demyelinated 
lesion, suggesting that remyelinating cells must come from elsewhere. It would be 
difficult to test the presence of these cells as they would express the same 
oligodendroglial makers as other oligodendrocytes in the optic nerve. It could 
perhaps be useful to investigate distribution of oligodendrocyte progenitor cells (eg. 
olig2-positive but negative for MBP, a marker of differentiated oligodendrocytes) in 
cross sections of the optic nerve to see whether more progenitor cells are located 
around the physiologically unmyelinated area.   
Secondly, studies in the closely related goldfish investigating the origin of 
myelinating oligodendrocytes in the regenerated optic nerve described no 
apoptosis and new generation of oligodendrocyte following optic nerve crush. 
Rather, it  was thought that myelinating oligodendrocytes present around the lesion 
area might be able to undergo de-differentiation into precursor cells and re-
differentiate into new mature oligodendrocytes capable of forming myelin sheaths 
(Ankerhold and Stuermer, 1999). By using a dye-labelling protocol, which allows the 
visualisation of single cells, they could show that some mature oligodendrocytes 
surviving in the lesion site lost their multiple processes and appeared more 
progenitor-like. As remyelination took place, these cells would again take on a more 
complex morphology with numerous processes reminiscent of internodes. Similarly 
experiments using primary mixed glial cultures demonstrated possible successful 
de-differentiation of oligodendroglial cells after treatment with basic fibroblast 
growth factor as there was an increase in O2A oligodendrocyte progenitor cells and 
a decrease of oligodendrocytes expressing markers of differentiation (Grinspan et 
al., 1993). These findings raise the possibility that de- and re-differentiation of 
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mature surviving oligodendrocytes might also contribute to myelin repair following 
focal injury, and could explain why I only observed EdU-labelling in 10% of 
oligodendroglial cells in the remyelinated lesions especially if these cells de-
differentiate but do not proliferate, perhaps as they may not de-differentiate to an 
precursor state. It is also not clear, whether de-differentiation would be compatible 
with my finding of reduced olig2:DsRed-positive cells in the lesion area, as this 
transcription factor is expressed very early in the oligodendroglial lineage and 
would suggest de-differentiation to an early precursor state. To investigate this 
possibility, it could be useful to explore makers such as PDGF-α receptor, NG2 and 
nestin, which are known to label precursor cells.       
It has also been shown that peripheral myelinating Schwann cells may be involved 
in CNS remyelination as they were observed in the regenerated goldfish optic nerve 
(Nona et al., 1992) and in rodent experimental de/remyelination models (Black et 
al., 2006; Blakemore, 1975; Felts and Smith, 1992; Gilson and Blakemore, 2002). 
This might suggest that peripheral myelinating Schwann cells can invade the CNS 
and aid remyelination. I investigated this possibility by making use of the transgenic 
zebrafish line Tg(FoxD3:GFP), which labels all neural crest-derived cells. At 28 dpl, 
when remyelination was complete according to myelin markers and electron 
microscopic analysis, I found no labelled cells in the remyelinated optic nerve, 
whereas labelled cells were readily detectable in peripheral nerves in the same 
animals. As such, neural crest derived cells are not likely to be involved in zebrafish 
optic nerve remyelination. 
Lastly, technical aspects also have to be taken into account as the Edu/BrdU 
labelling protocols are limited by the bioavailability of the compounds and the 
toxicity of the anaesthetising agent to the zebrafish. Studies show that 
intravenously applied EdU has a half-life of less than one hour and raises questions 
about the effective labelling of cells dividing over a long time period (Cheraghali et 
al., 1995). To reliably label all proliferating cells, EdU would need to be injected 
intraperitoneally multiple times per day throughout the period of interest, but as 
fish tend to succumb to frequent use of anaesthetising agents this is experimentally 
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undesirable. Alternatively, the proliferation marker could also be administered by 
letting the fish swim in a diluted concentration; however in our laboratory this 
technique has been previously associated with weak EdU labelling.   
In summary, although much progress has been made in other experimental models 
to determine the origin of remyelinating cells, further experiments are needed, 
especially to evaluate if all cells come from the same endogenous source and 
whether they are different between different areas of the central nervous system 
and even within species. For studies in the zebrafish it would therefore be helpful to 
develop a transgenic zebrafish line allowing lineage tracing of oligodendroglial cells 
following demyelinating lesions. For example, the photoactivatable fluorescent 
protein Kaede could be expressed under a myelinating oligodendrocyte specific 
promoter, eg. myelin protein zero. By placing a demyelinating lesion and 
photoconverting the Kaede in all existing myelinating oligodendrocytes in the optic 
nerve into a different fluorescent colour, it would presumably be possible to 
determine whether the remyelinating oligodendrocytes were newly generated (ie 
came from precursors and expressed the original, non-photoconverted transgene) 
or were a product of de- and re-differentiation (ie expressed the different 
photoconverted transgene). Such lines have been developed for selective labelling 
of neuronal networks in zebrafish (Sato et al., 2006), however to generate a specific 
line expressing Kaede under the oligodendrocyte specific promoter is difficult as 
variegated transgene expression would need to be absolutely excluded to avoid 
confusion between new and old myelinating cells. This technique may also bear 
limitations, such as insufficient UV-light needed for photo-conversion passing 
through the non-transparent adult zebrafish skull reach cells in the brain, or the de-
differentiation of oligodendrocytes to very early progenitor stages where Kaede 
expression may be turned off, and then on re-differentiation the initial transgene 
would be re-expressed in the non-photoactivated colour. To bypass this problem, 
one could perhaps design a transgenic line in which a myelin marker, eg myelin 
basic protein, drives red fluorescent protein (RFP) and Cre expression, which in turn 
would excise a floxed stop-cassette in front of an actin promoter (or another 
general house-keeping gene) driving GFP expression. Under normal circumstances, 
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transgenic fish containing this construct should have RFP-labelled myelinating 
oligodendrocytes. Upon placement of the lesion, tamoxifen administration would 
lead to Cre expression and excision of the stop cassette, resulting in RFP and GFP-
positive newly generated oligodendrocytes. This however, works on the principle 
that MBP is turned over very slowly in already myelinating cells, so after Cre 
expression the pre-existing myelinating cells would only express a small amount of 
GFP or none at all. Lineage tracing using the Cre/loxP system has already been 
successfully used in zebrafish to trace Müller glia in the retina as they undergo 
reprogramming and proliferation following injury (Ramachandran et al., 2010; 
Ramachandran et al., 2012). 
 
Manipulation of remyelination with human recombinant Semaphorin 3A 
The axonal guidance molecules Semaphorin 3A and 3F (Sema3A/3F) have a well 
described role in the recruitment of oligodendrocyte precursor cells in 
development, as Sema3A repels and Sema3F attracts OPCs (Spassky et al., 2002; 
Sugimoto et al., 2001), and it has been suggested that they might also occupy a key 
function in OPC recruitment during remyelination. Transcripts of Sema3A and 3F 
were found up-regulated in lesions within post-mortem brain tissue of MS patients 
and also in a rodent demyelination model, with increased expression of Sema3F and 
Sema3A after the lesion (Williams et al., 2007). The semaphorin class 3 receptors 
neuropilins and plexins have also been identified on oligodendrocyte precursor cells 
and studies in an adult murine demyelination model demonstrated that lentiviral 
induced over-expression of Sema3A in lesions impaired OPC recruitment, while 
Sema3F accelerated OPC migration and remyelination rate (Piaton et al., 2011). 
Alignment studies of human and zebrafish Semaphorin 3A show high amino acid 
sequence identity (human Sema3A is 64.9% identical/77.3% similar to zebrafish 
Sema3Aa and 75.1% identical/85.2% similar to zebrafish Sema3Ab using EMBL 
clustal alignment analysis), which proposes evolutionary conservation and possibly 
similar signalling mechanisms of this protein in both species. To investigate the role 
of Sema3A in zebrafish optic nerve remyelination, I analysed Sema3A levels in 
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whole optic nerve lysates by western blot analysis. For this I used an antibody, 
which is commonly used in rodent studies to detect Sema3A. In an alignment of the 
antigen peptide recognised by the anti-Sema3A antibody and the zebrafish 
homologues of Sema3A, the sequences mostly overlapped and suggested that the 
antibody would most likely also recognise zebrafish Sema3A. In the western blot 
analysis, I observed a specific single band at 110kDa marked by the anti-Sema3A 
antibody, which was reduced at 4, 8 and 14 days post lesion. These findings are 
similar to observations made in our laboratory in rodent models of experimental 
demyelination. In rodent demyelinating lesions Sema3A protein was detected at 3 
dpl, the time point of maximal demyelination, much reduced and limited to the 
lesion edge at 7 dpl and not detectable at 14 dpl (Boyd et al., 2013). It has been 
shown that in this rodent model migration of OPCs into the lesion area occurs from 
around post-lesion day 6, with their subsequent differentiation taking place at 10-
14 dpl (Huang et al., 2011b). This suggests that the initial Sema3A expression 
response is suppressed at around the time that OPC migration into the lesion 
begins, perhaps correlating to the success of OPC recruitment and remyelination in 
rodents. My findings in zebrafish also support a hypothesis based around OPC 
recruitment, whereby Sema3A levels in the zebrafish optic nerve reduce to allow 
OPC migration towards the lesion area. Hence, my results might indicate that some 
remyelination mechanisms in zebrafish are perhaps homologous to those observed 
in mammals, allowing experimental demyelination in zebrafish to be used for 
investigation and identification of therapeutic targets to aid remyelination.  
To further examine a possible role of Sema3A zebrafish remyelination I treated 
lesioned animals with human recombinant Semaphorin 3A (rSema3A) and found a 
decreased number of olig2:DsRed-positive oligodendroglial cells in the lesion area 
after treatment compared to vehicle treated controls at 14 dpl and fewer 
myelinated axons at 28 dpl. This might indicate a repelling effect on the migration 
of oligodendrocytes as described in previous studies, or could also be due to 
decreased cell proliferation, which has not been previously associated with 
Sema3A, or toxic effects. To exclude cell death, I attempted approaches including 
TUNEL and various anti-activated caspase 3 antibodies, but could not get these 
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protocols to work sufficiently in cryostat sections of zebrafish optic nerve.  As 
Sema3A has also been associated with neuronal toxicity (Yasuhara et al., 2005), 
further experiments including neuronal tracer experiments to assess axonal damage 
could give valuable insight into the effects of exogenous Sema3A in zebrafish. Small 
axons reminiscent of re-growing axons observed in electron microscopy images 
suggest that axon damage might have occurred following rSema3A treatment; it 
would therefore be useful to test different treatment doses. To validate the effects 
of Sema3A on OPC migration following demyelinating lesions, it would be crucial to 
test whether Sema3A also exhibits effects on OPCs without a demyelinating lesion. 
Further it could be helpful to determine the dose of rSema3A needed to reach 
concentrations comparable to endogenous levels found in an unlesioned optic 
nerve; this could be achieved by treating optic nerve with different doses of 
rSema3A and determining Sema3A levels by whole optic nerve lysates in western 
blot. And lastly, one would need to exclude the effect of rSema3A treatment on cell 
survival, proliferation and differentiation to evaluate whether Sema3A solely 
influences OPC migration. It might also be useful to determine whether Sema3A 
receptors are expressed by oligodendrocytes and how they are regulated during 
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Figure 5.11: Microglia and ventricular progenitor cells following LPC-induced optic nerve 
demyelination. (A) Schematic shows location of images presented in B and C. (B) In a cross section of 
adult zebrafish optic chiasm at 8 dpl, an increase of microglia in around the lesion site and in the 
optic tract (arrows) is observed brains. (C) A cross sections of adult zebrafish brain show 
olig2:DsRed+ progenitor cells in the periventricular progenitor zone with long processes extending 
right up to the optic projection. The fluorescence was inverted to allow easier visualisation of the cell 
processes. Scale bar: B,C = 100 µm.  
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Figure 5.12: Unmyelinated area zebrafish optic nerve. (A) In electron microscopic analysis of optic 
nerve cross sections, a well-defined area of unmyelinated axons can be observed. In the closely 
related goldfish, this area occupies less than 1% of the cross section through the optic nerve (Easter 
et al., 1981). (B) Higher magnification of box in A. Scale bars: A = 1 µm, B = 2 µm. 
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CHAPTER 6 – Discussion  
_____________________________________________ 
 
6.1 Zebrafish as a model to study demyelinating disease 
 
Multiple sclerosis is an intriguing disease with no curative treatments and many 
experimental models have been developed to study various aspects of multiple 
sclerosis ranging from disease pathology and correlation with imaging modalities to 
targets for therapeutic intervention. These models include toxin-mediated 
demyelination, where locally applied myelinotoxic agents such as ethidium bromide 
or LPC cause focal demyelination in the spinal cord or brain in experimental animals 
including rodents, cats and primates (Blakemore, 1982; Hall, 1972; Woodruff and 
Franklin, 1999). In another model the cuprizone diet leads to demyelination in 
major myelinated tracts of the rodent brain (Blakemore, 1973a). The value of these 
toxin-mediated demyelination models lies mostly in their regenerative aspect, as 
the focal lesions remyelinate several weeks after the demyelinating insult by 
ethidium bromide or LPC or following cessation of the cuprizone diet with a known 
time course (Blakemore, 1973b; Ludwin, 1978). These models lend themselves to 
the exploration of myelin repair mechanisms, including the origin of remyelinating 
cells and efficiency of remyelination. As multiple sclerosis is thought to be immune 
mediated, demyelination models with viral- and auto-immune induced 
demyelination are studied for further understanding of disease pathology and more 
specifically to model immune cells within MS lesions. Murine models using Theiler 
virus-induced encephalomyelitis mirrors some immunological aspects of MS by 
presenting with chronic inflammation in the white and grey matter and resulting 
demyelination (reviewed in Oleszak et al., 1995). In contrast, experimental 
autoimmune encephalomyelitis (EAE) is induced by injecting a CNS-specific myelin 
protein such as myelin associated glycoprotein (MAG) or myelin oligodendrocyte 
protein (MOG) with adjuvants and mimics primarily the multifocal presentation of 
MS and its different clinical stages, though most changes occur in spinal cord or 
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brainstem and only rarely affect the hemispheres (reviewed in Glynn and Linington, 
1989). As such these models have been used extensively to study the role of 
inflammatory cells and cytokines in MS pathology and to identify 
immunomodulatory targets for possible therapeutic intervention.  
 
It has been previously suggested that zebrafish could potentially also be very useful 
in modelling demyelinating disease due to their transparency and rapid 
development at the larval stage (Buckley et al., 2008). While the myelin composition 
of fish is also similar to mammals with the major exception that myelin protein zero 
is found in the zebrafish CNS, it is not clear that the actual process of myelin 
formation is homologous, which is essential when attempting to model a human 
disease in animals. Studies investigating genes involved in regulating myelin 
formation in zebrafish suggest conservation of mechanisms between mammals and 
zebrafish (for examples see Kucenas et al., 2008; Park and Appel, 2003; Takada et 
al., 2010) and advances are being made constantly to understand this further. Live 
imaging in transgenic zebrafish larvae has revealed that myelinating 
oligodendroglial cells go through the same stages of axon glial contact formation 
and process extension as rodent oligodendrocytes in vitro, and this is could mean 
that homologous processes are likely involved (Czopka and Lyons, 2011). As such, 
this model platform may be useful to study the physiological processes of 
myelination.  Moreover, zebrafish larvae have been successfully used to visualise 
myelin repair by oligodendrocytes. In zebrafish larvae expressing membrane-bound 
GFP under the oligodendrocyte specific promoter nkx2.2, laser ablation of 
myelinating oligodendrocytes resulted in compensation by neighbouring cells, 
which quickly extended new processes and migrated to the lesioned area (Kirby et 
al., 2006). Ablation over several muscle segments showed that oligodendrocyte 
precursor cells from not affected areas were capable of responding to the insult by 
migration to the lesion site. This highlights the importance for model organisms 
such as zebrafish, which bear the benefit of a transparent larval stage and are 
therefore suitable for in vivo live imaging. Similarly, I have shown in this thesis that 
by using an inducible genetic cell ablation approach, it is possible to specifically 
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ablate myelinating cells in the developing zebrafish, and that this system is able to 
generate new oligodendrocytes following the insult. These results are also 
consistent with findings in an experimental model of targeted genetic 
oligodendrocyte ablation in Xenopus laevis (Kaya et al., 2012).  
 
These approaches to visualise oligodendrocyte response to injury in fish all have the 
common derivative of working with developing systems, however it is critical to 
differentiate between de novo myelination of developing axons and remyelination 
of ones that already were myelinated once, as developmental myelination capacity 
and mechanisms may be different to those implied during adult myelin repair. This 
difficulty might be overcome in models using developmental stages by measuring 
the rate of regeneration and comparing it to the rate of normal development, but 
could on a molecular level still involve developmental signals which may not be 
active or relevant in remyelination of the adult CNS. I therefore sought to develop 
experimental demyelinating lesions in adult zebrafish to study the events following 
myelin injury in a system in which developmental myelination is largely completed 
and which could be potentially useful to for in vivo live imaging of remyelination on 
a cellular level and to identify potential therapeutic targets to aid remyelination in 
scenarios where this is insufficient. 
 
For this, I firstly characterised a novel myelin protein, Claudin k, which was 
identified in a microarray screen investigating differential myelin gene expression in 
hypomyelinating zebrafish (Schaefer, 2009) and evaluated its use as a tool to label 
myelin in zebrafish. To date many myelin proteins in zebrafish have already been 
described and are used in zebrafish myelination studies; these include myelin basic 
protein, myelin protein zero and DM20, a short isoform of proteolipid protein. 
Studies show that RNA transcripts for these proteins were detected in 
oligodendrocytes in the CNS of zebrafish larvae from 2 days post fertilisation 
onwards (Bai et al., 2011; Brosamle and Halpern, 2002) similar to Claudin k, 
however a transgenic line with variegated membrane bound GFP expression in 
myelinating glia using the GAL4-UAS system allowed visualisation of single 
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myelinating oligodendrocytes at various stages of myelination as well as flexibility 
to generate new transgenic lines by crossing this line into other effector lines for 
specific cell ablation (Davison et al., 2007).  
 
Claudin k is specifically expressed in tight junctions of myelinating cells of the 
central and peripheral nervous system in zebrafish and I have used the transgenic 
line Tg(claudin k:GAL4,UAS:GFP) and specific Claudin k antibodies to describe the 
events occurring during developmental myelination and myelin regeneration in 
more detail. By being a constituent of tight junctions within the myelin sheath, a 
major function of Claudin k is to closely join the several lamellae of myelin, and its 
clear localisation to Schmidt-Lanterman incisures, mesaxon and paranodal loops 
suggests that the majority of Claudin k-containing tight junctions are located in 
close proximity to the cytoplasmic channels, which show similar distribution 
(Velumian et al., 2011). This suggests a function in early myelination as myelin 
wraps are beginning to form and was further confirmed by time course studies and 
comparison to other myelin markers such as myelin basic protein and myelin 
protein zero indicating that Claudin k was one of the earliest detectable markers in 
myelinated structures in developing embryos. While it is not clear how the compact 
myelin sheath is actually formed, whether several layers are loosely wrapped 
around the axon and then all compact together, or whether it is an integrated 
process whereby the inner layers are already compacting as outer layers are being 
formed, high resolution live imaging of CNS myelin formation is beginning to help us 
understand this intricate process better (Ioannidou et al., 2012; Sobottka et al., 
2011). Studies have suggested specific functions of other myelin proteins during the 
myelination process, in particular a role of myelin basic protein and myelin protein 
zero during myelin compaction (Baumann and Pham-Dinh, 2001; Hartline and 
Colman, 2007) and hence support the theory that there is a dynamic but distinct 
timeline along which myelination is achieved during development. Furthermore, my 
studies in the adult zebrafish visual system demonstrated a difference between 
markers expressed in “loose” and “compact” myelin wrappings with myelin protein 
zero clearly absent from the myelinated retinal fibre layer, which only contains non-
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compacted myelin wraps (Schweitzer et al., 2007). Hence, Claudin k is useful for 
studying axon-glial interaction as it is expressed early and throughout all 
myelination stages during zebrafish development. To investigate whether Claudin k 
would also be useful as a marker of myelin regeneration in adult zebrafish, I 
performed regeneration studies of the adult zebrafish optic nerve. I observed a 
reduction of myelin immunofluorescence across the optic nerve following crush 
injury, which regenerated within 4 weeks and is similar to previous findings in 
related fish studies (Ankerhold and Stuermer, 1999), and further suggests that 
Claudin k is also useful to track and quantify myelin during regeneration. Moreover, 
a novel transgenic line expressing a membrane bound GFP under the claudin k 
promoter using the GAL4:UAS system allowed the observation of single myelinating 
cells during the process of optic nerve regeneration. The GFP-positive cells observed 
in the lesion area were of a simple bipolar morphology at early time points after the 
optic nerve crush and had multiple processes and a complex morphology at later 
stages during regeneration. These findings are indicative of oligodendroglial cell 
differentiation throughout the regeneration process and show that myelin 
regeneration following optic nerve crush in zebrafish is unlikely to involve Schwann 
cells, which have been shown to invade the regenerating optic nerve of goldfish 
(Nona et al., 1992). My studies also showed that approximately 25% of 
oligodendrocytes in the lesion site were newly generated as they incorporated the 
proliferation marker BrdU. This is different to findings in the goldfish, in which less 
than 10% of oligodendrocytes were newly generated and myelination was thought 
to be carried out by de- and re-differentiation of oligodendrocytes in the lesion area 
(Ankerhold and Stuermer, 1999). These findings highlight the opportunities of 
Claudin k to visualise cellular events during de- and remyelination.  
In summary, my studies show that Claudin k is a reliable and quantifiable marker of 
myelin in zebrafish, which compares to other, previously described myelin markers 
in zebrafish such as myelin protein zero and myelin basic protein, with the 
advantage that the variegated expression within the transgenic line allows 
visualisation of single cells and the GAL4:UAS system gives some flexibility in terms 
of generating new lines.    
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6.2 Zebrafish remyelination – homology to mammals  
 
Previous studies on myelin regeneration in the closely related goldfish involve axon 
severance, and therefore do not investigate remyelination per se but rather 
myelination in a regenerating environment (Ankerhold and Stuermer, 1999). Hence 
I sought to develop experimental focal demyelinating lesions in the adult zebrafish 
to specifically study changes associated with de- and remyelination and for this I 
used the myelin toxin LPC to induce focal demyelinating lesions, which is commonly 
used in rodent experimental models. After LPC-mediated demyelination in the 
zebrafish optic nerve, without concurrent axonal damage, I observed a clear 
reduction of both immunohistochemical markers for myelin and oligodendrocytes 
and a regeneration of these within 4 weeks. This is consistent with remyelination 
time courses described in rodent models of LPC-induced demyelination (Foster et 
al., 1980; Hall, 1973) and might possibly hint towards some similarities in the repair 
mechanisms.  
 
While immunohistological studies give some indication of the time line of myelin 
repair, a more accurate measurement is the G-ratio, which takes into account the 
myelin thickness in relation to the axon diameter it surrounds. It has been shown 
that in remyelinated MS plaques, also called “shadow plaques”, the regenerated 
myelin is much thinner (and thus presents with a higher G-ratio) compared to the 
normal appearing white matter and these findings are also reflected in some rodent 
experimental models of MS (Blakemore and Franklin, 2008; Hampton et al., 2012). 
In my remyelination model in the adult zebrafish optic nerve, I found that while the 
relative myelin thickness of remyelinated fibres was not different to before 
demyelination in young zebrafish, aged zebrafish seem to lack this regenerative 
capacity and presented with thinner myelin sheaths after 4 weeks of regeneration. 
This raises questions around whether old zebrafish truly remyelinate insufficiently 
or whether the process is just slower and a longer regenerative period would result 
in normal myelin sheath regeneration, given their generally high regeneration 
capacity. Studies in young and aged mice report similar findings, and that 
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remyelination in old age may be affected rather by slower remyelination rate than 
insufficient mechanisms (Shields et al., 1999). More specifically, changes in 
macrophage recruitment seem to be altered in aged mice, because when they were 
joined to young mice by parabiosis, the old mice were not only able to recruit from 
the macrophage pool of the young animal but also remyelinate the lesion area 
(Ruckh et al., 2012).  As the aim of working with experimental disease models is to 
mimic the human pathology as precisely as possible, these findings question 
whether young animals are a useful in modelling remyelination since they present 
with a higher regenerative ability than humans, or whether aged organisms would 
indeed be more accurate. The answer is two-fold and involves different approaches 
of understanding demyelinating disease. For studies investigating why 
remyelination in multiple sclerosis is insufficient, one needs an experimental 
paradigm, which mimics this pathology most closely and where pathways can be 
potentially altered to explore enhancing treatment strategies. Experimental models, 
which model only certain aspects of the disease can also be very powerful tools if 
they allow screening of pathways involved in remyelination and testing of candidate 
target molecules. On the other hand, however, it would be interesting to compare 
the mechanisms of repair of young zebrafish with full remyelination capacity to 
other models with insufficient remyelination, and to explore differences within 
myelin repair mechanisms. For example it would be interesting to isolate 
remyelinating cells in the optic nerve of young and old zebrafish and perform 
transcriptional profiling which might elucidate differences in signalling pathways 
that could explain this differential remyelination capacity. 
 
In the rodent central nervous system, there are two main areas from which 
oligodendrocytes can originate: firstly, OPCs expressing the progenitor markers NG2 
and PDGF-receptor-α are widely distributed in the postnatal brain and can 
differentiate into myelinating oligodendrocytes upon injury (Kang et al., 2010; 
Zawadzka et al., 2010); and secondly the OPCs can arise from progenitor cells in the 
subventricular zone (SVZ) (Menn et al., 2006; Nait-Oumesmar et al., 1999). In the 
zebrafish, it is unclear whether oligodendrocytes can only originate from the 
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precursor cells in the periventricular progenitor zone, or whether parenchymal 
progenitor cells such as NG2+ cells exist in zebrafish. It has been shown that the 
zebrafish brain parenchyma contains a population of slowly dividing 
oligodendroglial progenitor cells (Marz et al., 2010). However it is not known which 
progenitor population gives rise to remyelinating cells in the zebrafish optic nerve 
or whether it is perhaps a contribution of both populations. Much research has 
been performed to determine the sources of OPCs responsible for remyelination in 
the rodent brain, and while results show that oligodendrocyte precursor cells from 
both regions are capable of remyelinating, there appears to be a difference in 
recruitment origin depending on the location of the lesion. Studies investigating 
myelin repair in demyelinating spinal cord lesions in rodents indicate that 
remyelination is carried out by oligodendrocyte precursor cells in the immediately 
surrounding white matter and surviving oligodendrocytes in the lesion site do not 
contribute to this process (reviewed in Blakemore and Keirstead, 1999). By contrast, 
in experimental demyelination models where the lesion is located in the brain an 
increased proliferation in the SVZ has been described, which is also observed in 
post-mortem brain of MS patients (reviewed in Nait-Oumesmar et al., 2008). It is 
thought that this proliferation in response to injury is triggered by Cdk2, a cyclin-
dependent kinase which controls the cell cycle by promoting cell cycle exit and 
differentiation (Caillava et al., 2011). Cell tracing experiments showed that these 
proliferating progenitor cells were able to migrate to the lesion area, differentiate 
into myelinating oligodendrocytes and contribute to remyelination, however this 
was only observed for lesions within close vicinity of the ventricles, for example in 
the corpus callosum or the rostral migratory stream, but not for more distant 
lesions for example in the cerebellum. This suggests that perhaps, depending on the 
location of the demyelinating lesion, different sources of progenitor cells are 
activated; however the relative contribution of both SVZ-derived and adult 
progenitor cell populations and detailed signalling mechanisms remain unclear. In 
my studies in the zebrafish, I also observed an increased proliferation in the 
periventricular progenitor zone following optic nerve demyelination. Furthermore, I 
found an activation of microglia along the entire optic tract of the lesioned optic 
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nerve, which might suggest an inflammatory signalling mechanism as the 
periventricular progenitor cells possess very long processes that end in close 
proximity of the optic projection and could possibly directly respond to chemokines. 
This is supported by recent studies in the zebrafish, which report progenitor 
proliferation after the inflammatory agent zymosan was injected into the ventricle 
(Kyritsis et al., 2012). Further, it has been shown that OPCs of rodents express 
cytokine receptors that can mediate a chemotactic-induced proliferative and 
migratory response through their ligands which are up-regulated in demyelinating 
lesions of experimental animal models and within MS (Carbajal et al., 2010; 
Dziembowska et al., 2005; Kelland et al., 2011; Nguyen and Stangel, 2001). 
Experimental models also demonstrate that a depletion of macrophages reduces 
remyelination of spinal cord lesions (Kotter et al., 2001); and moreover induction of 
inflammation can enhance remyelination of chronically demyelinated areas (Foote 
and Blakemore, 2005) as well as myelination of the normally unmyelinated rodent 
retina by transplanted OPCs (Setzu et al., 2006), These finding support the 
hypothesis that inflammatory signalling seems to be an important mechanism for 
proliferation and recruitment of progenitor cells and subsequent successful 
remyelination, and together with my results might indicates that homologous 
signalling mechanisms may be involved in OPC recruitment in zebrafish. This might 
perhaps also question the need for anti-inflammatory treatment in human disease, 
especially as all approved therapies suppress and/or modulate the immune system 
and thereby possibly dampen the regenerative response. Closer investigation of the 
signalling mechanisms involved in remyelination, in particular the involvement of 
the immune system, could potentially present useful ways to specifically manipulate 
the immune response to dampen disease activity but aid regeneration.  Further 
experiments in the zebrafish investigating the effect of optic nerve inflammation on 
cells of the progenitor zone and progenitor cell tracing following demyelinating 
optic nerve lesions would give more insight into whether recruitment mechanisms 
are homologous between species; and knockdown of various cytokine receptors 
expressed on OPCs in zebrafish could elucidate specific immunological signalling 
cascades. Moreover it could be interesting to explore demyelinating lesions in 
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various CNS locations to establish whether this system is similar to rodents in that 
there is no increased proliferation in the periventricular progenitor zone if the 
lesion area is not in close proximity.  
 
Remyelination studies in rodents have revealed several pathways likely involved 
myelin repair through the regulation of oligodendroglial differentiation, such as 
Notch-Jagged and retinoid X receptor-ϒ signalling (Huang and Franklin, 2011; Huang 
et al., 2011b), some of which might also be implemented in fish. It has been shown 
that Notch mutant zebrafish are not able to generate myelinating oligodendrocytes 
from precursor cells and upon Notch overexpression increased oligodendrocyte 
development was observed (Park and Appel, 2003). Notch therefore appears to play 
a role in regulating specification of oligodendrocytes during development in 
zebrafish and hence could also be important in remyelination; however this has not 
been shown yet. Similarly, mechanisms of oligodendrocyte recruitment may also 
play a key role in successful remyelination. This possibility has been explored and it 
has been suggested that the guidance molecules Semaphorin 3A and 3F are able to 
guide oligodendrocyte precursor cells to the lesion area due to their respective 
chemo repelling and attracting properties (Williams et al., 2007). Indeed in rodent 
LPC-demyelination models overexpression studies of these molecules were able to 
show that Semaphorin 3A inhibits OPC recruitment to the lesion area and 
Semaphorin 3F aids OPC migration and therefore also remyelination (Piaton et al., 
2011). Similarly, treatment with recombinant Semaphorin 3A and 3F also effectively 
altered remyelination in a mouse model of LPC-induced demyelination, without 
affecting cell survival, proliferation or differentiation, and therefore suggest a 
migratory effect (Boyd et al., 2013). In fish, the semaphorins have mainly been 
assigned a function in axon path finding; however the similarity between fish 
oligodendrocytes in terms of morphology and expressed markers, as well as 
remyelination time course opens potential questions about the role of class 3 
semaphorins in myelin repair in zebrafish. To explore this further, I investigated 
Sema3A in the zebrafish optic nerve after demyelinating lesions and found reduced 
levels present at early time points after the lesion, suggesting a hypothesis based 
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around Sema3A negatively effecting OPC recruitment and homologous signalling 
mechanisms to mammals. Moreover, treatment with human recombinant Sema3A 
decreased the number of oligodendroglial cells and percentage of myelinated axons 
in the lesion area following demyelination, which is similar to results observed in 
rodent models (Boyd et al., 2013). However, to make clear statements about the 
exact signalling mechanisms and homologies to rodent systems, these studies 
would need to be extended. My studies show co-localisation of Sema3A expression 
with neuronal markers suggesting that, like in rodents it is produced in neuronal cell 
bodies and transported along the axon (de Wit et al., 2006). However, whether 
there is a local down-regulation in the lesion site after demyelination or a more 
global effect along the entire optic nerve is not clear. Western blots for Sema3A 
levels of different parts of the optic could give more insight into this. Furthermore, 
it is also not known whether high levels of Sema3A affects the axons in the optic 
nerve, as it has been previously suggested that Sema3A might be toxic to some 
kinds of neurons (Yasuhara et al., 2005).  Axonal injury could be assessed by 
neuronal tracer experiments after Sema3A treatment where optic nerve axons are 
retrogradely labelled or by staining for phosphorylated or dephosphorylated 
neurofilament with SMI31 or SMI32 antibodies, as dephosphorylated neurofilament 
is associated with demyelinated axons. Alternative antibodies which detect axonal 
injury and may work in zebrafish include Amyloid precursor protein (APP). In 
addition, it would need to be determined whether Sema3A affects cell proliferation 
and differentiation and cell death analysis could ensure that Sema3A does not 
affect cell survival. Finally, knockdown of Sema3A in the zebrafish larvae could 
provide useful information about the role of Sema3A in OPC migration during 
development, and conditional knockdown in adult zebrafish could perhaps 
elucidate whether Sema3A affects myelin repair, as one would expect more OPC 
migration and perhaps faster or even more remyelination. Findings in our 
laboratory show that Sema3A knockdown mice remyelinate faster after LPC-
induced lesions in the corpus callosum compared to control animals (Boyd et al., 
2013). Hence, the investigation of remyelination in adult zebrafish with knocked 
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down Sema3A could perhaps support the hypothesis that some signalling 
mechanisms are homologous between zebrafish and mammals. 
 
Taken together, my studies show that the time course of de- and remyelination 
between zebrafish and rodents is similar, and that perhaps homologous signalling 
mechanisms are implied in OPC recruitment and migration. 
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6.3 Clinical relevance of my findings 
 
Although much research about disease pathology and possible therapeutic 
intervention in MS has been conducted, it still remains unclear what mechanisms 
cause the disease and how to treat it most effectively. 
Experimental models of demyelinating disease have proven very useful in the 
search for therapeutic targets; the immunomodulators interferon-beta 1α, 
glatiramer acetate and the recently licensed fingolimod, which are currently the 
therapeutic mainstay for the relapsing-remitting form of MS (RRMS), and 
natalizumab, which is used for disease with more aggressive relapses, were initially 
validated in experimental animal models (reviewed in Denic et al., 2011). For 
example, studies in rodents and non-human primates clearly demonstrate that 
glatiramer acetate is able to suppress EAE by inhibiting cell proliferation in the 
spleen and cytokine response to auto-antigens, and animals treated with the drug 
showed less demyelination in the spinal cord compared to untreated EAE mice 
(Aharoni et al., 2008; Teitelbaum et al., 2004). Hence, through their ability to target 
immune cells and prevent lymphocyte migration into the CNS, as well as positively 
affect the blood-brain barrier integrity, which has been suggested by MRI imaging 
studies of patients with RRMS (Stone et al., 1995), these medical interventions are 
useful in suppressing inflammation and therefore potentially preventing and/or 
delaying progression and neurodegeneration. In my zebrafish-based demyelination 
model I observed an activation of microglia/macrophages following the 
demyelinating optic nerve lesion and hence it could be useful to study the effect of 
immunosuppression on remyelination. It would be particularly interesting to 
investigate whether inhibition of the immune response also leads to increased 
proliferation in the periventricular progenitor zone as recent studies have suggested 
that acute inflammation alone can trigger regeneration in the adult zebrafish brain 
(Kyritsis et al., 2012). Moreover, microglia/macrophage recruitment is impaired in 
old rats and investigation of the inflammatory response in my zebrafish-based 
demyelination model could lead to valuable information regarding the cause of 
insufficient myelin repair in old zebrafish. 
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Other groups are currently investigating immune-mediated mitochondrial injury, 
which has been associated with axonal damage and is thought to contribute to 
disease progression in MS. It has been shown that mitochondria are highly 
vulnerable to free radicals and Ca+ overload (Barrientos et al., 2011; Forte et al., 
2007), and that suppression of mitochondrial oxidative stress might have long-term 
effects on neuroprotection (Qi et al., 2007). Studies in zebrafish propose the 
possibility of conducting screens to investigate mitochondrial function in vivo, which 
could be used to explore chemical compounds capable of preventing mitochondrial 
dysfunction (Stackley et al., 2011). Moreover, the recent development of  
transgenic zebrafish lines allowing real-time in vivo observation of mitochondria 
might also deliver new insights into pathology and help to devise neuroprotective 
mechanisms (Kim et al., 2008; Plucinska et al., 2012). Demyelinating optic nerve 
lesions in these transgenic lines could elucidate whether fish mitochondria are also 
vulnerable to demyelination and whether they possess different mechanisms to 
deal with oxidative stress compared to the mammalian mitochondria. 
 
Another potential therapeutic strategy is to protect axons by enhancing 
remyelination by oligodendrocyte progenitor cells from endogenous sources and 
this has been the focus of much recent research (reviewed in Huang et al., 2011a). 
As axons are more vulnerable to inflammatory mechanisms when they are 
demyelinated, enhancing the process of remyelination could perhaps protect the 
axons from inflammatory injury and as such not only prevent axonal degeneration 
but also aid functional recovery after a demyelinating insult. As the remyelination 
process involves two major steps – the recruitment of oligodendrocyte precursors 
and their differentiation – enhancement of either of these might lead to increased 
remyelination capability. For example, studies in rodent demyelination models 
identified LINGO-1 as a negative regulator of oligodendrocyte differentiation and 
EAE mice treated with an antibody antagonist of LINGO-1 exhibited increased 
remyelination and functional recovery (Mi et al., 2007). A clinical trial investigating 
the use of a LINGO-1 antagonist in phase 1b has already been completed, however 
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the results remain to be reported (http://clinicaltrials.gov/ct2/show/NCT01244139). 
Similarly, it has been shown that signalling through the retinoid X receptor-ϒ 
positively affects oligodendrocyte maturation and increased remyelination, making 
this a potential therapeutic target although exact signalling mechanisms are yet 
unclear (Huang et al., 2011b). However as a licenced agonist of RXR-ϒ is already in 
clinical use for certain types of cancer, patient trials for RXR-ϒ as a treatment for MS 
may be conducted in the near future. Semaphorin 3A and 3F were shown to alter 
remyelination in rodent studies by affecting OPC recruitment through their 
respective repellent and attractive properties and although these molecules are 
currently far from being implemented in clinical practice, further investigation of 
these signalling pathways might lead to powerful targets that could be used for 
drug development (Williams et al., 2007). Using the experimental demyelination 
model in adult zebrafish described in this thesis, I was able to show that 
semaphorins may also play a role in oligodendrocyte recruitment in fish, 
highlighting possible similarities in remyelination mechanisms between species and 
the importance of this model organism for the discovery of therapy development.   
 
Zebrafish are amendable to high throughput screening of chemical compound 
libraries due to their transparent larval stage, rapid development and capacity for 
transgenesis (Hao et al., 2010; Hong, 2009). These screens have already been 
implemented in the discovery of pro-myelinating substances (Buckley et al., 2010), 
and my work shows that as zebrafish possibly exhibit conserved remyelination 
mechanisms as rodents, findings made in fish can potentially be extrapolated to and 
benefit mammalian systems. Moreover, zebrafish have the potential for live 
imaging so that cellular events of remyelination can be followed by time lapse 
imaging. This method is widely used in larval zebrafish as they are transparent and 
technically easy to embed for in vivo live imaging, and I hypothesised that this 
methodology may also be possible in adult fish. For this I trialled a hand-held fibre 
optic confocal microscope with which I hoped to visualise single cells in the optic 
nerve. While it was possible to image individual transgenic cell bodies, the 
resolution was not high enough to observe cell processes and associated internodes 
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and moreover it would have been difficult to reliably image the same location to 
follow remyelination without a rig that would fix the position of the fish in relation 
to the fibre optic microscope. To further explore the possibility of single cell live 
imaging during remyelination, I wondered whether demyelination could be induced 
in the zebrafish tectum by local placement of LPC and subsequent confocal time 
lapse imaging through a tectal window. For this, I placed LPC onto the adult 
zebrafish optic tectum through a small hole in the skull and found that both loss of 
claudin k+ myelin and olig2:DsRed+ oligodendrocytes were present on the surface 
of the tectum as well as a local activation of microglia. By mounting the tectal 
surface of these adult zebrafish onto a coverslip, I was able to image single 
transgenic cells live under the confocal microscope, and as such this technique 
might be helpful in real-time imaging of cellular events occurring during 
remyelination in the adult zebrafish tectum, however a rig allowing water 
immersion and ventilation of the fish during live imaging over long periods of time 
would probably be necessary.   
 
Taken together, my studies show that focal demyelinating lesions in the optic nerve 
of adult zebrafish facilitate the study of remyelination. This zebrafish-based model 
could be useful in exploring mechanisms involved in remyelination in organisms 
with high regenerative capacity and the possibility of in vivo live imaging of single 
cells. In addition, studies utilising mammalian experimental demyelination models 
could also benefit from the screening potential of larval zebrafish, which allows very 
fast, and often automated, assessment of the effects of chemical compounds on 
myelination. A strategy for the discovery of pro-myelinating substances could be to 
perform chemical compound screens in zebrafish larvae to determine initial 
candidate substances and test them in the adult zebrafish-based remyelination 
model, prior to moving onto rodent experimental models, which are more 
expensive and currently less amendable to spatial and temporal manipulation of 
gene expression and function. In addition, comparisons of mechanisms involved in 
remyelination between the regenerating optic nerve of young zebrafish and those 
in models with insufficient remyelination such as older zebrafish or rodents, for 
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example by transcriptional profiling of oligodendrocytes, could give valuable 
information about possible causes of remyelination failure. 
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6.4 Concluding remarks and future directions 
 
In this thesis I propose adult zebrafish as a model to study remyelination after 
experimental demyelination. Zebrafish are being exploited for their high throughput 
screening potential of chemical compound libraries to discover putative substances 
that could enhance remyelination. However, it is unclear whether zebrafish and 
mammals share similar myelination and remyelination mechanisms and whether 
findings in the zebrafish could be extrapolated to mammals. The studies herein 
describe developmental myelination and myelin repair in zebrafish and show 
similarities of remyelination time course and possible signalling mechanisms in 
oligodendrocyte progenitor cell recruitment to findings made in experimental 
rodent models. Moreover, the data suggests that there is a differential myelin 
regeneration capacity between young and old zebrafish, which would lend itself to 
comparative studies of gene expression regulation and mechanisms of repair to 
determine why ageing impairs the remyelination process and what strategies 
zebrafish employ to be capable of regeneration. This may elucidate differences 
between complete and insufficient myelin repair mechanisms and as such might 
present potential targets for therapeutic intervention that could be useful in the 









BSA Bovine serum albumin 
BrdU Bromodeoxyuridine 
CNS Central nervous system 
DAB Diaminobenzidine 
DMEM Dulbecco’s Modified Eagle Medium 
dH2O Distilled water 
DMSO Dimethyl sulfoxide 
dpf Days post fertilisation 
dpl Days post lesion 
DTR Diphtheria toxin receptor 
EAE Experimental autoimmune encephalomyelitis 
EdU Ethynyl-deoxyuridine 
EDTA Ethylenediaminetetraacetic acid 
EGTA Ethylene glycol tetraacetic acid 
EM Electron microscopy 
EtBr Ethidium Bromide 
GFP Green fluorescent protein 
hpf Hours post fertilisation 




MAG Myelin associated glycoprotein 
MAPK Mitogen-activated protein kinase 




MOG Myelin/oligodendrocyte protein 





ON Optic nerve 
OPC Oligodendrocyte progenitor/precursor cell 
P0 Myelin protein zero 
PBS Phosphate buffered saline 
PBStx PBS containing Triton X-100 
PBST PBS containing Tween20 
PCNA Proliferating cell nuclear antigen 




PLLN Peripheral lateral line nerve 
PLP Proteolipid protein 
PMP22 Peripheral myelin protein 22 
PNS Peripheral nervous system 
PPMS Primary progressive multiple sclerosis 
PTU N-phenylthiourea 
RFP Red fluorescent protein 
rpm Rotations per minute 
RRMS Relapsing-remitting multiple sclerosis 
SD Standard deviation 
SEM Standard error of the mean 
SDS Sodium dodecyl sulphate 
SPMS Secondary progressive multiple sclerosis 
SVZ Subventricular zone 
TBS Tris buffered saline 
TBST TBS containing Tween20 
UAS Upstream activating sequence 
VEGF Vascular endothelial growth factor 
ZF Zebrafish 





Abdul-Majid, K.B., Wefer, J., Stadelmann, C., Stefferl, A., Lassmann, H., Olsson, T., 
and Harris, R.A. (2003). Comparing the pathogenesis of experimental autoimmune 
encephalomyelitis in CD4-/- and CD8-/- DBA/1 mice defines qualitative roles of 
different T cell subsets. Journal of neuroimmunology 141, 10-19. 
Acs, P., and Komoly, S. (2012). Selective ultrastructural vulnerability in the 
cuprizone-induced experimental demyelination. Ideggyogyaszati szemle 65, 266-
270. 
Adlkofer, K., Martini, R., Aguzzi, A., Zielasek, J., Toyka, K.V., and Suter, U. (1995). 
Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient 
mice. Nature genetics 11, 274-280. 
Aharoni, R., Herschkovitz, A., Eilam, R., Blumberg-Hazan, M., Sela, M., Bruck, W., 
and Arnon, R. (2008). Demyelination arrest and remyelination induced by glatiramer 
acetate treatment of experimental autoimmune encephalomyelitis. Proceedings of 
the National Academy of Sciences of the United States of America 105, 11358-
11363. 
Akitake, C.M., Macurak, M., Halpern, M.E., and Goll, M.G. (2011). Transgenerational 
analysis of transcriptional silencing in zebrafish. Developmental biology 352, 191-
201. 
Almeida, R.G., Czopka, T., Ffrench-Constant, C., and Lyons, D.A. (2011). Individual 
axons regulate the myelinating potential of single oligodendrocytes in vivo. 
Development 138, 4443-4450. 
Amor, S., Baker, D., Groome, N., and Turk, J.L. (1993). Identification of a major 
encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of 
experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. 
J Immunol 150, 5666-5672. 
Amor, S., Groome, N., Linington, C., Morris, M.M., Dornmair, K., Gardinier, M.V., 
Matthieu, J.M., and Baker, D. (1994). Identification of epitopes of myelin 
oligodendrocyte glycoprotein for the induction of experimental allergic 
encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153, 4349-4356. 
Andrews, H.E., Nichols, P.P., Bates, D., and Turnbull, D.M. (2005). Mitochondrial 
dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis. Medical 
hypotheses 64, 669-677. 
Page | 216  
 
Ankerhold, R., and Stuermer, C.A. (1999). Fate of oligodendrocytes during retinal 
axon degeneration and regeneration in the goldfish visual pathway. Journal of 
neurobiology 41, 572-584. 
Ara, J., See, J., Mamontov, P., Hahn, A., Bannerman, P., Pleasure, D., and Grinspan, 
J.B. (2008). Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse 
spinal cord during experimental autoimmune encephalomyelitis. Journal of 
neuroscience research 86, 125-135. 
Ariga, J., Walker, S.L., and Mumm, J.S. (2010). Multicolor time-lapse imaging of 
transgenic zebrafish: visualizing retinal stem cells activated by targeted neuronal 
cell ablation. Journal of visualized experiments : JoVE. 
Asakawa, K., and Kawakami, K. (2008). Targeted gene expression by the Gal4-UAS 
system in zebrafish. Development, growth & differentiation 50, 391-399. 
Azim, K., and Butt, A.M. (2011). GSK3beta negatively regulates oligodendrocyte 
differentiation and myelination in vivo. Glia 59, 540-553. 
Back, S.A., Tuohy, T.M., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N.L., 
Banine, F., Liu, Y., Chang, A., et al. (2005). Hyaluronan accumulates in demyelinated 
lesions and inhibits oligodendrocyte progenitor maturation. Nature medicine 11, 
966-972. 
Bai, Q., Sun, M., Stolz, D.B., and Burton, E.A. (2011). Major isoform of zebrafish P0 is 
a 23.5 kDa myelin glycoprotein expressed in selected white matter tracts of the 
central nervous system. The Journal of comparative neurology 519, 1580-1596. 
Baker, D., O'Neill, J.K., Gschmeissner, S.E., Wilcox, C.E., Butter, C., and Turk, J.L. 
(1990). Induction of chronic relapsing experimental allergic encephalomyelitis in 
Biozzi mice. Journal of neuroimmunology 28, 261-270. 
Bankston, A.N., Mandler, M.D., and Feng, Y. (2013). Oligodendroglia and 
neurotrophic factors in neurodegeneration. Neuroscience bulletin 29, 216-228. 
Barbin, G., Aigrot, M.S., Charles, P., Foucher, A., Grumet, M., Schachner, M., Zalc, B., 
and Lubetzki, C. (2004). Axonal cell-adhesion molecule L1 in CNS myelination. 
Neuron glia biology 1, 65-72. 
Baron-Van Evercooren, A., Gansmuller, A., Duhamel, E., Pascal, F., and Gumpel, M. 
(1992). Repair of a myelin lesion by Schwann cells transplanted in the adult mouse 
spinal cord. Journal of neuroimmunology 40, 235-242. 
Barres, B.A., and Raff, M.C. (1993). Proliferation of oligodendrocyte precursor cells 
depends on electrical activity in axons. Nature 361, 258-260. 
 
Page | 217  
 
Barrientos, S.A., Martinez, N.W., Yoo, S., Jara, J.S., Zamorano, S., Hetz, C., Twiss, J.L., 
Alvarez, J., and Court, F.A. (2011). Axonal degeneration is mediated by the 
mitochondrial permeability transition pore. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 31, 966-978. 
Barros, C.S., Nguyen, T., Spencer, K.S., Nishiyama, A., Colognato, H., and Muller, U. 
(2009). Beta1 integrins are required for normal CNS myelination and promote AKT-
dependent myelin outgrowth. Development 136, 2717-2724. 
Baumann, N., and Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in 
the mammalian central nervous system. Physiological reviews 81, 871-927. 
Bechtold, D.A., Miller, S.J., Dawson, A.C., Sun, Y., Kapoor, R., Berry, D., and Smith, 
K.J. (2006). Axonal protection achieved in a model of multiple sclerosis using 
lamotrigine. Journal of neurology 253, 1542-1551. 
Becker, C.G., and Becker, T. (2007). Growth and pathfinding of regenerating axons 
in the optic projection of adult fish. Journal of neuroscience research 85, 2793-
2799. 
Becker, C.G., and Becker, T. (2008). Adult zebrafish as a model for successful central 
nervous system regeneration. Restorative neurology and neuroscience 26, 71-80. 
Becker, C.G., Meyer, R.L., and Becker, T. (2000). Gradients of ephrin-A2 and ephrin-
A5b mRNA during retinotopic regeneration of the optic projection in adult 
zebrafish. The Journal of comparative neurology 427, 469-483. 
Benetti, F., Ventura, M., Salmini, B., Ceola, S., Carbonera, D., Mammi, S., Zitolo, A., 
D'Angelo, P., Urso, E., Maffia, M., et al. (2010). Cuprizone neurotoxicity, copper 
deficiency and neurodegeneration. Neurotoxicology 31, 509-517. 
Bernardos, R.L., Barthel, L.K., Meyers, J.R., and Raymond, P.A. (2007). Late-stage 
neuronal progenitors in the retina are radial Muller glia that function as retinal stem 
cells. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 27, 7028-7040. 
Bielenberg, D.R., Hida, Y., Shimizu, A., Kaipainen, A., Kreuter, M., Kim, C.C., and 
Klagsbrun, M. (2004). Semaphorin 3F, a chemorepulsant for endothelial cells, 
induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. The 
Journal of clinical investigation 114, 1260-1271. 
Bingham, C.O., 3rd, and Austen, K.F. (1999). Phospholipase A2 enzymes in 
eicosanoid generation. Proceedings of the Association of American Physicians 111, 
516-524. 
Birchmeier, C., and Nave, K.A. (2008). Neuregulin-1, a key axonal signal that drives 
Schwann cell growth and differentiation. Glia 56, 1491-1497. 
Page | 218  
 
Birgbauer, E., Rao, T.S., and Webb, M. (2004). Lysolecithin induces demyelination in 
vitro in a cerebellar slice culture system. Journal of neuroscience research 78, 157-
166. 
Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T., and Bruck, W. (2000). Acute 
axonal injury in multiple sclerosis. Correlation with demyelination and 
inflammation. Brain : a journal of neurology 123 ( Pt 6), 1174-1183. 
Black, J.A., Newcombe, J., Trapp, B.D., and Waxman, S.G. (2007). Sodium channel 
expression within chronic multiple sclerosis plaques. Journal of neuropathology and 
experimental neurology 66, 828-837. 
Black, J.A., Waxman, S.G., and Smith, K.J. (2006). Remyelination of dorsal column 
axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and 
Kv1.2 at nodes of Ranvier. Brain : a journal of neurology 129, 1319-1329. 
Blakemore, W.F. (1973a). Demyelination of the superior cerebellar peduncle in the 
mouse induced by cuprizone. Journal of the neurological sciences 20, 63-72. 
Blakemore, W.F. (1973b). Remyelination of the superior cerebellar peduncle in the 
mouse following demyelination induced by feeding cuprizone. Journal of the 
neurological sciences 20, 73-83. 
Blakemore, W.F. (1975). Remyelination by Schwann cells of axons demyelinated by 
intraspinal injection of 6-aminonicotinamide in the rat. Journal of neurocytology 4, 
745-757. 
Blakemore, W.F. (1982). Ethidium bromide induced demyelination in the spinal cord 
of the cat. Neuropathology and applied neurobiology 8, 365-375. 
Blakemore, W.F., Chari, D.M., Gilson, J.M., and Crang, A.J. (2002). Modelling large 
areas of demyelination in the rat reveals the potential and possible limitations of 
transplanted glial cells for remyelination in the CNS. Glia 38, 155-168. 
Blakemore, W.F., and Franklin, R.J. (2008). Remyelination in experimental models of 
toxin-induced demyelination. Current topics in microbiology and immunology 318, 
193-212. 
Blakemore, W.F., and Keirstead, H.S. (1999). The origin of remyelinating cells in the 
central nervous system. Journal of neuroimmunology 98, 69-76. 
Boggs, J.M. (2006). Myelin basic protein: a multifunctional protein. Cellular and 
molecular life sciences : CMLS 63, 1945-1961. 
Bondan, E.F., Custodio, P.R., Lallo, M.A., Bentubo, H.D., and Graca, D.L. (2009). 
Ethidium bromide-induced demyelination in the sciatic nerve of diabetic rats. 
Arquivos de neuro-psiquiatria 67, 1066-1070. 
Page | 219  
 
Boyd, A., Zhang, H., and Williams, A. (2013). Insufficient OPC migration into 
demyelinated lesions is a cause of poor remyelination in MS and mouse models. 
Acta neuropathologica. 
Brand, A.H., and Perrimon, N. (1993). Targeted gene expression as a means of 
altering cell fates and generating dominant phenotypes. Development 118, 401-
415. 
Brinkmann, B.G., Agarwal, A., Sereda, M.W., Garratt, A.N., Muller, T., Wende, H., 
Stassart, R.M., Nawaz, S., Humml, C., Velanac, V., et al. (2008). Neuregulin-1/ErbB 
signaling serves distinct functions in myelination of the peripheral and central 
nervous system. Neuron 59, 581-595. 
Brosamle, C., and Halpern, M.E. (2002). Characterization of myelination in the 
developing zebrafish. Glia 39, 47-57. 
Bruck, W. (2005). The pathology of multiple sclerosis is the result of focal 
inflammatory demyelination with axonal damage. Journal of neurology 252 Suppl 5, 
v3-9. 
Brunner, C., Lassmann, H., Waehneldt, T.V., Matthieu, J.M., and Linington, C. (1989). 
Differential ultrastructural localization of myelin basic protein, 
myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-
phosphodiesterase in the CNS of adult rats. Journal of neurochemistry 52, 296-304. 
Buch, T., Heppner, F.L., Tertilt, C., Heinen, T.J., Kremer, M., Wunderlich, F.T., Jung, 
S., and Waisman, A. (2005). A Cre-inducible diphtheria toxin receptor mediates cell 
lineage ablation after toxin administration. Nature methods 2, 419-426. 
Buckley, C.E., Goldsmith, P., and Franklin, R.J. (2008). Zebrafish myelination: a 
transparent model for remyelination? Disease models & mechanisms 1, 221-228. 
Buckley, C.E., Marguerie, A., Roach, A.G., Goldsmith, P., Fleming, A., Alderton, W.K., 
and Franklin, R.J. (2010). Drug reprofiling using zebrafish identifies novel 
compounds with potential pro-myelination effects. Neuropharmacology 59, 149-
159. 
Cai, J., Qi, Y., Hu, X., Tan, M., Liu, Z., Zhang, J., Li, Q., Sander, M., and Qiu, M. (2005). 
Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord 
independent of Nkx6 regulation and Shh signaling. Neuron 45, 41-53. 
Caillava, C., Vandenbosch, R., Jablonska, B., Deboux, C., Spigoni, G., Gallo, V., 
Malgrange, B., and Baron-Van Evercooren, A. (2011). Cdk2 loss accelerates 
precursor differentiation and remyelination in the adult central nervous system. The 
Journal of cell biology 193, 397-407. 
 
Page | 220  
 
Calabrese, M., Agosta, F., Rinaldi, F., Mattisi, I., Grossi, P., Favaretto, A., Atzori, M., 
Bernardi, V., Barachino, L., Rinaldi, L., et al. (2009). Cortical lesions and atrophy 
associated with cognitive impairment in relapsing-remitting multiple sclerosis. 
Archives of neurology 66, 1144-1150. 
Campbell, G.R., and Mahad, D.J. (2011). Mitochondria as crucial players in 
demyelinated axons: lessons from neuropathology and experimental 
demyelination. Autoimmune diseases 2011, 262847. 
Carbajal, K.S., Schaumburg, C., Strieter, R., Kane, J., and Lane, T.E. (2010). Migration 
of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a 
viral model of multiple sclerosis. Proceedings of the National Academy of Sciences 
of the United States of America 107, 11068-11073. 
Carre, J.L., Goetz, B.D., O'Connor, L.T., Bremer, Q., and Duncan, I.D. (2002). 
Mutations in the rat myelin basic protein gene are associated with specific 
alterations in other myelin gene expression. Neuroscience letters 330, 17-20. 
Catterall, W.A. (2012). Voltage-gated sodium channels at 60: structure, function and 
pathophysiology. The Journal of physiology 590, 2577-2589. 
Chang, A., Nishiyama, A., Peterson, J., Prineas, J., and Trapp, B.D. (2000). NG2-
positive oligodendrocyte progenitor cells in adult human brain and multiple 
sclerosis lesions. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 20, 6404-6412. 
Chang, A., Tourtellotte, W.W., Rudick, R., and Trapp, B.D. (2002). Premyelinating 
oligodendrocytes in chronic lesions of multiple sclerosis. The New England journal 
of medicine 346, 165-173. 
Chari, D.M., and Blakemore, W.F. (2002). Efficient recolonisation of progenitor-
depleted areas of the CNS by adult oligodendrocyte progenitor cells. Glia 37, 307-
313. 
Charles, P., Reynolds, R., Seilhean, D., Rougon, G., Aigrot, M.S., Niezgoda, A., Zalc, 
B., and Lubetzki, C. (2002). Re-expression of PSA-NCAM by demyelinated axons: an 
inhibitor of remyelination in multiple sclerosis? Brain : a journal of neurology 125, 
1972-1979. 
Chastain, E.M., and Miller, S.D. (2012). Molecular mimicry as an inducing trigger for 
CNS autoimmune demyelinating disease. Immunological reviews 245, 227-238. 
Chelur, D.S., and Chalfie, M. (2007). Targeted cell killing by reconstituted caspases. 
Proceedings of the National Academy of Sciences of the United States of America 
104, 2283-2288. 
Page | 221  
 
Chen, H., Chedotal, A., He, Z., Goodman, C.S., and Tessier-Lavigne, M. (1997). 
Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for 
the semaphorins Sema E and Sema IV but not Sema III. Neuron 19, 547-559. 
Cheraghali, A.M., Kumar, R., Knaus, E.E., and Wiebe, L.I. (1995). Pharmacokinetics 
and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-
ethoxy-5,6-dihydro prodrugs in mice. Drug metabolism and disposition: the 
biological fate of chemicals 23, 223-226. 
Cohen, J.A., Coles, A.J., Arnold, D.L., Confavreux, C., Fox, E.J., Hartung, H.P., 
Havrdova, E., Selmaj, K.W., Weiner, H.L., Fisher, E., et al. (2012). Alemtuzumab 
versus interferon beta 1a as first-line treatment for patients with relapsing-
remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 380, 
1819-1828. 
Cohen, N.R., Taylor, J.S., Scott, L.B., Guillery, R.W., Soriano, P., and Furley, A.J. 
(1998). Errors in corticospinal axon guidance in mice lacking the neural cell adhesion 
molecule L1. Current biology : CB 8, 26-33. 
Coles, A.J., Twyman, C.L., Arnold, D.L., Cohen, J.A., Confavreux, C., Fox, E.J., Hartung, 
H.P., Havrdova, E., Selmaj, K.W., Weiner, H.L., et al. (2012). Alemtuzumab for 
patients with relapsing multiple sclerosis after disease-modifying therapy: a 
randomised controlled phase 3 trial. Lancet 380, 1829-1839. 
Colman, D.R., Kreibich, G., Frey, A.B., and Sabatini, D.D. (1982). Synthesis and 
incorporation of myelin polypeptides into CNS myelin. The Journal of cell biology 95, 
598-608. 
Compston, A., and Coles, A. (2002). Multiple sclerosis. Lancet 359, 1221-1231. 
Compston, A., and Coles, A. (2008). Multiple sclerosis. Lancet 372, 1502-1517. 
Costenbader, K.H., Gay, S., Alarcon-Riquelme, M.E., Iaccarino, L., and Doria, A. 
(2012). Genes, epigenetic regulation and environmental factors: which is the most 
relevant in developing autoimmune diseases? Autoimmunity reviews 11, 604-609. 
Craner, M.J., Newcombe, J., Black, J.A., Hartle, C., Cuzner, M.L., and Waxman, S.G. 
(2004). Molecular changes in neurons in multiple sclerosis: altered axonal 
expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger. 
Proceedings of the National Academy of Sciences of the United States of America 
101, 8168-8173. 
Curado, S., Stainier, D.Y., and Anderson, R.M. (2008). Nitroreductase-mediated 
cell/tissue ablation in zebrafish: a spatially and temporally controlled ablation 
method with applications in developmental and regeneration studies. Nature 
protocols 3, 948-954. 
Page | 222  
 
Czepiel, M., Balasubramaniyan, V., Schaafsma, W., Stancic, M., Mikkers, H., 
Huisman, C., Boddeke, E., and Copray, S. (2011). Differentiation of induced 
pluripotent stem cells into functional oligodendrocytes. Glia 59, 882-892. 
Czopka, T., and Lyons, D.A. (2011). Dissecting mechanisms of myelinated axon 
formation using zebrafish. Methods in cell biology 105, 25-62. 
D'Urso, D., Ehrhardt, P., and Muller, H.W. (1999). Peripheral myelin protein 22 and 
protein zero: a novel association in peripheral nervous system myelin. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 19, 3396-3403. 
Dal Canto, M.C., and Lipton, H.L. (1975). Primary demyelination in Theiler's virus 
infection. An ultrastructural study. Laboratory investigation; a journal of technical 
methods and pathology 33, 626-637. 
Dal Canto, M.C., and Lipton, H.L. (1977). Multiple sclerosis. Animal model:Theiler's 
virus infection in mice. The American journal of pathology 88, 497-500. 
Davison, J.M., Akitake, C.M., Goll, M.G., Rhee, J.M., Gosse, N., Baier, H., Halpern, 
M.E., Leach, S.D., and Parsons, M.J. (2007). Transactivation from Gal4-VP16 
transgenic insertions for tissue-specific cell labeling and ablation in zebrafish. 
Developmental biology 304, 811-824. 
Dawson, M.R., Polito, A., Levine, J.M., and Reynolds, R. (2003). NG2-expressing glial 
progenitor cells: an abundant and widespread population of cycling cells in the 
adult rat CNS. Molecular and cellular neurosciences 24, 476-488. 
De Benedictis, L., Bizzoca, A., Corsi, P., Albieri, I., Consalez, G.G., and Gennarini, G. 
(2006). Activation profile of the F3/Contactin gene in the developing mouse 
cerebellum. Molecular and cellular neurosciences 32, 403-418. 
de Wit, J., Toonen, R.F., Verhaagen, J., and Verhage, M. (2006). Vesicular trafficking 
of semaphorin 3A is activity-dependent and differs between axons and dendrites. 
Traffic 7, 1060-1077. 
Debanne, D., Campanac, E., Bialowas, A., Carlier, E., and Alcaraz, G. (2011). Axon 
physiology. Physiological reviews 91, 555-602. 
Decker, L., Picard-Riera, N., Lachapelle, F., and Baron-Van Evercooren, A. (2002). 
Growth factor treatment promotes mobilization of young but not aged adult 
subventricular zone precursors in response to demyelination. Journal of 
neuroscience research 69, 763-771. 
Denic, A., Johnson, A.J., Bieber, A.J., Warrington, A.E., Rodriguez, M., and Pirko, I. 
(2011). The relevance of animal models in multiple sclerosis research. 
Pathophysiology : the official journal of the International Society for 
Pathophysiology / ISP 18, 21-29. 
Page | 223  
 
Devaux, J., and Gow, A. (2008). Tight junctions potentiate the insulative properties 
of small CNS myelinated axons. The Journal of cell biology 183, 909-921. 
Dougherty, K.D., Dreyfus, C.F., and Black, I.B. (2000). Brain-derived neurotrophic 
factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord 
injury. Neurobiology of disease 7, 574-585. 
Druskovic, M., Suput, D., and Milisav, I. (2006). Overexpression of caspase-9 triggers 
its activation and apoptosis in vitro. Croatian medical journal 47, 832-840. 
Duncan, I.D., Brower, A., Kondo, Y., Curlee, J.F., Jr., and Schultz, R.D. (2009). 
Extensive remyelination of the CNS leads to functional recovery. Proceedings of the 
National Academy of Sciences of the United States of America 106, 6832-6836. 
Dutton, K.A., Pauliny, A., Lopes, S.S., Elworthy, S., Carney, T.J., Rauch, J., Geisler, R., 
Haffter, P., and Kelsh, R.N. (2001). Zebrafish colourless encodes sox10 and specifies 
non-ectomesenchymal neural crest fates. Development 128, 4113-4125. 
Dziembowska, M., Tham, T.N., Lau, P., Vitry, S., Lazarini, F., and Dubois-Dalcq, M. 
(2005). A role for CXCR4 signaling in survival and migration of neural and 
oligodendrocyte precursors. Glia 50, 258-269. 
Easter, S.S., Jr., Bratton, B., and Scherer, S.S. (1984). Growth-related order of the 
retinal fiber layer in goldfish. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 4, 2173-2190. 
Easter, S.S., Jr., Rusoff, A.C., and Kish, P.E. (1981). The growth and organization of 
the optic nerve and tract in juvenile and adult goldfish. The Journal of neuroscience 
: the official journal of the Society for Neuroscience 1, 793-811. 
Edgar, J.M., McLaughlin, M., Werner, H.B., McCulloch, M.C., Barrie, J.A., Brown, A., 
Faichney, A.B., Snaidero, N., Nave, K.A., and Griffiths, I.R. (2009). Early 
ultrastructural defects of axons and axon-glia junctions in mice lacking expression of 
Cnp1. Glia 57, 1815-1824. 
Eichberg, J. (2002). Myelin P0: new knowledge and new roles. Neurochemical 
research 27, 1331-1340. 
Emery, B. (2010). Regulation of oligodendrocyte differentiation and myelination. 
Science 330, 779-782. 
England, J.D., Gamboni, F., Levinson, S.R., and Finger, T.E. (1990). Changed 
distribution of sodium channels along demyelinated axons. Proceedings of the 
National Academy of Sciences of the United States of America 87, 6777-6780. 
 
 
Page | 224  
 
Fancy, S.P., Baranzini, S.E., Zhao, C., Yuk, D.I., Irvine, K.A., Kaing, S., Sanai, N., 
Franklin, R.J., and Rowitch, D.H. (2009). Dysregulation of the Wnt pathway inhibits 
timely myelination and remyelination in the mammalian CNS. Genes & 
development 23, 1571-1585. 
Fancy, S.P., Chan, J.R., Baranzini, S.E., Franklin, R.J., and Rowitch, D.H. (2011). 
Myelin regeneration: a recapitulation of development? Annual review of 
neuroscience 34, 21-43. 
Fancy, S.P., Kotter, M.R., Harrington, E.P., Huang, J.K., Zhao, C., Rowitch, D.H., and 
Franklin, R.J. (2010). Overcoming remyelination failure in multiple sclerosis and 
other myelin disorders. Experimental neurology 225, 18-23. 
Fang, C., Bourdette, D., and Banker, G. (2012). Oxidative stress inhibits axonal 
transport: implications for neurodegenerative diseases. Molecular 
neurodegeneration 7, 29. 
Fausett, B.V., and Goldman, D. (2006). A role for alpha1 tubulin-expressing Muller 
glia in regeneration of the injured zebrafish retina. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 26, 6303-6313. 
Feldner, J. (2005). In vivo analysis of cell recognition molecules involved in axonal 
pathfinding of motor neurons in the trunk of embryonic zebrafish Danio rerio. In 
Biology (Hamburg: Universität Hamburg), pp. 118. 
Felts, P.A., and Smith, K.J. (1992). Conduction properties of central nerve fibers 
remyelinated by Schwann cells. Brain research 574, 178-192. 
Ferent, J., Zimmer, C., Durbec, P., Ruat, M., and Traiffort, E. (2013). Sonic Hedgehog 
Signaling Is a Positive Oligodendrocyte Regulator during Demyelination. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 33, 1759-1772. 
Ferguson, B., Matyszak, M.K., Esiri, M.M., and Perry, V.H. (1997). Axonal damage in 
acute multiple sclerosis lesions. Brain : a journal of neurology 120 ( Pt 3), 393-399. 
Fewou, S.N., Ramakrishnan, H., Bussow, H., Gieselmann, V., and Eckhardt, M. 
(2007). Down-regulation of polysialic acid is required for efficient myelin formation. 
The Journal of biological chemistry 282, 16700-16711. 
Ffrench-Constant, C., Miller, R.H., Burne, J.F., and Raff, M.C. (1988). Evidence that 
migratory oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells are kept out of 
the rat retina by a barrier at the eye-end of the optic nerve. Journal of 
neurocytology 17, 13-25. 
Fimbel, S.M., Montgomery, J.E., Burket, C.T., and Hyde, D.R. (2007). Regeneration of 
inner retinal neurons after intravitreal injection of ouabain in zebrafish. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 27, 1712-1724. 
Page | 225  
 
Findley, M.K., and Koval, M. (2009). Regulation and roles for claudin-family tight 
junction proteins. IUBMB life 61, 431-437. 
Flores, A.I., Narayanan, S.P., Morse, E.N., Shick, H.E., Yin, X., Kidd, G., Avila, R.L., 
Kirschner, D.A., and Macklin, W.B. (2008). Constitutively active Akt induces 
enhanced myelination in the CNS. The Journal of neuroscience : the official journal 
of the Society for Neuroscience 28, 7174-7183. 
Fogarty, M., Richardson, W.D., and Kessaris, N. (2005). A subset of oligodendrocytes 
generated from radial glia in the dorsal spinal cord. Development 132, 1951-1959. 
Foote, A.K., and Blakemore, W.F. (2005). Inflammation stimulates remyelination in 
areas of chronic demyelination. Brain : a journal of neurology 128, 528-539. 
Forte, M., Gold, B.G., Marracci, G., Chaudhary, P., Basso, E., Johnsen, D., Yu, X., 
Fowlkes, J., Rahder, M., Stem, K., et al. (2007). Cyclophilin D inactivation protects 
axons in experimental autoimmune encephalomyelitis, an animal model of multiple 
sclerosis. Proceedings of the National Academy of Sciences of the United States of 
America 104, 7558-7563. 
Foster, R.E., Kocsis, J.D., Malenka, R.C., and Waxman, S.G. (1980). Lysophosphatidyl 
choline-induced focal demyelination in the rabbit corpus callosum. Electron-
microscopic observations. Journal of the neurological sciences 48, 221-231. 
Franklin, R.J. (2002a). Remyelination of the demyelinated CNS: the case for and 
against transplantation of central, peripheral and olfactory glia. Brain research 
bulletin 57, 827-832. 
Franklin, R.J. (2002b). Why does remyelination fail in multiple sclerosis? Nature 
reviews Neuroscience 3, 705-714. 
Franklin, R.J., and Ffrench-Constant, C. (2008). Remyelination in the CNS: from 
biology to therapy. Nature reviews Neuroscience 9, 839-855. 
Franklin, R.J., ffrench-Constant, C., Edgar, J.M., and Smith, K.J. (2012). 
Neuroprotection and repair in multiple sclerosis. Nature reviews Neurology 8, 624-
634. 
Franklin, R.J., Gilson, J.M., and Blakemore, W.F. (1997). Local recruitment of 
remyelinating cells in the repair of demyelination in the central nervous system. 
Journal of neuroscience research 50, 337-344. 
Franklin, R.J., and Hinks, G.L. (1999). Understanding CNS remyelination: clues from 
developmental and regeneration biology. Journal of neuroscience research 58, 207-
213. 
Franklin, R.J., Zhao, C., and Sim, F.J. (2002). Ageing and CNS remyelination. 
Neuroreport 13, 923-928. 
Page | 226  
 
Fressinaud, C. (2005). Repeated injuries dramatically affect cells of the 
oligodendrocyte lineage: effects of PDGF and NT-3 in vitro. Glia 49, 555-566. 
Friese, M.A., and Fugger, L. (2009). Pathogenic CD8(+) T cells in multiple sclerosis. 
Annals of neurology 66, 132-141. 
Frost, E.E., Buttery, P.C., Milner, R., and ffrench-Constant, C. (1999). Integrins 
mediate a neuronal survival signal for oligodendrocytes. Current biology : CB 9, 
1251-1254. 
Funfschilling, U., Supplie, L.M., Mahad, D., Boretius, S., Saab, A.S., Edgar, J., 
Brinkmann, B.G., Kassmann, C.M., Tzvetanova, I.D., Mobius, W., et al. (2012). 
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 
485, 517-521. 
Gennarini, G., Cibelli, G., Rougon, G., Mattei, M.G., and Goridis, C. (1989). The 
mouse neuronal cell surface protein F3: a phosphatidylinositol-anchored member of 
the immunoglobulin superfamily related to chicken contactin. The Journal of cell 
biology 109, 775-788. 
Gensert, J.M., and Goldman, J.E. (1997). Endogenous progenitors remyelinate 
demyelinated axons in the adult CNS. Neuron 19, 197-203. 
Geren, B.B., and Schmitt, F.O. (1954). The Structure of the Schwann Cell and Its 
Relation to the Axon in Certain Invertebrate Nerve Fibers. Proceedings of the 
National Academy of Sciences of the United States of America 40, 863-870. 
Geretti, E., Shimizu, A., and Klagsbrun, M. (2008). Neuropilin structure governs 
VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11, 31-39. 
Ghasemlou, N., Jeong, S.Y., Lacroix, S., and David, S. (2007). T cells contribute to 
lysophosphatidylcholine-induced macrophage activation and demyelination in the 
CNS. Glia 55, 294-302. 
Giger, R.J., Cloutier, J.F., Sahay, A., Prinjha, R.K., Levengood, D.V., Moore, S.E., 
Pickering, S., Simmons, D., Rastan, S., Walsh, F.S., et al. (2000). Neuropilin-2 is 
required in vivo for selective axon guidance responses to secreted semaphorins. 
Neuron 25, 29-41. 
Gilmour, D.T., Maischein, H.M., and Nusslein-Volhard, C. (2002). Migration and 
function of a glial subtype in the vertebrate peripheral nervous system. Neuron 34, 
577-588. 
Gilson, J.M., and Blakemore, W.F. (2002). Schwann cell remyelination is not 
replaced by oligodendrocyte remyelination following ethidium bromide induced 
demyelination. Neuroreport 13, 1205-1208. 
Page | 227  
 
Givogri, M.I., Costa, R.M., Schonmann, V., Silva, A.J., Campagnoni, A.T., and 
Bongarzone, E.R. (2002). Central nervous system myelination in mice with deficient 
expression of Notch1 receptor. Journal of neuroscience research 67, 309-320. 
Glynn, P., and Linington, C. (1989). Cellular and molecular mechanisms of 
autoimmune demyelination in the central nervous system. Critical reviews in 
neurobiology 4, 367-385. 
Goldschmidt, T., Antel, J., Konig, F.B., Bruck, W., and Kuhlmann, T. (2009). 
Remyelination capacity of the MS brain decreases with disease chronicity. 
Neurology 72, 1914-1921. 
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M.H., 
Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998). Axonal 
swellings and degeneration in mice lacking the major proteolipid of myelin. Science 
280, 1610-1613. 
Grinspan, J. (2002). Cells and signaling in oligodendrocyte development. Journal of 
neuropathology and experimental neurology 61, 297-306. 
Grinspan, J.B., Reeves, M.F., Coulaloglou, M.J., Nathanson, D., and Pleasure, D. 
(1996). Re-entry into the cell cycle is required for bFGF-induced oligodendroglial 
dedifferentiation and survival. Journal of neuroscience research 46, 456-464. 
Grinspan, J.B., Stern, J.L., Franceschini, B., and Pleasure, D. (1993). Trophic effects of 
basic fibroblast growth factor (bFGF) on differentiated oligodendroglia: a 
mechanism for regeneration of the oligodendroglial lineage. Journal of 
neuroscience research 36, 672-680. 
Groves, A.K., Barnett, S.C., Franklin, R.J., Crang, A.J., Mayer, M., Blakemore, W.F., 
and Noble, M. (1993). Repair of demyelinated lesions by transplantation of purified 
O-2A progenitor cells. Nature 362, 453-455. 
Hagemeier, K., Bruck, W., and Kuhlmann, T. (2012). Multiple sclerosis - 
remyelination failure as a cause of disease progression. Histology and 
histopathology 27, 277-287. 
Hall, S.M. (1972). The effect of injections of lysophosphatidyl choline into white 
matter of the adult mouse spinal cord. Journal of cell science 10, 535-546. 
Hall, S.M. (1973). Some aspects of remyelination after demyelination produced by 
the intraneural injection of lysophosphatidyl choline. Journal of cell science 13, 461-
477. 
Hall, S.M., and Gregson, N.A. (1971). The in vivo and ultrastructural effects of 
injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the 
adult mouse. Journal of cell science 9, 769-789. 
Page | 228  
 
Hampton, D.W., Anderson, J., Pryce, G., Irvine, K.A., Giovannoni, G., Fawcett, J.W., 
Compston, A., Franklin, R.J., Baker, D., and Chandran, S. (2008). An experimental 
model of secondary progressive multiple sclerosis that shows regional variation in 
gliosis, remyelination, axonal and neuronal loss. Journal of neuroimmunology 201-
202, 200-211. 
Hampton, D.W., Innes, N., Merkler, D., Zhao, C., Franklin, R.J., and Chandran, S. 
(2012). Focal immune-mediated white matter demyelination reveals an age-
associated increase in axonal vulnerability and decreased remyelination efficiency. 
The American journal of pathology 180, 1897-1905. 
Hanafy, K.A., and Sloane, J.A. (2011). Regulation of remyelination in multiple 
sclerosis. FEBS letters 585, 3821-3828. 
Hao, J., Williams, C.H., Webb, M.E., and Hong, C.C. (2010). Large scale zebrafish-
based in vivo small molecule screen. Journal of visualized experiments : JoVE. 
Harrington, E.P., Zhao, C., Fancy, S.P., Kaing, S., Franklin, R.J., and Rowitch, D.H. 
(2010). Oligodendrocyte PTEN is required for myelin and axonal integrity, not 
remyelination. Annals of neurology 68, 703-716. 
Hartline, D.K., and Colman, D.R. (2007). Rapid conduction and the evolution of giant 
axons and myelinated fibers. Current biology : CB 17, R29-35. 
Hassen, G.W., Feliberti, J., Kesner, L., Stracher, A., and Mokhtarian, F. (2008). 
Prevention of axonal injury using calpain inhibitor in chronic progressive 
experimental autoimmune encephalomyelitis. Brain research 1236, 206-215. 
Hayasaka, K., Himoro, M., Sato, W., Takada, G., Uyemura, K., Shimizu, N., Bird, T.D., 
Conneally, P.M., and Chance, P.F. (1993). Charcot-Marie-Tooth neuropathy type 1B 
is associated with mutations of the myelin P0 gene. Nature genetics 5, 31-34. 
Hayashi, S., and McMahon, A.P. (2002). Efficient recombination in diverse tissues by 
a tamoxifen-inducible form of Cre: a tool for temporally regulated gene 
activation/inactivation in the mouse. Developmental biology 244, 305-318. 
He, Z., and Tessier-Lavigne, M. (1997). Neuropilin is a receptor for the axonal 
chemorepellent Semaphorin III. Cell 90, 739-751. 
Hendriks, J.J., Teunissen, C.E., de Vries, H.E., and Dijkstra, C.D. (2005). Macrophages 
and neurodegeneration. Brain research Brain research reviews 48, 185-195. 
Hong, C.C. (2009). Large-scale small-molecule screen using zebrafish embryos. 
Methods Mol Biol 486, 43-55. 
 
 
Page | 229  
 
Huang, J.K., Fancy, S.P., Zhao, C., Rowitch, D.H., Ffrench-Constant, C., and Franklin, 
R.J. (2011a). Myelin regeneration in multiple sclerosis: targeting endogenous stem 
cells. Neurotherapeutics : the journal of the American Society for Experimental 
NeuroTherapeutics 8, 650-658. 
Huang, J.K., and Franklin, R.J. (2011). Regenerative medicine in multiple sclerosis: 
identifying pharmacological targets of adult neural stem cell differentiation. 
Neurochemistry international 59, 329-332. 
Huang, J.K., Jarjour, A.A., Nait Oumesmar, B., Kerninon, C., Williams, A., Krezel, W., 
Kagechika, H., Bauer, J., Zhao, C., Evercooren, A.B., et al. (2011b). Retinoid X 
receptor gamma signaling accelerates CNS remyelination. Nature neuroscience 14, 
45-53. 
Huxley, A.F., and Stampfli, R. (1949). Evidence for saltatory conduction in peripheral 
myelinated nerve fibres. The Journal of physiology 108, 315-339. 
Inder, T.E., and Huppi, P.S. (2000). In vivo studies of brain development by magnetic 
resonance techniques. Mental retardation and developmental disabilities research 
reviews 6, 59-67. 
Ioannidou, K., Anderson, K.I., Strachan, D., Edgar, J.M., and Barnett, S.C. (2012). 
Time-lapse imaging of the dynamics of CNS glial-axonal interactions in vitro and ex 
vivo. PloS one 7, e30775. 
Irvine, K.A., and Blakemore, W.F. (2008). Remyelination protects axons from 
demyelination-associated axon degeneration. Brain : a journal of neurology 131, 
1464-1477. 
Jarjour, A.A., Zhang, H., Bauer, N., Ffrench-Constant, C., and Williams, A. (2012). In 
vitro modeling of central nervous system myelination and remyelination. Glia 60, 1-
12. 
Jepson, S., Vought, B., Gross, C.H., Gan, L., Austen, D., Frantz, J.D., Zwahlen, J., 
Lowe, D., Markland, W., and Krauss, R. (2012). LINGO-1, a transmembrane signaling 
protein, inhibits oligodendrocyte differentiation and myelination through 
intercellular self-interactions. The Journal of biological chemistry 287, 22184-22195. 
Jeserich, G., and Rauen, T. (1990). Cell cultures enriched in oligodendrocytes from 
the central nervous system of trout in terms of phenotypic expression exhibit 
parallels with cultured rat Schwann cells. Glia 3, 65-74. 
Ji, Q., and Goverman, J. (2007). Experimental autoimmune encephalomyelitis 
mediated by CD8+ T cells. Annals of the New York Academy of Sciences 1103, 157-
166. 
Page | 230  
 
John, G.R., Shankar, S.L., Shafit-Zagardo, B., Massimi, A., Lee, S.C., Raine, C.S., and 
Brosnan, C.F. (2002). Multiple sclerosis: re-expression of a developmental pathway 
that restricts oligodendrocyte maturation. Nature medicine 8, 1115-1121. 
Johns, T.G., and Bernard, C.C. (1999). The structure and function of myelin 
oligodendrocyte glycoprotein. Journal of neurochemistry 72, 1-9. 
Johnson, A.J., Suidan, G.L., McDole, J., and Pirko, I. (2007). The CD8 T cell in multiple 
sclerosis: suppressor cell or mediator of neuropathology? International review of 
neurobiology 79, 73-97. 
Joosten, E.A., and Gribnau, A.A. (1989). Immunocytochemical localization of cell 
adhesion molecule L1 in developing rat pyramidal tract. Neuroscience letters 100, 
94-98. 
Kabarowski, J.H., Xu, Y., and Witte, O.N. (2002). Lysophosphatidylcholine as a ligand 
for immunoregulation. Biochemical pharmacology 64, 161-167. 
Kang, S.H., Fukaya, M., Yang, J.K., Rothstein, J.D., and Bergles, D.E. (2010). NG2+ 
CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal 
life and following neurodegeneration. Neuron 68, 668-681. 
Katrych, O., Simone, T.M., Azad, S., and Mousa, S.A. (2009). Disease-modifying 
agents in the treatment of multiple sclerosis: a review of long-term outcomes. CNS 
& neurological disorders drug targets 8, 512-519. 
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., and Fujisawa, 
H. (1999). A requirement for neuropilin-1 in embryonic vessel formation. 
Development 126, 4895-4902. 
Kaya, F., Mannioui, A., Chesneau, A., Sekizar, S., Maillard, E., Ballagny, C., Houel-
Renault, L., Dupasquier, D., Bronchain, O., Holtzmann, I., et al. (2012). Live imaging 
of targeted cell ablation in Xenopus: a new model to study demyelination and 
repair. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 32, 12885-12895. 
Keirstead, H.S., and Blakemore, W.F. (1997). Identification of post-mitotic 
oligodendrocytes incapable of remyelination within the demyelinated adult spinal 
cord. Journal of neuropathology and experimental neurology 56, 1191-1201. 
Kelland, E.E., Gilmore, W., Weiner, L.P., and Lund, B.T. (2011). The dual role of 
CXCL8 in human CNS stem cell function: multipotent neural stem cell death and 
oligodendrocyte progenitor cell chemotaxis. Glia 59, 1864-1878. 
Kessler, O., Shraga-Heled, N., Lange, T., Gutmann-Raviv, N., Sabo, E., Baruch, L., 
Machluf, M., and Neufeld, G. (2004). Semaphorin-3F is an inhibitor of tumor 
angiogenesis. Cancer research 64, 1008-1015. 
Page | 231  
 
Kim, M.J., Kang, K.H., Kim, C.H., and Choi, S.Y. (2008). Real-time imaging of 
mitochondria in transgenic zebrafish expressing mitochondrially targeted GFP. 
BioTechniques 45, 331-334. 
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., and Schilling, T.F. (1995). 
Stages of embryonic development of the zebrafish. Developmental dynamics : an 
official publication of the American Association of Anatomists 203, 253-310. 
Kipp, M., van der Star, B., Vogel, D.Y.S., Puentes, F., van der Valk, P., Baker, D., and 
Amor, S. (2012). Experimental in vivo and in vitro models of multiple sclerosis: EAE 
and beyond. Multiple Sclerosis and Related Disorders, 15-28. 
Kirby, B.B., Takada, N., Latimer, A.J., Shin, J., Carney, T.J., Kelsh, R.N., and Appel, B. 
(2006). In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor 
behavior during zebrafish development. Nature neuroscience 9, 1506-1511. 
Kirschner, D.A., Inouye, H., Ganser, A.L., and Mann, V. (1989). Myelin membrane 
structure and composition correlated: a phylogenetic study. Journal of 
neurochemistry 53, 1599-1609. 
Kitagawa, K., Sinoway, M.P., Yang, C., Gould, R.M., and Colman, D.R. (1993). A 
proteolipid protein gene family: expression in sharks and rays and possible 
evolution from an ancestral gene encoding a pore-forming polypeptide. Neuron 11, 
433-448. 
Kizil, C., Kaslin, J., Kroehne, V., and Brand, M. (2012). Adult neurogenesis and brain 
regeneration in zebrafish. Developmental neurobiology 72, 429-461. 
Knapp, P.E., Bartlett, W.P., and Skoff, R.P. (1987). Cultured oligodendrocytes mimic 
in vivo phenotypic characteristics: cell shape, expression of myelin-specific antigens, 
and membrane production. Developmental biology 120, 356-365. 
Kolodkin, A.L. (1996). Semaphorins: mediators of repulsive growth cone guidance. 
Trends in cell biology 6, 15-22. 
Kolodkin, A.L., Levengood, D.V., Rowe, E.G., Tai, Y.T., Giger, R.J., and Ginty, D.D. 
(1997). Neuropilin is a semaphorin III receptor. Cell 90, 753-762. 
Kotter, M.R., Li, W.W., Zhao, C., and Franklin, R.J. (2006). Myelin impairs CNS 
remyelination by inhibiting oligodendrocyte precursor cell differentiation. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 26, 
328-332. 
Kotter, M.R., Setzu, A., Sim, F.J., Van Rooijen, N., and Franklin, R.J. (2001). 
Macrophage depletion impairs oligodendrocyte remyelination following 
lysolecithin-induced demyelination. Glia 35, 204-212. 
Page | 232  
 
Kotter, M.R., Zhao, C., van Rooijen, N., and Franklin, R.J. (2005). Macrophage-
depletion induced impairment of experimental CNS remyelination is associated with 
a reduced oligodendrocyte progenitor cell response and altered growth factor 
expression. Neurobiology of disease 18, 166-175. 
Kroehne, V., Freudenreich, D., Hans, S., Kaslin, J., and Brand, M. (2011). 
Regeneration of the adult zebrafish brain from neurogenic radial glia-type 
progenitors. Development 138, 4831-4841. 
Kucenas, S., Snell, H., and Appel, B. (2008). nkx2.2a promotes specification and 
differentiation of a myelinating subset of oligodendrocyte lineage cells in zebrafish. 
Neuron glia biology 4, 71-81. 
Kuhlmann, T., Lingfeld, G., Bitsch, A., Schuchardt, J., and Bruck, W. (2002). Acute 
axonal damage in multiple sclerosis is most extensive in early disease stages and 
decreases over time. Brain : a journal of neurology 125, 2202-2212. 
Kuhlmann, T., Miron, V., Cui, Q., Wegner, C., Antel, J., and Bruck, W. (2008). 
Differentiation block of oligodendroglial progenitor cells as a cause for 
remyelination failure in chronic multiple sclerosis. Brain : a journal of neurology 
131, 1749-1758. 
Kume, N., and Gimbrone, M.A., Jr. (1994). Lysophosphatidylcholine transcriptionally 
induces growth factor gene expression in cultured human endothelial cells. The 
Journal of clinical investigation 93, 907-911. 
Kyritsis, N., Kizil, C., Zocher, S., Kroehne, V., Kaslin, J., Freudenreich, D., Iltzsche, A., 
and Brand, M. (2012). Acute inflammation initiates the regenerative response in the 
adult zebrafish brain. Science 338, 1353-1356. 
Laeng, P., Molthagen, M., Yu, E.G., and Bartsch, U. (1996). Transplantation of 
oligodendrocyte progenitor cells into the rat retina: extensive myelination of retinal 
ganglion cell axons. Glia 18, 200-210. 
Lai, K., Kaspar, B.K., Gage, F.H., and Schaffer, D.V. (2003). Sonic hedgehog regulates 
adult neural progenitor proliferation in vitro and in vivo. Nature neuroscience 6, 21-
27. 
Lal-Nag, M., and Morin, P.J. (2009). The claudins. Genome biology 10, 235. 
Larochelle, C., Alvarez, J.I., and Prat, A. (2011). How do immune cells overcome the 
blood-brain barrier in multiple sclerosis? FEBS letters 585, 3770-3780. 
Lassmann, H., Bruck, W., Lucchinetti, C., and Rodriguez, M. (1997). Remyelination in 
multiple sclerosis. Mult Scler 3, 133-136. 
Page | 233  
 
Laursen, L.S., Chan, C.W., and ffrench-Constant, C. (2009). An integrin-contactin 
complex regulates CNS myelination by differential Fyn phosphorylation. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 29, 9174-9185. 
Laursen, L.S., Chan, C.W., and Ffrench-Constant, C. (2011). Translation of myelin 
basic protein mRNA in oligodendrocytes is regulated by integrin activation and 
hnRNP-K. The Journal of cell biology 192, 797-811. 
Lee, K.K., de Repentigny, Y., Saulnier, R., Rippstein, P., Macklin, W.B., and Kothary, 
R. (2006). Dominant-negative beta1 integrin mice have region-specific myelin 
defects accompanied by alterations in MAPK activity. Glia 53, 836-844. 
Lee, X., Yang, Z., Shao, Z., Rosenberg, S.S., Levesque, M., Pepinsky, R.B., Qiu, M., 
Miller, R.H., Chan, J.R., and Mi, S. (2007). NGF regulates the expression of axonal 
LINGO-1 to inhibit oligodendrocyte differentiation and myelination. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 27, 220-225. 
Lee, Y., Morrison, B.M., Li, Y., Lengacher, S., Farah, M.H., Hoffman, P.N., Liu, Y., 
Tsingalia, A., Jin, L., Zhang, P.W., et al. (2012). Oligodendroglia metabolically support 
axons and contribute to neurodegeneration. Nature 487, 443-448. 
Lendahl, U., Zimmerman, L.B., and McKay, R.D. (1990). CNS stem cells express a new 
class of intermediate filament protein. Cell 60, 585-595. 
Li, C., Trapp, B., Ludwin, S., Peterson, A., and Roder, J. (1998). Myelin associated 
glycoprotein modulates glia-axon contact in vivo. Journal of neuroscience research 
51, 210-217. 
Li, C., Tropak, M.B., Gerlai, R., Clapoff, S., Abramow-Newerly, W., Trapp, B., 
Peterson, A., and Roder, J. (1994). Myelination in the absence of myelin-associated 
glycoprotein. Nature 369, 747-750. 
Li, H., de Faria, J.P., Andrew, P., Nitarska, J., and Richardson, W.D. (2011). 
Phosphorylation regulates OLIG2 cofactor choice and the motor neuron-
oligodendrocyte fate switch. Neuron 69, 918-929. 
Li, H., Lu, Y., Smith, H.K., and Richardson, W.D. (2007). Olig1 and Sox10 interact 
synergistically to drive myelin basic protein transcription in oligodendrocytes. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 27, 
14375-14382. 
Liang, X., Draghi, N.A., and Resh, M.D. (2004). Signaling from integrins to Fyn to Rho 
family GTPases regulates morphologic differentiation of oligodendrocytes. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 24, 
7140-7149. 
 
Page | 234  
 
Lieberoth, B.C., Becker, C.G., and Becker, T. (2003). Double labeling of neurons by 
retrograde axonal tracing and non-radioactive in situ hybridization in the CNS of 
adult zebrafish. Methods in cell science : an official journal of the Society for In Vitro 
Biology 25, 65-70. 
Liebetanz, D., and Merkler, D. (2006). Effects of commissural de- and remyelination 
on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. 
Experimental neurology 202, 217-224. 
Lindvall, O., and Kokaia, Z. (2010). Stem cells in human neurodegenerative 
disorders--time for clinical translation? The Journal of clinical investigation 120, 29-
40. 
Linker, R.A., Lee, D.H., Demir, S., Wiese, S., Kruse, N., Siglienti, I., Gerhardt, E., 
Neumann, H., Sendtner, M., Luhder, F., et al. (2010). Functional role of brain-
derived neurotrophic factor in neuroprotective autoimmunity: therapeutic 
implications in a model of multiple sclerosis. Brain : a journal of neurology 133, 
2248-2263. 
Lipton, H.L. (1975). Theiler's virus infection in mice: an unusual biphasic disease 
process leading to demyelination. Infection and immunity 11, 1147-1155. 
Loh, Y.H., Christoffels, A., Brenner, S., Hunziker, W., and Venkatesh, B. (2004). 
Extensive expansion of the claudin gene family in the teleost fish, Fugu rubripes. 
Genome research 14, 1248-1257. 
Loulier, K., Ruat, M., and Traiffort, E. (2006). Increase of proliferating 
oligodendroglial progenitors in the adult mouse brain upon Sonic hedgehog delivery 
in the lateral ventricle. Journal of neurochemistry 98, 530-542. 
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H. 
(1999). A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A 
study of 113 cases. Brain : a journal of neurology 122 ( Pt 12), 2279-2295. 
Ludwin, S.K. (1978). Central nervous system demyelination and remyelination in the 
mouse: an ultrastructural study of cuprizone toxicity. Laboratory investigation; a 
journal of technical methods and pathology 39, 597-612. 
Lyons, D.A., Pogoda, H.M., Voas, M.G., Woods, I.G., Diamond, B., Nix, R., Arana, N., 
Jacobs, J., and Talbot, W.S. (2005). erbb3 and erbb2 are essential for schwann cell 
migration and myelination in zebrafish. Current biology : CB 15, 513-524. 
Machold, R., Hayashi, S., Rutlin, M., Muzumdar, M.D., Nery, S., Corbin, J.G., Gritli-
Linde, A., Dellovade, T., Porter, J.A., Rubin, L.L., et al. (2003). Sonic hedgehog is 
required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 
39, 937-950. 
Page | 235  
 
Macklin, W.B., Campagnoni, C.W., Deininger, P.L., and Gardinier, M.V. (1987). 
Structure and expression of the mouse myelin proteolipid protein gene. Journal of 
neuroscience research 18, 383-394. 
Mallet, V.O., Mitchell, C., Guidotti, J.E., Jaffray, P., Fabre, M., Spencer, D., Arnoult, 
D., Kahn, A., and Gilgenkrantz, H. (2002). Conditional cell ablation by tight control of 
caspase-3 dimerization in transgenic mice. Nature biotechnology 20, 1234-1239. 
Manrique-Hoyos, N., Jurgens, T., Gronborg, M., Kreutzfeldt, M., Schedensack, M., 
Kuhlmann, T., Schrick, C., Bruck, W., Urlaub, H., Simons, M., et al. (2012). Late motor 
decline after accomplished remyelination: impact for progressive multiple sclerosis. 
Annals of neurology 71, 227-244. 
Martini, R., Mohajeri, M.H., Kasper, S., Giese, K.P., and Schachner, M. (1995). Mice 
doubly deficient in the genes for P0 and myelin basic protein show that both 
proteins contribute to the formation of the major dense line in peripheral nerve 
myelin. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 15, 4488-4495. 
Marz, M., Schmidt, R., Rastegar, S., and Strahle, U. (2010). Expression of the 
transcription factor Olig2 in proliferating cells in the adult zebrafish telencephalon. 
Developmental dynamics : an official publication of the American Association of 
Anatomists 239, 3336-3349. 
Matsushima, G.K., and Morell, P. (2001). The neurotoxicant, cuprizone, as a model 
to study demyelination and remyelination in the central nervous system. Brain 
Pathol 11, 107-116. 
McKay, R. (1997). Stem cells in the central nervous system. Science 276, 66-71. 
McMurray, H.F., Parthasarathy, S., and Steinberg, D. (1993). Oxidatively modified 
low density lipoprotein is a chemoattractant for human T lymphocytes. The Journal 
of clinical investigation 92, 1004-1008. 
Menn, B., Garcia-Verdugo, J.M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., and 
Alvarez-Buylla, A. (2006). Origin of oligodendrocytes in the subventricular zone of 
the adult brain. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 26, 7907-7918. 
Mi, S., Hu, B., Hahm, K., Luo, Y., Kam Hui, E.S., Yuan, Q., Wong, W.M., Wang, L., Su, 
H., Chu, T.H., et al. (2007). LINGO-1 antagonist promotes spinal cord remyelination 
and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. 
Nature medicine 13, 1228-1233. 
Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B., Relton, J., Levesque, M., Allaire, N., Perrin, S., 
Sands, B., et al. (2004). LINGO-1 is a component of the Nogo-66 receptor/p75 
signaling complex. Nature neuroscience 7, 221-228. 
Page | 236  
 
Mi, S., Miller, R.H., Lee, X., Scott, M.L., Shulag-Morskaya, S., Shao, Z., Chang, J., Thill, 
G., Levesque, M., Zhang, M., et al. (2005). LINGO-1 negatively regulates myelination 
by oligodendrocytes. Nature neuroscience 8, 745-751. 
Mi, S., Miller, R.H., Tang, W., Lee, X., Hu, B., Wu, W., Zhang, Y., Shields, C.B., Miklasz, 
S., Shea, D., et al. (2009). Promotion of central nervous system remyelination by 
induced differentiation of oligodendrocyte precursor cells. Annals of neurology 65, 
304-315. 
Miller, D.J., Duka, T., Stimpson, C.D., Schapiro, S.J., Baze, W.B., McArthur, M.J., 
Fobbs, A.J., Sousa, A.M., Sestan, N., Wildman, D.E., et al. (2012). Prolonged 
myelination in human neocortical evolution. Proceedings of the National Academy 
of Sciences of the United States of America 109, 16480-16485. 
Mirsky, R., Woodhoo, A., Parkinson, D.B., Arthur-Farraj, P., Bhaskaran, A., and 
Jessen, K.R. (2008). Novel signals controlling embryonic Schwann cell development, 
myelination and dedifferentiation. Journal of the peripheral nervous system : JPNS 
13, 122-135. 
Miyamoto, T., Morita, K., Takemoto, D., Takeuchi, K., Kitano, Y., Miyakawa, T., 
Nakayama, K., Okamura, Y., Sasaki, H., Miyachi, Y., et al. (2005). Tight junctions in 
Schwann cells of peripheral myelinated axons: a lesson from claudin-19-deficient 
mice. The Journal of cell biology 169, 527-538. 
Monk, K.R., Naylor, S.G., Glenn, T.D., Mercurio, S., Perlin, J.R., Dominguez, C., 
Moens, C.B., and Talbot, W.S. (2009). A G protein-coupled receptor is essential for 
Schwann cells to initiate myelination. Science 325, 1402-1405. 
Monk, K.R., Oshima, K., Jors, S., Heller, S., and Talbot, W.S. (2011). Gpr126 is 
essential for peripheral nerve development and myelination in mammals. 
Development 138, 2673-2680. 
Montag, D., Giese, K.P., Bartsch, U., Martini, R., Lang, Y., Bluthmann, H., 
Karthigasan, J., Kirschner, D.A., Wintergerst, E.S., Nave, K.A., et al. (1994). Mice 
deficient for the myelin-associated glycoprotein show subtle abnormalities in 
myelin. Neuron 13, 229-246. 
Morcos, Y., and Chan-Ling, T. (1997). Identification of oligodendrocyte precursors in 
the myelinated streak of the adult rabbit retina in vivo. Glia 21, 163-182. 
Münzel, E.J., Schaefer, K., Obirei, B., Kremmer, E., Burton, E.A., Kuscha, V., Becker, 
C.G., Brosamle, C., Williams, A., and Becker, T. (2012). Claudin k is specifically 
expressed in cells that form myelin during development of the nervous system and 
regeneration of the optic nerve in adult zebrafish. Glia 60, 253-270. 
 
Page | 237  
 
Murray, P.D., McGavern, D.B., Sathornsumetee, S., and Rodriguez, M. (2001). 
Spontaneous remyelination following extensive demyelination is associated with 
improved neurological function in a viral model of multiple sclerosis. Brain : a 
journal of neurology 124, 1403-1416. 
Nait-Oumesmar, B., Decker, L., Lachapelle, F., Avellana-Adalid, V., Bachelin, C., and 
Baron-Van Evercooren, A. (1999). Progenitor cells of the adult mouse subventricular 
zone proliferate, migrate and differentiate into oligodendrocytes after 
demyelination. The European journal of neuroscience 11, 4357-4366. 
Nait-Oumesmar, B., Picard-Riera, N., Kerninon, C., and Baron-Van Evercooren, A. 
(2008). The role of SVZ-derived neural precursors in demyelinating diseases: from 
animal models to multiple sclerosis. Journal of the neurological sciences 265, 26-31. 
Nait-Oumesmar, B., Picard-Riera, N., Kerninon, C., Decker, L., Seilhean, D., 
Hoglinger, G.U., Hirsch, E.C., Reynolds, R., and Baron-Van Evercooren, A. (2007). 
Activation of the subventricular zone in multiple sclerosis: evidence for early glial 
progenitors. Proceedings of the National Academy of Sciences of the United States 
of America 104, 4694-4699. 
Nave, K.A., Lai, C., Bloom, F.E., and Milner, R.J. (1987). Splice site selection in the 
proteolipid protein (PLP) gene transcript and primary structure of the DM-20 
protein of central nervous system myelin. Proceedings of the National Academy of 
Sciences of the United States of America 84, 5665-5669. 
Newbern, J., and Birchmeier, C. (2010). Nrg1/ErbB signaling networks in Schwann 
cell development and myelination. Seminars in cell & developmental biology 21, 
922-928. 
Nguyen, D., and Stangel, M. (2001). Expression of the chemokine receptors CXCR1 
and CXCR2 in rat oligodendroglial cells. Brain research Developmental brain 
research 128, 77-81. 
Nicholson, G.A., Valentijn, L.J., Cherryson, A.K., Kennerson, M.L., Bragg, T.L., 
DeKroon, R.M., Ross, D.A., Pollard, J.D., McLeod, J.G., Bolhuis, P.A., et al. (1994). A 
frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to 
pressure palsies. Nature genetics 6, 263-266. 
Noll, E., and Miller, R.H. (1993). Oligodendrocyte precursors originate at the ventral 
ventricular zone dorsal to the ventral midline region in the embryonic rat spinal 
cord. Development 118, 563-573. 
Nona, S. (1995). Regeneration in the Goldfish Visual System. In Webvision: The 
Organization of the Retina and Visual System, H. Kolb, E. Fernandez, and R. Nelson, 
eds. (Salt Lake City (UT)). 
Page | 238  
 
Nona, S.N. (1994). Regeneration in the Goldfish Visual System. In Webvision - The 
organisation of the retina and visual system, H. Kolb, Nelson, R., Fernandez, E., 
Jones, B.,, ed. 
Nona, S.N., Duncan, A., Stafford, C.A., Maggs, A., Jeserich, G., and Cronly-Dillon, J.R. 
(1992). Myelination of regenerated axons in goldfish optic nerve by Schwann cells. 
Journal of neurocytology 21, 391-401. 
Nona, S.N., Thomlinson, A.M., and Stafford, C.A. (1998). Temporary colonization of 
the site of lesion by macrophages is a prelude to the arrival of regenerated axons in 
injured goldfish optic nerve. Journal of neurocytology 27, 791-803. 
Noseworthy, J.H., Lucchinetti, C., Rodriguez, M., and Weinshenker, B.G. (2000). 
Multiple sclerosis. The New England journal of medicine 343, 938-952. 
O'Meara, R.W., Michalski, J.P., and Kothary, R. (2011). Integrin signaling in 
oligodendrocytes and its importance in CNS myelination. Journal of signal 
transduction 2011, 354091. 
Okita, C., Sato, M., and Schroeder, T. (2004). Generation of optimized yellow and 
red fluorescent proteins with distinct subcellular localization. BioTechniques 36, 
418-422, 424. 
Oleszak, E.L., Kuzmak, J., Good, R.A., and Platsoucas, C.D. (1995). Immunology of 
Theiler's murine encephalomyelitis virus infection. Immunologic research 14, 13-33. 
Omari, K.M., John, G., Lango, R., and Raine, C.S. (2006). Role for CXCR2 and CXCL1 
on glia in multiple sclerosis. Glia 53, 24-31. 
Omari, K.M., John, G.R., Sealfon, S.C., and Raine, C.S. (2005). CXC chemokine 
receptors on human oligodendrocytes: implications for multiple sclerosis. Brain : a 
journal of neurology 128, 1003-1015. 
Orentas, D.M., Hayes, J.E., Dyer, K.L., and Miller, R.H. (1999). Sonic hedgehog 
signaling is required during the appearance of spinal cord oligodendrocyte 
precursors. Development 126, 2419-2429. 
Owens, G.P., and Bennett, J.L. (2012). Trigger, pathogen, or bystander: the complex 
nexus linking Epstein- Barr virus and multiple sclerosis. Mult Scler 18, 1204-1208. 
Park, H.C., and Appel, B. (2003). Delta-Notch signaling regulates oligodendrocyte 
specification. Development 130, 3747-3755. 
Patel, J.R., McCandless, E.E., Dorsey, D., and Klein, R.S. (2010). CXCR4 promotes 
differentiation of oligodendrocyte progenitors and remyelination. Proceedings of 
the National Academy of Sciences of the United States of America 107, 11062-
11067. 
Page | 239  
 
Patel, P.I., Roa, B.B., Welcher, A.A., Schoener-Scott, R., Trask, B.J., Pentao, L., Snipes, 
G.J., Garcia, C.A., Francke, U., Shooter, E.M., et al. (1992). The gene for the 
peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease 
type 1A. Nature genetics 1, 159-165. 
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., 
Laursen, H., Sorensen, P.S., Bruck, W., Lucchinetti, C., and Lassmann, H. (2006). 
Remyelination is extensive in a subset of multiple sclerosis patients. Brain : a journal 
of neurology 129, 3165-3172. 
Penderis, J., Shields, S.A., and Franklin, R.J. (2003). Impaired remyelination and 
depletion of oligodendrocyte progenitors does not occur following repeated 
episodes of focal demyelination in the rat central nervous system. Brain : a journal 
of neurology 126, 1382-1391. 
Pepinsky, R.B., Walus, L., Shao, Z., Ji, B., Gu, S., Sun, Y., Wen, D., Lee, X., Wang, Q., 
Garber, E., et al. (2011). Production of a PEGylated Fab' of the anti-LINGO-1 Li33 
antibody and assessment of its biochemical and functional properties in vitro and in 
a rat model of remyelination. Bioconjugate chemistry 22, 200-210. 
Perier, O., and Gregoire, A. (1965). Electron microscopic features of multiple 
sclerosis lesions. Brain : a journal of neurology 88, 937-952. 
Pfeiffer, S.E., Warrington, A.E., and Bansal, R. (1993). The oligodendrocyte and its 
many cellular processes. Trends in cell biology 3, 191-197. 
Pfriem, A., Pylatiuk, C., Alshut, R., Ziegener, B., Schulz, S., and Bretthauer, G. (2012). 
A modular, low-cost robot for zebrafish handling. Conference proceedings :  Annual 
International Conference of the IEEE Engineering in Medicine and Biology Society 
IEEE Engineering in Medicine and Biology Society Conference 2012, 980-983. 
Piaton, G., Aigrot, M.S., Williams, A., Moyon, S., Tepavcevic, V., Moutkine, I., Gras, 
J., Matho, K.S., Schmitt, A., Soellner, H., et al. (2011). Class 3 semaphorins influence 
oligodendrocyte precursor recruitment and remyelination in adult central nervous 
system. Brain : a journal of neurology 134, 1156-1167. 
Piaton, G., Williams, A., Seilhean, D., and Lubetzki, C. (2009). Remyelination in 
multiple sclerosis. Progress in brain research 175, 453-464. 
Plucinska, G., Paquet, D., Hruscha, A., Godinho, L., Haass, C., Schmid, B., and 
Misgeld, T. (2012). In vivo imaging of disease-related mitochondrial dynamics in a 
vertebrate model system. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 32, 16203-16212. 
Pogoda, H.M., Sternheim, N., Lyons, D.A., Diamond, B., Hawkins, T.A., Woods, I.G., 
Bhatt, D.H., Franzini-Armstrong, C., Dominguez, C., Arana, N., et al. (2006). A genetic 
screen identifies genes essential for development of myelinated axons in zebrafish. 
Developmental biology 298, 118-131. 
Page | 240  
 
Poliak, S., Matlis, S., Ullmer, C., Scherer, S.S., and Peles, E. (2002). Distinct claudins 
and associated PDZ proteins form different autotypic tight junctions in myelinating 
Schwann cells. The Journal of cell biology 159, 361-372. 
Poss, K.D., Wilson, L.G., and Keating, M.T. (2002). Heart regeneration in zebrafish. 
Science 298, 2188-2190. 
Prayoonwiwat, N., and Rodriguez, M. (1993). The potential for oligodendrocyte 
proliferation during demyelinating disease. Journal of neuropathology and 
experimental neurology 52, 55-63. 
Prineas, J.W., and Connell, F. (1979). Remyelination in multiple sclerosis. Annals of 
neurology 5, 22-31. 
Pringle, N.P., Yu, W.P., Guthrie, S., Roelink, H., Lumsden, A., Peterson, A.C., and 
Richardson, W.D. (1996). Determination of neuroepithelial cell fate: induction of the 
oligodendrocyte lineage by ventral midline cells and sonic hedgehog. 
Developmental biology 177, 30-42. 
Pringproa, K., Rohn, K., Kummerfeld, M., Wewetzer, K., and Baumgartner, W. 
(2010). Theiler's murine encephalomyelitis virus preferentially infects immature 
stages of the murine oligodendrocyte precursor cell line BO-1 and blocks 
oligodendrocytic differentiation in vitro. Brain research 1327, 24-37. 
Puckett, C., Hudson, L., Ono, K., Friedrich, V., Benecke, J., Dubois-Dalcq, M., and 
Lazzarini, R.A. (1987). Myelin-specific proteolipid protein is expressed in myelinating 
Schwann cells but is not incorporated into myelin sheaths. Journal of neuroscience 
research 18, 511-518. 
Pugliatti, M., Sotgiu, S., and Rosati, G. (2002). The worldwide prevalence of multiple 
sclerosis. Clinical neurology and neurosurgery 104, 182-191. 
Qi, X., Lewin, A.S., Sun, L., Hauswirth, W.W., and Guy, J. (2007). Suppression of 
mitochondrial oxidative stress provides long-term neuroprotection in experimental 
optic neuritis. Investigative ophthalmology & visual science 48, 681-691. 
Qi, Y., Cai, J., Wu, Y., Wu, R., Lee, J., Fu, H., Rao, M., Sussel, L., Rubenstein, J., and 
Qiu, M. (2001). Control of oligodendrocyte differentiation by the Nkx2.2 
homeodomain transcription factor. Development 128, 2723-2733. 
Quintana, F.J., Iglesias, A.H., Farez, M.F., Caccamo, M., Burns, E.J., Kassam, N., 
Oukka, M., and Weiner, H.L. (2010). Adaptive autoimmunity and Foxp3-based 
immunoregulation in zebrafish. PloS one 5, e9478. 
Raff, M.C., Abney, E.R., and Fok-Seang, J. (1985). Reconstitution of a developmental 
clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte 
differentiation. Cell 42, 61-69. 
Page | 241  
 
Raff, M.C., Miller, R.H., and Noble, M. (1983). A glial progenitor cell that develops in 
vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 
303, 390-396. 
Raine, C.S., and Wu, E. (1993). Multiple sclerosis: remyelination in acute lesions. 
Journal of neuropathology and experimental neurology 52, 199-204. 
Ramachandran, R., Reifler, A., Parent, J.M., and Goldman, D. (2010). Conditional 
gene expression and lineage tracing of tuba1a expressing cells during zebrafish 
development and retina regeneration. The Journal of comparative neurology 518, 
4196-4212. 
Ramachandran, R., Reifler, A., Wan, J., and Goldman, D. (2012). Application of Cre-
loxP recombination for lineage tracing of adult zebrafish retinal stem cells. Methods 
Mol Biol 884, 129-140. 
Ranscht, B. (1988). Sequence of contactin, a 130-kD glycoprotein concentrated in 
areas of interneuronal contact, defines a new member of the immunoglobulin 
supergene family in the nervous system. The Journal of cell biology 107, 1561-1573. 
Rao, M.S. (1999). Multipotent and restricted precursors in the central nervous 
system. The Anatomical record 257, 137-148. 
Raphael, A.R., and Talbot, W.S. (2011). New insights into signaling during 
myelination in zebrafish. Current topics in developmental biology 97, 1-19. 
Rash, J.E. (2010). Molecular disruptions of the panglial syncytium block potassium 
siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and 
other demyelinating diseases of the central nervous system. Neuroscience 168, 982-
1008. 
Readhead, C., Takasashi, N., Shine, H.D., Saavedra, R., Sidman, R., and Hood, L. 
(1990). Role of myelin basic protein in the formation of central nervous system 
myelin. Annals of the New York Academy of Sciences 605, 280-285. 
Redwine, J.M., and Armstrong, R.C. (1998). In vivo proliferation of oligodendrocyte 
progenitors expressing PDGFalphaR during early remyelination. Journal of 
neurobiology 37, 413-428. 
Reimer, M.M., Sorensen, I., Kuscha, V., Frank, R.E., Liu, C., Becker, C.G., and Becker, 
T. (2008). Motor neuron regeneration in adult zebrafish. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 28, 8510-8516. 
Reynolds, R., Roncaroli, F., Nicholas, R., Radotra, B., Gveric, D., and Howell, O. 
(2011). The neuropathological basis of clinical progression in multiple sclerosis. Acta 
neuropathologica 122, 155-170. 
Page | 242  
 
Richardson, W.D., Kessaris, N., and Pringle, N. (2006). Oligodendrocyte wars. Nature 
reviews Neuroscience 7, 11-18. 
Richardson, W.D., Young, K.M., Tripathi, R.B., and McKenzie, I. (2011). NG2-glia as 
multipotent neural stem cells: fact or fantasy? Neuron 70, 661-673. 
Ritchie, J.M., and Rogart, R.B. (1977). Density of sodium channels in mammalian 
myelinated nerve fibers and nature of the axonal membrane under the myelin 
sheath. Proceedings of the National Academy of Sciences of the United States of 
America 74, 211-215. 
Roa, B.B., Garcia, C.A., Pentao, L., Killian, J.M., Trask, B.J., Suter, U., Snipes, G.J., 
Ortiz-Lopez, R., Shooter, E.M., Patel, P.I., et al. (1993). Evidence for a recessive 
PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nature genetics 5, 
189-194. 
Rong, J.X., Berman, J.W., Taubman, M.B., and Fisher, E.A. (2002). 
Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene 
expression in rat aortic smooth muscle cells. Arteriosclerosis, thrombosis, and 
vascular biology 22, 1617-1623. 
Roos, M., Schachner, M., and Bernhardt, R.R. (1999). Zebrafish semaphorin Z1b 
inhibits growing motor axons in vivo. Mechanisms of development 87, 103-117. 
Rothenaigner, I., Krecsmarik, M., Hayes, J.A., Bahn, B., Lepier, A., Fortin, G., Gotz, 
M., Jagasia, R., and Bally-Cuif, L. (2011). Clonal analysis by distinct viral vectors 
identifies bona fide neural stem cells in the adult zebrafish telencephalon and 
characterizes their division properties and fate. Development 138, 1459-1469. 
Ruckh, J.M., Zhao, J.W., Shadrach, J.L., van Wijngaarden, P., Rao, T.N., Wagers, A.J., 
and Franklin, R.J. (2012). Rejuvenation of regeneration in the aging central nervous 
system. Cell stem cell 10, 96-103. 
Rus, H., Cudrici, C., David, S., and Niculescu, F. (2006). The complement system in 
central nervous system diseases. Autoimmunity 39, 395-402. 
Saavedra, R.A., Fors, L., Aebersold, R.H., Arden, B., Horvath, S., Sanders, J., and 
Hood, L. (1989). The myelin proteins of the shark brain are similar to the myelin 
proteins of the mammalian peripheral nervous system. Journal of molecular 
evolution 29, 149-156. 
Sabo, J.K., Aumann, T.D., Merlo, D., Kilpatrick, T.J., and Cate, H.S. (2011). 
Remyelination is altered by bone morphogenic protein signaling in demyelinated 
lesions. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 31, 4504-4510. 
Page | 243  
 
Saher, G., Brugger, B., Lappe-Siefke, C., Mobius, W., Tozawa, R., Wehr, M.C., 
Wieland, F., Ishibashi, S., and Nave, K.A. (2005). High cholesterol level is essential 
for myelin membrane growth. Nature neuroscience 8, 468-475. 
Sato, T., Takahoko, M., and Okamoto, H. (2006). HuC:Kaede, a useful tool to label 
neural morphologies in networks in vivo. Genesis 44, 136-142. 
Schaefer, K. (2009). Characterization of two novel myelin proteins. In Fakultät für 
Chemie und Pharmazie (Munich: Ludwig-Maximilians-Universtität München), pp. 
124. 
Schweitzer, J., Becker, T., Becker, C.G., and Schachner, M. (2003). Expression of 
protein zero is increased in lesioned axon pathways in the central nervous system of 
adult zebrafish. Glia 41, 301-317. 
Schweitzer, J., Becker, T., Schachner, M., Nave, K.A., and Werner, H. (2006). 
Evolution of myelin proteolipid proteins: gene duplication in teleosts and expression 
pattern divergence. Molecular and cellular neurosciences 31, 161-177. 
Schweitzer, J., Gimnopoulos, D., Lieberoth, B.C., Pogoda, H.M., Feldner, J., Ebert, A., 
Schachner, M., Becker, T., and Becker, C.G. (2007). Contactin1a expression is 
associated with oligodendrocyte differentiation and axonal regeneration in the 
central nervous system of zebrafish. Molecular and cellular neurosciences 35, 194-
207. 
See, J.M., and Grinspan, J.B. (2009). Sending mixed signals: bone morphogenetic 
protein in myelination and demyelination. Journal of neuropathology and 
experimental neurology 68, 595-604. 
Segovia, K.N., McClure, M., Moravec, M., Luo, N.L., Wan, Y., Gong, X., Riddle, A., 
Craig, A., Struve, J., Sherman, L.S., et al. (2008). Arrested oligodendrocyte lineage 
maturation in chronic perinatal white matter injury. Annals of neurology 63, 520-
530. 
Setzu, A., Ffrench-Constant, C., and Franklin, R.J. (2004). CNS axons retain their 
competence for myelination throughout life. Glia 45, 307-311. 
Setzu, A., Lathia, J.D., Zhao, C., Wells, K., Rao, M.S., Ffrench-Constant, C., and 
Franklin, R.J. (2006). Inflammation stimulates myelination by transplanted 
oligodendrocyte precursor cells. Glia 54, 297-303. 
Sharma, A., Verhaagen, J., and Harvey, A.R. (2012). Receptor complexes for each of 
the Class 3 Semaphorins. Frontiers in cellular neuroscience 6, 28. 
Sheikh, A.M., Nagai, A., Ryu, J.K., McLarnon, J.G., Kim, S.U., and Masuda, J. (2009). 
Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia 57, 898-
907. 
Page | 244  
 
Sherman, D.L., and Brophy, P.J. (2005). Mechanisms of axon ensheathment and 
myelin growth. Nature reviews Neuroscience 6, 683-690. 
Shields, S.A., Gilson, J.M., Blakemore, W.F., and Franklin, R.J. (1999). Remyelination 
occurs as extensively but more slowly in old rats compared to young rats following 
gliotoxin-induced CNS demyelination. Glia 28, 77-83. 
Shin, J., Park, H.C., Topczewska, J.M., Mawdsley, D.J., and Appel, B. (2003). Neural 
cell fate analysis in zebrafish using olig2 BAC transgenics. Methods in cell science : 
an official journal of the Society for In Vitro Biology 25, 7-14. 
Sim, F.J., Zhao, C., Penderis, J., and Franklin, R.J. (2002). The age-related decrease in 
CNS remyelination efficiency is attributable to an impairment of both 
oligodendrocyte progenitor recruitment and differentiation. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 22, 2451-2459. 
Simmons, T., and Appel, B. (2012). Mutation of pescadillo disrupts oligodendrocyte 
formation in zebrafish. PloS one 7, e32317. 
Sloane, J.A., Batt, C., Ma, Y., Harris, Z.M., Trapp, B., and Vartanian, T. (2010). 
Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination 
through TLR2. Proceedings of the National Academy of Sciences of the United States 
of America 107, 11555-11560. 
Smith, G.S., Samborska, B., Hawley, S.P., Klaiman, J.M., Gillis, T.E., Jones, N., Boggs, 
J.M., and Harauz, G. (2013). Nucleus-localized 21.5-kDa myelin basic protein 
promotes oligodendrocyte proliferation and enhances neurite outgrowth in 
coculture, unlike the plasma membrane-associated 18.5-kDa isoform. Journal of 
neuroscience research 91, 349-362. 
Smith, K.J. (2007). Sodium channels and multiple sclerosis: roles in symptom 
production, damage and therapy. Brain Pathol 17, 230-242. 
Sobottka, B., Ziegler, U., Kaech, A., Becher, B., and Goebels, N. (2011). CNS live 
imaging reveals a new mechanism of myelination: the liquid croissant model. Glia 
59, 1841-1849. 
Sommer, I., and Schachner, M. (1981). Monoclonal antibodies (O1 to O4) to 
oligodendrocyte cell surfaces: an immunocytological study in the central nervous 
system. Developmental biology 83, 311-327. 
Spassky, N., de Castro, F., Le Bras, B., Heydon, K., Queraud-LeSaux, F., Bloch-
Gallego, E., Chedotal, A., Zalc, B., and Thomas, J.L. (2002). Directional guidance of 
oligodendroglial migration by class 3 semaphorins and netrin-1. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 22, 5992-6004. 
Page | 245  
 
Spomer, W., Pfriem, A., Alshut, R., Just, S., and Pylatiuk, C. (2012). High-throughput 
screening of zebrafish embryos using automated heart detection and imaging. 
Journal of laboratory automation 17, 435-442. 
Sriram, S. (2011). Role of glial cells in innate immunity and their role in CNS 
demyelination. Journal of neuroimmunology 239, 13-20. 
Stackley, K.D., Beeson, C.C., Rahn, J.J., and Chan, S.S. (2011). Bioenergetic profiling 
of zebrafish embryonic development. PloS one 6, e25652. 
Stadelmann, C., and Bruck, W. (2008). Interplay between mechanisms of damage 
and repair in multiple sclerosis. Journal of neurology 255 Suppl 1, 12-18. 
Steelman, A.J., Thompson, J.P., and Li, J. (2012). Demyelination and remyelination in 
anatomically distinct regions of the corpus callosum following cuprizone 
intoxication. Neuroscience research 72, 32-42. 
Stolt, C.C., Rehberg, S., Ader, M., Lommes, P., Riethmacher, D., Schachner, M., 
Bartsch, U., and Wegner, M. (2002). Terminal differentiation of myelin-forming 
oligodendrocytes depends on the transcription factor Sox10. Genes & development 
16, 165-170. 
Stone, L.A., Frank, J.A., Albert, P.S., Bash, C., Smith, M.E., Maloni, H., and McFarland, 
H.F. (1995). The effect of interferon-beta on blood-brain barrier disruptions 
demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-
remitting multiple sclerosis. Annals of neurology 37, 611-619. 
Stratmann, A., and Jeserich, G. (1995). Molecular cloning and tissue expression of a 
cDNA encoding IP1--a P0-like glycoprotein of trout CNS myelin. Journal of 
neurochemistry 64, 2427-2436. 
Stys, P.K., Waxman, S.G., and Ransom, B.R. (1991). Na(+)-Ca2+ exchanger mediates 
Ca2+ influx during anoxia in mammalian central nervous system white matter. 
Annals of neurology 30, 375-380. 
Stys, P.K., Zamponi, G.W., van Minnen, J., and Geurts, J.J. (2012). Will the real 
multiple sclerosis please stand up? Nature reviews Neuroscience 13, 507-514. 
Su, K.G., Banker, G., Bourdette, D., and Forte, M. (2009). Axonal degeneration in 
multiple sclerosis: the mitochondrial hypothesis. Current neurology and 
neuroscience reports 9, 411-417. 
Sugimoto, Y., Taniguchi, M., Yagi, T., Akagi, Y., Nojyo, Y., and Tamamaki, N. (2001). 
Guidance of glial precursor cell migration by secreted cues in the developing optic 
nerve. Development 128, 3321-3330. 
Page | 246  
 
Swanborg, R.H. (2001). Experimental autoimmune encephalomyelitis in the rat: 
lessons in T-cell immunology and autoreactivity. Immunological reviews 184, 129-
135. 
Takada, N., and Appel, B. (2010). Identification of genes expressed by zebrafish 
oligodendrocytes using a differential microarray screen. Developmental dynamics : 
an official publication of the American Association of Anatomists 239, 2041-2047. 
Takada, N., Kucenas, S., and Appel, B. (2010). Sox10 is necessary for 
oligodendrocyte survival following axon wrapping. Glia 58, 996-1006. 
Targett, M.P., Sussman, J., Scolding, N., O'Leary, M.T., Compston, D.A., and 
Blakemore, W.F. (1996). Failure to achieve remyelination of demyelinated rat axons 
following transplantation of glial cells obtained from the adult human brain. 
Neuropathology and applied neurobiology 22, 199-206. 
Tasaki, I. (1939). The electro-saltatory transmission of the nerve impulse and the 
effect of narcosis upton the nerve fiber. Am J Physiol 127, 211-227. 
Taveggia, C., Thaker, P., Petrylak, A., Caporaso, G.L., Toews, A., Falls, D.L., Einheber, 
S., and Salzer, J.L. (2008). Type III neuregulin-1 promotes oligodendrocyte 
myelination. Glia 56, 284-293. 
Tawk, M., Makoukji, J., Belle, M., Fonte, C., Trousson, A., Hawkins, T., Li, H., 
Ghandour, S., Schumacher, M., and Massaad, C. (2011). Wnt/beta-catenin signaling 
is an essential and direct driver of myelin gene expression and myelinogenesis. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 31, 
3729-3742. 
Tegla, C.A., Cudrici, C., Rozycka, M., Soloviova, K., Ito, T., Singh, A.K., Khan, A., 
Azimzadeh, P., Andrian-Albescu, M., Niculescu, F., et al. (2011). C5b-9-activated, 
K(v)1.3 channels mediate oligodendrocyte cell cycle activation and 
dedifferentiation. Experimental and molecular pathology 91, 335-345. 
Teitelbaum, D., Aharoni, R., Klinger, E., Kreitman, R., Raymond, E., Malley, A., Shofti, 
R., Sela, M., and Arnon, R. (2004). Oral glatiramer acetate in experimental 
autoimmune encephalomyelitis: clinical and immunological studies. Annals of the 
New York Academy of Sciences 1029, 239-249. 
Theiler, M. (1934). Spontaneous Encephalomyelitis of Mice--a New Virus Disease. 
Science 80, 122. 
Thomas, J.L., Spassky, N., Perez Villegas, E.M., Olivier, C., Cobos, I., Goujet-Zalc, C., 
Martinez, S., and Zalc, B. (2000). Spatiotemporal development of oligodendrocytes 
in the embryonic brain. Journal of neuroscience research 59, 471-476. 
Thornberry, N.A., and Lazebnik, Y. (1998). Caspases: enemies within. Science 281, 
1312-1316. 
Page | 247  
 
Trapp, B.D., Andrews, S.B., Cootauco, C., and Quarles, R. (1989). The myelin-
associated glycoprotein is enriched in multivesicular bodies and periaxonal 
membranes of actively myelinating oligodendrocytes. The Journal of cell biology 
109, 2417-2426. 
Trapp, B.D., Ransohoff, R., and Rudick, R. (1999). Axonal pathology in multiple 
sclerosis: relationship to neurologic disability. Current opinion in neurology 12, 295-
302. 
Trojano, M., Paolicelli, D., Tortorella, C., Iaffaldano, P., Lucchese, G., Di Renzo, V., 
and D'Onghia, M. (2011). Natural history of multiple sclerosis: have available 
therapies impacted long-term prognosis? Neurologic clinics 29, 309-321. 
Tse, C., Xiang, R.H., Bracht, T., and Naylor, S.L. (2002). Human Semaphorin 3B 
(SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an 
adenocarcinoma cell line. Cancer research 62, 542-546. 
Tsunoda, I., and Fujinami, R.S. (2010). Neuropathogenesis of Theiler's murine 
encephalomyelitis virus infection, an animal model for multiple sclerosis. Journal of 
neuroimmune pharmacology : the official journal of the Society on NeuroImmune 
Pharmacology 5, 355-369. 
Vallstedt, A., Klos, J.M., and Ericson, J. (2005). Multiple dorsoventral origins of 
oligodendrocyte generation in the spinal cord and hindbrain. Neuron 45, 55-67. 
van den Pol, A.N., and Kim, W.T. (1993). NILE/L1 and NCAM-polysialic acid 
expression on growing axons of isolated neurons. The Journal of comparative 
neurology 332, 237-257. 
van Noort, J.M., Baker, D., and Amor, S. (2012). Mechanisms in the development of 
multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factors. 
CNS & neurological disorders drug targets 11, 556-569. 
Vandenberg, J.I., and Waxman, S.G. (2012). Hodgkin and Huxley and the basis for 
electrical signalling: a remarkable legacy still going strong. The Journal of physiology 
590, 2569-2570. 
Velumian, A.A., Samoilova, M., and Fehlings, M.G. (2011). Visualization of 
cytoplasmic diffusion within living myelin sheaths of CNS white matter axons using 
microinjection of the fluorescent dye Lucifer Yellow. NeuroImage 56, 27-34. 
Vercellino, M., Masera, S., Lorenzatti, M., Condello, C., Merola, A., Mattioda, A., 
Tribolo, A., Capello, E., Mancardi, G.L., Mutani, R., et al. (2009). Demyelination, 
inflammation, and neurodegeneration in multiple sclerosis deep gray matter. 
Journal of neuropathology and experimental neurology 68, 489-502. 
Virchow, R. (1854). Über das ausgebreitete Vorkommen einer dem Nervenmark 
analogen Substanz in den tierischen Geweben. Virchows Arch Pathol Anat, 562-572. 
Page | 248  
 
Waehneldt, T.V. (1990). Phylogeny of myelin proteins. Annals of the New York 
Academy of Sciences 605, 15-28. 
Waehneldt, T.V., Matthieu, J.M., and Jeserich, G. (1986). Appearance of Myelin 
proteins during vertebrate evolution. Neurochemistry international 9, 463-474. 
Wang, J., Hamm, R.J., and Povlishock, J.T. (2011a). Traumatic axonal injury in the 
optic nerve: evidence for axonal swelling, disconnection, dieback, and 
reorganization. Journal of neurotrauma 28, 1185-1198. 
Wang, J., Panakova, D., Kikuchi, K., Holdway, J.E., Gemberling, M., Burris, J.S., Singh, 
S.P., Dickson, A.L., Lin, Y.F., Sabeh, M.K., et al. (2011b). The regenerative capacity of 
zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. 
Development 138, 3421-3430. 
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., 
Studer, L., Hochedlinger, K., Windrem, M., et al. (2013). Human iPSC-Derived 
Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of 
Congenital Hypomyelination. Cell stem cell 12, 252-264. 
Wang, S., Sdrulla, A.D., diSibio, G., Bush, G., Nofziger, D., Hicks, C., Weinmaster, G., 
and Barres, B.A. (1998). Notch receptor activation inhibits oligodendrocyte 
differentiation. Neuron 21, 63-75. 
Warf, B.C., Fok-Seang, J., and Miller, R.H. (1991). Evidence for the ventral origin of 
oligodendrocyte precursors in the rat spinal cord. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 11, 2477-2488. 
Waxman, S.G., Kocsis, J.D., and Nitta, K.C. (1979). Lysophosphatidyl choline-induced 
focal demyelination in the rabbit corpus callosum. Light-microscopic observations. 
Journal of the neurological sciences 44, 45-53. 
Waxman, S.G., and Ritchie, J.M. (1985). Organization of ion channels in the 
myelinated nerve fiber. Science 228, 1502-1507. 
Westerfield, M. (1995). The zebrafish book (Eugene, OR: University of Oregon 
Press). 
White, Y.A., Woods, D.C., and Wood, A.W. (2011). A transgenic zebrafish model of 
targeted oocyte ablation and de novo oogenesis. Developmental dynamics : an 
official publication of the American Association of Anatomists 240, 1929-1937. 
Wilkins, A., Chandran, S., and Compston, A. (2001). A role for oligodendrocyte-
derived IGF-1 in trophic support of cortical neurons. Glia 36, 48-57. 
 
 
Page | 249  
 
Wilkins, A., Majed, H., Layfield, R., Compston, A., and Chandran, S. (2003). 
Oligodendrocytes promote neuronal survival and axonal length by distinct 
intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-
derived neurotrophic factor. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 23, 4967-4974. 
Williams, A., Piaton, G., Aigrot, M.S., Belhadi, A., Theaudin, M., Petermann, F., 
Thomas, J.L., Zalc, B., and Lubetzki, C. (2007). Semaphorin 3A and 3F: key players in 
myelin repair in multiple sclerosis? Brain : a journal of neurology 130, 2554-2565. 
Wolburg, H. (1978). Growth and myelination of goldfish optic nerve fibers after 
retina regeneration and nerve crush. Zeitschrift fur Naturforschung Section C: 
Biosciences 33, 988-996. 
Wolburg, H. (1980). Myelinated axons of ganglion cells in the retinae of teleosts. 
Cell and tissue research 210, 517-520. 
Wolburg, H. (1981). Myelination and remyelination in the regenerating visual 
system of the goldfish. Experimental brain research Experimentelle Hirnforschung 
Experimentation cerebrale 43, 199-206. 
Wolswijk, G. (1998). Chronic stage multiple sclerosis lesions contain a relatively 
quiescent population of oligodendrocyte precursor cells. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 18, 601-609. 
Wolswijk, G. (2002). Oligodendrocyte precursor cells in the demyelinated multiple 
sclerosis spinal cord. Brain : a journal of neurology 125, 338-349. 
Woodruff, R.H., and Franklin, R.J. (1999). Demyelination and remyelination of the 
caudal cerebellar peduncle of adult rats following stereotaxic injections of 
lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a 
comparative study. Glia 25, 216-228. 
Wu, G.F., and Alvarez, E. (2011). The immunopathophysiology of multiple sclerosis. 
Neurologic clinics 29, 257-278. 
Wulf, P., Bernhardt, R.R., and Suter, U. (1999). Characterization of peripheral myelin 
protein 22 in zebrafish (zPMP22) suggests an early role in the development of the 
peripheral nervous system. Journal of neuroscience research 57, 467-478. 
Wyatt, C., Ebert, A., Reimer, M.M., Rasband, K., Hardy, M., Chien, C.B., Becker, T., 
and Becker, C.G. (2010). Analysis of the astray/robo2 zebrafish mutant reveals that 
degenerating tracts do not provide strong guidance cues for regenerating optic 
axons. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 30, 13838-13849. 
Page | 250  
 
Yang, P., Peairs, J.J., Tano, R., Zhang, N., Tyrell, J., and Jaffe, G.J. (2007). Caspase-8-
mediated apoptosis in human RPE cells. Investigative ophthalmology & visual 
science 48, 3341-3349. 
Yasuhara, T., Shingo, T., Muraoka, K., Kameda, M., Agari, T., Wenji, Y., Hishikawa, T., 
Matsui, T., Miyoshi, Y., Kimura, T., et al. (2005). Toxicity of semaphorin3A for 
dopaminergic neurons. Neuroscience letters 382, 61-65. 
Ye, F., Chen, Y., Hoang, T., Montgomery, R.L., Zhao, X.H., Bu, H., Hu, T., Taketo, 
M.M., van Es, J.H., Clevers, H., et al. (2009). HDAC1 and HDAC2 regulate 
oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. 
Nature neuroscience 12, 829-838. 
Yoshida, M., and Colman, D.R. (1996). Parallel evolution and coexpression of the 
proteolipid proteins and protein zero in vertebrate myelin. Neuron 16, 1115-1126. 
Yuan, L., Moyon, D., Pardanaud, L., Breant, C., Karkkainen, M.J., Alitalo, K., and 
Eichmann, A. (2002). Abnormal lymphatic vessel development in neuropilin 2 
mutant mice. Development 129, 4797-4806. 
Zawadzka, M., Rivers, L.E., Fancy, S.P., Zhao, C., Tripathi, R., Jamen, F., Young, K., 
Goncharevich, A., Pohl, H., Rizzi, M., et al. (2010). CNS-resident glial 
progenitor/stem cells produce Schwann cells as well as oligodendrocytes during 
repair of CNS demyelination. Cell stem cell 6, 578-590. 
Zhang, H., Jarjour, A.A., Boyd, A., and Williams, A. (2011). Central nervous system 
remyelination in culture--a tool for multiple sclerosis research. Experimental 
neurology 230, 138-148. 
Zhang, H., Vutskits, L., Calaora, V., Durbec, P., and Kiss, J.Z. (2004). A role for the 
polysialic acid-neural cell adhesion molecule in PDGF-induced chemotaxis of 
oligodendrocyte precursor cells. Journal of cell science 117, 93-103. 
Zhang, Y., Argaw, A.T., Gurfein, B.T., Zameer, A., Snyder, B.J., Ge, C., Lu, Q.R., 
Rowitch, D.H., Raine, C.S., Brosnan, C.F., et al. (2009). Notch1 signaling plays a role 
in regulating precursor differentiation during CNS remyelination. Proceedings of the 
National Academy of Sciences of the United States of America 106, 19162-19167. 
Zhang, Y., Zhang, J., Navrazhina, K., Argaw, A.T., Zameer, A., Gurfein, B.T., Brosnan, 
C.F., and John, G.R. (2010). TGFbeta1 induces Jagged1 expression in astrocytes via 
ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor 
proliferation and differentiation. Glia 58, 964-974. 
Zhang, Y.W., Denham, J., and Thies, R.S. (2006). Oligodendrocyte progenitor cells 
derived from human embryonic stem cells express neurotrophic factors. Stem cells 
and development 15, 943-952. 
Page | 251  
 
Zhou, W., and Hildebrandt, F. (2012). Inducible podocyte injury and proteinuria in 
transgenic zebrafish. Journal of the American Society of Nephrology : JASN 23, 
1039-1047. 
Zhou, Y., Gunput, R.A., and Pasterkamp, R.J. (2008). Semaphorin signaling: progress 
made and promises ahead. Trends in biochemical sciences 33, 161-170. 
Zhu, X., Hill, R.A., Dietrich, D., Komitova, M., Suzuki, R., and Nishiyama, A. (2011). 
Age-dependent fate and lineage restriction of single NG2 cells. Development 138, 
745-753. 
Zuo, H., and Nishiyama, A. (2013). Polydendrocytes in development and myelin 
repair. Neuroscience bulletin 29, 165-176. 
 
 
